MetLife Annual Report 2005

Plain-text annual report

Chairman’s Letter To MetLife’s Shareholders: In 1998, MetLife announced that it would create a new financial services holding company and raise capital through an initial public offering of common stock. Through this IPO, we fueled the company’s growth and created an enterprise that, today, addresses shifting demographics in the United States and abroad through MetLife’s best-in-class products and services. The tasks and requirements associated with such a successful transformation were certainly very challenging but, now more than five years after becoming a public company, the results of our efforts are evident: since 2000, total assets have increased 90%; premiums, fees and other revenues are up 55%; life insurance in-force is up 65%; and MetLife’s market capitalization is now more than three times what it was in April 2000. In 2005 alone, MetLife’s achievements and growth were equally impressive. Not only did we announce, close and integrate our acquisition of Travelers Life & Annuity, substantially all of Citigroup Inc.’s international insurance businesses and CitiStreet Associates (collectively, Travelers) in ten months, we once again generated record financial results. It is with great pride that, in my last letter to you as chairman of the board, I can report to you, our shareholders, that 2005 marked MetLife’s fourth consecutive year of record net income growth. In 2005, MetLife earned $6.16 per diluted common share in net income available to common shareholders, a 69% increase over 2004’s results. Amid modest equity market performance and rising interest rates, MetLife’s premiums, fees and other revenues reached $30 billion, a 14% increase over 2004. In addition, total assets grew 35%, in large part due to the Travelers acquisition, to reach $482 billion. Meeting our business objectives and closing and integrating the Travelers acquisition were aggressive, but equally crucial goals. However, the results of our efforts are clear: record financial results, a seamless integration of the Travelers businesses and—perhaps most important—the demonstration that MetLife is a company that delivers on its promises. Record Business Performance H During the year, our diversified businesses performed extremely well, both financially and operationally, as they achieved record net income and contributed to MetLife’s growth and expansion. Institutional Business continued to demonstrate and reinforce its market leadership as it grew net income by 23% over 2004’s results. MetLife remains a leader in the group product area and, according to LIMRA and MetLife Market Research, continues to hold the number one ranking in sales of group life, auto and home, long-term care and disability products, as well as institutional annuities and structured settlements. While generating record sales growth in multiple product lines, Institutional also introduced a new long-term care product and improved efficiencies by holding expenses at 2004 levels. All of this was accomplished while integrating the Travelers retirement business, which increased MetLife’s retirement and savings general account assets by 62%. Institutional also continues to focus on both growing and maintaining its market share. It has reorganized its product groups to better align with customers’ needs and placed a renewed emphasis on service, which both our customers and distributors identify as an important differentiator in our business. On the retail side, Individual Business (IB) net income increased 70% as the segment grew life sales faster than the industry, retained agents at record levels and improved distribution profitability by more than 20%. During the year, IB’s distribution network continued to diversify and grow, particularly in independent distribution channels. While managing Travelers integration work, IB reorganized its independent distribution channels to better serve client needs; redesigned the life and annuity product portfolio; restructured the operations platform for the independent channel and realigned its affiliated distribution network and offered new products. These new product offerings included new living benefits for MetLife’s variable annuities, including the Guaranteed Minimum Accumulation Benefit rider and an enhancement to the Guaranteed Minimum Income Benefit rider, as well as a new suite of universal life insurance products. In addition to ensuring that MetLife is taking advantage of shifting demographics and growing multicultural markets, IB continues to further its retail growth strategy of focusing on the needs of both clients and distributors in order to drive profitability. Auto & Home net income was up 8% in 2005 over the prior year. Despite the impact of some of the most destructive hurricanes in history and other catastrophes, new business sales grew 16% over 2004, customer retention grew and the non-catastrophe combined ratio improved from 90.4% in 2004 to 86.7% in 2005. During 2005, Auto & Home launched a new product, GrandProtect, a comprehen- sive ‘‘package’’ policy that provides personal insurance protection for consumers with complex insurance needs. In addition, MetLife Auto & Home was ranked one of the top companies for delivering customer satisfaction to homeowners in J.D. Power and Associates’ annual 2005 National Homeowners Insurance Satisfaction Study. Adding to our growth in the marketplace was MetLife Bank, which grew deposits by 61% to reach $4.3 billion at the end of 2005. In addition, MetLife Bank introduced residential mortgages as it took steps towards becoming an increasingly important contributor to MetLife’s overall success. In International, net income increased 18% over the prior year, driven in large part by the acquisition of Travelers’ international businesses. This acquisition significantly increased MetLife’s presence in markets outside of the United States and gave us access to new countries, including Australia, Belgium, Japan, Poland and the United Kingdom. Today, MetLife has access to 71% of the world’s life insurance markets, up from 36% in 2004. At the same time, the transaction increased MetLife’s number of customers outside of the U.S. from 9 million to 15 million and also added new distribution capabilities. In addition to the U.S., MetLife now holds lead ing market positions in Japan, Mexico and South Korea. As MetLife seeks opportunities for growth in the future, we will continue to tap a shifting and diverse marketplace beyond the borders of the U.S., in countries where we see the potential to grow and expand. MetLife demonstrated again in 2005 that it has the ability to create shareholder value. During the year, book value increased 19% over 2004 to $35.83 per diluted common share. MetLife also increased its common stock dividend 13% over 2004 to $0.52 per common share. Moving Ahead H In 2005, MetLife celebrated its fifth anniversary as a public company and its 137th year of providing financial solutions for generations of individuals and their families. It was also a very special year for me, as it marked my last full year as the head of this outstanding organization. And while 2006 will be another evolutionary year for MetLife, filled with new beginnings, one thing that will remain a constant is MetLife’s commitment to offering the best products and services that our customers can rely on for their lifetimes. This company is extremely well positioned to continue to achieve great things and I can’t think of anyone more experienced than Rob Henrikson to take MetLife to the next level among the giant league of financial services companies. I wish all of you and all of my colleagues at MetLife the very best. Sincerely, Robert H. Benmosche Chairman of the Board MetLife, Inc. February 28, 2006 TABLE OF CONTENTS Note Regarding Forward-Looking Statements ****************************************************************************** Selected Financial Data ************************************************************************************************ Management’s Discussion and Analysis of Financial Condition and Results of Operations ***************************************** Quantitative and Qualitative Disclosures About Market Risk******************************************************************* Changes in and Disagreements With Accountants on Accounting and Financial Disclosure**************************************** Management’s Annual Report on Internal Control Over Financial Reporting****************************************************** Attestation Report of the Company’s Registered Public Accounting Firm******************************************************** Financial Statements*************************************************************************************************** Board of Directors***************************************************************************************************** Executive Ofﬁcers ***************************************************************************************************** Corporate Information ************************************************************************************************** Page Number 2 2 5 53 57 57 57 59 60 60 61 MetLife, Inc. 1 Note Regarding Forward-Looking Statements This Annual Report, including the Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in the operations and ﬁnancial results and the business and the products of MetLife, Inc. (the ‘‘Holding Company’’) and its subsidiaries (collectively, ‘‘MetLife’’ or the ‘‘Company’’), as well as other statements including words such as ‘‘anticipate,’’ ‘‘believe,’’ ‘‘plan,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘intend’’ and other similar expressions. Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects on MetLife, Inc. and its subsidiaries. Such forward-looking statements are not guarantees of future performance. See ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations.’’ Selected Financial Data The following tables set forth selected consolidated ﬁnancial information for the Company. The selected consolidated ﬁnancial information for the years ended December 31, 2005, 2004 and 2003, and at December 31, 2005 and 2004 has been derived from the Company’s audited consolidated ﬁnancial statements included elsewhere herein. The selected consolidated ﬁnancial information for the years ended December 31, 2002 and 2001 and at December 31, 2003, 2002 and 2001 has been derived from the Company’s audited consolidated ﬁnancial statements not included elsewhere herein. The following information should be read in conjunction with and is qualiﬁed in its entirety by the information contained in ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations,’’ and the consolidated ﬁnancial statements appearing elsewhere herein. Some previously reported amounts have been reclassiﬁed to conform with the presentation at and for the year ended December 31, 2005. 2005 2004 2003 2002 2001 Years Ended December 31, (In millions) Statements of Income Data(1) Revenues: Premiums ************************************************************* $24,860 Universal life and investment-type product policy fees ************************ 3,828 Net investment income(2) ************************************************ 14,910 Other revenues ******************************************************** 1,271 Net investment gains (losses)(2)(3)(4) ************************************** (93) Total revenues(5)(6)(7)(8) ******************************************* 44,776 $22,200 2,867 12,364 1,198 175 $20,575 2,495 11,472 1,199 (551) $19,020 2,145 11,123 1,166 (895) $16,962 1,888 11,106 1,340 (713) 38,804 35,190 32,559 30,583 Expenses: Policyholder beneﬁts and claims ****************************************** Interest credited to policyholder account balances *************************** Policyholder dividends *************************************************** Other expenses(2) ****************************************************** Total expenses(5)(6)(7)(8)******************************************* Income from continuing operations before provision for income taxes ************* Provision for income taxes(2)(5)(6) ******************************************* Income from continuing operations ****************************************** Income from discontinued operations, net of income taxes(2)(5)(6) **************** Income before cumulative effect of a change in accounting, net of income taxes**** Cumulative effect of a change in accounting, net of income taxes **************** Net income************************************************************** Preferred stock dividends ************************************************** Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust ********************************************************* 25,506 3,925 1,679 9,267 40,377 4,399 1,260 3,139 1,575 4,714 — 4,714 63 — Net income available to common shareholders ******************************** $ 4,651 22,662 2,997 1,666 7,813 35,138 3,666 1,029 2,637 207 2,844 (86) 2,758 — 20,811 3,035 1,731 7,168 32,745 2,445 616 1,829 414 2,243 (26) 2,217 — 19,455 2,950 1,803 6,862 31,070 1,489 448 1,041 564 1,605 — 1,605 — — 21 — 18,329 3,084 1,802 6,894 30,109 474 170 304 169 473 — 473 — — $ 2,758 $ 2,196 $ 1,605 $ 473 2 MetLife, Inc. 2005 2004 2003 2002 2001 At December 31, (In millions) Balance Sheet Data(1) Assets: General account assets ******************************************** $353,776 Separate account assets******************************************* 127,869 Total assets(5)(6) ************************************************ $481,645 $270,039 86,769 $251,085 75,756 $217,733 59,693 $194,256 62,714 $356,808 $326,841 $277,426 $256,970 Liabilities: Life and health policyholder liabilities(9) ******************************* $258,881 Property and casualty policyholder liabilities**************************** 3,490 Short-term debt ************************************************** 1,414 Long-term debt *************************************************** 12,022 Other liabilities **************************************************** 48,868 Separate account liabilities ***************************************** 127,869 Total liabilities(5)(6)*********************************************** Company-obligated mandatorily redeemable securities of subsidiary trusts** 452,544 — $193,612 3,180 1,445 7,412 41,566 86,769 $177,947 2,943 3,642 5,703 39,701 75,756 $162,986 2,673 1,161 4,411 27,852 59,693 $148,598 2,610 355 3,614 21,761 62,714 333,984 305,692 258,776 239,652 — — 1,265 1,256 Stockholders’ Equity: Preferred stock, at par value(10)************************************* Common stock, at par value(10) ************************************ Additional paid-in capital(10) **************************************** Retained earnings(10)********************************************** Treasury stock, at cost(10) ***************************************** Accumulated other comprehensive income(10) ************************ Total stockholders’ equity***************************************** 29,101 Total liabilities and stockholders’ equity ***************************** $481,645 1 8 17,274 10,865 (959) 1,912 — 8 15,037 6,608 (1,785) 2,956 22,824 — 8 14,991 4,193 (835) 2,792 21,149 — 8 14,968 2,807 (2,405) 2,007 17,385 — 8 14,966 1,349 (1,934) 1,673 16,062 $356,808 $326,841 $277,426 $256,970 At or For the Years Ended December 31, 2005 2004 2003 2002 2001 (In millions, except per share data) Other Data(1) Net income available to common shareholders************************* $ Return on common equity(11)*************************************** Return on common equity, excluding accumulated other comprehensive income******************************************************** Income from Continuing Operations Per Common Share(1) Basic *********************************************************** $ Diluted ********************************************************** $ Income from Discontinued Operations Per Common Share(1) Basic *********************************************************** $ Diluted ********************************************************** $ Cumulative Effect of a Change in Accounting Per Common Share(1) Basic *********************************************************** $ Diluted ********************************************************** $ Net Income Available to Common Shareholders Per Common Share(1) Basic *********************************************************** $ Diluted ********************************************************** $ Dividends Declared Per Common Share(1) ************************* $ 4,651 $ 2,758 $ 2,196 $ 1,605 $ 18.5% 12.5% 11.4% 9.6% 20.4% 14.4% 13.0% 10.8% 4.19 4.16 2.10 2.09 — — 6.21 6.16 0.52 $ $ $ $ $ $ $ $ $ 3.51 3.49 0.28 0.27 (0.11) (0.11) 3.67 3.65 0.46 $ $ $ $ $ $ $ $ $ 2.45 2.42 0.56 0.55 (0.04) (0.03) 2.97 2.94 0.23 $ $ $ $ $ $ $ $ $ 1.48 1.43 0.80 0.77 $ $ $ $ — $ — $ 2.28 2.20 0.21 $ $ $ 473 2.9% 3.2% 0.41 0.40 0.23 0.22 — — 0.64 0.62 0.20 (1) On July 1, 2005, the Company acquired The Travelers Insurance Company (‘‘TIC’’), excluding certain assets, most signiﬁcantly, Primerica, from Citigroup Inc. (‘‘Citigroup’’), and substantially all of Citigroup’s international insurance businesses (collectively, ‘‘Travelers’’). The results of this acquisition are reﬂected in the 2005 selected ﬁnancial data. See ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations — Acquisitions and Dispositions.’’ MetLife, Inc. 3 (2) In accordance with Statement of Financial Accounting Standards (‘‘SFAS’’) No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (‘‘SFAS 144’’), income related to real estate sold or classiﬁed as held-for-sale for transactions initiated on or after January 1, 2002 is presented as discontinued operations. The following table presents the components of income from discontinued real estate operations (see footnotes 5 and 6): Years Ended December 31, 2005 2004 2003 2002 2001 (In millions) Investment income ********************************************** $ 140 Investment expense ********************************************* (82) Net investment gains (losses) ************************************* 2,125 Total revenues************************************************ Interest expense ************************************************ Provision for income taxes *************************************** 2,183 — 776 Income from discontinued operations, net of income taxes ********** $1,407 $ 409 (240) 146 315 13 105 $ 491 (279) 420 632 4 230 $ 644 (351) 585 878 — 319 $ 583 (338) — 245 1 89 $ 197 $ 398 $ 559 $ 155 (3) Net investment gains (losses) exclude amounts related to real estate operations reported as discontinued operations in accordance with SFAS 144. (4) Net investment gains (losses) presented include scheduled periodic settlement payments on derivative instruments that do not qualify for hedge accounting under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended, of $99 million, $51 million, $84 million, $32 million and $24 million for the years ended December 31, 2005, 2004, 2003, 2002 and 2001, respectively. Additionally, excluded from net investment gains (losses) for the year ended December 31, 2005 is ($13) million related to revaluation losses on derivatives used to hedge interest rate and currency risk on policyholder account balances that do not qualify for hedge accounting. (5) On September 29, 2005, the Company completed the sale of P.T. Sejahtera (‘‘MetLife Indonesia’’) to a third party. In accordance with SFAS 144, the assets, liabilities and operations of MetLife Indonesia have been reclassiﬁed into discontinued operations for all years presented. The following tables present the operations of MetLife Indonesia: Years Ended December 31, 2005 2004 2003 2002 2001 (In millions) Revenues from discontinued operations ************************************* Expenses from discontinued operations************************************** Income from discontinued operations, before provision for income taxes ********** (5) Provision for income taxes************************************************* — $ 5 10 Income (loss) from discontinued operations, net of income taxes*************** Net investment gains, net of income taxes *********************************** Income (loss) from discontinued operations, net of income taxes*************** (5) 10 $ 5 $ 5 14 (9) — (9) — $ 4 9 (5) — (5) — $ 5 8 (3) — (3) — $ 3 6 (3) — (3) — $(9) $(5) $(3) $(3) At December 31, 2004 2003 2002 2001 (In millions) General account assets ********************************************************** $31 Total assets ****************************************************************** $31 Life and health policyholder liabilities ************************************************ $24 Other liabilities ****************************************************************** 4 Total liabilities ***************************************************************** $28 $27 $27 $17 3 $20 $23 $23 $11 5 $16 $21 $21 $ 8 5 $13 (6) On January 31, 2005, the Company sold its wholly-owned subsidiary, SSRM Holdings, Inc. (‘‘SSRM’’), to a third party. In accordance with SFAS 144, the assets, liabilities and operations of SSRM have been reclassiﬁed into discontinued operations for all years presented. The following tables present the operations of SSRM: Revenues from discontinued operations ******************************** $ 19 Expenses from discontinued operations ******************************** 38 $328 296 $231 197 $239 225 $254 230 Income (loss) from discontinued operations, before provision (beneﬁt) for Years Ended December 31, 2005 2004 2003 2002 2001 (In millions) income taxes **************************************************** Provision (beneﬁt) for income taxes ************************************ Income (loss) from discontinued operations, net of income taxes ********* Net investment gains, net of income taxes****************************** (14) 177 Income from discontinued operations, net of income taxes ************** $163 (19) (5) 32 13 19 — 34 13 21 — 14 6 8 — 24 7 17 — $ 19 $ 21 $ 8 $ 17 4 MetLife, Inc. General account assets****************************************************** $379 Total assets ************************************************************** $379 $183 $183 $198 $198 $203 $203 At December 31, 2004 2003 2002 2001 (In millions) Short-term debt ************************************************************ $ 19 Long-term debt************************************************************* — Other liabilities ************************************************************** 221 Total liabilities************************************************************* $240 (7) Includes the following combined ﬁnancial statement data of Conning Corporation, which was sold in 2001: $ — $ — $ — 14 80 14 78 — 70 $ 70 $ 92 $ 94 Total revenues ********************************************************************************* Total expenses********************************************************************************* Year Ended December 31, 2001 (In millions) $32 $33 (8) As a result of this sale, an investment gain of $25 million was recorded for the year ended December 31, 2001. Included in total revenues and total expenses for the year ended December 31, 2002 are $421 million and $358 million, respectively, related to Aseguradora Hidalgo S.A., which was acquired in June 2002. (9) Policyholder liabilities include future policy beneﬁts and other policyholder funds. Life and health policyholder liabilities also include policyholder account balances, policyholder dividends payable and the policyholder dividend obligation. (10) For additional information regarding these items, see Notes 1 and 14 of Notes to Consolidated Financial Statements. (11) Return on common equity is deﬁned as net income available to common shareholders divided by average common stockholders’ equity. Management’s Discussion and Analysis of Financial Condition and Results of Operations For purposes of this discussion, the terms ‘‘MetLife’’ or the ‘‘Company’’ refer to MetLife, Inc., a Delaware corporation (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). Following this summary is a discussion addressing the consolidated results of operations and ﬁnancial condition of the Company for the periods indicated. This discussion should be read in conjunction with the Company’s consolidated ﬁnancial statements included elsewhere herein. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in the operations and ﬁnancial results and the business and the products of MetLife, Inc. and its subsidiaries, as well as other statements including words such as ‘‘anticipate,’’ ‘‘believe,’’ ‘‘plan,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘intend’’ and other similar expressions. Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Such forward-looking statements are not guarantees of future performance. Actual results may differ materially from those included in the forward-looking statements as a result of risks and uncertainties including, but not limited to, the following: (i) changes in general economic conditions, including the performance of ﬁnancial markets and interest rates; (ii) heightened competition, including with respect to pricing, entry of new competitors and the development of new products by new and existing competitors; (iii) unanticipated changes in industry trends; (iv) MetLife, Inc.’s primary reliance, as a holding company, on dividends from its subsidiaries to meet debt payment obligations and the applicable regulatory restrictions on the ability of the subsidiaries to pay such dividends; (v) deterioration in the experience of the ‘‘closed block’’ established in connection with the reorganization of Metropolitan Life; (vi) catastrophe losses; (vii) adverse results or other consequences from litigation, arbitration or regulatory investigations; (viii) regulatory, accounting or tax changes that may affect the cost of, or demand for, the Company’s products or services; (ix) downgrades in the Company’s and its afﬁliates’ claims paying ability, ﬁnancial strength or credit ratings; (x) changes in rating agency policies or practices; (xi) discrepancies between actual claims experience and assumptions used in setting prices for the Company’s products and establishing the liabilities for the Company’s obligations for future policy beneﬁts and claims; (xii) discrepancies between actual experience and assumptions used in establishing liabilities related to other contingencies or obligations; (xiii) the effects of business disruption or economic contraction due to terrorism or other hostilities; (xiv) the Company’s ability to identify and consummate on successful terms any future acquisitions, and to successfully integrate acquired businesses with minimal disruption; and (xv) other risks and uncertainties described from time to time in MetLife, Inc.’s ﬁlings with the United States Securities and Exchange Commission (‘‘SEC’’), including its S-1 and S-3 registration statements. The Company speciﬁcally disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Economic Capital Economic Capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The Economic Capital model accounts for the unique and speciﬁc nature of the risks inherent in MetLife’s businesses. This is in contrast to the standardized regulatory RBC formula, which is not as reﬁned in its risk calculations with respect to the nuances of the Company’s businesses. As part of the economic capital process a portion of net investment income is credited to the segments based on the level of allocated equity. Acquisitions and Dispositions On September 29, 2005, the Company completed the sale of P.T. Sejahtera (‘‘MetLife Indonesia’’) to a third party resulting in a gain upon disposal of $10 million, net of income taxes. As a result of this sale, the Company recognized income from discontinued operations of $5 million, net of income taxes, for the year ended December 31, 2005. The Company reclassiﬁed the assets, liabilities and operations of MetLife Indonesia into discontinued operations for all periods presented. MetLife, Inc. 5 On September 1, 2005, the Company completed the acquisition of CitiStreet Associates, a division of CitiStreet LLC, that is primarily involved in the distribution of annuity products and retirement plans to the education, healthcare, and not-for-proﬁt markets, for approximately $56 million, of which $2 million was allocated to goodwill and $54 million to other identiﬁable intangibles, speciﬁcally the value of customer relationships acquired, which has a weighted average amortization period of 16 years. CitiStreet Associates will be integrated with MetLife Resources, a division of MetLife dedicated to providing retirement plans and ﬁnancial services to the same markets. On July 1, 2005, the Holding Company completed the acquisition of The Travelers Insurance Company (‘‘TIC’’), excluding certain assets, most signiﬁcantly, Primerica, from Citigroup Inc. (‘‘Citigroup’’), and substantially all of Citigroup’s international insurance businesses (collectively, ‘‘Travelers’’), for $12.0 billion. The results of Travelers’ operations were included in the Company’s consolidated ﬁnancial statements beginning July 1, 2005. As a result of the acquisition, management of the Company increased signiﬁcantly the size and scale of the Company’s core insurance and annuity products and expanded the Company’s presence in both the retirement & savings domestic and international markets. The distribution agreements executed with Citigroup as part of the acquisition will provide the Company with one of the broadest distribution networks in the industry. Consideration paid by the Holding Company for the purchase consisted of approximately $10.9 billion in cash and 22,436,617 shares of the Holding Company’s common stock with a market value of approximately $1.0 billion to Citigroup and approximately $100 million in other transaction costs. Consideration paid to Citigroup will be ﬁnalized subject to review of the June 30, 2005 ﬁnancial statements of Travelers by both the Company and Citigroup and interpretation of the provisions of the acquisition agreement by both parties. In addition to cash on-hand, the purchase price was ﬁnanced through the issuance of common stock as described above, debt securities, common equity units and preferred shares. See ‘‘— Liquidity and Capital Resources — The Holding Company — Liquidity Sources.’’ On January 31, 2005, the Company completed the sale of SSRM Holdings, Inc. (‘‘SSRM’’) to a third party for $328 million in cash and stock. As a result of the sale of SSRM, the Company recognized income from discontinued operations of approximately $157 million, net of income taxes, comprised of a realized gain of $165 million, net of income taxes, and an operating expense related to a lease abandonment of $8 million, net of income taxes. Under the terms of the sale agreement, MetLife will have an opportunity to receive, prior to the end of 2006, payments aggregating up to approximately 25% of the base purchase price, based on, among other things, certain revenue retention and growth measures. The purchase price is also subject to reduction over ﬁve years, depending on retention of certain MetLife-related business. Also under the terms of such agreement, MetLife had the opportunity to receive additional consideration for the retention of certain customers for a speciﬁc period in 2005. In the fourth quarter of 2005, upon ﬁnalization of the computation, the Company received a payment of $12 million, net of income taxes, due to the retention of these speciﬁc customer accounts. The Company reclassiﬁed the assets, liabilities and operations of SSRM into discontinued operations for all periods presented. Additionally, the sale of SSRM resulted in the elimination of the Company’s Asset Management segment. The remaining asset management business, which is insigniﬁcant, has been reclassiﬁed into Corporate & Other. The Company’s discontinued operations for the year ended December 31, 2005 also includes expenses of approximately $6 million, net of income taxes, related to the sale of SSRM. In 2003, a subsidiary of MetLife, Inc., Reinsurance Group of America, Incorporated (‘‘RGA’’), entered into a coinsurance agreement under which it assumed the traditional U.S. life reinsurance business of Allianz Life Insurance Company of North America (‘‘Allianz Life’’). The transaction added approximately $278 billion of life reinsurance in-force, $246 million of premiums and $11 million of income before income tax expense, excluding minority interest expense, in 2003. The effects of such transaction are included within the Reinsurance segment. In 2002, the Company acquired Aseguradora Hidalgo S.A. (‘‘Hidalgo’’), an insurance company based in Mexico with approximately $2.5 billion in assets as of the date of acquisition (June 20, 2002). During the second quarter of 2003, as a part of its acquisition and integration strategy, the International segment completed the legal merger of Hidalgo into its original Mexican subsidiary, Seguro Genesis, S.A., forming MetLife Mexico, S.A. As a result of the merger of these companies, the Company recorded $62 million of earnings, net of income taxes, from the merger and a reduction in policyholder liabilities resulting from a change in methodology in determining the liability for future policy beneﬁts. Such beneﬁt was recorded in the second quarter of 2003 in the International segment. Impact of Hurricanes On August 29, 2005, Hurricane Katrina made landfall in the states of Louisiana, Mississippi and Alabama causing catastrophic damage to these coastal regions. As of December 31, 2005, the Company recognized total net losses related to the catastrophe of $134 million, net of income taxes and reinsurance recoverables and including reinstatement premiums and other reinsurance-related premium adjustments, which impacted the Auto & Home and Institutional segments. The Auto & Home and Institutional segments recorded net losses related to the catastrophe of $120 million and $14 million, each net of income taxes and reinsurance recoverables and including reinstatement premiums and other reinsurance-related premium adjustments, respectively. MetLife’s gross losses from Katrina were approximately $335 million, primarily arising from the Company’s homeowners business. On October 24, 2005, Hurricane Wilma made landfall across the state of Florida. As of December 31, 2005, the Company’s Auto & Home segment recognized total losses related to the catastrophe of $32 million, net of income taxes and reinsurance recoverables. MetLife’s gross losses from Hurricane Wilma were approximately $57 million arising from the Company’s homeowners and automobile businesses. Additional hurricane-related losses may be recorded in future periods as claims are received from insureds and claims to reinsurers are processed. Reinsurance recoveries are dependent on the continued creditworthiness of the reinsurers, which may be affected by their other reinsured losses in connection with Hurricanes Katrina and Wilma and otherwise. In addition, lawsuits, including purported class actions, have been ﬁled in Mississippi and Louisiana challenging denial of claims for damages caused to their property during Hurricane Katrina. Metropolitan Property and Casualty Insurance Company (‘‘MPC’’) is a named party in some of these lawsuits. In addition, rulings in cases in which MPC is not a party may affect interpretation of its policies. MPC intends to vigorously defend these matters. However, any adverse rulings could result in an increase in the Company’s hurricane-related claim exposure and losses. Based on information currently known by management, it does not believe that additional claim losses resulting from Hurricane Katrina will have a material adverse impact on the Company’s consolidated ﬁnancial statements. Summary of Critical Accounting Estimates The preparation of ﬁnancial statements in conformity with accounting principles generally accepted in the United States of America (‘‘GAAP’’) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated ﬁnancial statements. The most critical estimates include those used in determining: (i) investment impairments; (ii) the fair value of investments in the absence of quoted market values; (iii) application of the consolidation rules to certain investments; (iv) the fair value of and accounting for derivatives; (v) the capitalization and amortization of deferred policy acquisition costs (‘‘DAC’’), including value of business acquired (‘‘VOBA’’); (vi) the measurement of goodwill and related impairment, if any; (vii) the liability for future policyholder beneﬁts; (viii) accounting for reinsurance transactions;(ix) the liability for litigation and regulatory matters; and (x) accounting for employee beneﬁt plans. The application of purchase accounting requires the use of estimation techniques in determining 6 MetLife, Inc. the fair value of the assets acquired and liabilities assumed — the most signiﬁcant of which relate to the aforementioned critical estimates. In applying these policies, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and ﬁnancial services industries; others are speciﬁc to the Company’s businesses and operations. Actual results could differ from these estimates. Investments The Company’s principal investments are in ﬁxed maturities, mortgage and consumer loans, other limited partnerships, and real estate and real estate joint ventures, all of which are exposed to three primary sources of investment risk: credit, interest rate and market valuation. The ﬁnancial statement risks are those associated with the recognition of impairments and income, as well as the determination of fair values. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used by the Company in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the market value has been below cost or amortized cost; (ii) the potential for impairments of securities when the issuer is experiencing signiﬁcant ﬁnancial difﬁculties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources; (vi) the Company’s ability and intent to hold the security for a period of time sufﬁcient to allow for the recovery of its value to an amount equal to or greater than cost or amortized cost; (vii) unfavorable changes in forecasted cash ﬂows on asset-backed securities; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. In addition, the earnings on certain investments are dependent upon market conditions, which could result in prepayments and changes in amounts to be earned due to changing interest rates or equity markets. The determination of fair values in the absence of quoted market values is based on: (i) valuation methodologies; (ii) securities the Company deems to be comparable; and (iii) assumptions deemed appropriate given the circumstances. The use of different methodologies and assumptions may have a material effect on the estimated fair value amounts. In addition, the Company enters into certain structured investment transactions, real estate joint ventures and limited partnerships for which the Company may be deemed to be the primary beneﬁciary and, therefore, may be required to consolidate such investments. The accounting rules for the determination of the primary beneﬁciary are complex and require evaluation of the contractual rights and obligations associated with each party involved in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party. Derivatives The Company enters into freestanding derivative transactions primarily to manage the risk associated with variability in cash ﬂows or changes in fair values related to the Company’s ﬁnancial assets and liabilities. The Company also uses derivative instruments to hedge its currency exposure associated with net investments in certain foreign operations. The Company also purchases investment securities, issues certain insurance policies and engages in certain reinsurance contracts that have embedded derivatives. The associated ﬁnancial statement risk is the volatility in net income which can result from (i) changes in fair value of derivatives not qualifying as accounting hedges; (ii) ineffectiveness of designated hedges; and (iii) counterparty default. In addition, there is a risk that embedded derivatives requiring bifurcation are not identiﬁed and reported at fair value in the consolidated ﬁnancial statements. Accounting for derivatives is complex, as evidenced by signiﬁcant authoritative interpretations of the primary accounting standards which continue to evolve, as well as the signiﬁcant judgments and estimates involved in determining fair value in the absence of quoted market values. These estimates are based on valuation methodologies and assumptions deemed appropriate under the circumstances. Such assumptions include estimated volatility and interest rates used in the determination of fair value where quoted market values are not available. The use of different assumptions may have a material effect on the estimated fair value amounts. Deferred Policy Acquisition Costs and Value of Business Acquired The Company incurs signiﬁcant costs in connection with acquiring new and renewal insurance business. These costs, which vary with and are primarily related to the production of that business, are deferred. The recovery of DAC is dependent upon the future proﬁtability of the related business. The amount of future proﬁt is dependent principally on investment returns in excess of the amounts credited to policyholders, mortality, morbidity, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inﬂation. Of these factors, the Company anticipates that investment returns are most likely to impact the rate of amortization of such costs. The aforementioned factors enter into management’s estimates of gross margins and proﬁts, which generally are used to amortize such costs. VOBA, included in DAC, reﬂects the estimated fair value of in-force contracts in a life insurance company acquisition and represents the portion of the purchase price that is allocated to the value of the right to receive future cash ﬂows from the insurance and annuity contracts in force at the acquisition date. VOBA is based on actuarially determined projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns and other factors. Actual experience on the purchased business may vary from these projections. Revisions to estimates result in changes to the amounts expensed in the reporting period in which the revisions are made and could result in the impairment of the asset and a charge to income if estimated future gross margins and proﬁts are less than amounts deferred. In addition, the Company utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC. This practice assumes that the expectation for long-term appreciation in equity markets is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Goodwill Goodwill is the excess of cost over the fair value of net assets acquired. The Company tests goodwill for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justiﬁcation for conducting an interim test. Impairment testing is performed using the fair value approach, which requires the use of estimates and judgment, at the ‘‘reporting unit’’ level. A reporting unit is the operating segment, or a business that is one level below the operating segment if discrete ﬁnancial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, goodwill within Corporate & Other is allocated to reporting units within the Company’s business segments. If the carrying value of a reporting unit’s goodwill exceeds its fair value, the excess is recognized as an MetLife, Inc. 7 impairment and recorded as a charge against net income. The fair values of the reporting units are determined using a market multiple or discounted cash ﬂow model. The critical estimates necessary in determining fair value are projected earnings, comparative market multiples and the discount rate. Liability for Future Policy Beneﬁts and Unpaid Claims and Claim Expenses The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities and non- medical health insurance. Generally, amounts are payable over an extended period of time and liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy beneﬁts are mortality, morbidity, expenses, persistency, investment returns and inﬂation. Utilizing these assumptions, liabilities are estab- lished on a block of business basis. The Company also establishes liabilities for unpaid claims and claim expenses for property and casualty claim insurance which represent the amount estimated for claims that have been reported but not settled and claims incurred but not reported. Liabilities for unpaid claims are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation. Differences between actual experience and the assumptions used in pricing these policies and in the establishment of liabilities result in variances in proﬁt and could result in losses. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur. Reinsurance The Company enters into reinsurance transactions as both a provider and a purchaser of reinsurance. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the ﬁnancial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Additionally, for each of its reinsurance contracts, the Company must determine if the contract provides indemniﬁcation against loss or liability relating to insurance risk, in accordance with applicable accounting standards. The Company must review all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. If the Company determines that a reinsurance contract does not expose the reinsurer to a reasonable possibility of a signiﬁcant loss from insurance risk, the Company records the contract using the deposit method of accounting. Litigation The Company is a party to a number of legal actions and regulatory investigations. Given the inherent unpredictability of these matters, it is difﬁcult to estimate the impact on the Company’s consolidated ﬁnancial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities related to certain lawsuits, including the Company’s asbestos-related liability, are especially difﬁcult to estimate due to the limitation of available data and uncertainty regarding numerous variables used to determine amounts recorded. The data and variables that impact the assumptions used to estimate the Company’s asbestos-related liability include the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. On a quarterly and annual basis the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. It is possible that an adverse outcome in certain of the Company’s litigation and regulatory investigations, including asbestos- related cases, or the use of different assumptions in the determination of amounts recorded could have a material effect upon the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Employee Beneﬁt Plans Certain subsidiaries of the Holding Company sponsor pension and other retirement plans in various forms covering employees who meet speciﬁed eligibility requirements. The reported expense and liability associated with these plans require an extensive use of assumptions which include the discount rate, expected return on plan assets and rate of future compensation increases as determined by the Company. Management determines these assumptions based upon currently available market and industry data, historical performance of the plan and its assets, and consultation with an independent consulting actuarial ﬁrm. These assumptions used by the Company may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of the participants. These differences may have a signiﬁcant effect on the Company’s consolidated ﬁnancial statements and liquidity. Financial Condition As a result of the Travelers acquisition, management of the Company increased signiﬁcantly the size and scale of the Company’s core insurance and annuity products and expanded the Company’s presence in both the retirement & savings domestic and international markets. The distribution agreements executed with Citigroup as part of the acquisition will provide the Company with one of the broadest distribution networks in the industry. The Travelers assets and liabilities acquired of $102 billion and $90 billion, respectively, have been included in the consolidated balance sheet of the Company at their estimated fair market values as of the date of acquisition, July 1, 2005, and signiﬁcantly increased the Company’s assets and liabilities in its consolidated ﬁnancial statements as of December 31, 2005, as included elsewhere herein. The purchase price of $12 billion was ﬁnanced through the issuance of common stock of $1 billion to Citigroup, issuances to the public of preferred stock of $2 billion, common equity units of $2 billion and debt securities of $3 billion and the use of cash on hand of $4 billion. Results of Operations Executive Summary MetLife, Inc. is a leading provider of insurance and other ﬁnancial services to millions of individual and institutional customers throughout the United States. Through its subsidiaries and afﬁliates, MetLife, Inc. offers life insurance, annuities, automobile and homeowners insurance and retail banking services to individuals, as well as group insurance, reinsurance and retirement & savings products and services to corporations and other institutions. Outside the United States, the MetLife companies have direct insurance operations in Asia Paciﬁc, Latin America and Europe. MetLife is organized into ﬁve operating segments: Institutional, Individual, Auto & Home, International and Reinsurance, as well as Corporate & Other. 8 MetLife, Inc. The management’s discussion and analysis which follows isolates, in order to be meaningful, the results of the Travelers acquisition in the period over period comparison as the Travelers acquisition was not included in the results of the Company until July 1, 2005. The Travelers’ amounts which have been isolated represent the results of the Travelers legal entities which have been acquired. These amounts represent the impact of the Travelers acquisition; however, as business currently transacted through the acquired Travelers legal entities is transitioned to legal entities already owned by the Company, some of which has already occurred, the identiﬁcation of the Travelers legal entity business will not necessarily be indicative of the impact of the Travelers acquisition on the results of the Company. As a part of the Travelers acquisition, management realigned certain products and services within several of the Company’s segments to better conform to the way it manages and assesses its business. Accordingly, all prior period segment results have been adjusted to reﬂect such product reclassiﬁcations. Also in connection with the Travelers acquisition, management has utilized its economic capital model to evaluate the deployment of capital based upon the unique and speciﬁc nature of the risks inherent in the Company’s existing and newly acquired businesses and has adjusted such allocations based upon this model. Year ended December 31, 2005 compared with the year ended December 31, 2004 The Company reported $4,651 million in net income available to common shareholders and diluted earnings per common share of $6.16 for the year ended December 31, 2005 compared to $2,758 million in net income available to common shareholders and diluted earnings per common share of $3.65 for the year ended December 31, 2004. The acquisition of Travelers contributed $233 million to net income available to common shareholders for the year ended December 31, 2005. Excluding the impact of Travelers, net income available to common shareholders increased by $1,660 million in the 2005 period. The years ended December 31, 2005 and 2004 include the impact of certain transactions or events, the timing, nature and amount of which are generally unpredictable. These transactions are described in each applicable segment’s discussion below. These items contributed a beneﬁt of $71 million, net of income taxes, to the year ended December 31, 2005 and a beneﬁt of $113 million, net of income taxes, to the comparable 2004 period. Excluding the impact of these items, net income available to common shareholders increased by $1,702 million for the year ended December 31, 2005 compared to the prior 2004 period. In 2005, the Company sold its One Madison Avenue and 200 Park Avenue properties in Manhattan, New York, which, combined, resulted in a gain of $1,193 million, net of income taxes. In addition, during 2005, the Company completed the sales of SSRM and MetLife Indonesia and recognized gains of $177 million and $10 million, respectively, both net of income taxes. In 2004, the Company completed the sale of the Sears Tower property resulting in a gain of $85 million, net of income taxes. Accordingly, income from discontinued operations and, correspondingly, net income, increased by $1,368 million for the year ended December 31, 2005 compared to the 2004 period primarily as a result of the aforementioned sales. These increases were partially offset by an increase in net investment losses of $170 million, net of income taxes, for the year ended December 31, 2005 as compared to the corresponding period in 2004. The acquisition of Travelers contributed a loss of $132 million, net of income taxes, to this decrease. Excluding the impact of Travelers, net investment gains (losses) decreased by $38 million, net of income taxes, in the 2005 period. This decrease is primarily due to losses on ﬁxed maturity security sales resulting from continued portfolio repositioning in the 2005 period. Signiﬁcantly offsetting these reductions is an increase in gains from the mark-to-market on derivatives in 2005. The derivative gains resulted from changes in the value of the dollar versus major foreign currencies, including the euro and pound sterling, and changes in U.S. interest rates during the year ended December 31, 2005. The increase in net income available to common shareholders during the year ended December 31, 2005 as compared to the prior year is partially due to the decrease in net income available to common shareholders in the prior year of $86 million, net of income taxes, as a result of a cumulative effect of a change in accounting principle in 2004 recorded in accordance with Statement of Position (‘‘SOP’’) 03-1, Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts (‘‘SOP 03-1’’). In addition, during the second half of the year ended December 31, 2005, the Company paid $63 million in dividends on its Series A and Series B preferred shares issued in connection with ﬁnancing the acquisition of Travelers. The remaining increase in net income available to common shareholders of $349 million is primarily due to an increase in premiums, fees and other revenues primarily from continued sales growth across most of the Company’s business segments, as well as the positive impact of the U.S. ﬁnancial markets on policy fees. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. In addition, continued strong investment spreads are largely due to higher than expected net investment income from corporate joint venture income and bond and commercial mortgage prepayment fees. Partially offsetting these increases is a rise in expenses primarily due to higher interest expense, integration costs, corporate incentive expenses, non deferrable volume-related expenses, corporate support expenses and DAC amortization. Year ended December 31, 2004 compared with the year ended December 31, 2003 The Company reported $2,758 million in net income available to common shareholders and diluted earnings per common share of $3.65 for the year ended December 31, 2004 compared to $2,196 million in net income available to common shareholders and diluted earnings per common share of $2.94 for the year ended December 31, 2003. Continued top-line revenue growth across all of the Company’s business segments, strong interest rate spreads and an improvement in net investment gains (losses) are the leading contributors to the 26% increase in net income available to common shareholders for the year ended December 31, 2004 over the comparable 2003 period. Total premiums, fees and other revenues increased to $26.3 billion, up 8%, from the year ended December 31, 2003, primarily from continued sales growth across most of the Company’s business segments, as well as the positive impact of the U.S. ﬁnancial markets on policy fees. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. Continued strong investment spreads are largely due to higher than expected net investment income from corporate joint venture income and bond and commercial mortgage prepayment fees. In addition, an improvement in net investment gains (losses), net of income taxes, of $461 million is primarily due to the more favorable economic environment in 2004. These increases are partially offset by an $86 million, net of income taxes, cumulative effect of a change in accounting principle in 2004 recorded in accordance with SOP 03-1. In comparison, in the 2003 period the Company recorded a $26 million charge for a cumulative effect of a change in accounting in accordance with Financial Accounting Standards Board (‘‘FASB’’) Statement 133 Implementation Issue No. B36, Embedded Derivatives: Modiﬁed Coinsurance Arrangements and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to the Creditworthiness of the Obligor under Those Instruments (‘‘Issue B36’’). MetLife, Inc. 9 Industry Trends The Company’s segments continue to be inﬂuenced by a variety of trends that affect the industry. Financial Environment. The current ﬁnancial environment presents a challenge for the life insurance industry. A low general level of short-term and long-term interest rates can have a negative impact on the demand for and the proﬁtability of spread-based products such as ﬁxed annuities, guaranteed interest contracts and universal life insurance. In addition, continued low interest rates could put pressure on interest spreads on existing blocks of business as declining investment portfolio yields draw closer to minimum crediting rate guarantees on certain products. The compression of the yields between spread-based products and interest rates will be a concern until new money rates on corporate bonds are higher than overall life insurer investment portfolio yields. Recent volatile equity market performance has also presented challenges for life insurers, as fee revenue from variable annuities and pension products is tied to separate account balances, which reﬂect equity market performance. Also, variable annuity product demand often mirrors consumer demand for equity market investments. Improving Economy. A recovery in the employment market combined with higher corporate conﬁdence should improve demand for group insurance and retirement & savings-type products. Group insurance premium growth, for example, with respect to life and disability products, are closely tied to employers’ total payroll growth. Additionally, the potential market for these products is expanded by new business creation. Bond portfolio credit losses have also beneﬁted from an increasingly healthy economy. Demographics. In the coming decade, a key driver shaping the actions of the life insurance industry will be the rising income protection, wealth accumulation, protection and transfer needs of the retiring Baby Boomers — the ﬁrst of whom have entered their pre-retirement, peak savings years. As a result of increasing longevity, retirees will need to accumulate sufﬁcient savings to ﬁnance retirements that may span 30 or more years. Helping the Baby Boomers accumulate assets for retirement and subsequently converting these assets into retirement income represents a transformative opportunity for the life insurance industry. Life insurers are well positioned to address the Baby Boomers’ rapidly increasing need for savings tools and for income protection. In light of recent Social Security reform and pension solvency concerns, ‘‘protection’’ is what sets the U.S. life insurance industry apart from other ﬁnancial services providers pursuing the retiring Baby Boomer segment. The Company believes that, among life insurers, those with strong brands, high ﬁnancial strength ratings, and broad distribution, are best positioned to capitalize on the opportunity to offer income protection products to Baby Boomers. Moreover, the life insurance industry’s products and the needs they are designed to address are complex. The Company believes that individuals approaching retirement age will need to seek advice to plan for and manage their retirements and that, in the workplace, as employees take greater responsibility for their beneﬁt options and retirement planning, they will need individually tailored advice. The challenge for the life insurance industry remains delivering tailored advice in a cost effective manner. Competitive Pressures. The life insurance industry is becoming increasingly competitive. The product development and product life-cycles have shortened in many product segments, leading to more intense competition with respect to product features. Larger companies have the ability to invest in brand equity, product development and risk management, which are among the fundamentals for sustained proﬁtable growth in the life insurance industry. In addition, several of the industry’s products can be quite homogeneous and subject to intense price competition, and sufﬁcient scale, ﬁnancial strength and ﬂexibility are becoming prerequisites for sustainable growth in the life insurance industry. Larger market participants tend to have the capacity to invest in additional distribution capability and the information technology needed to offer the superior customer service demanded by an increasingly sophisticated industry client base. Regulatory Changes. The life insurance industry is regulated at the state level, with some products also subject to federal regulation. As life insurers introduce new and often more complex products, regulators reﬁne capital requirements and introduce new reserving standards for the life insurance industry. Regulation recently adopted or currently under review can potentially impact the reserve and capital requirements for several of the industry’s products. In addition, regulators have undertaken market and sales practices reviews of several markets or products including equity-indexed annuities, variable annuities and group products. 10 MetLife, Inc. Discussion of Results Year Ended December 31, 2005 2004 2003 Revenues Premiums****************************************************************************** $24,860 Universal life and investment-type product policy fees ***************************************** 3,828 Net investment income ****************************************************************** 14,910 Other revenues ************************************************************************* 1,271 Net investment gains (losses) ************************************************************* (93) Total revenues ************************************************************************ 44,776 Expenses Policyholder beneﬁts and claims *********************************************************** Interest credited to policyholder account balances ******************************************** Policyholder dividends ******************************************************************* Other expenses ************************************************************************ Total expenses *********************************************************************** Income from continuing operations before provision for income taxes **************************** Provision for income taxes**************************************************************** Income from continuing operations********************************************************* Income from discontinued operations, net of income taxes************************************* Income before cumulative effect of a change in accounting, net of income taxes ****************** Cumulative effect of a change in accounting, net of income taxes ****************************** Net income **************************************************************************** 4,714 Preferred stock dividends **************************************************************** 63 Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust** — Net income available to common shareholders*********************************************** $ 4,651 25,506 3,925 1,679 9,267 4,399 1,260 3,139 1,575 4,714 — 40,377 (In millions) $22,200 2,867 12,364 1,198 175 $20,575 2,495 11,472 1,199 (551) 38,804 35,190 22,662 2,997 1,666 7,813 35,138 3,666 1,029 2,637 207 2,844 (86) 2,758 — — 20,811 3,035 1,731 7,168 32,745 2,445 616 1,829 414 2,243 (26) 2,217 — 21 $ 2,758 $ 2,196 Year ended December 31, 2005 compared with the year ended December 31, 2004 — The Company Income from continuing operations increased by $502 million, or 19%, to $3,139 million for the year ended December 31, 2005 from $2,637 million in the comparable 2004 period. The current period includes $233 million of income from continuing operations related to the acquisition of Travelers. Included in the Travelers results is a charge for the establishment of an excess mortality reserve related to group of speciﬁc policies. In connection with MetLife’s acquisition of Travelers, the Company has performed reviews of Travelers underwriting criteria in its effort to reﬁne its estimated fair values for the purchase price allocation. As a result of these reviews and actuarial analyses, and to be consistent with MetLife’s existing reserving methodologies, the Company has established an excess mortality reserve on a speciﬁc group of policies. This resulted in a charge of $20 million, net of income taxes, to fourth quarter results. The Company expects to complete its reviews and reﬁne its estimate of the excess mortality reserve by June 30, 2006. Excluding the acquisition of Travelers, income from continuing operations increased by $269 million, or 10%. Income from continuing operations for the year ended December 31, 2005 and 2004 includes the impact of certain transactions or events, the timing, nature and amount of which are generally unpredictable. These transactions are described in each applicable segment’s discussion below. These items contributed a beneﬁt of $71 million, net of income taxes, to the year ended December 31, 2005 and a beneﬁt of $113 million, net of income taxes, to the comparable 2004 period. Excluding the impact of these items, income from continuing operations increased by $311 million for the year ended December 31, 2005 compared to the prior 2004 period. The Individual segment contributed $248 million, net of income taxes, to the increase, as a result of interest rate spreads, increased fee income related to the growth in separate account products, favorable underwriting, a decrease in the closed block-related policyholder dividend obligation, lower annuity net guaranteed beneﬁt costs and lower DAC amortization. These increases were partially offset by lower net investment income, net investment losses and higher operating costs offset by revisions to certain expense, premium tax and policyholder liability estimates in the current year and write-offs of certain assets in the prior year. The Institutional segment contributed $50 million, net of income taxes, to this increase primarily due to favorable interest spreads, partially offset by a decrease in net investment gains, an adjustment recorded on DAC associated with certain long-term care products in 2005, unfavorable underwriting and an increase in other expenses. The Auto & Home segment contributed $16 million, net of income taxes, to the 2005 increase primarily due to improvements in the development of prior year claims, the non-catastrophe combined ratio, and losses from the involuntary Massachusetts automobile plan, as well as an increase in net investment income and earned premium. These increases in the Auto & Home segment were partially offset by an increase in catastrophes as a result of the impact of Hurricanes Katrina and Wilma and an increase in other expenses. The Reinsurance segment contributed $9 million, net of income taxes, to this increase primarily due to premium growth and higher net investment income, partially offset by unfavorable mortality as a result of higher claim levels in the U.S. and U.K. and a reduction in net investment gains. The International segment contributed $9 million, net of income taxes, primarily due to business growth in South Korea, Chile and Mexico. These increases in the International segment were partially offset by an increase in certain policyholder liabilities caused by unrealized investment gains (losses) on the invested assets supporting those liabilities, an increase in expenses for start up costs and contingency liabilities in Mexico, as well as a decrease in Canada primarily due to a realignment of economic capital offset by the strengthening of the liability on its pension business related to changes in mortality assumptions in the prior year and higher oversight and infrastructure expenditures in support of the segment growth. These increases in income from continuing operations were partially offset by a decrease of $21 million, net of income taxes, in Corporate & Other. The decrease in Corporate & Other is primarily due to higher interest expense on debt, integration costs associated with the acquisition of Travelers, higher interest credited on bank holder deposits and legal-related liabilities, partially offset by an increase in net investment income, higher net investment gains and a decrease in corporate support expenses. MetLife, Inc. 11 Premiums, fees and other revenues increased by $3,694 million, or 14%, to $29,959 million for the year ended December 31, 2005 from $26,265 million for the comparable 2004 period. The current period includes $1,009 million of premium, fees and other revenues related to the acquisition of Travelers. Excluding the acquisition of Travelers, premium, fees and other revenues increased by $2,685 million, or 10%. The Institutional segment contributed $1,266 million, or 47%, to the year over year increase. The Institutional segment increase is primarily due to sales growth and the acquisition of new business in the non-medical health & other business, as well as improved sales and favorable persistency in group life and higher structured settlement sales and pension close-outs in retirement & savings. The Reinsurance segment contributed $523 million, or 19%, to the Company’s year over year increase in premiums, fees and other revenues. This growth is primarily attributable to new premiums from facultative and automatic treaties and renewal premiums on existing blocks of business, as well as favorable exchange rate movements. The International segment contributed $452 million, or 17%, to the year over year increase primarily due to business growth through increased sales and renewal business in Mexico, South Korea, Brazil, and Taiwan, as well as changes in foreign currency rates. In addition, Chile’s premiums, fees and other revenues increased due to the new bank distribution channel established in 2005. The Individual segment contributed $445 million, or 17%, to the year over year increase primarily due to higher fee income from variable annuity and universal life products, active marketing of income annuity products and growth in the business in traditional life products. The growth in traditional products more than offset the decline in premiums in the Company’s closed block business as this business continues to run-off. Corporate & Other contributed $38 million, or 1%, to the year over year increase, primarily due to intersegment eliminations. The increase in premiums, fees and other revenues were partially offset by a decrease in the Auto & Home segment of $39 million, or 1%. This decrease is primarily attributable to reinstatement and additional reinsurance-related premiums due to Hurricane Katrina. Interest rate margins, which generally represent the margin between net investment income and interest credited to policyholder account balances, increased in the Institutional and Individual segments for the year ended December 31, 2005 compared to the prior year period. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment-related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees, the timing and amount of which are generally unpredictable and, as a result, can ﬂuctuate from period to period. If interest rates remain low, it could result in compression of the Company’s interest rate spreads on several of its products, which provide guaranteed minimum rates of return to policyholders. This compression could adversely impact the Company’s future ﬁnancial results. Underwriting results were favorable within the life products in the Individual and Institutional segments, while underwriting results were unfavorable in the Reinsurance segment and in the retirement & savings and non medical health & other products within the Institutional segment. Underwriting results are generally the difference between the portion of premium and fee income intended to cover mortality, morbidity or other insurance costs, less claims incurred, and the change in insurance-related liabilities. Underwriting results are signiﬁcantly inﬂuenced by mortality, morbidity or other insurance-related experience trends and the reinsurance activity related to certain blocks of business and, as a result, can ﬂuctuate from period to period. Underwriting results, excluding catastrophes, in the Auto & Home segment were favorable for the year ended December 31, 2005, as the combined ratio, excluding catastrophes and before the reinstatement premiums and other reinsurance related premium adjustments due to Hurricane Katrina, decreased to 86.7% from 90.4% in the prior year period. Offsetting the improved non-catastrophe ratios in the Auto & Home segment was an increase in catastrophes primarily due to Hurricanes Katrina and Wilma. Underwriting results in the International segment increased commensurate with the growth in the business as discussed above. Other expenses increased by $1,454 million, or 19%, to $9,267 million for the year ended December 31, 2005 from $7,813 million for the comparable 2004 period. The current period includes $618 million of other expenses related to the acquisition of Travelers. Excluding the acquisition of Travelers, other expenses increased by $836 million, or 11%. The year ended December 31, 2005 includes a $28 million beneﬁt associated with the reduction of a previously established real estate transfer tax liability related to the Company’s demutualization in 2000. The year ended December 31, 2004 reﬂects a $49 million reduction of a premium tax liability and a $22 million reduction of a liability for interest associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. These decreases were partially offset by a $50 million contribution of appreciated stock to the MetLife Foundation. Excluding the impact of these transactions, other expenses increased by $843 million, or 11%, from the comparable 2004 period. Corporate & Other contributed $413 million, or 49%, to the year over year variance primarily due to higher interest expense, integration costs associated with the Travelers acquisition, growth in interest credited to bank holder deposits at MetLife Bank, National Association (‘‘MetLife Bank’’ or ‘‘MetLife Bank, N.A.’’) and legal-related liabilities, partially offset by a reduction in corporate support expenses. The Institutional segment contributed $178 million, or 21%, to the year over year variance primarily due to higher non- deferrable volume-related expenses associated with general business growth, corporate support expenses, higher expenses related to additional Travelers incentive accruals, as well as an adjustment recorded on DAC associated with certain long-term care products in 2005. In addition, $174 million, or 21%, of this increase is primarily attributable to higher amortization of DAC, changes in foreign currency rates, business growth commensurate with the increase in revenues discussed above, a decrease in the payroll tax liability and an accrual for an early retirement program in the International segment. Other expenses in the International segment also increased due to higher consultant fees for growth initiative projects, an increase in compensation and incentive expenses, as well as higher costs for legal, marketing and other corporate allocated expenses. The Reinsurance segment also contributed $34 million, or 4%, to the increase in other expenses primarily due to an increase in the amortization of DAC. The Auto & Home segment contributed $33 million, or 4%, to this increase primarily due to increased information technology, advertising and incentive and other compensation costs. In addition, the Individual segment contributed $11 million, or 1%, to the year over year increase primarily due to higher corporate incentive expenses and general spending, partially offset by the revision of prior period estimates for certain expense, premium tax and policyholder liabilities, as well as certain asset write-offs in the prior year and lower DAC amortization. Net investment gains (losses) decreased by $268 million, or 153%, to a loss of $93 million for the year ended December 31, 2005 from a net investment gain of $175 million for the comparable 2004 period. The current year includes $208 million of net investment losses related to the acquisition of Travelers. Excluding the acquisition of Travelers, net investment gains (losses) decreased by $60 million, or 34%. This decrease is primarily due to losses on ﬁxed maturity security sales resulting from continued portfolio repositioning in the 2005 period. Signiﬁcantly offsetting these reductions is an increase in gains from the mark-to-market on derivatives in 2005. The derivative gains resulted from changes in the value of the dollar versus major foreign currencies, including the euro and pound sterling, and changes in U.S. interest rates during the year ended December 31, 2005. Income tax expense for the year ended December 31, 2005 is $1,260 million, or 29% of income from continuing operations before provision for income taxes, compared with $1,029 million, or 28%, for the comparable 2004 period. The current period includes $80 million of income tax expense related to the acquisition of Travelers. Excluding the acquisition of Travelers, income tax expense for the year ended December 31, 2005 is $1,180 million, or 29% of income from continuing operations before provision for income taxes, compared with $1,029 million, or 28%, for the comparable 2004 period. The 2005 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment 12 MetLife, Inc. income and tax credits for investments in low income housing. In addition, the 2005 effective tax rate reﬂects a tax beneﬁt of $27 million related to the repatriation of foreign earnings pursuant to Internal Revenue Code Section 965 for which a U.S. deferred tax provision had previously been recorded and an adjustment of a beneﬁt of $31 million consisting primarily of a revision in the estimate of income taxes for 2004 had been made. The 2004 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, a decrease in the deferred tax valuation allowance to recognize the effect of certain foreign net operating loss carryforwards in South Korea, and the contribution of appreciated stock to the MetLife Foundation. In addition, the 2004 effective tax rate reﬂects an adjustment for the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999 and an adjustment of a beneﬁt of $9 million consisting primarily of a revision in the estimate of income taxes for 2003. Income from discontinued operations is comprised of the operations and the gain upon disposal from the sale of MetLife Indonesia on Septem- ber 29, 2005 and SSRM on January 31, 2005, as well as net investment income and net investment gains related to real estate properties that the Company has classiﬁed as available-for-sale or has sold. Income from discontinued operations, net of income taxes, increased by $1,368 million, or 661%, to $1,575 million for the year ended December 31, 2005 from $207 million for the comparable 2004 period. This increase is primarily due to a gain of $1,193 million, net of income taxes, on the sales of the One Madison Avenue and 200 Park Avenue properties in Manhattan, New York, and the gains on the sales of SSRM and MetLife Indonesia of $177 million and $10 million, respectively, both net of income taxes, in the year ended December 31, 2005. Partially offsetting this increase is the gain on the sale of the Sears Tower property of $85 million, net of income taxes, in the year ended December 31, 2004. During the year ended December 31, 2004, the Company recorded an $86 million charge, net of income taxes, for a cumulative effect of a change in accounting principle in accordance with SOP 03-1, which provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. This charge is primarily related to those long-duration contract liabilities where the amount of the liability is indexed to the performance of a target portfolio of investment securities. In addition, during the second half of the year ended December 31, 2005, the Company paid $63 million in dividends on its Series A and Series B preferred shares issued in connection with ﬁnancing the acquisition of Travelers. Year ended December 31, 2004 compared with the year ended December 31, 2003 — The Company Income from continuing operations increased by $808 million, or 44%, to $2,637 million for the year ended December 31, 2004 from $1,829 million in the comparable 2003 period. Income from continuing operations for the years ended December 31, 2004 and 2003 includes the impact of certain transactions or events, the timing, nature and amount of which are generally unpredictable. These transactions are described in each applicable segment’s discussion below. These items contributed a beneﬁt of $113 million, net of income taxes, to the year ended December 31, 2004 and a beneﬁt of $159 million, net of income taxes, to the comparable 2003 period. Excluding the impact of these items, income from continuing operations increased by $854 million for the year ended December 31, 2004 compared to the prior 2003 period. This increase is primarily the result of an improvement in net investment gains (losses), net of income taxes, of $461 million. Also contributing to the increase is higher earnings from interest rate spreads of approximately $306 million, net of income taxes, in the Institutional and Individual segments. Additionally, the Individual segment contributed $186 million, net of income taxes, as a result of increased income from policy fees on investment-type products partially offset by higher amortization associated with DAC of $72 million, net of income taxes, and a reduction in earnings of $101 million, net of income taxes, resulting from an increase in the closed block policyholder dividend obligation. In addition, the Auto & Home segment’s earnings increased primarily due to an improved non-catastrophe combined ratio and favorable claim development related to prior accident years of $113 million, net of income taxes. This increase was partially offset by higher catastrophe losses of $73 million, net of income taxes, in 2004. Premiums, fees and other revenues increased by $1,996 million, or 8%, to $26,265 million for the year ended December 31, 2004 from $24,269 million for the comparable 2003 period. The Institutional segment contributed 53% to the year over year increase. This increase stems largely from sales growth and the acquisitions of new businesses in the group life and the non-medical health & other businesses, as well as an increase in structured settlements sales and pension close outs. The Reinsurance segment contributed approximately 36% to the Company’s year over year increase in premiums, fees and other revenues. This growth is primarily attributable to this segment’s coinsurance agreement with Allianz Life and continued growth in its traditional life reinsurance operations. The Individual segment contributed 6% to the year over year increase primarily due to higher fee income, partially offset by a reduction in the Company’s closed block premiums as the business continues to run-off. Interest rate spreads, which generally represent the margin between net investment income and interest credited to policyholder account balances, increased across the Institutional and Individual segments during the year ended December 31, 2004 compared to the prior year period. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment- related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees for which the timing and amount are generally unpredictable and, as a result, can ﬂuctuate from period to period. Underwriting results in the Institutional and Individual segments in the year ended December 31, 2004 were less favorable compared to the 2003 period. Underwriting results are signiﬁcantly inﬂuenced by mortality and morbidity trends, claim experience and the reinsurance activity related to certain blocks of business, and, as a result, can ﬂuctuate from period to period. Underwriting results in the Auto & Home segment were favorable in 2004 as the combined ratio declined to 90.4%, excluding catastrophes, from 97.1% in the prior year period. This result is largely due to continued improvement in both auto and homeowner claim frequencies, lower auto severities and an increase in average earned premiums. Other expenses increased by $645 million, or 9%, to $7,813 million for the year ended December 31, 2004 from $7,168 million for the comparable 2003 period. The 2004 period reﬂects a $49 million reduction of a premium tax liability and a $22 million reduction of a liability for interest associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. These decreases were partially offset by a $50 million contribution of appreciated stock to the MetLife Foundation. The 2003 period includes the impact of a $144 million reduction of a previously established liability related to the Company’s race-conscious underwriting settlement. In addition, the 2003 period includes a $48 million charge related to certain improperly deferred expenses at New England Financial and a $45 million charge related to VOBA associated with a change in methodology in determining the liability for future policy beneﬁts in the Company’s International segment. Excluding the impact of these transactions, other expenses increased by $615 million, or 9%, from the comparable 2003 period. The Reinsurance segment contributed 31% to this year over year variance primarily due to the growth in expenses associated with the Allianz Life acquisition and continued revenue growth, as mentioned above. In addition, 27% of this variance is primarily attributable to increases in direct business support expenses and non- deferrable commission expenses associated with general business growth, as well as infrastructure improvements, partially offset by costs in 2003 associated with ofﬁce consolidations and an impairment of assets in the Institutional segment. The Individual segment contributed 23% to this increase MetLife, Inc. 13 primarily due to accelerated DAC amortization, as well as an increase in expenses associated with general business growth. The remainder of the increase is the result of general business growth across the remaining segments and Corporate & Other. Net investment gains (losses) increased by $726 million, or 132%, to a net investment gain of $175 million for the year ended December 31, 2004 from a net investment loss of ($551) million for the comparable 2003 period. This increase is primarily due to the more favorable economic environment in 2004. Income tax expense for the year ended December 31, 2004 was $1,029 million, or 28% of income from continuing operations before provision for income taxes, compared with $616 million, or 25%, for the comparable 2003 period. The 2004 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, a decrease in the deferred tax valuation allowance to recognize the effect of certain foreign net operating loss carryforward in South Korea, and the contribution of appreciated stock to the MetLife Foundation. In addition, the 2004 effective tax rate reﬂects an adjustment of $91 million for the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Also, the 2004 effective tax rate reﬂects an adjustment of $9 million consisting primarily of a revision in the estimate of income taxes for 2003. The 2003 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, and tax beneﬁts related to the sale of foreign subsidiaries. In addition, the 2003 effective tax rate reﬂects an adjustment of a beneﬁt of $36 million consisting primarily of a revision in the estimate of income taxes for 2002. The income from discontinued operations is comprised of the operations of SSRM and net investment income and net investment gains related to real estate properties that the Company has classiﬁed as available-for-sale. The Company entered into an agreement to sell SSRM during the third quarter of 2004. As previously discussed, SSRM was sold effective January 31, 2005. Income from discontinued operations, net of income taxes, decreased $207 million, or 50%, to $207 million for the year ended December 31, 2004 from $414 million for the comparable 2003 period. The decrease is primarily due to lower recognized net investment gains from real estate properties sold in 2004 as compared to the prior year. For the years ended December 31, 2004 and 2003, the Company recognized $146 million and $420 million of net investment gains, respectively, from discontinued operations related to real estate properties sold or held-for-sale. During the year ended December 31, 2004, the Company recorded an $86 million charge, net of income taxes, for a cumulative effect of a change in accounting principle in accordance with SOP 03-1, which provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. This charge is primarily related to those long-duration contract liabilities where the amount of the liability is indexed to the performance of a target portfolio of investment securities. During the year ended December 31, 2003, the Company recorded a $26 million charge, net of income taxes, for a cumulative effect of a change in accounting in accordance with Issue B36. Institutional The following table presents consolidated ﬁnancial information for the Institutional segment for the years indicated: Year Ended December 31, 2005 2004 2003 Revenues Premiums****************************************************************************** $11,387 Universal life and investment-type product policy fees ***************************************** 772 Net investment income ****************************************************************** 5,962 Other revenues ************************************************************************* 653 Net investment gains (losses) ************************************************************* (10) Total revenues ************************************************************************ 18,764 Expenses Policyholder beneﬁts and claims *********************************************************** Interest credited to policyholder account balances ******************************************** Policyholder dividends ******************************************************************* Other expenses ************************************************************************ Total expenses *********************************************************************** Income from continuing operations before provision for income taxes **************************** Provision for income taxes**************************************************************** Income from continuing operations********************************************************* Income (loss) from discontinued operations, net of income taxes******************************** Income before cumulative effect of a change in accounting, net of income taxes ****************** 1,562 Cumulative effect of a change in accounting, net of income taxes ****************************** — Net income **************************************************************************** $ 1,562 12,776 1,652 1 2,229 1,400 162 2,106 706 16,658 (In millions) $10,037 711 4,582 654 163 $ 9,063 660 4,146 618 (289) 16,147 14,198 11,173 1,016 — 1,972 14,161 1,986 678 1,308 19 1,327 (60) 10,023 974 (1) 1,854 12,850 1,348 485 863 49 912 (26) $ 1,267 $ 886 Year ended December 31, 2005 compared with the year ended December 31, 2004 — Institutional Income from continuing operations increased by $92 million, or 7%, to $1,400 million for the year ended December 31, 2005 from $1,308 million for the comparable 2004 period. The acquisition of Travelers accounted for $73 million of this increase, which includes $57 million, net of income taxes, of net investment losses. Excluding the impact of the Travelers acquisition, income from continuing operations increased by $19 million, or 1%, from the comparable 2004 period. An increase in interest margins of $124 million, net of income taxes, compared to the prior year period contributed to the increase in income from continuing operations. Management attributes this increase primarily to improvements in interest spreads for the retirement & savings and non-medical health products of $81 million and $44 million, both net of income taxes, respectively. Higher earnings from growth in the asset 14 MetLife, Inc. base, interest on economic capital, corporate and real estate joint venture income and income from securities lending activities are the primary drivers of the year over year increase. Interest margins in group life were relatively ﬂat with a decrease of $1 million. The interest margins in the retirement & savings and the group life businesses include the impact of a reduction in interest spreads compared to the prior year period. Interest spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads for the year ended December 31, 2005 increased to 3.38% from 3.06% in the prior year period for the non-medical health & other business. Interest rate spreads for the year ended December 31, 2005 decreased to 1.81% and 2.04% from 1.83% and 2.19%, in the prior year period for the retirement and savings and group life businesses, respectively. Management generally expects these spreads to be in the range of 1.30% to 1.60%, 1.20% to 1.35%, and 1.60% to 1.80% for the non-medical health & other, retirement & savings, and the group life businesses, respectively. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment-related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees for which the timing and amount are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from period to period. The increase in interest margins is partially offset by a decrease of $57 million, net of income taxes, in net investment gains (losses), which is partially offset by a decrease of $10 million, net of income taxes, in policyholder beneﬁts and claims related to net investment gains (losses). Also contributing to the decline in income from continuing operations is a $14 million charge, net of income taxes, related to an adjustment recorded on DAC associated with certain long-term care products in 2005 and a reduction of a premium tax liability of $31 million, net of income taxes, recorded in 2004. Underwriting results decreased by $7 million, net of income taxes, compared to the prior year. This decline is primarily due to less favorable results of $27 million, net of income taxes, in retirement & savings and a $24 million, net of income taxes, decrease in non-medical health & other. These unfavorable results were partially offset by an improvement of $44 million, net of income taxes, in group life’s underwriting results, primarily due to favorable claim experience. Underwriting results are generally the difference between the portion of premium and fee income intended to cover mortality, morbidity or other insurance costs less claims incurred and the change in insurance-related liabilities. Underwriting results are signiﬁcantly inﬂuenced by mortality, morbidity, or other insurance-related experience trends and the reinsurance activity related to certain blocks of business and, as a result, can ﬂuctuate from period to period. In addition, increases in operating expenses, which include higher expenses related to the Travelers integration, have more than offset the remaining growth in premiums, fees and other revenues. Total revenues, excluding net investment gains (losses), increased by $2,790 million, or 17%, to $18,774 million for the year ended December 31, 2005 from $15,984 million for the comparable 2004 period. The acquisition of Travelers accounted for $855 million of this increase. Excluding the impact of the Travelers acquisition, total revenues, excluding net investment gains (losses), increased by $1,935 million, or 12%, from the comparable 2004 period. This increase is comprised of growth in premiums, fees and other revenues of $1,266 million and higher net investment income of $669 million. The increase of $1,266 million in premiums, fees, and other revenues is largely due to an increase in non-medical health & other of $520 million, primarily due to growth in the disability, dental and accidental death and dismemberment (‘‘AD&D’’) products of $360 million. In addition, continued growth in the long-term care business contributed $138 million, of which $25 million is related to the 2004 acquisition of TIAA/CREF’s long-term care business. Group life insurance premiums, fees and other revenues increased by $481 million, which management primarily attributes to improved sales and favorable persistency, as well as a signiﬁcant increase in premiums from two large customers. Retirement & savings’ premiums, fees and other revenues increased by $265 million, which is largely due to growth in premiums, resulting primarily from an increase of $166 million in structured settlement sales and $107 million in pension close-outs. Premiums, fees and other revenues from retirement & savings products are signiﬁcantly inﬂuenced by large transactions, and as a result, can ﬂuctuate from period to period. In addition, net investment income increased by $669 million primarily due to higher income from growth in the asset base driven by sales, particularly in guaranteed interest contracts and the structured settlement business. In addition, increases in corporate and real estate joint venture income, interest on economic capital, and income from securities lending activities across the majority of the businesses, and higher short-term interest rates contributed to the growth compared to the prior year. Total expenses increased by $2,497 million, or 18%, to $16,658 million for the year ended December 31, 2005 from $14,161 million for the comparable 2004 period. The acquisition of Travelers accounted for $658 million of this increase. Excluding the impact of the acquisition of Travelers, total expenses increased by $1,839 million, or 13%, from the comparable 2004 period. This increase is comprised of higher policyholder beneﬁts and claims of $1,278 million, an increase in interest credited to policyholder account balances of $334 million and an increase in other expenses of $227 million. The increase in policyholder beneﬁts and claims of $1,278 million is attributable to a $482 million, a $452 million, and a $344 million increase in the non-medical health & other, group life, and retirement & savings businesses, respectively. These increases are predominantly attributable to the business growth referenced in the revenue discussion above. The increase in policyholder beneﬁts and claims in the non-medical health & other business include the impact of the acquisition of TIAA/CREF of $43 million. These increases include $2 million and $18 million of policyholder beneﬁts and claims related to Hurricane Katrina in the group life and non-medical health & other business, respectively. The increase in interest credited to policyholder account balances of $334 million is primarily the result of the impact of growth in guaranteed interest contracts within the retirement & savings business. In addition, the impact of higher short-term interest rates in the current year, also contributed to the increase. The rise in other expenses of $227 million is primarily due to higher non-deferrable volume-related expenses of $61 million, which are largely associated with business growth, an increase of $39 million in corporate support expenses, and $43 million of Travelers-related integration costs, principally incentive accruals. In addition, expenses increased as a result of the impact of a $49 million beneﬁt recorded in the second quarter of 2004, which is related to a reduction in a premium tax liability. Expenses also increased by $22 million related to an adjustment of DAC for certain long-term care products in 2005. Year ended December 31, 2004 compared with the year ended December 31, 2003 — Institutional Income from continuing operations increased by $445 million, or 52%, to $1,308 million for the year ended December 31, 2004 from $863 million for the comparable 2003 period. An improvement of $287 million, net of income taxes, in net investment gains (losses), which is partially offset by an increase of $63 million, net of income taxes, in policyholder beneﬁts and claims related to net investment gains (losses), is a signiﬁcant component of the increase. In addition, favorable interest rate spreads contributed $219 million, net of income taxes, to the increase compared to the prior year period, with the retirement & savings products generating $182 million, net of income taxes, of this increase. Higher investment yields, growth in the asset base and lower average crediting rates are the primary drivers of the year over year increase in interest rate spreads. These spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads for the year ended December 31, 2004 increased to 2.06%, 1.66% and 1.88% for group life, retirement & savings and the non-medical health & other businesses, respectively, from 2.04%, 1.40% and 1.51% for the group life, retirement & savings, and the non-medical health & other businesses, respectively, in the comparable prior year period. Management generally expects these spreads to be in the range of 1.60% to 1.80%, 1.30% to 1.45%, MetLife, Inc. 15 and 1.30% to 1.50% for the group life, retirement & savings and the non-medical health & other businesses, respectively. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment-related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees for which the timing and amount are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from period to period. Also contributing to the increase in income from continuing operations is a reduction in a premium tax liability of $31 million in the second quarter of 2004, net of income taxes. These increases in income from continuing operations are partially offset by less favorable underwriting results, which are estimated to have declined $40 million, net of income taxes, compared to the prior year period. Management attributes this decrease to mixed claim experience in the non-medical health & other and group life business. Underwriting results are signiﬁcantly inﬂuenced by mortality and morbidity trends, as well as claim experience and, as a result, can ﬂuctuate from period to period. Total revenues, excluding net investment gains (losses), increased by $1,497 million, or 10%, to $15,984 million for the year ended December 31, 2004 from $14,487 million for the comparable 2003 period. Growth of $1,061 million in premiums, fees, and other revenues contributed to the revenue increase. Group life insurance premiums, fees and other revenues increased by $452 million, which management primarily attributes to improved sales and favorable persistency, as well as the acquisition of the John Hancock group life insurance business in late 2003, which contributed $20 million to the increase. Non-medical health & other business premiums, fees and other revenues increased by $421 million partly due to the continued growth in long- term care of $149 million, of which $41 million is related to the 2004 acquisition of TIAA/CREF’s long-term care business. Growth in the disability business, dental business and AD&D products contributed $260 million to the year over year increase. Retirement & savings’ premiums, fees and other revenues increased by $188 million, which is largely due to a growth in premiums of $172 million, resulting primarily from an increase in structured settlement sales and pension close-outs. Premiums, fees and other revenues from retirement & savings products are signiﬁcantly inﬂuenced by large transactions, and as a result, can ﬂuctuate from year to year. In addition, an increase of $436 million in net investment income, which is primarily due to higher income from growth in the asset base, earnings on corporate joint venture income and bond and commercial mortgage prepayment fees contributed to the overall increase in revenues. This increase is a component of the favorable interest rate spreads discussed above. Total expenses increased by $1,311 million, or 10%, to $14,161 million for the year ended December 31, 2004 from $12,850 million for the comparable 2003 period. This increase is comprised of higher policyholder beneﬁts and claims of $1,150 million, an increase to interest credited to policyholder account balances of $42 million and an increase in other expenses of $118 million. The increase in policyholder beneﬁts and claims of $1,150 million is primarily attributable to a $453 million, $412 million, and $285 million increase in the group life, non-medical health & other and retirement & savings businesses, respectively. These increases are predominantly attributable to the business growth discussed in the revenue discussion above. The increases in group life and the non-medical health & other businesses include the impact of the acquisition of certain businesses from John Hancock and TIAA/CREF of $11 million and $39 million, respectively. Also included in the increase is the impact of less favorable claim experience, primarily in the non-medical health & other business. Interest credited to policyholder account balances increased by $42 million over the prior year period primarily as a result of the impact of growth in guaranteed interest contracts within the retirement & savings business. Other operating expenses increased $118 million. The largest component of this expense growth is an increase of $92 million related to increases in direct business support expenses. In addition, non-deferrable commissions and premium taxes increased by $25 million. This item is net of a $49 million reduction in a premium tax liability in the second quarter of 2004. Excluding this item, non-deferrable commissions and premium taxes increased by $74 million, which is commensurate with the aforementioned revenue growth. In addition, the Company incurred infrastructure improvement costs of $34 million and expenses of $12 million related to the closing of one of the Company’s disability claims centers which were partially offset by a decline of $45 million primarily relating to expenses incurred in the prior year for ofﬁce closures and consolidations and an impairment of related assets. Individual The following table presents consolidated ﬁnancial information for the Individual segment for the years indicated: Year Ended December 31, 2005 2004 2003 Revenues Premiums****************************************************************************** $ 4,502 Universal life and investment-type product policy fees ***************************************** 2,476 Net investment income ****************************************************************** 6,535 Other revenues ************************************************************************* 477 Net investment gains (losses) ************************************************************* (50) Total revenues ************************************************************************ 13,940 Expenses Policyholder beneﬁts and claims *********************************************************** Interest credited to policyholder account balances ******************************************** Policyholder dividends ******************************************************************* Other expenses ************************************************************************ Total expenses *********************************************************************** Income from continuing operations before provision for income taxes **************************** Provision for income taxes**************************************************************** Income from continuing operations********************************************************* 1,208 Income from discontinued operations, net of income taxes************************************* 295 Net income **************************************************************************** $ 1,503 5,420 1,775 1,670 3,272 1,803 595 12,137 (In millions) $ 4,204 1,805 6,031 422 91 $ 4,363 1,564 6,069 380 (311) 12,553 12,065 5,107 1,618 1,657 2,879 5,048 1,734 1,721 2,783 11,261 11,286 1,292 428 864 21 885 $ 779 260 519 51 570 $ 16 MetLife, Inc. Year ended December 31, 2005 compared with the year ended December 31, 2004 — Individual Income from continuing operations increased by $344 million, or 40%, to $1,208 million for the year ended December 31, 2005 from $863 million for the comparable 2004 period. The acquisition of Travelers accounted for $96 million of the increase which includes $66 million, net of income taxes, of net investment losses. Included in the Travelers results is a charge for the establishment of an excess mortality reserve related to group of speciﬁc policies. In connection with MetLife’s acquisition of Travelers, the Company has performed reviews of Travelers underwriting criteria in its effort to reﬁne its estimated fair values for the purchase allocation. As a result of these reviews and actuarial analyses, and to be consistent with MetLife’s existing reserving methodologies, the Company has established an excess mortality reserve on a speciﬁc group of policies. This resulted in a charge of $20 million, net of income taxes, to fourth quarter results. The Company expects to complete its reviews and reﬁne its estimate of the excess mortality reserve by June 30, 2006. Excluding the impact of the acquisition of Travelers, income from continuing operations increased by $248 million, or 29%, for the comparable 2004 period. Included in this increase are net investment losses of $26 million, net of income taxes. Improvements in interest rate spreads contributed $117 million, net of income taxes, to the year over year increase. These spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment-related transactions, such as corporate joint venture income and prepayment fees on bonds and commercial mortgages, the timing and amount of which are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from period to period. Fee income from separate account products increased by $126 million, net of income taxes, primarily related to growth in the business and favorable market conditions. Favorable underwriting results in life products contributed $37 million, net of income taxes, to the increase in income from continuing operations. Underwriting results are generally the difference between the portion of premium and fee income intended to cover mortality, morbidity or other insurance costs less claims incurred and the change in insurance-related liabilities. Underwriting results are signiﬁcantly inﬂuenced by mortality, morbidity, or other insurance-related experience trends and the reinsurance activity related to certain blocks of business and, as a result, can ﬂuctuate from period to period. The decrease in the closed-block related policyholder dividend obligation of $27 million, net of income taxes, lower annuity net guaranteed beneﬁt costs of $12 million, net of income taxes, and lower DAC amortization of $6 million, net of income taxes, all contributed to the increase. These increases in income from continuing operations are partially offset by lower net investment income on blocks of business that are not driven by interest rate spreads of $19 million, net of income taxes. The increase in income from continuing operations is partially offset by higher expenses of $10 million, net of income taxes, primarily due to higher operating costs offset by the impact of revisions to certain expense, premium tax and policyholder liability estimates in the current year and certain asset write-offs in the prior year. Additionally, offsetting the increase in income from continuing operations, is a revision to the estimate for policyholder dividends of $9 million, net of income taxes, which occurred in the prior year. The changes in tax rates between years accounted for a decrease in income from continuing operations of $15 million. Total revenues, excluding net investment gains (losses), increased by $1,528 million, or 12%, to $13,990 million for the year ended December 31, 2005 from $12,462 million for the comparable 2004 period. The acquisition of Travelers accounted for $975 million of the increase. Excluding the impact of the acquisition of Travelers, total revenues, excluding net investment gains (losses) increased by $553 million, or 4%, to $13,015 million for the year ended December 31, 2005 from $12,462 million for the comparable 2004 period. This increase includes higher fee income primarily from variable annuity and universal life products of $239 million resulting from a combination of growth in the business and improved overall market performance. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. In addition, management attributes higher premiums of $170 million in 2005 to the active marketing of income annuity products. Although premiums associated with the Company’s closed block of business continue to decline, as expected, by $94 million, an increase in premiums of $130 million from other life products more than offset the decline of the closed block. Included in the premium increase of the other life products is the impact of growth in the business and a new reinsurance strategy where more business is retained. Net investment income increased by $108 million resulting from higher joint venture income and bond and commercial mortgage prepayment fees partially offset by a decline in bond yields. Total expenses increased by $876 million, or 8%, to $12,137 million for the year ended December 31, 2005 from $11,261 million for the comparable 2004 period. The acquisition of Travelers accounted for $761 million of the increase. Excluding the impact from the acquisition of Travelers, total expenses increased by $115 million, or 1%, to $11,376 million for the year ended December 31, 2005 from $11,261 million for the comparable 2004 period. Higher expenses are primarily the result of higher policyholder beneﬁts primarily due to the increase in future policy beneﬁts of $207 million, commensurate with the net increase in premium on annuity and life products discussed above, partially offset by $5 million due to better mortality in life products. Also partially offsetting the increase in policyholder beneﬁts was a reduction in the closed block-related policyholder dividend obligation of $41 million and a beneﬁt of $18 million associated with the hedging of guaranteed annuity beneﬁt riders. The reduction in the closed block-related policyholder dividend obligation was driven by lower net investment income, offset by higher realized gains in the closed block. Interest credited to policyholder account balances decreased by $45 million due to lower crediting rates, partially offset by the growth in policyholder account balances. In addition, total expenses increased by $13 million due to a revision in the estimate of policyholder dividends in the prior period. Other expenses increased primarily due to higher corporate incentive expenses of $60 million and higher general spending of $28 million. The current year includes revisions to prior period estimates for certain expense, premium tax and policyholder liabilities which reduce the current year expenses while the prior period includes certain asset write-offs which increased the prior year expenses. The impact of these two items resulted in a decrease in other expenses of $73 million. Also offsetting the increase in other expenses is lower DAC amortization of $9 million resulting from net investment losses and adjustments for management’s update of assumptions used to determine estimated gross margins partially offset by growth in the business. Year ended December 31, 2004 compared with the year ended December 31, 2003 — Individual Income from continuing operations increased by $345 million, or 66%, to $864 million for the year ended December 31, 2004 from $519 million for the comparable 2003 period. Included in this increase is an improvement in net investment gains (losses) of $269 million, net of income taxes. This increase includes additional fee income of $186 million, net of income taxes, primarily related to separate account products. In addition, improvement in interest rate spreads contributed $81 million, net of income taxes, to the year over year increase. These spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads include income from certain investment transactions, including corporate joint venture income and bond and commercial mortgage prepayment fees, the timing and amount of which are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from year to year. Additionally, the charge of $32 million, net of income taxes, in 2003 related to certain improperly deferred expenses at New England Financial, and a reduction in MetLife, Inc. 17 policyholder dividends of $43 million, net of income taxes, in 2004 contributed to the increase in income from continuing operations. These increases in income from continuing operations are partially offset by a reduction in earnings of $101 million, net of income taxes, resulting from an increase in the closed block-related policyholder dividend obligation, associated primarily with an improvement in net investment gains (losses). Higher DAC amortization of $72 million, net of income taxes, also increased expenses for the year ended December 31, 2004. Additionally, offsetting these increases are lower net investment income on traditional life and income annuity products of $32 million, net of income taxes. The application of SOP 03-1 and the corresponding cost of hedging guaranteed annuity beneﬁt riders reduced earnings by $30 million, net of income taxes. In addition, less favorable underwriting results in the traditional and universal life products of $22 million, net of income taxes, and higher general spending of $17 million, net of income taxes, added to this offset. These underwriting results are signiﬁcantly inﬂuenced by mortality experience and the reinsurance activity related to certain blocks of business and, as a result, can ﬂuctuate from period to period. Total revenues, excluding net investment gains (losses), increased by $86 million, or 1%, to $12,462 million for the year ended December 31, 2004 from $12,376 million for the comparable 2003 period. This increase includes higher fee income primarily from separate account products of $256 million resulting from a combination of growth in the business and improved overall market performance. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. In addition, management attributes higher premiums of $37 million in 2004 to the active marketing of income annuity products. The increased volume of sales in 2004 also resulted in higher broker/dealer and other subsidiaries revenues of $27 million. Partially offsetting the increases in total revenues for the year ended December 31, 2004 are lower premiums of $196 million which are primarily related to the Company’s closed block of business which decreased by $209 million and continues to run off at management’s expected range of 3% to 6% per year. In addition, lower net investment income of $38 million resulting from lower investment yields offset increases in total revenues. Total expenses decreased by $25 million, or less than 1%, to $11,261 million for the year ended December 31, 2004 from $11,286 million for the comparable 2003 period. Lower expenses are primarily the result of a $193 million decrease in the closed block policyholder beneﬁts, commensurate with the net decrease in premiums and a $116 million decline in interest credited to policyholder account balances due to lower crediting rates. Also included in the decrease in expenses are lower policyholder dividends of $64 million primarily resulting from reductions in the dividend scale in late 2003 and a charge in 2003 related to certain improperly deferred expenses at New England Financial of $48 million. Partially offsetting these decreases in expenses is a $151 million increase in the closed block-related policyholder dividend obligation based on positive performance of the closed block and higher DAC amortization of $108 million. The increase in DAC amortization is a result of accelerated amortization resulting from improvement in net investment gains (losses) and the update of management’s assumptions used to determine estimated gross margins. Additionally, offsetting the decrease to expenses is a $46 million increase from the application of SOP 03-1 and the corresponding cost of hedging guaranteed annuity beneﬁt riders, a $35 million increase in future policy beneﬁts commensurate with the increase in income annuity premiums, and a $10 million increase in policyholder beneﬁts primarily due to higher amortization of deferred sales inducements due to growth in expenses. Further, the decrease in expenses was offset by higher general spending of $26 million and a $10 million increase in broker/dealer and other subsidiary-related expenses. Additionally, unfavorable underwriting results in the traditional and universal life products of $9 million contributed to the increase. Auto & Home The following table presents consolidated ﬁnancial information for the Auto & Home segment for the years indicated: Year Ended December 31, 2005 2004 2003 (In millions) Revenues Premiums ********************************************************************************* $2,911 Net investment income ********************************************************************** 181 Other revenues **************************************************************************** 33 Net investment gains (losses) **************************************************************** (12) Total revenues *************************************************************************** 3,113 Expenses Policyholder beneﬁts and claims ************************************************************** Policyholder dividends*********************************************************************** Other expenses **************************************************************************** Total expenses*************************************************************************** Income before provision for income taxes ****************************************************** 288 Provision for income taxes ******************************************************************* 64 Net income ******************************************************************************* $ 224 1,994 3 828 2,825 $2,948 171 35 (9) $2,908 158 33 (15) 3,145 3,084 2,079 2 795 2,876 269 61 2,139 2 756 2,897 187 30 $ 208 $ 157 Year ended December 31, 2005 compared with the year ended December 31, 2004 — Auto & Home Net income increased by $16 million, or 8%, to $224 million for the year ended December 31, 2005 from $208 million for the comparable 2004 period. The increase is primarily the result of improvements in the development of prior years claims of $40 million, net of income taxes, and an improvement in the non-catastrophe combined ratio resulting in $16 million, net of income taxes, primarily due to lower automobile and homeowner claim frequencies. Also contributing to this increase in net income is an improvement in losses from the involuntary Massachusetts automobile plan of $12 million, net of income taxes, an increase in net investment income of $6 million, net of income taxes, and an increase in earned premium of $4 million, net of income taxes, as discussed below. Offsetting these improved results, is an increase in catastrophes, including Hurricanes Katrina and Wilma of $63 million, net of income taxes. Total revenues, excluding net investment gains (losses), decreased by $29 million, or 1%, to $3,125 million for the year ended December 31, 2005 from $3,154 million for the comparable 2004 period. This decrease is primarily attributable to reinstatement and additional reinsurance-related premiums due to Hurricane Katrina of $43 million. This decrease was partially offset by higher net investment income of $10 million, primarily due to a change in the 18 MetLife, Inc. allocation of economic capital, offset by a lower yield on a slightly higher invested asset base and an increase in earned premium of $6 million primarily due to rate increases, higher inﬂation guard endorsements and higher insurance-to-value programs, all in the homeowners business. Total expenses decreased by $51 million, or 2%, to $2,825 million for the year ended December 31, 2005 from $2,876 million for the comparable 2004 period. This decrease is predominantly due to improved non-catastrophe losses of $32 million. This is primarily due to lower non-catastrophe automobile and homeowner claim frequencies of $18 million and a smaller exposure base of $15 million for the year ended December 31, 2005 versus the comparable 2004 period. Improvement in the development of losses reported in prior years contributed $61 million. Unallocated claim expenses, excluding the expenses associated with Hurricane Katrina, decreased by $28 million mainly due to a smaller increase in the year over year change in unallocated claim expense liability due to a smaller increase in the related loss reserve and related unallocated claim expense reserve rate. Assumed losses from the involuntary Massachusetts automobile plan decreased by $18 million primarily due to improved claim frequency and severity trends. These improvements were partially offset by an increase in catastrophe losses, including Hurricanes Katrina and Wilma, of $54 million and an increase in other expenses of $33 million primarily as a result of higher information technology, advertising and compensation costs. The combined ratio, excluding catastrophes and before the reinstatement premiums and other reinsurance-related premium adjustments due to Hurricane Katrina, is 86.7% for the year ended December 31, 2005 versus 90.4% for the comparable 2004 period. Year ended December 31, 2004 compared with the year ended December 31, 2003 — Auto & Home Net income increased by $51 million, or 32%, to $208 million for the year ended December 31, 2004 from $157 million for the comparable 2003 period. This increase is primarily attributable to an improved non-catastrophe combined ratio, which resulted in a beneﬁt of $52 million, net of income taxes, improved claim development related to prior accident years of $61 million, net of income taxes, and an increase in net investment income of $13 million, net of income taxes. Partially offsetting these favorable variances are increased catastrophe losses of $73 million, net of income taxes. This increase resulted from the four hurricanes that struck the Southeastern United States in August and September of 2004. Total revenues, excluding net investment gains (losses), increased by $55 million, or 2%, to $3,154 million for the year ended December 31, 2004 from $3,099 million for the comparable 2003 period. This increase is primarily attributable to a $40 million increase in premiums, which is largely the result of an increase in the average earned premium resulting from continued rate increases. In addition, a $13 million increase in net investment income is largely attributable to growth in the underlying asset base, an increase in the investment yield and higher income related to tax advantaged municipal bonds. Total expenses decreased by $21 million, or 1%, to $2,876 for the year ended December 31, 2004 from $2,897 million for the comparable 2003 period. This decrease is the result of an improvement in policyholder beneﬁts and claims due to a favorable change of $94 million in prior year claim development, as well as a decrease in expenses of $80 million resulting from an improved non-catastrophe combined ratio primarily attributable to lower automobile and homeowners claim frequencies. These favorable changes in expenses are partially offset by an increase in losses from catastrophes of $112 million and a $39 million increase in expenses primarily due to inﬂation and employee and other related labor costs. The combined ratio excluding catastrophes declined to 90.4% for the year ended December 31, 2004 from 97.1% for the comparable 2003 period. International The following table presents consolidated ﬁnancial information for the International segment for the years indicated: Year Ended December 31, 2005 2004 2003 (In millions) Revenues Premiums ***************************************************************************************** $2,186 Universal life and investment-type product policy fees **************************************************** 579 Net investment income ****************************************************************************** 844 Other revenues ************************************************************************************ 20 Net investment gains (losses) ************************************************************************ 5 Total revenues *********************************************************************************** 3,634 Expenses Policyholder beneﬁts and claims ********************************************************************** Interest credited to policyholder account balances ******************************************************* Policyholder dividends******************************************************************************* Other expenses ************************************************************************************ Total expenses*********************************************************************************** Income from continuing operations before provision for income taxes *************************************** Provision (beneﬁt) for income taxes ******************************************************************** Income from continuing operations ******************************************************************** Income (loss) from discontinued operations, net of income taxes ******************************************* Income before cumulative effect of a change in accounting, net of income taxes ***************************** 192 Cumulative effect of a change in accounting, net of income taxes ****************************************** — Net income *************************************************************************************** $ 192 2,128 278 5 1,000 223 36 187 5 3,411 $1,690 349 585 23 23 2,670 1,611 151 6 614 2,382 288 86 202 (9) 193 (30) $1,631 271 500 80 8 2,490 1,456 143 9 652 2,260 230 17 213 (5) 208 — $ 163 $ 208 Year ended December 31, 2005 compared with the year ended December 31, 2004 — International Income from continuing operations decreased by $15 million, or 7%, to $187 million for the year ended December 31, 2005 from $202 million for the comparable 2004 period. The acquisition of Travelers accounted for a loss from continuing operations of $24 million including net investment losses of $14 million, net of income taxes. Excluding the impact of the Travelers acquisition, income from continuing operations increased by $9 million, or 4%, MetLife, Inc. 19 over the prior year. South Korea’s income from continuing operations increased by $26 million, net of income taxes, primarily due to growth in business, speciﬁcally higher sales of its variable universal life product and a larger in-force business. Chile’s income from continuing operations increased by $8 million primarily due to growth in business, speciﬁcally in the new bank distribution channel, as well as an increase in net investment income primarily due to higher inﬂation rates. Mexico’s income from continuing operations increased by $8 million, primarily due to tax beneﬁts of $27 million under the American Jobs Creation Act of 2004, higher net investment earnings, an adjustment to the amortization of DAC for management’s update of assumptions used to determine estimated gross margins and several other one-time revenue items. These increases in Mexico were substantially offset by an increase in certain policyholder liabilities caused by unrealized investment losses on the invested assets supporting those liabilities, as well as an increase in expenses for start up costs for the new Mexican Pension Business (‘‘AFORE’’) and contingency liabilities. Partially offsetting these increases in income from continuing operations was a decrease in Canada of $13 million, net of income taxes, primarily due to a realignment of economic capital, offset by the strengthening of the liability on its pension business related to changes in mortality assumptions in the prior year and higher home ofﬁce and infrastructure expenditures in support of the segment growth of $16 million, net of income taxes. The remainder of the variance can be attributed to various other countries. Additionally, $4 million of the increase in income from continuing operations is due to changes in the foreign currency exchange rates. Total revenues, excluding net investment gains (losses), increased by $982 million, or 37%, to $3,629 million for the year ended December 31, 2005 from $2,647 million for the comparable 2004 period. The acquisition of Travelers accounted for $377 million of this increase. Excluding the impact of the Travelers acquisition, total revenues, excluding net investment gains, increased by $605 million, or 23%, over the comparable 2004 period. Premiums, fees and other revenues increased by $452 million, or 22%, to $2,514 million for the year ended December 31, 2005 from $2,062 million for the comparable 2004 period. This increase is primarily the result of continued business growth through increased sales and renewal business within South Korea, Brazil and Taiwan of $216 million, $48 million and $31 million, respectively. Mexico’s premiums, fees and other revenues increased by $78 million primarily due to increases in the institutional and agency business channels, as well as several one-time other revenue items of $19 million. Chile’s premiums, fees and other revenues increased by $64 million mainly due to its new bank distribution channel. Net investment income increased by $153 million, or 26%, to $738 million for the year ended December 31, 2005 from $585 million for the comparable 2004 period. Mexico’s net investment income increased by $89 million due principally to increases in interest rates and also as a result of an increase in invested assets. Chile’s net investment income increased by $58 million primarily due to higher inﬂation rates and an increase in invested assets. Investment valuations and returns on invested assets in Chile are linked to the inﬂation rates. South Korea and Taiwan’s net investment income increased by $20 million and $11 million, respectively, primarily due to an increase in their invested assets. These increases in net investment income were partially offset by a decrease of $21 million due to the realignment of economic capital. The remainder of the increases in total revenues, excluding net investment gains can be attributed to business growth and investment income in other countries. Additionally, $221 million of the increase in total revenues, excluding net investment gains (losses), is due to changes in foreign currency exchange rates. Total expenses increased by $1,029 million, or 43%, to $3,411 million for the year ended December 31, 2005 from $2,382 million for the comparable 2004 period. The acquisition of Travelers accounted for $404 million of this increase. Excluding the impact of the Travelers acquisition, total expenses increased by $625 million, or 26%, over the comparable 2004 period. Policyholder beneﬁts and claims, policyholder dividends and interest credited to policyholder account balances increased by $451 million, or 26%, to $2,219 million for the year ended December 31, 2005 from $1,768 million for the comparable 2004 period. Policyholder beneﬁts and claims and dividends in Mexico increased by $177 million primarily due to an increase in certain policyholder liabilities caused by unrealized investment gains (losses) on the invested assets supporting those liabilities of $110 million, as well as an increase in interest credited to policyholder accounts of $65 million in line with the net investment income increase in Mexico. South Korea, Taiwan and Brazil’s policyholder beneﬁts and claims, policyholder dividends and interest credited to policyholder accounts increased by $122 million, $41 million and $27 million, respectively, commensurate with the business growth discussed above. Chile’s policyholder beneﬁts and claims, policyholder dividends and interest credited to policyholder accounts increased by $86 million due to the business growth primarily in the bank distribution channel business, as well as to an increase in the liabilities for annuity beneﬁts, which, like net investment income on related assets, are linked to the inﬂation rate. Hong Kong’s policyholder beneﬁts and claims and policyholder dividends increased by $3 million due to higher claims and the associated increase in liabilities in 2005. These increases were partially offset by a decrease of $10 million in Canada’s policyholder beneﬁts and claims, policyholder dividends and interest credited to policyholder account balances primarily due to the strengthening of the liability on its pension business related to changes in mortality assumptions in the prior year. Other expenses increased by $174 million, or 28%, to $788 million for the year ended December 31, 2005 from $614 million for the comparable 2004 period. South Korea’s other expenses increased by $73 million primarily due to higher amortization of deferred acquisition costs driven by the rapid growth in the business, a decrease in a payroll tax liability in the prior year resulting from the resolution of the related tax matter, an accrual for an early retirement program in 2005, as well as additional overhead expenses in line with the growth in business. Mexico’s other expenses increased by $17 million primarily due to incurred start up costs during the current year associated with the AFORE operations, an increase in liabilities related to potential employment matters in 2005, an increase in consulting services and a decrease in the prior year of severance accruals. Partially offsetting these increases in Mexico is a decrease in the amortization of DAC due to an adjustment for management’s update of assumptions used to determine estimated gross margins. Brazil’s other expenses increased by $28 million, primarily due to growth in business discussed above including an increase in non-deferrable sales expenses. Chile’s other expenses increased by $24 million due primarily to increases in non-deferrable expenses for the bank distribution channel of business in 2005. Other expenses at home ofﬁce also increased by $26 million primarily due to increased consultant fees for growth initiative projects, an increase in compensation resulting from increased headcount, higher incentive compensa- tion, as well as higher costs for legal, marketing and other corporate support expenses. The remainder of the increase in total expenses can be attributed to business growth in other countries. Additionally, a component of the growth in total expenses is due to changes in foreign currency exchange rates of $202 million. Year ended December 31, 2004 compared with the year ended December 31, 2003 — International Income from continuing operations decreased by $11 million, or 5%, to $202 million for the year ended December 31, 2004 from $213 million for the comparable 2003 period. The prior year includes a $62 million beneﬁt, net of income taxes, from the merger of the Mexican operations and a reduction in policyholder liabilities resulting from a change in methodology in determining the liability for future policy beneﬁts, a $12 million tax beneﬁt in Chile related to the merger of two subsidiaries and an $8 million beneﬁt, net of income taxes, related to reinsurance treaties. These increases are partially offset by a $19 million charge, net of income taxes, in Taiwan related to an increased loss recognition liability due to low interest rates relative to product guarantees. The prior year also includes a $4 million beneﬁt, net of income taxes, related to the Spanish operations, which were sold in 2003. Excluding these items, income from continuing operations increased by $56 million, or 38%. A signiﬁcant component of this increase is attributable to the application of SOP 03-1 in 2004, which resulted in a $21 million decrease, net of income taxes, in policyholder liabilities in Mexico. The primary driver of 20 MetLife, Inc. the 2004 impact is a decline in the fair value of the underlying assets associated with these contracts. Additionally, a $10 million, net of income taxes, increase in net investment gains is primarily due to the gain from the sale of the Spanish operations. In addition, 2004 includes $8 million of certain tax- related beneﬁts in South Korea. The remainder of the increase can be attributed to business growth in other countries. Additionally, $8 million of the decrease in income from continuing operations is due to changes in the foreign currency exchange rates. Total revenues, excluding net investment gains (losses), increased by $165 million, or 7%, to $2,647 million for the year ended December 31, 2004 from $2,482 million for the comparable 2003 period. The prior year period includes $230 million of revenues related to the Spanish operations, which were sold in 2003. Excluding the sale of these operations, revenues increased by $395 million, or 18%. The Company’s Mexican and Chilean operations increased revenues by $144 million and $58 million, respectively, primarily due to growth in the business, as well as improved investment earnings. The Company’s operations in South Korea and Taiwan also have increased revenues by $121 million and $34 million, respectively, primarily due to increased new sales and renewal business. The remainder of the increase can be attributed to business growth in other countries. Changes in foreign currency exchange rates contributed $14 million to the year over year increase in total revenues. Total expenses increased by $122 million, or 5%, to $2,382 million for the year ended December 31, 2004 from $2,260 million for the comparable 2003 period. The prior year includes expenses of $223 million related to the Spanish operations, which were sold in 2003. The prior year also includes a $79 million beneﬁt related to a reduction in the Mexican operation’s policyholder liabilities resulting from a change in methodology in determining the liability for future policy beneﬁts, partially offset by a related increase of $45 million in amortization of VOBA. Additionally, Taiwan’s 2003 expenses include a $30 million pre-tax charge due to an increased loss recognition reserve as a result of low interest rates relative to product guarantees. Excluding these items, expenses increased $341 million, or 17%, over the prior year. Expenses grew by $71 million, $98 million, $58 million and $36 million for the operations in Mexico, South Korea, Chile and Taiwan, respectively, which is commensurate with the revenue growth discussed above. In addition, 2004 includes a $33 million decrease in Mexico’s policyholder liabilities resulting from the application of SOP 03-1. Canada’s expenses increased by $13 million due primarily to the strengthening of the liability on its pension business related to changes in mortality assumptions in the fourth quarter of 2004. The remainder of the increase in total expenses is primarily related to the ongoing investment in infrastructure. Changes in foreign currency exchange rates contributed $18 million to the year over year increase in total expenses. Reinsurance The following table presents consolidated ﬁnancial information for the Reinsurance segment for the years indicated: Year Ended December 31, 2005 2004 2003 (In millions) Revenues Premiums ***************************************************************************************** $3,869 Universal life and investment-type product policy fees **************************************************** — Net investment income ****************************************************************************** 606 Other revenues ************************************************************************************ 58 Net investment gains (losses) ************************************************************************ 22 Total revenues *********************************************************************************** 4,555 Expenses Policyholder beneﬁts and claims ********************************************************************** Interest credited to policyholder account balances ******************************************************* Policyholder dividends******************************************************************************* Other expenses ************************************************************************************ Total expenses*********************************************************************************** Income before provision for income taxes ************************************************************** Provision for income taxes *************************************************************************** Net income *************************************************************************************** $ 3,206 220 — 991 4,417 138 46 92 $3,348 — 538 56 59 4,001 2,694 212 1 957 3,864 137 46 $2,648 — 431 47 62 3,188 2,109 184 — 764 3,057 131 45 $ 91 $ 86 Year ended December 31, 2005 compared with the year ended December 31, 2004 — Reinsurance Net income increased by $1 million, or 1%, to $92 million for the year ended December 31, 2005 from $91 million for the comparable 2004 period. This increase is attributable to a 14% increase in revenues, primarily due to new premiums from facultative and automatic treaties and renewal premiums on existing blocks of business in the U.S. and international operations, as well as an increase in net investment income due to growth in RGA’s operations and invested asset base. The increase in net income is partially offset by a reduction in net investment gains of $12 million, net of income taxes and minority interest, and a higher loss ratio in the current year, primarily due to unfavorable mortality experience as a result of high claim levels in the U.S. and the U.K. during the ﬁrst six months of the year. Reserve strengthening in RGA’s Argentine pension business in 2005 reduced net income by $11 million, net of income taxes and minority interest. The comparable 2004 period included a negotiated claim settlement in RGA’s accident and health business, reducing net income by $8 million, net of income taxes and minority interest. The Argentine pension business and the accident and health business are currently in run-off. Total revenues, excluding net investment gains (losses), increased by $591 million, or 15%, to $4,533 million for the year ended December 31, 2005 from $3,942 million for the comparable 2004 period primarily due to a $521 million, or 16%, increase in premiums and a $68 million, or 13%, increase in net investment income. New premiums from facultative and automatic treaties and renewal premiums on existing blocks of business in the U.S. and international operations contributed to the premium growth. Premium levels are signiﬁcantly inﬂuenced by large transactions and reporting practices of ceding companies and, as a result, can ﬂuctuate from period to period. The growth in net investment income is the result of the growth in RGA’s operations and invested asset base. Additionally, a component of the total revenue increase is attributable to foreign currency exchange rate movements contributing an estimated $49 million. MetLife, Inc. 21 Total expenses increased by $553 million, or 14%, to $4,417 million for the year ended December 31, 2005 from $3,864 million for the comparable 2004 period. This increase is commensurate with growth in revenues and is primarily attributable to an increase of $520 million in policyholder beneﬁts and claims and interest credited to policyholder account balances, primarily associated with RGA’s growth in insurance in force of approximately $270 billion, the aforementioned unfavorable mortality experience in the U.S. and U.K. during the ﬁrst six months of the year, and strengthening of reserves of $33 million for the Argentine pension business. The comparable 2004 period included a negotiated claim settlement in RGA’s accident and health business of $24 million and $18 million in policy beneﬁts and claims as a result of the Indian Ocean tsunami on December 26, 2004 and claims development associated with the reinsurance of the Argentine pension business. Other expenses increased by $34 million, or 4%, primarily due to an increase in the amortization of DAC. Changes in DAC, included in other expenses, can vary from period to period primarily due to changes in the mixture of the business being reinsured. Additionally, $46 million of the total expense increase is attributable to foreign currency exchange rate movements. Year ended December 31, 2004 compared with the year ended December 31, 2003 — Reinsurance Net income increased by $5 million, or 6%, to $91 million for the year ended December 31, 2004 from $86 million for the comparable 2003 period. This increase is attributable to a 26% increase in revenues, primarily due to strong premium growth across all of RGA’s geographical segments, which includes the effect of the Allianz Life transaction. The growth in income from continuing operations is partially offset by higher minority interest expense as the Company’s ownership in RGA decreased from 59% to 52% in the comparable periods and a negotiated claim settlement in RGA’s accident and health business, which is currently in run-off, of $8 million for the third quarter of 2004, net of income taxes and minority interest. Total revenues, excluding net investment gains (losses), increased by $816 million, or 26%, to $3,942 million for the year ended December 31, 2004 from $3,126 million for the comparable 2003 period due primarily to a $700 million increase in premiums. The premium increase during the year ended December 31, 2004 is partially the result of RGA’s coinsurance agreement with Allianz Life under which RGA assumed 100% of Allianz Life’s United States traditional life reinsurance business. This transaction closed during 2003, with six months of reinsurance activity recorded in 2003, as compared to twelve months in 2004. New premiums from facultative and automatic treaties and renewal premiums on existing blocks of business in the United States and certain international operations also contributed to the premium growth. Premium levels are signiﬁcantly inﬂuenced by large transactions, such as the Allianz Life transaction, and reporting practices of ceding companies, and as a result, can ﬂuctuate from period to period. Net investment income also contributed to revenue growth, increasing $107 million, or 25%, to $538 million in 2004 from $431 million in 2003. The growth in net investment income is the result of the growth in RGA’s operations and invested asset base, as well as the conversion of a large reinsurance treaty from a funds withheld to coinsurance basis which resulted in an increase of $12 million in net investment income. Additionally, a component of the total revenue increase is attributable to foreign currency exchange rate movements contributing an estimated $99 million. Total expenses increased by $807 million, or 26%, to $3,864 million for the year ended December 31, 2004 from $3,057 million for the comparable 2003 period. This increase is commensurate with the growth in revenues and is primarily attributable to an increase of $613 million in policyholder beneﬁts and claims and interest credited to policyholder account balances, primarily associated with RGA’s growth in insurance in force of approximately $200 billion, a negotiated claim settlement in RGA’s accident and health business of $24 million, and the inclusion of only six months of results from the Allianz Life transaction in the prior year. The growth in interest credited is associated with an increase in the account balances of market value adjusted annuity products and is generally offset by corresponding change in investment income. Also, during the fourth quarter of 2004, RGA recorded approximately $18 million in policy beneﬁts and claims as a result of the Indian Ocean tsunami on December 26, 2004 and claims development associated with its reinsurance of Argentine pension business. Other expenses increased primarily due to an increase of $106 million in allowances and related expenses on assumed reinsurance associated with RGA’s growth in premiums and insurance in force and $15 million in additional amortization of DAC from the conversion of a large reinsurance treaty from a funds withheld to coinsurance basis. The balance of the growth in other expenses is primarily due to additional costs in the U.S. associated with the Allianz Life transaction, start-up costs in various international markets, and the aforementioned increase in minority interest expense from $114 million in 2003 to $161 million in 2004. Additionally, $95 million of the total expense increase is attributable to foreign currency exchange rate movements. 22 MetLife, Inc. Corporate & Other The following table presents consolidated ﬁnancial information for Corporate & Other for the years indicated: Revenues Premiums ******************************************************************************************* $ Universal life and investment-type product policy fees******************************************************* Net investment income ******************************************************************************** Other revenues*************************************************************************************** Net investment gains (losses) *************************************************************************** Total revenues ************************************************************************************* 5 1 782 30 (48) 770 $ (27) 2 457 8 (152) 288 $ (38) — 168 41 (6) 165 Year Ended December 31, 2005 2004 2003 (In millions) Expenses Policyholder beneﬁts and claims************************************************************************* Other expenses ************************************************************************************** Total expenses ************************************************************************************* Income (loss) from continuing operations before income tax beneﬁt ******************************************* Income tax beneﬁt ************************************************************************************ Income from continuing operations ********************************************************************** Income from discontinued operations, net of income taxes ************************************************** Income before cumulative effect of a change in accounting, net of income taxes ******************************** Cumulative effect of a change in accounting, net of income taxes ******************************************** Net income ****************************************************************************************** 1,141 Preferred stock dividends ****************************************************************************** 63 Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust *************** — Net income available to common shareholders ************************************************************ $1,078 28 1,113 1,141 — 929 (159) (187) (18) 947 (2) 596 594 (306) (270) (36) 176 140 4 144 — — 36 359 395 (230) (221) (9) 319 310 — 310 — 21 $ 144 $ 289 Year ended December 31, 2005 compared with the year ended December 31, 2004 — Corporate & Other Income from continuing operations increased by $64 million, or 178%, to $28 million for the year ended December 31, 2005 from a loss of $36 million for the comparable 2004 period. The acquisition of Travelers, excluding Travelers ﬁnancing and integration costs incurred by the Company, accounted for $88 million of this increase. Excluding the impact of the Travelers acquisition, income from continuing operations decreased by $24 million for the year ended December 31, 2005 from the comparable 2004 period. The 2005 period includes a $31 million beneﬁt from a revision of the estimate of income taxes for 2004, a $30 million beneﬁt, net of income taxes, associated with the reduction of a previously established liability for settlement death beneﬁts related to the Company’s sales practices class action settlement recorded in 1999, and an $18 million beneﬁt, net of income taxes, associated with the reduction of a previously established real estate transfer tax liability related to the Company’s demutualization in 2000. The 2004 period includes a $105 million beneﬁt associated with the resolution of issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Also included in the 2004 period is an expense related to a $32 million, net of income taxes, contribution to the MetLife Foundation and a $9 million beneﬁt from a revision of the estimate of income taxes for 2003. Excluding the impact of these items, income from continuing operations decreased by $21 million for the year ended December 31, 2005 from the comparable 2004 period. The decrease is primarily attributable to higher interest expense on debt (principally associated with the issuance of debt to ﬁnance the Travelers acquisition), integration costs associated with the acquisition of Travelers, interest credited to bank holder deposits and legal-related liabilities of $119 million, $76 million, $44 million and $4 million, respectively, all of which are net of income taxes. This is partially offset by an increase in net investment income of $107 million, net of income taxes, higher net investment gains of $66 million, net of income taxes, and a decrease in corporate support expenses of $10 million, net of income taxes. The remainder of the difference is primarily driven by the difference between the actual and the estimated tax rate allocated to the various segments. Total revenues, excluding net investment gains (losses), increased by $378 million, or 86%, to $818 million for the year ended December 31, 2005 from $440 million for the comparable 2004 period. The acquisition of Travelers accounted for $152 million of this increase. Excluding the impact of the acquisition of Travelers, the increase of $226 million is primarily attributable to increases in income on ﬁxed maturities as a result of higher yields from lengthening the duration and a higher asset base, as well as increased income from corporate joint ventures and mortgage loans on real estate. Also included as a component of total revenues are intersegment eliminations which are offset within total expenses. Total expenses increased by $335 million, or 56%, to $929 million for the year ended December 31, 2005 from $594 million for the comparable 2004 period. The acquisition of Travelers, excluding Travelers ﬁnancing and integration costs incurred by the Company, accounted for $15 million of this increase. Excluding the impact of the acquisition of Travelers, total expenses increased by $320 million for the year ended December 31, 2005 from the comparable 2004 period. The 2005 period includes a $47 million beneﬁt associated with a reduction of a previously established liability for settlement death beneﬁts related to the Company’s sales practices class action settlement recorded in 1999, a $28 million beneﬁt associated with the reduction of a previously established real estate transfer tax liability related to the Company’s demutualization in 2000. The 2004 period includes a $50 million contribution to the MetLife Foundation, partially offset by a $22 million reduction of a liability associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Excluding the impact of these items, total expenses increased by $423 million for the year ended December 31, 2005 from the comparable 2004 period. This increase is attributable to higher interest expense of $187 million as a result of the issuance of senior notes in 2004 and 2005, which includes $129 million of expenses from the ﬁnancing of the acquisition of Travelers. Integration costs associated with the acquisition of Travelers were $120 million. As a result of growth in the business, interest credited to bank holder deposits increased by $70 million at MetLife Bank. In addition, legal-related liabilities increased by $5 million. These MetLife, Inc. 23 increases were offset by a reduction in corporate support expenses of $16 million. The remainder of the increase is attributable to intersegment eliminations. Year ended December 31, 2004 compared with the year ended December 31, 2003 — Corporate & Other Income (loss) from continuing operations decreased by $27 million, or 300%, to ($36) million for the year ended December 31, 2004 from ($9) million for the comparable 2003 period. The 2004 period includes a $105 million beneﬁt associated with the resolution of issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Also included in 2004 is an expense related to a $32 million contribution, net of income taxes, to the MetLife Foundation and a $9 million beneﬁt from a revision of the estimate of income taxes for 2003. The year ended December 31, 2003 includes a $92 million beneﬁt, net of income taxes, from the reduction of a previously established liability related to the Company’s race-conscious underwriting settlement, as well as a $36 million beneﬁt from a revision of the estimate of income taxes for 2002. Excluding the impact of these items, income from continuing operations increased by $19 million in the year ended December 31, 2004 from the comparable 2003 period. The increase in earnings in 2004 over the prior year period is primarily attributable to an increase in net investment income of $184 million and a decrease in policyholder beneﬁts and claims of $24 million, both of which are net of income taxes. This increase is partially offset by an increase in net investment losses of $93 million and an increase in interest on bank holder deposits of $14 million, a charge related to unoccupied space of $10 million, as well as expenses associated with the piloting of a new product of $7 million, all net of income taxes. In addition, the tax beneﬁt increased by $41 million as a result of a change in the Company’s allocation of tax expense among segments. Total revenues, excluding net investment gains (losses), increased by $269 million, or 157%, to $440 million for the year ended December 31, 2004 from $171 million for the comparable 2003 period. The increase in revenue is primarily attributable to increases in income on ﬁxed maturity securities, corporate joint venture income, mortgage loans on real estate and equity securities due to increased invested assets and higher yields. Also included as a component of total revenues are intersegment eliminations which are offset within total expenses. Total expenses increased by $199 million, or 50%, to $594 million for the year ended December 31, 2004 from $395 million for the comparable 2003 period. The year ended December 31, 2004 includes a $50 million contribution to the MetLife Foundation, partially offset by a $22 million reduction of interest expense associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. The year ended December 31, 2003 includes a $144 million beneﬁt from a reduction of a previously established liability associated with the Company’s race-conscious underwriting settlement. Excluding these items, total expenses increased by $27 million for the year ended December 31, 2004. This increase is attributable to higher interest expense of $61 million as a result of the issuance of senior notes at the end of 2003 and during 2004, as well as higher interest credited to bank holder deposits of $22 million as a result of growth in MetLife Bank’s business. This increase is partially offset by a decrease of $54 million from lower interest expense on surplus notes, as well as lower expenses from policyholder beneﬁts and claims of $38 million, a charge related to unoccupied space of $15 million, as well as expenses associated with the piloting of a new product of $11 million. The remainder of the increase is attributable to intersegment eliminations. MetLife Capital Trust I In connection with MetLife, Inc.’s initial public offering in April 2000, the Holding Company and MetLife Capital Trust I, a wholly-owned trust, (the ‘‘Trust’’) issued equity security units (the ‘‘units’’). Each unit originally consisted of (i) a contract to purchase, for $50, shares of the Holding Company’s common stock (the ‘‘purchase contracts’’) on May 15, 2003; and (ii) a capital security of the Trust, with a stated liquidation amount of $50. In accordance with the terms of the units, the Trust was dissolved on February 5, 2003, and $1,006 million aggregate principal amount of 8.00% debentures of the Holding Company (the ‘‘MetLife debentures’’), the sole assets of the Trust, were distributed to the owners of the Trust’s capital securities in exchange for their capital securities. The MetLife debentures were remarketed on behalf of the debenture owners on February 12, 2003 and the interest rate on the MetLife debentures was reset as of February 15, 2003 to 3.911% per annum. As a result of the remarketing, the debenture owners received $21 million ($0.03 per diluted common share) in excess of the carrying value of the capital securities. This excess was recorded by the Company as a charge to additional paid-in capital and, for the purpose of calculating earnings per share, is subtracted from net income to arrive at net income available to common shareholders. On May 15, 2003, the purchase contracts associated with the units were settled. In exchange for $1,006 million, the Company issued 2.97 shares of MetLife, Inc. common stock per purchase contract, or 59.8 million shares of treasury stock. The excess of the Company’s cost of the treasury stock ($1,662 million) over the contract price of the stock issued to the purchase contract holders ($1,006 million) was $656 million, which was recorded as a direct reduction to retained earnings. Due to the dissolution of the Trust in 2003, there was no interest expense on capital securities for the years ended December 31, 2005 and 2004. Interest expense on the capital securities is included in other expenses and was $10 million for the year ended December 31, 2003. Liquidity and Capital Resources The Company Capital Risk based capital (‘‘RBC’’) requirements are used as minimum capital requirements by the National Association of Insurance Commissioners (‘‘NAIC’’) and the state insurance departments to identify companies that merit further regulatory action. RBC is based on a formula calculated by applying factors to various asset, premium and statutory reserve items and takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk and business risk. These rules apply to each of the Company’s domestic insurance subsidiaries. At December 31, 2005, each of the Holding Company’s domestic insurance subsidiaries’ total adjusted capital was in excess of the RBC levels required by their respective states of domicile. The NAIC adopted the Codiﬁcation of Statutory Accounting Principles (‘‘Codiﬁcation’’) in 2001 to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. The New York State Department of Insurance (the ‘‘Department’’) has adopted Codiﬁcation with certain modiﬁcations for the preparation of statutory ﬁnancial statements of insurance companies domiciled in New York. Modiﬁcations by the various state insurance departments may impact the effect of Codiﬁcation on the statutory capital and surplus of the Holding Company’s insurance subsidiaries. 24 MetLife, Inc. Asset/Liability Management The Company actively manages its assets using an approach that balances quality, diversiﬁcation, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that the assets and liabilities are managed on a cash ﬂow and duration basis. The asset/liability management process is the shared responsibility of the Portfolio Management Unit, the Business Finance Asset/Liability Management Unit, and the operating business segments under the supervision of the various product line speciﬁc Asset/Liability Management Committees (‘‘ALM Committees’’). The ALM Committees’ duties include reviewing and approving target portfolios on a periodic basis, establishing investment guidelines and limits and providing oversight of the asset/liability management process. The portfolio managers and asset sector specialists, who have responsibility on a day-to-day basis for risk management of their respective investing activities, implement the goals and objectives established by the ALM Committees. The Company establishes target asset portfolios for each major insurance product, which represent the investment strategies used to proﬁtably fund its liabilities within acceptable levels of risk. These strategies include objectives for effective duration, yield curve sensitivity, convexity, liquidity, asset sector concentration and credit quality. In executing these asset/liability matching strategies, management regularly reevaluates the estimates used in determining the approximate amounts and timing of payments to or on behalf of policyholders for insurance liabilities. Many of these estimates are inherently subjective and could impact the Company’s ability to achieve its asset/liability management goals and objectives. Liquidity Liquidity refers to a company’s ability to generate adequate amounts of cash to meet its needs. The Company’s liquidity position (cash and cash equivalents and short-term investments, excluding securities lending) was $6.7 billion and $5.4 billion at December 31, 2005 and 2004, respectively. Liquidity needs are determined from a rolling 12-month forecast by portfolio and are monitored daily. Asset mix and maturities are adjusted based on forecast. Cash ﬂow testing and stress testing provide additional perspectives on liquidity. The Company believes that it has sufﬁcient liquidity to fund its cash needs under various scenarios that include the potential risk of early contractholder and policyholder withdrawal. The Company includes provisions limiting withdrawal rights on many of its products, including general account institutional pension products (generally group annuities, including guaranteed interest contracts (‘‘GICs’’), and certain deposit funds liabilities) sold to employee beneﬁt plan sponsors. Certain of these provisions prevent the customer from making withdrawals prior to the maturity date of the product. In the event of signiﬁcant unanticipated cash requirements beyond normal liquidity, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These options include cash ﬂow from operations, the sale of liquid assets, global funding sources and various credit facilities. The Company’s ability to sell investment assets could be limited by accounting rules including rules relating to the intent and ability to hold impaired securities until the market value of those securities recovers. In extreme circumstances, all general account assets within a statutory legal entity are available to fund any obligation of the general account within that legal entity. Liquidity Sources Cash Flow from Operations. The Company’s principal cash inﬂows from its insurance activities come from insurance premiums, annuity considera- tions and deposit funds. A primary liquidity concern with respect to these cash inﬂows is the risk of early contractholder and policyholder withdrawal. The Company’s principal cash inﬂows from its investment activities come from repayments of principal, proceeds from maturities and sales of invested assets and investment income. The primary liquidity concerns with respect to these cash inﬂows are the risk of default by debtors and market volatilities. The Company closely monitors and manages these risks through its credit risk management process. Liquid Assets. An integral part of the Company’s liquidity management is the amount of liquid assets it holds. Liquid assets include cash, cash equivalents, short-term investments, marketable ﬁxed maturity and equity securities. Liquid assets exclude assets relating to securities lending and dollar roll activities. At December 31, 2005 and 2004, the Company had $179 billion and $136 billion in liquid assets, respectively. Global Funding Sources. Liquidity is also provided by a variety of both short-term and long-term instruments, including repurchase agreements, commercial paper, medium- and long-term debt, capital securities and stockholders’ equity. The diversiﬁcation of the Company’s funding sources enhances funding ﬂexibility, limits dependence on any one source of funds and generally lowers the cost of funds. At December 31, 2005 and 2004, the Company had $1.4 billion in short-term debt outstanding, and $9.9 billion and $7.4 billion in long-term debt outstanding, respectively. Debt Issuances. On June 23, 2005, the Holding Company issued in the United States public market $1,000 million aggregate principal amount of 5.00% senior notes due June 15, 2015 at a discount of $2.7 million ($997.3 million), and $1,000 million aggregate principal amount of 5.70% senior notes due June 15, 2035 at a discount of $2.4 million ($997.6 million). On June 29, 2005, the Holding Company issued 400 million pounds sterling ($729.2 million at issuance) aggregate principal amount of 5.25% senior notes due June 29, 2020 at a discount of 4.5 million pounds sterling ($8.1 million at issuance), for aggregate proceeds of 395.5 million pounds sterling ($721.1 million at issuance). The senior notes were initially offered and sold outside the United States in reliance upon Regulation S under the Securities Act of 1933, as amended. On December 8, 2005, RGA issued junior subordinated debentures with a face amount of $400 million. Interest is payable semi-annually at a ﬁxed rate of 6.75% until December 15, 2015. Subsequent to December 15, 2015, interest on these debentures will accrue at an annual rate of 3-month LIBOR plus a margin equal to 266.5 basis points, payable quarterly until maturity in 2065. The Company repaid a $250 million, 7% surplus note which matured on November 1, 2005 and repaid a $1,006 million, 3.911% senior note which matured on May 15, 2005. MetLife Bank has entered into several repurchase agreements with the Federal Home Loan Bank of New York (the ‘‘FHLB of NY’’) whereby MetLife Bank has issued such repurchase agreements in exchange for cash and for which the FHLB of NY has been granted a blanket lien on MetLife Bank’s residential mortgages and mortgage-backed securities to collateralize MetLife Bank’s obligations under the repurchase agreements. The repurchase agreements and the related security agreement represented by this blanket lien provide that upon any event of default by MetLife Bank, the FHLB of NY’s recovery is limited to the amount of MetLife Bank’s liability under the outstanding repurchase agreements. During 2005, the Company increased its MetLife, Inc. 25 liability for repurchase agreements with the FHLB of NY by $750 million. As of December 31, 2005 and 2004, the Company’s total liability was $855 million and $105 million, respectively, which is included in long-term debt. MetLife Funding, Inc. (‘‘MetLife Funding’’), a subsidiary of Metropolitan Life, serves as a centralized ﬁnance unit for the Company. Pursuant to a support agreement, Metropolitan Life has agreed to cause MetLife Funding to have a tangible net worth of at least one dollar. At December 31, 2005 and 2004, MetLife Funding had a tangible net worth of $11.2 million and $10.9 million, respectively. MetLife Funding raises cash from various funding sources and uses the proceeds to extend loans, through MetLife Credit Corp., another subsidiary of Metropolitan Life, to the Holding Company, Metropolitan Life and other afﬁliates. MetLife Funding manages its funding sources to enhance the ﬁnancial ﬂexibility and liquidity of Metropolitan Life and other afﬁliated companies. At December 31, 2005 and 2004, MetLife Funding had total outstanding liabilities, including accrued interest payable, of $456 million and $1,448 million, respectively, consisting primarily of commercial paper. Credit Facilities. The Company maintains committed and unsecured credit facilities aggregating $3.85 billion as of December 31, 2005. When drawn upon, these facilities bear interest at varying rates in accordance with the respective agreements. The facilities can be used for general corporate purposes and $3.0 billion of the facilities also serve as back-up lines of credit for the Company’s commercial paper programs. The following table provides details on these facilities as of December 31, 2005: Borrower(s) Expiration Capacity Issuances Drawdowns Commitments (In millions) Letter of Credit Unused MetLife, Inc., MetLife Funding, Inc. and Metropolitan Life Insurance Company ***** April 2009 MetLife, Inc. and MetLife Funding, Inc. ************************************* April 2010 MetLife Bank, N.A. ****************************************************** July 2006 Reinsurance Group of America, Incorporated ******************************** January 2006 Reinsurance Group of America, Incorporated ******************************** May 2007 Reinsurance Group of America, Incorporated ******************************** September 2010 Total ****************************************************************** $1,500 1,500 200 26 26 600 $3,852 $374 — — — — 320 $694 $ — — — 26 26 50 $102 $1,126 1,500 200 — — 230 $3,056 Letters of Credit. On July 1, 2005, in connection with the closing of the acquisition of Travelers, the $2.0 billion amended and restated ﬁve-year letter of credit and reimbursement agreement (the ‘‘L/C Agreement’’) entered into by The Travelers Life and Annuity Reinsurance Company (‘‘TLARC’’) and various institutional lenders on April 25, 2005 became effective. Under the L/C Agreement, the Holding Company agreed to unconditionally guarantee reimbursement obligations of TLARC with respect to reinsurance letters of credit issued pursuant to the L/C Agreement and replaced Citigroup Insurance Holding Company as guarantor upon closing of the Travelers acquisition. The L/C Agreement expires ﬁve years after the closing of the acquisition. Also during 2005, Exeter Reassurance Company Ltd. (‘‘Exeter’’) entered into three ten-year letter of credit and reimbursement agreements totaling $800 mil- lion with an institutional lender, and the Holding Company and Exeter entered into a $500 million ten-year letter of credit and reimbursement agreement with another institutional lender. The following table provides details on the capacity and outstanding balances of such committed facilities as of December 31, 2005: Account Party Expiration Capacity The Travelers Life and Annuity Reinsurance Company *************************** Exeter Reassurance Company Ltd. ****************************************** March 2015 Exeter Reassurance Company Ltd. ****************************************** June 2015 Exeter Reassurance Company Ltd. ****************************************** September 2015 Exeter Reassurance Company Ltd. and MetLife, Inc. **************************** December 2015 Total********************************************************************* July 2010 $2,000 225 250 325 500 $3,300 Letter of Credit Issuances (In millions) $1,930 225 250 — 280 $2,685 Unused Commitments $ 70 — — 325 220 $615 Note: The Holding Company is a guarantor under the ﬁrst four agreements and a party to the ﬁfth agreement above. At December 31, 2005 and 2004, the Company had outstanding $3.6 billion and $961 million, respectively, in letters of credit from various banks, of which $3.4 billion and $470 million, respectively, were part of committed facilities. The letters of credit outstanding at December 31, 2005 and 2004 all automatically renew for one year periods except for $755 million in the current period which expires in ten years. Since commitments associated with letters of credit and ﬁnancing arrangements may expire unused, these amounts do not necessarily reﬂect the Company’s actual future cash funding requirements. Liquidity Uses Insurance Liabilities. The Company’s principal cash outﬂows primarily relate to the liabilities associated with its various life insurance, property and casualty, annuity and group pension products, operating expenses and income taxes, as well as principal and interest on its outstanding debt obligations. Liabilities arising from its insurance activities primarily relate to beneﬁt payments under the aforementioned products, as well as payments for policy surrenders, withdrawals and loans. Investment and Other. Additional cash outﬂows include those related to obligations of securities lending and dollar roll activities, investments in real estate, limited partnerships and joint ventures, as well as litigation-related liabilities. 26 MetLife, Inc. The following table summarizes the Company’s major contractual obligations as of December 31, 2005: Contractual Obligations Total Less Than Three Years Three to Five Years More than Five Years (In millions) Other long-term liabilities(1)(2) ****************************************************** $106,522 Payables for collateral under securities loaned and other transactions ********************* 34,515 Long-term debt(3) **************************************************************** 19,506 Mortgage commitments *********************************************************** 2,974 Partnership investments(4) ********************************************************* 2,684 Junior subordinated debt securities underlying common equity units(5) ******************** 2,433 Operating leases ***************************************************************** 1,338 Shares subject to mandatory redemption(3) ****************************************** 350 Capital leases ******************************************************************* 73 Contracts to purchase real estate*************************************************** 36 Total *************************************************************************** $170,431 $19,089 34,515 2,836 2,030 2,684 1,359 579 — 38 36 $63,166 $ 8,026 — 1,376 296 — 1,074 235 — 9 — $11,016 $79,407 — 15,294 648 — — 524 350 26 — $96,249 (1) Other long-term liabilities include various investment-type products with contractually scheduled maturities, including guaranteed interest contracts, structured settlements, pension closeouts, certain annuity policies and certain indemnities. (2) Other long-term liabilities include beneﬁt and claim liabilities for which the Company believes the amount and timing of the payment is essentially ﬁxed and determinable. Such amounts generally relate to (i) policies or contracts where the Company is currently making payments and will continue to do so until the occurrence of a speciﬁc event, such as death; and (ii) life insurance and property and casualty incurred and reported claims. Liabilities for future policy beneﬁts of $82.4 billion and policyholder account balances of $113.4 billion, both at December 31, 2005, have been excluded from this table. Amounts excluded from the table are generally comprised of policies or contracts where (i) the Company is not currently making payments and will not make payments in the future until the occurrence of an insurable event, such as death or disability, or (ii) the occurrence of a payment triggering event, such as a surrender of a policy or contract, is outside the control of the Company. The determination of these liability amounts and the timing of payment are not reasonably ﬁxed and determinable since the insurable event or payment triggering event has not yet occurred. Such excluded liabilities primarily represent future policy beneﬁts of approximately $63.4 billion relating to traditional life, health and disability insurance products and policyholder account balances of approximately $41.7 billion relating to deferred annuities, $27.3 billion for group and universal life products and approximately $27.0 billion for funding agreements without ﬁxed maturity dates. Signiﬁcant uncertainties relating to these liabilities include mortality, morbidity, expenses, persistency, investment returns, inﬂation and the timing of payments. See ‘‘— The Company — Asset/Liability Management.’’ Amounts included in other long-term liabilities reﬂect estimated cash payments to be made to policyholders. Such cash outﬂows reﬂect adjustments for the estimated timing of mortality, retirement, and other appropriate factors, but are undiscounted with respect to interest. The amount shown in the More than Five Years column represents the sum of cash ﬂows, also adjusted for the estimated timing of mortality, retirement and other appropriate factors and undiscounted with respect to interest, extending for more than 100 years from the present date. As a result, the sum of the cash outﬂows shown for all years in the table of $104.4 billion exceeds the corresponding liability amounts of $51.4 billion included in the consolidated ﬁnancial statements at December 31, 2005. The liability amount in the consolidated ﬁnancial statements reﬂects the discounting for interest, as well as adjustments for the timing of other factors as described above. (3) Amounts differ from the balances presented on the consolidated balance sheets. The amounts above do not include any fair value adjustments, related premiums and discounts or capital leases which are presented separately. Amounts include interest to be paid on ﬁxed-rate debt only. (4) The Company anticipates that these amounts could be invested in these partnerships any time over the next ﬁve years, but are presented in the current period, as the timing of the fulﬁllment of the obligation cannot be predicted. (5) Amounts include interest paid on junior subordinated debt. As of December 31, 2005, and relative to its liquidity program, the Company had no material (individually or in the aggregate) purchase obligations or material (individually or in the aggregate) unfunded pension or other postretirement beneﬁt obligations due within one year. Support Agreements. Metropolitan Life entered into a net worth maintenance agreement with New England Life Insurance Company (‘‘NELICO’’) at the time Metropolitan Life merged with New England Mutual Life Insurance Company. Under the agreement, Metropolitan Life agreed, without limitation as to the amount, to cause NELICO to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than the company action level RBC (or not less than 125% of the company action level RBC, if NELICO has a negative trend), as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. At December 31, 2005, the capital and surplus of NELICO was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recently referenced RBC-based amount calculated at December 31, 2005. In connection with the Company’s acquisition of the parent of General American Life Insurance Company (‘‘General American’’), Metropolitan Life entered into a net worth maintenance agreement with General American. Under the agreement, as subsequently amended, Metropolitan Life agreed, without limitation as to amount, to cause General American to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than 250% of the company action level RBC, as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. At December 31, 2005, the capital and surplus of General American was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2005. Metropolitan Life has also entered into arrangements for the beneﬁt of some of its other subsidiaries and afﬁliates to assist such subsidiaries and afﬁliates in meeting various jurisdictions’ regulatory requirements regarding capital and surplus and security deposits. In addition, Metropolitan Life has entered into a support arrangement with respect to a subsidiary under which Metropolitan Life may become responsible, in the event that the subsidiary becomes the subject of insolvency proceedings, for the payment of certain reinsurance recoverables due from the subsidiary to one or more of its cedents in accordance with the terms and conditions of the applicable reinsurance agreements. General American has agreed to guarantee the contractual obligations of its subsidiary, Paragon Life Insurance Company, and certain contractual obligations of its former subsidiaries, MetLife Investors Insurance Company (‘‘MetLife Investors’’), First MetLife Investors Insurance Company and MetLife MetLife, Inc. 27 Investors Insurance Company of California. In addition, General American has entered into a contingent reinsurance agreement with MetLife Investors. Under this agreement, in the event that MetLife Investors’ statutory capital and surplus is less than $10 million or total adjusted capital falls below 180% of the company action level RBC, as deﬁned by state insurance statutes, General American would assume as assumption reinsurance, subject to regulatory approvals and required consents, all of MetLife Investors’ life insurance policies and annuity contract liabilities. At December 31, 2005, the capital and surplus of MetLife Investors was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2005. In connection with the acquisition of Travelers, MetLife International Holdings, Inc. (‘‘MIH’’), a subsidiary of the Holding Company, committed to the Australian Prudential Regulatory Authority that it will provide or procure the provision of additional capital to MetLife General Insurance Limited (‘‘MGIL’’), an Australian subsidiary of MIH, to the extent necessary to enable MGIL to meet insurance capital adequacy and solvency requirements. In addition, MetLife International Insurance, Ltd. (‘‘MIIL’’), a Bermuda insurance company, was acquired as part of the Travelers transaction. In connection with the assumption of a block of business by MIIL from a company in liquidation in 1995, Citicorp Life Insurance Company (‘‘CLIC’’), an afﬁliate of MIIL and a subsidiary of the Holding Company, agreed with MIIL and the liquidator to make capital contributions to MIIL to ensure that, for so long as any policies in such block remain outstanding, MIIL remains solvent and able to honor the liabilities under such policies. Management does not anticipate that these arrangements will place any signiﬁcant demands upon the Company’s liquidity resources. Litigation. Various litigation, including purported or certiﬁed class actions, and various claims and assessments against the Company, in addition to those discussed elsewhere herein and those otherwise provided for in the Company’s consolidated ﬁnancial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. It is not feasible to predict or determine the ultimate outcome of all pending investigations and legal proceedings or provide reasonable ranges of potential losses except as noted elsewhere herein in connection with speciﬁc matters. In some of the matters referred to herein, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations, it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s consolidated ﬁnancial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Other. Based on management’s analysis of its expected cash inﬂows from operating activities, the dividends it receives from subsidiaries, including Metropolitan Life, that are permitted to be paid without prior insurance regulatory approval and its portfolio of liquid assets and other anticipated cash ﬂows, management believes there will be sufﬁcient liquidity to enable the Company to make payments on debt, make cash dividend payments on its common stock, pay all operating expenses, and meet its cash needs. The nature of the Company’s diverse product portfolio and customer base lessens the likelihood that normal operations will result in any signiﬁcant strain on liquidity. Consolidated cash ﬂows. Net cash provided by operating activities was $8,005 million and $6,510 million for the years ended December 31, 2005 and 2004, respectively. The $1,495 million increase in operating cash ﬂows in 2005 over the comparable 2004 period is primarily attributable to the acquisition of Travelers, growth in disability, dental, long-term care business, group life and retirement & savings, as well as continued growth in the annuity business. Net cash provided by operating activities was $6,510 million and $6,127 million for the years ended December 31, 2004 and 2003, respectively. The $383 million increase in operating cash ﬂows in 2004 over the comparable 2003 period is primarily attributable to continued growth in the group life, long-term care, dental and disability businesses, as well as an increase in retirement & savings’ structured settlements due to a large multi-contract sale in 2004. Also, the late 2003 acquisition of John Hancock’s group TIAA/CREF’s long-term care business contributed to growth in the 2004 period. Net cash used in investing activities was $22,610 million and $14,417 million for the years ended December 31, 2005 and 2004, respectively. The $8,193 million increase in net cash used in investing activities in 2005 over the comparable 2004 period is primarily due to the acquisition of Travelers and CitiStreet Associates, the increase in net purchases of ﬁxed maturities and an increase in the origination of mortgage and consumer loans, primarily in commercial loans, as compared to the 2004 period. This was partially offset by an increase in repayments of mortgage and consumer loans, an increase in sales of equity real estate and a decrease in the cash used for short-term investments. In addition, the 2005 period includes proceeds associated with the sale of SSRM and MetLife Indonesia. Net cash used in investing activities was $14,417 million and $26,878 million for the years ended December 31, 2004 and 2003, respectively. The $12,461 million decrease in net cash used in investing activities in 2004 over the comparable 2003 period is primarily due to less cash provided by ﬁnancing activities, partially offset by an increase in cash generated from operations. This decrease in available cash resulted in reduced investments in ﬁxed maturities in 2004 as compared to 2003. These items are partially offset by an increase in mortgage and other loan origination as the Company continues to take advantage of favorable market conditions in this sector, as well as an increase in cash used for equity securities and short-term investments for the comparable periods. Net cash provided by ﬁnancing activities was $14,517 million and $8,280 million for the years ended December 31, 2005 and 2004, respectively. The $6,237 million increase in net cash provided by ﬁnancing activities in 2005 over the comparable 2004 period is primarily attributable to the Holding Company’s funding of the acquisition of Travelers through the issuance of long-term debt, junior subordinated debt securities and preferred shares. In addition, there was an increase in the amount of securities lending cash collateral invested in connection with the program. This increase was partially offset by a decrease in net cash provided by policyholder account balances, the repayment of previously issued long-term debt, the payment of common stock dividends, the payment of dividends on the preferred shares, the payment of debt and equity issuance costs, and the repurchase of its common stock by RGA. Net cash provided by ﬁnancing activities was $8,280 million and $22,161 million for the years ended December 31, 2004 and 2003, respectively. The $13,881 million decrease in net cash provided by ﬁnancing activities in 2004 over the comparable 2003 period is primarily due to a decrease in securities lending cash collateral invested in connection with the program. In addition, there were repayments of short-term debt associated with dollar roll activity, and an increase in cash used in the Company’s stock repurchase program. Net cash provided by policyholder account balances decreased 28 MetLife, Inc. from the comparable 2003 period mainly as a result of a decrease in GICs sold in 2004 as compared to 2003, partially offset by an increase in MetLife Bank’s customer deposits, particularly in the personal and business savings accounts. The 2003 period included payments of $1,006 million received on the settlement of common stock purchase contracts (see ‘‘— Results of Operations — MetLife Capital Trust I’’) and $317 million net cash proceeds associated with RGA’s issuance of common stock. The Company also doubled its annual dividend per share in 2004. These items were partially offset by additional proceeds from the issuance of senior notes by the Holding Company and a decrease in repayments of long-term debt for the comparable periods. The Holding Company Capital Restrictions and Limitations on Bank Holding Companies and Financial Holding Companies — Capital. The Holding Company and its insured depository institution subsidiary, MetLife Bank, are subject to risk-based and leverage capital guidelines issued by the federal banking regulatory agencies for banks and ﬁnancial holding companies. The federal banking regulatory agencies are required by law to take speciﬁc prompt corrective actions with respect to institutions that do not meet minimum capital standards. At December 31, 2005, MetLife, Inc. and MetLife Bank met the minimum capital standards as per federal banking regulatory agencies with all of MetLife Bank’s risk-based and leverage capital ratios meeting the federal banking regulatory agencies ‘‘well capitalized’’ standards and all of MetLife, Inc.’s risk-based and leverage capital ratios meeting the ‘‘adequately capitalized’’ standards. At December 31, 2004, MetLife, Inc. and MetLife Bank were in compliance with the aforementioned minimum capital standards and each had risk-based and leverage capital ratios that met the federal banking regulatory agencies ‘‘well capitalized’’ standards. The following table contains the RBC ratios as of December 31, 2005 and 2004 and the regulatory requirements for MetLife Inc., as a bank holding company, and MetLife Bank: MetLife, Inc. RBC Ratios — Bank Holding Company As of December 31, Total RBC Ratio ******************************************************* Tier 1 RBC Ratio ****************************************************** Tier 1 Leverage Ratio*************************************************** 9.57% 10.12% 9.21% 9.66% 5.39% 6.02% 8.00% 4.00% 4.00% 10.00% 6.00% N/A 2005 2004 Regulatory Requirements Minimum Regulatory Requirements ‘‘Well Capitalized’’ MetLife Bank RBC Ratios — Bank As of December 31, 2005 2004 Regulatory Requirements Minimum Regulatory Requirements ‘‘Well Capitalized’’ Total RBC Ratio ****************************************************** Tier 1 RBC Ratio ***************************************************** Tier 1 Leverage Ratio************************************************** 11.78% 17.09% 11.22% 16.38% 5.96% 10.84% 8.00% 4.00% 4.00% 10.00% 6.00% 5.00% Liquidity Liquidity is managed to preserve stable, reliable and cost-effective sources of cash to meet all current and future ﬁnancial obligations and is provided by a variety of sources, including a portfolio of liquid assets, a diversiﬁed mix of short- and long-term funding sources from the wholesale ﬁnancial markets and the ability to borrow through committed credit facilities. The Holding Company is an active participant in the global ﬁnancial markets through which it obtains a signiﬁcant amount of funding. These markets, which serve as cost-effective sources of funds, are critical components of the Holding Company’s liquidity management. Decisions to access these markets are based upon relative costs, prospective views of balance sheet growth and a targeted liquidity proﬁle. A disruption in the ﬁnancial markets could limit the Holding Company’s access to liquidity. The Holding Company’s ability to maintain regular access to competitively priced wholesale funds is fostered by its current high credit ratings from the major credit rating agencies. Management views its capital ratios, credit quality, stable and diverse earnings streams, diversity of liquidity sources and its liquidity monitoring procedures as critical to retaining high credit ratings. Liquidity is monitored through the use of internal liquidity risk metrics, including the composition and level of the liquid asset portfolio, timing differences in short-term cash ﬂow obligations, access to the ﬁnancial markets for capital and debt transactions and exposure to contingent draws on the Holding Company’s liquidity. Liquidity Sources Dividends. The primary source of the Holding Company’s liquidity is dividends it receives from its insurance subsidiaries. The Holding Company’s insurance subsidiaries are subject to regulatory restrictions on the payment of dividends imposed by the regulators of their respective domiciles. The dividend limitation for U.S. insurance subsidiaries is based on the surplus to policyholders as of the immediately preceding calendar year and statutory net gain from operations for the immediately preceding calendar year. Statutory accounting practices, as prescribed by insurance regulators of various states in which the Company conducts business, differ in certain respects from accounting principles used in ﬁnancial statements prepared in conformity with GAAP. The signiﬁcant differences relate to the treatment of DAC, certain deferred income taxes, required investment reserves, reserve calculation assumptions, goodwill and surplus notes. The maximum amount of dividends which could be paid to the Holding Company by Metropolitan Life, TIC, MPC and Metropolitan Tower Life Insurance Company (‘‘MTL’’), in 2005, without prior regulatory approval, was $880 million, $0 million, $187 million and $119 million, respectively. During the year ended December 31, 2005, Metropolitan Life paid $880 million in ordinary dividends for which prior insurance regulatory approval was not required and $2,320 million in special dividends as approved by the New York Superintendent of Insurance. TIC has not paid any dividends since its MetLife, Inc. 29 acquisition by the Holding Company and may not make dividend payments for a two-year period following the date of acquisition without regulatory approval. MPC paid $400 million in special dividends, as approved by the Rhode Island Superintendent of Insurance, during the year ended December 31, 2005. MTL paid $54 million in ordinary dividends for which prior insurance regulatory approval was not required and $873 million in special dividends as approved by the Delaware Superintendent of Insurance during the year ended December 31, 2005. MetLife Mexico, S.A. paid dividends to the Holding Company of $276 million during the year ended December 31, 2005. In addition, various subsidiaries paid $19 million in total to the Holding Company for the year ended December 31, 2005. The maximum amount of dividends which Metropolitan Life, TIC, MPC and MTL may pay to the Holding Company in 2006 without prior regulatory approval is $863 million, $0 million, $178 million, and $85 million, respectively. If paid before a speciﬁed date in 2006, some or all of an otherwise ordinary dividend may be deemed special by the relevant regulatory authority and require approval. Liquid Assets. An integral part of the Holding Company’s liquidity management is the amount of liquid assets it holds. Liquid assets include cash, cash equivalents, short-term investments and marketable ﬁxed maturity securities. At December 31, 2005 and 2004, the Holding Company had $668 million and $2.1 billion in liquid assets, respectively. Global Funding Sources. Liquidity is also provided by a variety of both short-term and long-term instruments, commercial paper, medium- and long-term debt, capital securities and stockholders’ equity. The diversity of the Holding Company’s funding sources enhances funding ﬂexibility and limits dependence on any one source of funds and generally lowers the cost of funds. Other sources of the Holding Company’s liquidity include programs for short- and long-term borrowing, as needed. At December 31, 2005 and 2004, the Holding Company had $961 million and $0 million in short-term debt outstanding, respectively. At December 31, 2005 and 2004, the Holding Company had $7.3 billion and $5.7 billion of unafﬁliated long-term debt outstanding, respectively. On December 30, 2005, the Holding Company issued $286 million of afﬁliated long-term debt with an interest rate of 5.24% maturing in 2015. On April 27, 2005, the Holding Company ﬁled a shelf registration statement (the ‘‘2005 Registration Statement’’) with the U.S. Securities and Exchange Commission (‘‘SEC’’), covering $11 billion of securities. On May 27, 2005, the 2005 Registration Statement became effective, permitting the offer and sale, from time to time, of a wide range of debt and equity securities. In addition to the $11 billion of securities registered on the 2005 Registration Statement, approximately $3.9 billion of registered but unissued securities remained available for issuance by the Holding Company as of such date, from the $5.0 billion shelf registration statement ﬁled with the SEC during the ﬁrst quarter of 2004, permitting the Holding Company to issue an aggregate of $14.9 billion of registered securities. The terms of any offering will be established at the time of the offering. During June 2005, in connection with the Company’s acquisition of Travelers, the Holding Company issued $2.0 billion of senior notes, $2.07 billion of common equity units and $2.1 billion of preferred stock under the 2005 Registration Statement. In addition, $0.7 billion of senior notes were sold outside the United States in reliance upon Regulation S under the Securities Act of 1933, as amended, a portion of which may be resold in the United States under the 2005 Registration Statement. Remaining capacity under the 2005 Registration Statement after such issuances is $6.6 billion. Debt Issuances. On June 23, 2005, the Holding Company issued in the United States public market $1,000 million aggregate principal amount of 5.00% senior notes due June 15, 2015 at a discount of $2.7 million ($997.3 million), and $1,000 million aggregate principal amount of 5.70% senior notes due June 15, 2035 at a discount of $2.4 million ($997.6 million). On June 29, 2005, the Holding Company issued 400 million pounds sterling ($729.2 million at issuance) aggregate principal amount of 5.25% senior notes due June 29, 2020 at a discount of 4.5 million pounds sterling ($8.1 million at issuance), for aggregate proceeds of 395.5 million pounds sterling ($721.1 million at issuance). The senior notes were initially offered and sold outside the United States in reliance upon Regulation S under the Securities Act of 1933, as amended. On December 30, 2005, the Holding Company issued $286 million of afﬁliated long-term debt with an interest rate of 5.24% maturing in 2015. The following table summarizes the Holding Company’s outstanding senior notes issuances: Issue Date Principal(3) Interest Rate (In millions) Maturity June 2005 *********************************************************************** June 2005 *********************************************************************** June 2005(1) ********************************************************************* December 2004(1) **************************************************************** June 2004(2) ********************************************************************* June 2004(2) ********************************************************************* November 2003 ****************************************************************** November 2003 ****************************************************************** December 2002 ****************************************************************** December 2002 ****************************************************************** November 2001 ****************************************************************** November 2001 ****************************************************************** $1,000 $1,000 $ 688 $ 602 $ 350 $ 750 $ 500 $ 200 $ 400 $ 600 $ 500 $ 750 5.00% 5.70% 5.25% 5.38% 5.50% 6.38% 5.00% 5.88% 5.38% 6.50% 5.25% 6.13% 2015 2035 2020 2024 2014 2034 2013 2033 2012 2032 2006 2011 (1) This amount represents the translation of pounds sterling into U.S. Dollars using the noon buying rate on December 30, 2005 of $1.7188 as announced by the Federal Reserve Bank of New York. (2) On July 23, 2004, the Holding Company reopened its June 3, 2004 senior notes offering and increased the principal outstanding on the 5.50% notes due June 2014, from $200 million to $350 million and on the 6.38% notes due June 2034, from $400 million to $750 million. (3) This table excludes any premium or discount on the senior notes issuances. See also ‘‘— Liquidity and Capital Resources — The Holding Company — Liquidity Sources — Common Equity Units’’ for junior subordinated debt securities of $2,134 million issued in connection with issuance of common equity units. Debt Repayments. The Holding Company repaid a $1,006 million, 3.911% senior note which matured on May 15, 2005. 30 MetLife, Inc. Preferred Stock. On June 13, 2005, the Holding Company issued 24 million shares of Floating Rate Non-Cumulative Preferred Stock, Series A (the ‘‘Series A preferred shares’’) with a $0.01 par value per share, and a liquidation preference of $25 per share for aggregate proceeds of $600 million. On June 16, 2005, the Holding Company issued 60 million shares of 6.50% Non-Cumulative Preferred Stock, Series B (the ‘‘Series B preferred shares’’), with a $0.01 par value per share, and a liquidation preference of $25 per share, for aggregate proceeds of $1.5 billion. The Series A and Series B preferred shares (the ‘‘Preferred Shares’’) rank senior to the common stock with respect to dividends and liquidation rights. Dividends on the Preferred Shares are not cumulative. Holders of the Preferred Shares will be entitled to receive dividend payments only when, as and if declared by the Holding Company’s board of directors or a duly authorized committee of the board. If dividends are declared on the Series A preferred shares, they will be payable quarterly, in arrears, at an annual rate of the greater of (i) 1.00% above three-month LIBOR on the related LIBOR determination date; or (ii) 4.00%. Any dividends declared on the Series B preferred shares will be payable quarterly, in arrears, at an annual ﬁxed rate of 6.50%. Accordingly, in the event that dividends are not declared on the Preferred Shares for payment on any dividend payment date, then those dividends will cease to accrue and be payable. If a dividend is not declared before the dividend payment date, the Holding Company has no obligation to pay dividends accrued for that dividend period whether or not dividends are declared and paid in future periods. No dividends may, however, be paid or declared on the Holding Company’s common stock — or any other securities ranking junior to the Preferred Shares — unless the full dividends for the latest completed dividend period on all Preferred Shares, and any parity stock, have been declared and paid or provided for. The Holding Company is prohibited from declaring dividends on the Preferred Shares if it fails to meet speciﬁed capital adequacy, net income and shareholders’ equity levels. In addition, under Federal Reserve Board policy, the Holding Company may not be able to pay dividends if it does not earn sufﬁcient operating income. The Preferred Shares do not have voting rights except in certain circumstances where the dividends have not been paid for an equivalent of six or more dividend payment periods whether or not those periods are consecutive. Under such circumstances, the holders of the Preferred Shares have certain voting rights with respect to members of the board of directors of the Holding Company. The Preferred Shares are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. The Preferred Shares are redeemable, but not prior to September 15, 2010. On and after that date, subject to regulatory approval, the Preferred Shares will be redeemable at the Holding Company’s option in whole or in part, at a redemption price of $25 per Preferred Share, plus declared and unpaid dividends. See ‘‘— Liquidity and Capital Resources — The Holding Company — Liquidity Uses — Dividends.’’ Common Equity Units. In connection with ﬁnancing the acquisition of Travelers on July 1, 2005, the Company distributed and sold 82.8 million 6.375% common equity units for $2,070 million in proceeds in a registered public offering on June 21, 2005. Each common equity unit has an initial stated amount of $25 per unit and consists of (i) a 1/80, or 1.25% ($12.50), undivided beneﬁcial ownership interest in a series A trust preferred security of MetLife Capital Trust II (‘‘Series A Trust’’), with an initial liquidation amount of $1,000; (ii) a 1/80, or 1.25% ($12.50), undivided beneﬁcial ownership interest in a series B trust preferred security of MetLife Capital Trust III (‘‘Series B Trust’’ and, together with the Series A Trust, the ‘‘Trusts’’), with an initial liquidation amount of $1,000; and (iii) a stock purchase contract under which the holder of the common equity unit will purchase and the Holding Company will sell, on each of the initial stock purchase date and the subsequent stock purchase date, a variable number of shares of the Holding Company’s common stock, par value $0.01 per share, for a purchase price of $12.50. The Holding Company issued $1,067 million 4.82% Series A and $1,067 million 4.91% Series B junior subordinated debt securities due no later than February 15, 2039 and February 15, 2040, respectively, for a total of $2,134 million, in exchange for $2,070 million in aggregate proceeds from the sale of the trust preferred securities by the Trusts and $64 million in trust common securities issued equally by the Trusts. The common and preferred securities of the Trusts, totaling $2,134 million, represent undivided beneﬁcial ownership interests in the assets of the Trusts, have no stated maturity and must be redeemed upon maturity of the corresponding series of junior subordinated debt securities — the sole assets of the respective Trusts. The Series A and Series B Trusts will make quarterly distributions on the common and preferred securities at an annual rate of 4.82% and 4.91%, respectively. The Holding Company has directly guaranteed the repayment of the trust preferred securities to the holders thereof to the extent that there are funds available in the Trusts. The guarantee will remain in place until the full redemption of the trust preferred securities. The trust preferred securities held by the common equity unit holders are pledged to the Holding Company to collateralize the obligation of the common equity unit holders under the related stock purchase contracts. The common equity unit holder may substitute certain zero coupon treasury securities in place of the trust preferred securities as collateral under the stock purchase contract. The trust preferred securities have remarketing dates which correspond with the initial and subsequent stock purchase dates to provide the holders of the common equity units with the proceeds to exercise the stock purchase contracts. The initial stock purchase date is expected to be August 15, 2008, but could be deferred for quarterly periods until February 15, 2009, and the subsequent stock purchase date is expected to be February 15, 2009, but could be deferred for quarterly periods until February 15, 2010. At the remarketing date, the remarketing agent will have the ability to reset the interest rate on the trust preferred securities to generate sufﬁcient remarketing proceeds to satisfy the common equity unit holder’s obligation under the stock purchase contract, subject to a reset cap for each of the ﬁrst two attempted remarketings of each series. The interest rate on the supporting junior subordinated debt securities issued by the Holding Company will be reset at a commensurate rate. If the initial remarketing is unsuccessful, the remarketing agent will attempt to remarket the trust preferred securities, as necessary, in subsequent quarters through February 15, 2009 for the Series A trust preferred securities and through February 15, 2010 for the Series B trust preferred securities. The ﬁnal attempt at remarketing will not be subject to the reset cap. If all remarketing attempts are unsuccessful, the Holding Company has the right, as a secured party, to apply the liquidation amount on the trust preferred securities to the common equity unit holders obligation under the stock purchase contract and to deliver to the common equity unit holder a junior subordinated debt security payable on August 15, 2010 at an annual rate of 4.82% and 4.91% on the Series A and Series B trust preferred securities, respectively, in payment of any accrued and unpaid distributions. Each stock purchase contract requires (i) the Holding Company to pay the holder of the common equity unit quarterly contract payments on the stock purchase contracts at the annual rate of 1.510% on the stated amount of $25 per stock purchase contract until the initial stock purchase date and at the annual rate of 1.465% on the remaining stated amount of $12.50 per stock purchase contract thereafter; and (ii) the holder of the common equity unit to purchase, and the Holding Company to sell, for $12.50, on each of the initial stock purchase date and the subsequent stock purchase date, a number of newly issued or treasury shares of the Holding Company’s common stock, par value $0.01 per share, equal to the MetLife, Inc. 31 applicable settlement rate. The settlement rate at the respective stock purchase date will be calculated based on the closing price of the common stock during a speciﬁed 20-day period immediately preceding the applicable stock purchase date. Accordingly, upon settlement in the aggregate, the Holding Company will receive proceeds of $2,070 million and issue between 39.0 million and 47.8 million shares of common stock. The stock purchase contract may be exercised at the option of the holder at any time prior to the settlement date. However, upon early settlement, the holder will receive the minimum settlement rate. Credit Facilities. The Holding Company maintains committed and unsecured credit facilities aggregating $3.0 billion ($1.5 billion expiring in 2009, which it shares with Metropolitan Life and MetLife Funding, and $1.5 billion expiring in 2010, which it shares with MetLife Funding) as of December 31, 2005. Borrowings under these facilities bear interest at varying rates as stated in the agreements. These facilities are primarily used for general corporate purposes and as back-up lines of credit for the borrowers’ commercial paper programs. At December 31, 2005, neither the Holding Company, Metropolitan Life nor MetLife Funding had borrowed against these credit facilities. At December 31, 2005, $374 million of the unsecured credit facilities were used in support of letters of credit issued on behalf of the Company. Letters of Credit. On July 1, 2005, in connection with the closing of the acquisition of Travelers, the L/C Agreement entered into by TLARC and various institutional lenders on April 25, 2005 became effective. Under the L/C Agreement, the Holding Company agreed to unconditionally guarantee reimbursement obligations of TLARC with respect to reinsurance letters of credit issued pursuant to the L/C Agreement and replaced Citigroup Insurance Holding Company as guarantor upon closing of the Travelers acquisition. The L/C Agreement expires ﬁve years after the closing of the acquisition. Also during 2005, Exeter entered into three ten-year letter of credit and reimbursement agreements totaling $800 million with an institutional lender, and the Holding Company and Exeter entered into a $500 million ten-year letter of credit and reimbursement agreement with another institutional lender. The following table provides details on the capacity and outstanding balances of such committed facilities as of December 31, 2005: Account Party Expiration Capacity The Travelers Life and Annuity Reinsurance Company *************************** Exeter Reassurance Company Ltd. ****************************************** March 2015 Exeter Reassurance Company Ltd. ****************************************** June 2015 Exeter Reassurance Company Ltd. ****************************************** September 2015 Exeter Reassurance Company Ltd. and MetLife, Inc. **************************** December 2015 Total********************************************************************* July 2010 $2,000 225 250 325 500 $3,300 Letter of Credit Issuances (In millions) $1,930 225 250 — 280 $2,685 Unused Commitments $ 70 — — 325 220 $615 Note: The Holding Company is a guarantor under the ﬁrst four agreements and a party to the ﬁfth agreement above. At December 31, 2005 and 2004, the Holding Company had $190 million and $369 million, respectively, in outstanding letters of credit from various banks, all of which automatically renew for one year periods. Since commitments associated with letters of credit and ﬁnancing arrangements may expire unused, these amounts do not necessarily reﬂect the Holding Company’s actual future cash funding requirements. Liquidity Uses The primary uses of liquidity of the Holding Company include service on debt, cash dividends on common and preferred stock, capital contributions to subsidiaries, payment of general operating expenses, acquisitions and the repurchase of the Holding Company’s common stock. Dividends. On November 15, 2005, the Holding Company’s board of directors declared dividends of $0.3077569 per share, for a total of $8 million, on the Series A preferred shares, and $0.4062500 per share, for a total of $24 million, on the Series B preferred shares. Both dividends were paid on December 15, 2005 to shareholders of record as of November 30, 2005. On October 25, 2005, the Holding Company’s board of directors approved an annual dividend for 2005 of $0.52 per share of common stock, for a total of $394 million, payable on December 15, 2005 to common shareholders of record on November 7, 2005. The 2005 common stock dividend represents a 13% increase from the 2004 annual common stock dividend of $0.46 per share. Future common stock dividend decisions will be determined by the Holding Company’s board of directors after taking into consideration factors such as the Company’s current earnings, expected medium- and long-term earnings, ﬁnancial condition, regulatory capital position, and applicable governmental regulations and policies. Furthermore, the payment of dividends and other distributions to the Holding Company by its insurance subsidiaries is regulated by insurance laws and regulations. See ‘‘— Liquidity and Capital Resources — The Holding Company — Liquidity Sources — Dividends.’’ On August 22, 2005, the Holding Company’s board of directors declared dividends of $0.286569 per share, for a total of $7 million, on the Series A preferred shares, and $0.4017361 per share, for a total of $24 million, on the Series B preferred shares. Both dividends were paid on September 15, 2005 to shareholders of record as of August 31, 2005. See ‘‘— Subsequent Events.’’ Afﬁliated Transactions. During the years ended December 31, 2005 and 2004, the Holding Company invested an aggregate of $904 million and $761 million in various subsidiaries, respectively. On December 12, 2005, RGA repurchased 1.6 million shares of its outstanding common stock at an aggregate price of approximately $76 million under an accelerated share repurchase agreement with a major bank. The bank borrowed the stock sold to RGA from third parties and is purchasing the shares in the open market over the subsequent few months to return to the lenders. RGA will either pay or receive an amount based on the actual amount paid by the bank to purchase the shares. These repurchases resulted in an increase in the Company’s ownership percentage of RGA to approximately to 53% at December 31, 2005 from approximately 52% at December 31, 2004. In February 2006, the ﬁnal purchase price was determined resulting in a cash settlement substantially equal to the aggregate cost. RGA recorded the initial repurchase of shares as treasury stock and recorded the amount received as an adjustment to the cost of the treasury stock. 32 MetLife, Inc. The Holding Company lends funds, as necessary, to its afﬁliates, some of which are regulated, to meet their capital requirements. Such loans to afﬁliates consisted of the following at December 31, 2005 and 2004: Afﬁliate Metropolitan Life ******************************************************** Metropolitan Life ******************************************************** Metropolitan Life ******************************************************** MetLife Investors USA Insurance Company ********************************** Total ****************************************************************** Interest Rate Maturity Date 7.13% 7.13% 5.00% 7.35% December 15, 2032 January 15, 2033 December 31, 2007 April 1, 2035 December 31, 2005 2004 (In millions) $ 400 100 800 400 $1,700 $400 100 — — $500 Share Repurchase. On October 26, 2004, the Holding Company’s Board of Directors authorized a $1 billion common stock repurchase program. Under this authorization, the Holding Company may purchase its common stock from the MetLife Policyholder Trust, in the open market and in privately negotiated transactions. On December 16, 2004, the Holding Company repurchased 7,281,553 shares of its outstanding common stock at an aggregate cost of $300 million under an accelerated common stock repurchase agreement with a major bank. The bank borrowed the stock sold to the Holding Company from third parties and purchased the common stock in the open market to return to such third parties. In April 2005, the Holding Company received a cash adjustment of approximately $7 million based on the actual amount paid by the bank to purchase the common stock, for a ﬁnal purchase price of approximately $293 million. The Holding Company recorded the shares initially repurchased as treasury stock and recorded the amount received as an adjustment to the cost of the treasury stock. At December 31, 2005, the Holding Company had approximately $716 million remaining on its October 26, 2004 common stock repurchase program. As a result of the acquisition of Travelers, the Holding Company has suspended its common stock repurchase activity. Future common stock repurchases will be dependent upon several factors, including the Company’s capital position, its ﬁnancial strength and credit ratings, general market conditions and the price of the Holding Company’s common stock. The following table summarizes the 2004 and 2003 common stock repurchase activity of the Holding Company, which includes the accelerated common stock repurchase activity in the fourth quarter of 2004: December 31, 2004 2003 (Dollars in millions) Shares Repurchased*********************************************************************** Cost ************************************************************************************ 26,373,952 1,000 $ 2,997,200 97 $ Support Agreements. The Holding Company has net worth maintenance agreements with three of its insurance subsidiaries, MetLife Investors, First MetLife Investors Insurance Company and MetLife Investors Insurance Company of California. Under these agreements, as subsequently amended, the Holding Company agreed, without limitation as to the amount, to cause each of these subsidiaries to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than 150% of the company action level RBC, as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. At December 31, 2005, the capital and surplus of each of these subsidiaries was in excess of the minimum capital and surplus amounts referenced above, and their total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2005. In connection with the acquisition of Travelers, support agreements regarding certain subsidiaries of the Holding Company were provided to various insurance regulators. The Holding Company committed to the Delaware Department of Insurance, in the event that at December 31, 2005 the total adjusted capital of MTL, a Delaware subsidiary of the Holding Company, is below 250% of the company action level RBC, the Holding Company would make a capital contribution to MTL in an amount that would make up for such shortfall. Pursuant to this commitment, during 2005, the Holding Company made a capital contribution of $50 million to MTL. At December 31, 2005, MTL’s company action level was in excess of 250%. The Holding Company also committed to the South Carolina Department of Insurance to take necessary action to maintain the minimum capital and surplus of The Travelers Life and Annuity Reinsurance Company, a South Carolina subsidiary of the Holding Company, at the greater of $250,000 or 10% of net loss reserves (loss reserves less deferred acquisition costs). Based on management’s analysis and comparison of its current and future cash inﬂows from the dividends it receives from subsidiaries, including Metropolitan Life, that are permitted to be paid without prior insurance regulatory approval, its portfolio of liquid assets, anticipated securities issuances and other anticipated cash ﬂows, management believes there will be sufﬁcient liquidity to enable the Holding Company to make payments on debt, make cash dividend payments on its common and preferred stock, contribute capital to its subsidiaries, pay all operating expenses, and meet its cash needs. Subsequent Events On February 21, 2006, the Holding Company’s board of directors declared dividends of $0.3432031 per share, for a total of $9 million, on its Series A preferred shares, and $0.4062500 per share, for a total of $24 million, on its Series B preferred shares, subject to the ﬁnal conﬁrmation that it has met the ﬁnancial tests speciﬁed in the Series A and Series B preferred shares, which the Holding Company anticipates will be made on or about March 5, 2006, the earliest date permitted in accordance with the terms of the securities. Both dividends will be payable March 15, 2006 to shareholders of record as of February 28, 2006. Off-Balance Sheet Arrangements Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business for the purpose of enhancing the Company’s total return on its investment portfolio. The amounts of these unfunded commitments were $2,684 million and $1,324 million at December 31, 2005 and 2004, respectively. The Company anticipates that these amounts will be invested in partnerships over the next ﬁve years. There are no other obligations or liabilities arising from such arrangements that are reasonably likely to become material. MetLife, Inc. 33 Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $2,974 million and $1,189 million at December 31, 2005 and 2004, respectively. The purpose of these loans is to enhance the Company’s total return on its investment portfolio. There are no other obligations or liabilities arising from such arrangements that are reasonably likely to become material. Lease Commitments The Company, as lessee, has entered into various lease and sublease agreements for ofﬁce space, data processing and other equipment. The Company’s commitments under such lease agreements are included within the contractual obligations table. See ‘‘— Liquidity and Capital Resources — The Company — Liquidity Uses.’’ Credit Facilities and Letters of Credit The Company maintains committed and unsecured credit facilities and letters of credit with various ﬁnancial institutions. See ‘‘— Liquidity and Capital Resources — The Company — Liquidity Sources — Credit Facilities and — Letters of Credit’’ for further description of such arrangements. Share-Based Arrangements In connection with the issuance of the common equity units, the Holding Company has issued forward stock purchase contracts under which the Company will issue, in 2008 and 2009, between 39.0 and 47.8 million shares, depending upon whether the share price is greater than $43.45 and less than $53.10. See ‘‘— Liquidity and Capital Resources — The Holding Company — Liquidity Sources — Common Equity Units’’ for further description of such arrangements. Guarantees In the course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties pursuant to which it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other speciﬁc liabilities, and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemniﬁcations to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $2 billion, with a cumulative maximum of $5.2 billion, while in other cases such limitations are not speciﬁed or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In addition, the Company indemniﬁes its directors and ofﬁcers as provided in its charters and by-laws. Also, the Company indemniﬁes other of its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these indemnities in the future. The Company has also guaranteed minimum investment returns on certain international retirement funds in accordance with local laws. Since these guarantees are not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In the ﬁrst quarter of 2005, the Company recorded a liability of $4 million with respect to indemnities provided in connection with a certain disposition. The approximate term for this liability is 18 months. The maximum potential amount of future payments the Company could be required to pay under these indemnities is approximately $500 million. Due to the uncertainty in assessing changes to the liability over the term, the liability on the Company’s consolidated balance sheet will remain until either expiration or settlement of the guarantee unless evidence clearly indicates that the estimates should be revised. In the third quarter of 2005, the Company released $6 million of a liability due to the expiration of indemnities provided in a prior year disposition. The Company’s recorded liabilities at December 31, 2005 and 2004 for indemnities, guarantees and commitments were $9 million and $10 million, respectively. In connection with RSATs, the Company writes credit default swap obligations requiring payment of principal due in exchange for the reference credit obligation, depending on the nature or occurrence of speciﬁed credit events for the referenced entities. In the event of a speciﬁed credit event, the Company’s maximum amount at risk, assuming the value of the referenced credits becomes worthless, is $593 million at December 31, 2005. The credit default swaps expire at various times during the next six years. Other Commitments TIC is a member of the Federal Home Loan Bank of Boston (the ‘‘FHLB of Boston’’) and has entered into several funding agreements with the FHLB of Boston whereby TIC has issued such funding agreements in exchange for cash and for which the FHLB of Boston has been granted a blanket lien on TIC’s residential mortgages and mortgage-backed securities to collateralize TIC’s obligations under the funding agreements. TIC maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualiﬁed collateral is sufﬁcient to satisfy the collateral maintenance level. The funding agreements and the related security agreement represented by this blanket lien, provide that upon any event of default by TIC, the FHLB of Boston’s recovery is limited to the amount of TIC’s liability under the outstanding funding agreements. The amount of the Company’s liability for funding agreements with the Bank as of December 31, 2005 is $1.1 billion, which is included in policyholder account balances. Collateral for Securities Lending The Company has noncash collateral for securities lending on deposits from customers, which cannot be sold or re-pledged, and which has not been recorded on its consolidated balance sheets. The amount of this collateral was $207 million and $17 million at December 31, 2005 and 2004, respectively. 34 MetLife, Inc. Pensions and Postretirement Beneﬁt Plans Description of Plans Plan Description Overview Subsidiaries of the Company (the ‘‘Subsidiaries’’) sponsor and/or administer various qualiﬁed and non-qualiﬁed deﬁned beneﬁt pension plans and postretirement employee beneﬁt plans covering employees and sales representatives who meet speciﬁed eligibility requirements. Virtually all of the Subsidiaries’ obligations under the deﬁned beneﬁt pension plans relate to traditional deﬁned beneﬁt obligations. Effective January 1, 1994, the basic plan beneﬁt under the traditional deﬁned beneﬁt pension plan was amended to provide an annual beneﬁt based upon a participant’s ﬁnal ﬁve year average earnings and credited years of service integrated with social security beneﬁts. Effective January 1, 2003 the pension plan was amended to incorporate a new beneﬁt formula for employees hired on or after January 1, 2002 and those existing employees who elected to have new accruals after December 31, 2002 determined under the new formula. Under the new beneﬁt formula, amounts are credited to individual participants’ ‘‘hypothetical’’ accounts. Such plan accumulations are commonly referred to as cash balance plans. Eligible participants accounts are credited monthly for beneﬁts equal to ﬁve percent of eligible monthly pay, and an additional ﬁve percent on the excess eligible monthly pay over the current social security wage base. Participants are also credited interest each month based on the average annual rate of interest on 30-year U.S. Treasury securities as published by the IRS in November of the prior year. Postretirement beneﬁts consist primarily of healthcare and life insurance beneﬁts. Employees of the Subsidiaries who were hired prior to 2003 (or, in certain cases, rehired during or after 2003) and meet age and service criteria while working for a covered subsidiary, may become eligible for these postretirement beneﬁts, at various levels, in accordance with the applicable plans. Employees hired after 2003 are not eligible for postretirement beneﬁts. Financial Summary A summary of the plan obligations and plan assets for the pension and postretirement beneﬁt plans for the years ended December 31, 2005 and 2004 are presented below. A December 31 measurement date is used for all the Subsidiaries’ deﬁned beneﬁt pension and other postretirement beneﬁt plans. As described more fully in the discussion of plan assets which follows, the Subsidiaries have issued group annuity and life insurance contracts supporting 98% of all pension and postretirement beneﬁt plan assets. The beneﬁt obligations and funded status of the Company’s deﬁned beneﬁt pension and postretirement beneﬁt plans are as follows: December 31, Pension Beneﬁts Postretirement Beneﬁts 2005 2004 2005 2004 Projected beneﬁt obligation at end of year ******************************************* $5,766 Fair value of plan assets at end of year********************************************** 5,518 Underfunded******************************************************************** $ (248) Unrecognized net asset at transition ************************************************ — Unrecognized net actuarial losses ************************************************** 1,528 Unrecognized prior service cost **************************************************** 54 Prepaid (accrued) beneﬁt cost ***************************************************** $1,334 Qualiﬁed plan prepaid pension cost************************************************* $1,691 Non-qualiﬁed plan accrued pension cost ******************************************** (435) Intangible assets***************************************************************** 12 Accumulated other comprehensive loss ********************************************* 66 Prepaid (accrued) beneﬁt cost ***************************************************** $1,334 (In millions) $5,523 5,392 $ (131) 1 1,510 67 $ 2,176 1,093 $(1,083) 1 377 (122) $1,975 1,062 $ (913) — 199 (165) $1,447 $ (827) $ (879) $1,782 (478) 13 130 $ — (827) — — $ — (879) — — $1,447 $ (827) $ (879) The prepaid (accrued) beneﬁt cost for pension beneﬁts presented in the above table consists of prepaid beneﬁt costs of $1,696 million and $1,785 million as of December 31, 2005 and 2004, respectively, and accrued beneﬁt costs of $362 million and $338 million as of December 31, 2005 and 2004, respectively. The aggregate projected beneﬁt obligation and aggregate fair value of plan assets for the pension plans were as follows: Qualiﬁed Plan Non-Qualiﬁed Plan Total 2005 2004 2005 2004 2005 2004 (In millions) Aggregate fair value of plan assets (principally Company contracts) ***** $5,518 Aggregate projected beneﬁt obligation ***************************** 5,258 Over (under) funded ******************************************** $ 260 $5,392 4,999 $ 393 $ — 508 $ — 524 $5,518 5,766 $5,392 5,523 $(508) $(524) $ (248) $ (131) The accumulated beneﬁt obligation for all deﬁned beneﬁt pension plans was $5,349 million and $5,149 million at December 31, 2005 and 2004, respectively. Information for pension plans with an accumulated beneﬁt obligation in excess of plan assets: Projected beneﬁt obligation ******************************************************************************** $538 Accumulated beneﬁt obligation ***************************************************************************** $449 Fair value of plan assets ********************************************************************************** $ 19 $550 $482 $ 17 December 31, 2005 2004 (In millions) MetLife, Inc. 35 Information for pension and other postretirement plans with a projected beneﬁt obligation in excess of plan assets: December 31, Pension Beneﬁts Postretirement Beneﬁts 2005 2004 2005 2004 (In millions) Projected beneﬁt obligation************************************************************ $538 Fair value of plan assets ************************************************************** $ 19 $550 $ 17 $2,176 $1,093 $1,975 $1,062 Pension and Postretirement Beneﬁt Plan Obligations Pension Plan Obligations Statement of Financial Accounting Standards (‘‘SFAS’’) No. 87, Employers’ Accounting for Pensions (‘‘SFAS 87’’) establishes the accounting for pension plan obligations. Under SFAS 87, the projected pension beneﬁt obligation (‘‘PBO’’) is deﬁned as the actuarially calculated present value of vested and non vested pension beneﬁts accrued based on future salary levels. The accumulated pension beneﬁt obligation (‘‘ABO’’) is the actuarial present value of vested and non-vested pension beneﬁts accrued based on current salary levels. The PBO and ABO of the pension plans are set forth in the preceding section. Obligations, both PBO and ABO, of the deﬁned beneﬁt pension plans are determined using a variety of actuarial assumptions, from which actual results may vary. Some of the more signiﬁcant of these assumptions include the discount rate used to determine the present value of future beneﬁt payments, the expected rate of compensation increases and average expected retirement age. Assumptions used in determining pension plan obligations were as follows: December 31, 2005 2004 Weighted average discount rate************************************************************************* Rate of compensation increase ************************************************************************* Average expected retirement age *********************************************************************** 5.82% 3%-8% 61 5.87% 3%-8% 61 The discount rate is determined annually based on the yield, measured on a yield to worst basis, of a hypothetical portfolio constructed of high- quality debt instruments available on the valuation date, which would provide the necessary future cash ﬂows to pay the aggregate projected pension beneﬁt obligation when due. The yield of this hypothetical portfolio, constructed of bonds rated AA or better by Moody’s resulted in a discount rate of approximately 5.82% and 5.87% for the deﬁned pension plans as of December 31, 2005 and 2004, respectively. A decrease (increase) in the discount rate increases (decreases) the pension beneﬁt obligation. This increase is amortized into earnings as an actuarial loss (gain). Based on the December 31, 2005 PBO, a 25 basis point decrease (increase) in the discount rate would result in an increase (decrease) in the PBO of approximately $175 million. Changes in discount rates are amortized into earnings as actuarial gains and losses. At the end of 2005, total unrecognized actuarial losses were $1,528 million, as compared to $1,510 million in 2004. The majority of the unrecognized actuarial losses are due to declining discount rates in recent years. These losses will be amortized on a straight-line basis over the average remaining service period of active employees expected to receive beneﬁts under the beneﬁt plans. At the end of 2005, the average remaining service period of active employees was 8.3 years for the pension plans. As the beneﬁts provided under the deﬁned pension plans are calculated as a percentage of future earnings, an assumption of future compensation increases is required to determine the projected beneﬁt obligation. These rates are derived through periodic analysis of historical demographic data conducted by an independent actuarial ﬁrm. The last review of such data was conducted using salary information through 2003 and the Subsidiaries believe that no circumstances have since occurred that would result in a material change to these rates. SFAS 87 also requires the recognition of an additional minimum liability and an intangible asset (limited to unrecognized prior service cost) if the market value of pension plan assets is less than the ABO at the measurement date. The Subsidiaries’ additional minimum liability was $78 million, and the intangible asset was $12 million, at December 31, 2005. The excess of the additional minimum liability over the intangible asset, of $66 million is recorded, net of income taxes, as a reduction of accumulated other comprehensive income. Postretirement Beneﬁt Plan Obligations SFAS No. 106, Employers Accounting for Postretirement Beneﬁts Other than Pensions (‘‘SFAS 106’’), establishes the accounting for expected postretirement plan beneﬁt obligations (‘‘EPBO’’) which represents the actuarial present value of all postretirement beneﬁts expected to be paid after retirement to employees and their dependents. Unlike for pensions, the EPBO is not recorded in the ﬁnancial statements but is used in measuring the periodic expense. The accumulated postretirement plan beneﬁt obligations (‘‘APBO’’) represents the actuarial present value of future postretirement beneﬁts attributed to employee services rendered through a particular date. The APBO is recorded in the ﬁnancial statements. The APBO is determined using a variety of actuarial assumptions, from which actual results may vary. Some of the more signiﬁcant of these assumptions include the discount rate, the health care cost trend rate and the average expected retirement age. The determination of the discount rate and the average expected retirement age are substantially consistent with the determination described previously under the pension plan. The assumed health care cost trend rates used in measuring the accumulated other postretirement beneﬁt obligation were as follows: Pre-Medicare eligible claims ****************************************** 9.5% down to 5% in 2014 Medicare eligible claims ********************************************** 11.5% down to 5% in 2018 8% down to 5% in 2010 10% down to 5% in 2014 December 31, 2005 2004 36 MetLife, Inc. Assumed health care cost trend rates may have a signiﬁcant effect on the amounts reported for health care plans. A one-percentage point change in assumed health care cost trend rates would have the following effects: One Percent Increase One Percent Decrease (In millions) Effect on total of service and interest cost components *********************************************** Effect of accumulated postretirement beneﬁt obligation ************************************************ $ 15 $182 $ (12) $(153) A decrease (increase) in the discount rate increases (decreases) the accumulated postretirement beneﬁt obligation. This increase is amortized into earnings as an actuarial loss (gain). Based on the December 31, 2005 APBO, a 25 basis point decrease (increase) in the discount rate would result in an increase (decrease) in the APBO of approximately $65 million. Changes in discount rates are amortized into earnings as actuarial gains and losses. At the end of 2005, total unrecognized actuarial losses were $377 million, as compared to $199 million in 2004. The majority of the unrecognized actuarial losses are due to declining discount rates, an increase in expected health care inﬂation and changes in demographic assumptions. These losses will be amortized on a straight-line basis over the average remaining service period of active employees expected to receive beneﬁts under the postretirement beneﬁt plans. At the end of 2005, the average remaining service period of active employees was 10.1 years for the postretirement beneﬁt plans. The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the ‘‘Prescription Drug Act’’). The other postretirement beneﬁt plan accumulated beneﬁt obligation was remeasured effective July 1, 2004 in order to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation was reduced by $213 million at July 1, 2004 and net periodic postretirement beneﬁt cost from July 1, 2004 through December 31, 2004 was reduced by $17 million. The reduction of net periodic beneﬁt cost was due to reductions in service cost of $3 million, interest cost of $6 million, and amortization of prior actuarial loss of $8 million. The reduction in the accumulated postretirement beneﬁt obligation related to the Prescription Drug Act was $298 million and $230 million as of December 31, 2005 and 2004, respectively. For the year ended December 31, 2005, the reduction of net periodic postretirement beneﬁt cost was $45 million, which was due to reductions in service cost of $6 million, interest cost of $16 million and amortization of prior actuarial loss of $23 million. An additional $23 million reduction in the December 31, 2005 accumulated postretirement beneﬁt plan obligation is the result of an acturial loss recognized during the year resulting from updated assumptions including a January 1, 2005 participant census and new claims cost experience and the effect of a December 31, 2005 change in the discount rate. Pension and Postretirement Net Periodic Beneﬁt Cost Pension Cost Net periodic pension cost is comprised of the following: 1) Service Cost — Service cost is the increase in the projected pension beneﬁt obligation resulting from beneﬁts payable to employees of the Subsidiaries on service rendered during the current year. 2) Interest Cost on the Liability — Interest cost is the time value adjustment on the projected pension beneﬁt obligation at the end of each year. 3) Expected Return on Plan Assets — Expected return on plan assets is the assumed return earned by the accumulated pension fund assets in a particular year. 4) Amortization of Unrecognized Prior Service Cost — This cost relates to the increase or decrease to pension beneﬁt cost for service provided in prior years due to amendments in plans or initiation of new plans. As the economic beneﬁts of these costs are realized in the future periods these costs are amortized to pension expense over the expected service years of the employees. 5) Amortization of Actuarial Loss — The amortization of actuarial loss comprises of differences between the actual experience and the expected experience on pension plan assets or projected beneﬁt obligation at the end of each year and the amortization of the unrecognized net gain or loss from prior periods. The Subsidiaries recognized pension expense of $146 million in 2005 as compared to $129 million in 2004 and $214 million in 2003. The major components of net periodic pension cost described above are as follows: Pension Beneﬁts 2005 2004 2003 (In millions) Service cost ****************************************************************************************** $ 142 Interest cost ****************************************************************************************** 318 Expected return on plan assets ************************************************************************** (446) Amortization of prior actuarial losses ********************************************************************** 116 Amortization of prior service cost ************************************************************************* 16 Curtailment cost *************************************************************************************** — Net periodic beneﬁt cost ******************************************************************************** $ 146 $ 129 311 (428) 101 16 — $ 129 $ 123 314 (335) 86 16 10 $ 214 The increase in expense was primarily a result of both increase in service cost and amortization of actuarial losses resulting largely from a declining discount rate, partially offset by the impact of an increase in the expected rates of return on plan assets. The weighted average discount rate used to calculate the net periodic pension cost was 5.83%, 6.10% and 6.74% for the years ended December 31, 2005, 2004 and 2003, respectively. The expected rate of return on pension plan assets used to calculate the net periodic pension cost for the years ended December 31, 2005, 2004 and 2003 was 8.50%, 8.50% and 8.51%, respectively. The expected rate of return on plan assets is based on anticipated performance of the various asset sectors in which the plan invests, weighted by target allocation percentages. Anticipated future performance is based on long-term historical returns of the plan assets by sector, adjusted for the Subsidiaries’ long-term expectations on the performance of the markets. While the precise expected return derived using this approach will ﬂuctuate from year to year, the Subsidiaries’ policy is to hold this long-term assumption constant as long as it remains within reasonable tolerance from the derived rate. The actual net return on the investments has been an approximation of the estimated return for MetLife, Inc. 37 the pension plan in 2005, 2004 and 2003. Due to anticipated changes in asset allocations, the expected rate of return will be lowered to 8.25% for purposes of determining 2006 net periodic pension beneﬁt cost. Based on the December 31, 2005 asset balances, a 25 basis point increase (decrease) in the expected rate of return on plan assets would result in a decrease (increase) in net periodic beneﬁt cost of approximately $14 million for the pension plans. Postretirement Beneﬁt Cost The net periodic postretirement beneﬁt cost beneﬁt consists of the following: 1) Service Cost — Service cost is the increase in the projected postretirement beneﬁt obligation resulting from beneﬁts payable to employees of the 2) Subsidiaries on service rendered during the current year. Interest Cost on the Liability — Interest cost is the time value adjustment on the projected postretirement beneﬁt obligation at the end of each year. 3) Expected Return on Plan Assets — Expected return on plan assets is the assumed return earned by the accumulated postretirement fund assets in a particular year. 4) Amortization of Unrecognized Prior Service Cost — This cost relates to the increase or decrease to postretirement beneﬁt cost for service provided in prior years due to amendments in plans or initiation of new plans. As the economic beneﬁts of these costs are realized in the future periods these costs are amortized to postretirement beneﬁt expense over the expected service years of the employees. 5) Amortization of Actuarial Loss — The amortization of actuarial loss comprises of differences between the actual experience and the expected experience on postretirement beneﬁt plan assets or expected postretirement plan beneﬁt obligation at the end of each year and the amortization of the unrecognized net gain or loss from prior periods. The Subsidiaries recognized postretirement beneﬁt expense of $77 million in 2005 as compared to $62 million in 2004 and $81 million in 2003. The major components of net periodic postretirement beneﬁt cost described above are as follows: Postretirement Beneﬁts 2005 2004 2003 (In millions) Service cost ****************************************************************************************** $ 37 Interest cost ****************************************************************************************** 121 Expected return on plan assets ************************************************************************** (79) Amortization of prior actuarial losses ********************************************************************** 15 Amortization of prior service cost ************************************************************************* (17) Curtailment cost *************************************************************************************** — Net periodic beneﬁt cost ******************************************************************************** $ 77 $ 32 119 (77) 7 (19) — $ 62 $ 39 123 (72) 8 (20) 3 $ 81 The increase in expense was primarily a result of both increase in service cost and amortization of actuarial losses resulting largely from a declining discount rate, partially offset by the impact of an increase in the expected rates of return on plan assets. The weighted average discount rate used to calculate the net periodic pension cost was 5.98%, 6.20% and 6.82% for the years ended December 31, 2005, 2004 and 2003, respectively. The expected rate of return on plan assets used to calculate the net postretirement beneﬁt cost for the years ended December 31, 2005, 2004 and 2003 was 7.51%, 7.91% and 7.79%. The expected rate of return on plan assets is based on anticipated performance of the various asset sectors in which the plan invests, weighted by target allocation percentages. Anticipated future performance is based on long-term historical returns of the plan assets by sector, adjusted for the Subsidiaries’ long-term expectations on the performance of the markets. While the precise expected return derived using this approach will ﬂuctuate from year to year, the Subsidiaries’ policy is to hold this long-term assumption constant as long as it remains within reasonable tolerance from the derived rate. The actual net return on the investments has been an approximation of the estimated return for the postretirement plans in 2005, 2004 and 2003. Due to anticipated changes in asset allocations, the expected rate of return will be lowered to 8.25% for healthcare beneﬁts and is estimated to remain the same at 6.25% for life beneﬁts. Based on the December 31, 2005 asset balances, a 25 basis point increase (decrease) in the expected rate of return on plan assets would result in a decrease (increase) in net periodic beneﬁt cost of approximately $3 million for the postretirement plans. Pension and Postretirement Beneﬁt Plan Assets Pension Plan Assets Assets of the pension plans are invested within group annuity and life insurance contracts issued by the Subsidiaries. The majority of assets are held in separate accounts established by the Subsidiaries. The account values of assets held with the Subsidiaries were $5,432 million and $5,324 million as of December 31, 2005 and 2004, respectively. The terms of these contracts are consistent in all material respects with what the Subsidiaries offer to unafﬁliated parties who are similarly situated. The pension plan’s net assets invested in separate accounts are stated at the aggregate fair value of units of participation. Such value reﬂects accumulated contributions, dividends and realized and unrealized investment gains or losses apportioned to such contributions, less withdrawals, distributions, allocable expenses relating to the purchase, sale and maintenance of the assets and an allocable part of such separate accounts’ investment expenses. Separate account investments in ﬁxed income and equity securities are generally carried at published market value, or if published market values are not readily available, at estimated market values. Investments in short-term ﬁxed income securities are generally reﬂected as cash equivalents and carried at fair value. Real estate investments are carried at estimated fair value based on appraisals performed by third-party real estate appraisal ﬁrms, and generally, determined by discounting projected cash ﬂows over periods of time and at interest rates deemed appropriate for each investment. Information on the physical value of the property and the sales prices of comparable properties is used to corroborate fair value estimates. Estimated fair value of hedge fund net assets is generally determined by third-party pricing vendors using quoted market prices or through the use of pricing models which are affected by changes in interest rates, foreign exchange rates, ﬁnancial indices, credit spreads, market supply and demand, market volatility and liquidity. 38 MetLife, Inc. The weighted average and weighted average target allocation of pension plan assets within the separate accounts is as follows: December 31, Weighted Average Weighted Average Target Allocation 2005 2004 2006 Asset Category Equity securities **************************************************************************** Fixed maturities ***************************************************************************** Other (Real Estate and Alternative Investments)*************************************************** 50% 36% 14% Total ************************************************************************************ 100% 100% 47% 37% 16% 30%-65% 20%-70% 0%-25% Target allocations of assets are determined with the objective of maximizing returns and minimizing volatility of net assets through adequate asset diversiﬁcation. Adjustments are made to target allocations based on an assessment of the impact of economic factors and market conditions. Postretirement Beneﬁt Plan Assets Assets of the postretirement beneﬁt plans are invested within life insurance and reserve contracts issued by the Subsidiaries. The majority of assets are held in separate accounts established by the Subsidiaries. The account values of assets held with the Subsidiaries were $1,039 million and $1,011 million as of December 31, 2005 and 2004, respectively. The terms of these contracts are consistent in all material respects with what the Subsidiaries offer to unafﬁliated parties who are similarly situated. The valuation of separate accounts and the investments within such separate accounts invested in by the postretirement plans are similar to that described in the preceding section on pension plans. The weighted average and weighted average target allocation of other postretirement beneﬁt plan assets within the separate account is as follows: December 31, Weighted Average Weighted Average Target Allocation 2005 2004 2006 Asset Category Equity securities ************************************************************************* Fixed maturities************************************************************************** Other ********************************************************************************** Total ********************************************************************************* 42% 53% 5% 41% 57% 2% 100% 100% 30%-45% 45%-70% 0%-10% Target allocations of assets are determined with the objective of maximizing returns and minimizing volatility of net assets through adequate asset diversiﬁcation. Adjustments are made to target allocations based on an assessment of the impact of economic factors and market conditions. Funding and Cash Flows of Pension and Postretirement Beneﬁt Plan Obligations Pension Plan Obligations It is the Subsidiaries’ practice to make contributions to the qualiﬁed pension plan to comply with minimum funding requirements of Employee Retirement Income Security Act of 1974, as amended, and/or to maintain a fully funded accumulated beneﬁt obligation. In accordance with such practice, no contributions were required for the year ended December 31, 2005 and no contributions are anticipated to be required for 2006. The non- qualiﬁed pension plans are funded as beneﬁt payments become due under the provision of the plans. The Subsidiaries expect to make discretionary contributions of $187 million towards the pension plans in 2006. Gross pension beneﬁt payments for the next ten years, which reﬂect expected future service as appropriate, are expected to be as follows: 2006 ******************************************************************************************************* 2007 ******************************************************************************************************* 2008 ******************************************************************************************************* 2009 ******************************************************************************************************* 2010 ******************************************************************************************************* 2011-2015************************************************************************************************** Postretirement Beneﬁt Plan Obligations Pension Beneﬁts (In millions) $320 $325 $337 $351 $355 $1,984 Postretirement beneﬁts represent a non-vested, non-guaranteed obligation of the Subsidiaries and current regulations do not require speciﬁc funding levels for these beneﬁts. While the Subsidiaries have funded such plans in advance, it has been the Subsidiaries’ practice to use their general assets to pay claims as they come due instead of utilizing plan assets. The Subsidiaries expect to make discretionary contributions of $128 million, based upon expected gross beneﬁt payments, towards the postretire- ment plan obligations in 2006. As noted previously, the Subsidiaries expect to receive subsidies under the Prescription Drug Act to offset such payments. MetLife, Inc. 39 Gross beneﬁt payments and gross subsidy payments under the Prescription Drug Act for the next ten years, which reﬂect expected future service as appropriate, are expected to be as follows: Postretirement Beneﬁts Prescription Drug Act Subsidies (In millions) Net Postretirement Beneﬁts 2006 ************************************************************************* 2007 ************************************************************************* 2008 ************************************************************************* 2009 ************************************************************************* 2010 ************************************************************************* 2011-2015 ******************************************************************** $128 $133 $138 $144 $150 $833 $11 $12 $13 $13 $14 $83 $117 $121 $125 $131 $136 $750 Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require life insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual beneﬁts owed pursuant to insurance policies issued by impaired, insolvent or failed life insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assessments levied against the Company were $4 million, $10 million and $6 million for the years ended December 31, 2005, 2004 and 2003, respectively. The Company maintained a liability of $90 million, and a related asset for premium tax offsets of $54 million, at December 31, 2005 for undiscounted future assessments in respect of currently impaired, insolvent or failed insurers. In the past ﬁve years, none of the aggregate assessments levied against MetLife’s insurance subsidiaries has been material. The Company has established liabilities for guaranty fund assessments that it considers adequate for assessments with respect to insurers that are currently subject to insolvency proceedings. Effects of Inﬂation The Company does not believe that inﬂation has had a material effect on its consolidated results of operations, except insofar as inﬂation may affect interest rates. Application of Recent Accounting Pronouncements In February 2006, the FASB issued SFAS No. 155, Accounting for Certain Hybrid Instruments (‘‘SFAS 155’’). SFAS 155 amends SFAS No. 133, Accounting for Derivative Instruments and Hedging (‘‘SFAS 133’’) and SFAS No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities (‘‘SFAS 140’’). SFAS 155 allows ﬁnancial instruments that have embedded derivatives to be accounted for as a whole, eliminating the need to bifurcate the derivative from its host, if the holder elects to account for the whole instrument on a fair value basis. In addition, among other changes, SFAS 155 (i) clariﬁes which interest-only strips and principal-only strips are not subject to the requirements of SFAS 133; (ii) establishes a requirement to evaluate interests in securitized ﬁnancial assets to identify interests that are freestanding derivatives or that are hybrid ﬁnancial instruments that contain an embedded derivative requiring bifurcation; (iii) clariﬁes that concentrations of credit risk in the form of subordination are not embedded derivatives; and (iv) eliminates the prohibition on a qualifying special-purpose entity (‘‘QSPE’’) from holding a derivative ﬁnancial instrument that pertains to a beneﬁcial interest other than another derivative ﬁnancial interest. SFAS 155 will be applied prospectively and is effective for all ﬁnancial instruments acquired or issued for ﬁscal years beginning after September 15, 2006. SFAS 155 is not expected to have a material impact on the Company’s consolidated ﬁnancial statements. The FASB has issued additional guidance relating to derivative ﬁnancial instruments as follows: ) In June 2005, the FASB cleared SFAS 133 Implementation Issue No. B38, Embedded Derivatives: Evaluation of Net Settlement with Respect to the Settlement of a Debt Instrument through Exercise of an Embedded Put Option or Call Option (‘‘Issue B38’’) and SFAS 133 Implementation Issue No. B39, Embedded Derivatives: Application of Paragraph 13(b) to Call Options That Are Exercisable Only by the Debtor (‘‘Issue B39’’). Issue B38 clariﬁed that the potential settlement of a debtor’s obligation to a creditor occurring upon exercise of a put or call option meets the net settlement criteria of SFAS No. 133. Issue B39 clariﬁed that an embedded call option, in which the underlying is an interest rate or interest rate index, that can accelerate the settlement of a debt host ﬁnancial instrument should not be bifurcated and fair valued if the right to accelerate the settlement can be exercised only by the debtor (issuer/borrower) and the investor will recover substantially all of its initial net investment. Issues B38 and B39, which must be adopted as of the ﬁrst day of the ﬁrst ﬁscal quarter beginning after December 15, 2005, did not have a material impact on the Company’s consolidated ﬁnancial statements. ) Effective October 1, 2003, the Company adopted Issue B36. Issue B36 concluded that (i) a company’s funds withheld payable and/or receivable under certain reinsurance arrangements; and (ii) a debt instrument that incorporates credit risk exposures that are unrelated or only partially related to the creditworthiness of the obligor include an embedded derivative feature that is not clearly and closely related to the host contract. Therefore, the embedded derivative feature is measured at fair value on the balance sheet and changes in fair value are reported in income. As a result of the adoption of Issue B36, the Company recorded a cumulative effect of a change in accounting of $26 million, net of income taxes, for the year ended December 31, 2003. ) Effective July 1, 2003, the Company adopted SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities (‘‘SFAS 149’’). SFAS 149 amended and clariﬁed the accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Except for certain previously issued and effective guidance, SFAS 149 was effective for contracts entered into or modiﬁed after June 30, 2003. The Company’s adoption of SFAS 149 did not have a signiﬁcant impact on its consolidated ﬁnancial statements. Effective November 9, 2005, the Company prospectively adopted the guidance in FASB Staff Position (‘‘FSP’’) FAS 140-2, Clariﬁcation of the Application of Paragraphs 40(b) and 40(c) of FAS 140 (‘‘FSP 140-2’’). FSP 140-2 clariﬁed certain criteria relating to derivatives and beneﬁcial interests when considering whether an entity qualiﬁes as a QSPE. Under FSP 140-2, the criteria must only be met at the date the QSPE issues beneﬁcial interests or when a derivative ﬁnancial instrument needs to be replaced upon the occurrence of a speciﬁed event outside the control of the transferor. FSP 140-2 did not have a material impact on the Company’s consolidated ﬁnancial statements. 40 MetLife, Inc. In September 2005, the American Institute of Certiﬁed Public Accountants (‘‘AICPA’’) issued SOP 05-1, Accounting by Insurance Enterprises for Deferred Acquisition Costs in Connection with Modiﬁcations or Exchanges of Insurance Contracts (‘‘SOP 05-1’’). SOP 05-1 provides guidance on accounting by insurance enterprises for deferred acquisition costs on internal replacements of insurance and investment contracts other than those speciﬁcally described in SFAS No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and For Realized Gains and Losses from the Sale of Investments. SOP 05-1 deﬁnes an internal replacement as a modiﬁcation in product beneﬁts, features, rights, or coverages that occurs by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. Under SOP 05-1, modiﬁcations that result in a substantially unchanged contract will be accounted for as a continuation of the replaced contract. A replacement contract that is substantially changed will be accounted for as an extinguishment of the replaced contract resulting in a release of unamortized deferred acquisition costs, unearned revenue and deferred sales inducements associated with the replaced contract. The guidance in SOP 05-1 will be applied prospectively and is effective for internal replacements occurring in ﬁscal years beginning after December 15, 2006. The Company is currently evaluating the impact of SOP 05-1 and does not expect that the pronouncement will have a material impact on the Company’s consolidated ﬁnancial statements. In September 2005, the Emerging Issues Task Force (‘‘EITF’’) reached consensus on Issue No. 05-7, Accounting for Modiﬁcations to Conversion Options Embedded in Debt Instruments and Related Issues (‘‘EITF 05-7’’). EITF 05-7 provides guidance on whether a modiﬁcation of conversion options embedded in debt results in an extinguishment of that debt. In certain situations, companies may change the terms of an embedded conversion option as part of a debt modiﬁcation. The EITF concluded that the change in the fair value of an embedded conversion option upon modiﬁcation should be included in the analysis of EITF Issue No. 96-19, Debtor’s Accounting for a Modiﬁcation or Exchange of Debt Instruments, to determine whether a modiﬁcation or extinguishment has occurred and that a change in the fair value of a conversion option should be recognized upon the modiﬁcation as a discount (or premium) associated with the debt, and an increase (or decrease) in additional paid-in capital. EITF 05-7 will be applied prospectively and is effective for all debt modiﬁcations occurring in periods beginning after December 15, 2005. EITF 05-7 did not have a material impact on the Company’s consolidated ﬁnancial statements. In September 2005, the EITF reached consensus on Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneﬁcial Conversion Feature (‘‘EITF 05-8’’). EITF 05-8 concludes that (i) the issuance of convertible debt with a beneﬁcial conversion feature results in a basis difference that should be accounted for as a temporary difference and (ii) the establishment of the deferred tax liability for the basis difference should result in an adjustment to additional paid in capital. EITF 05-8 will be applied retrospectively for all instruments with a beneﬁcial conversion feature accounted for in accordance with EITF Issue No. 98-5, Accounting for Convertible Securities with Beneﬁcial Conversion Features or Contingently Adjustable Conversion Ratios, and EITF Issue No. 00-27, Application of Issue No. 98-5 to Certain Convertible Instruments, and is effective for periods beginning after December 15, 2005. EITF 05-8 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective July 1, 2005, the Company adopted SFAS No. 153, Exchanges of Nonmonetary Assets, an amendment of Accounting Principles Board (‘‘APB’’) Opinion No. 29 (‘‘SFAS 153’’). SFAS 153 amended prior guidance to eliminate the exception for nonmonetary exchanges of similar productive assets and replaced it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial substance if the future cash ﬂows of the entity are expected to change signiﬁcantly as a result of the exchange. The provisions of SFAS 153 were required to be applied prospectively for ﬁscal periods beginning after June 15, 2005. The adoption of SFAS 153 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective July 1, 2005, the Company adopted EITF Issue No. 05-6, Determining the Amortization Period for Leasehold Improvements (‘‘EITF 05-6’’). EITF 05-6 provides guidance on determining the amortization period for leasehold improvements acquired in a business combination or acquired subsequent to lease inception. As required by EITF 05-6, the Company adopted this guidance on a prospective basis which had no material impact on the Company’s consolidated ﬁnancial statements. In June 2005, the FASB completed its review of EITF Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments (‘‘EITF 03-1’’). EITF 03-1 provides accounting guidance regarding the determination of when an impairment of debt and marketable equity securities and investments accounted for under the cost method should be considered other-than-temporary and recognized in income. EITF 03-1 also requires certain quantitative and qualitative disclosures for debt and marketable equity securities classiﬁed as available-for-sale or held-to- maturity under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities (‘‘SFAS 115’’), that are impaired at the balance sheet date but for which an other-than-temporary impairment has not been recognized. The FASB decided not to provide additional guidance on the meaning of other-than-temporary impairment but has issued FSP 115-1, The Meaning of Other-Than-Temporary Impairment and its Application to Certain Invest- ments (‘‘FSP 115-1’’), which nulliﬁes the accounting guidance on the determination of whether an investment is other-than-temporarily impaired as set forth in EITF 03-1. As required by FSP 115-1, the Company adopted this guidance on a prospective basis, which had no material impact on the Company’s consolidated ﬁnancial statements, and has provided the required disclosures. In June 2005, the EITF reached consensus on Issue No. 04-5, Determining Whether a General Partner, or the General Partners as a Group, Controls a Limited Partnership or Similar Entity When the Limited Partners Have Certain Rights (‘‘EITF 04-5’’). EITF 04-5 provides a framework for determining whether a general partner controls and should consolidate a limited partnership or a similar entity in light of certain rights held by the limited partners. The consensus also provides additional guidance on substantive rights. EITF 04-5 was effective after June 29, 2005 for all newly formed partnerships and for any pre-existing limited partnerships that modiﬁed their partnership agreements after that date. The adoption of this provision of EITF 04-5 did not have a material impact on the Company’s consolidated ﬁnancial statements. EITF 04-5 must be adopted by January 1, 2006 for all other limited partnerships through a cumulative effect of a change in accounting principle recorded in opening equity or it may be applied retrospectively by adjusting prior period ﬁnancial statements. The adoption of this provision of EITF 04-5 did not have a material impact on the Company’s consolidated ﬁnancial statements. In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, a replacement of APB Opinion No. 20 and FASB Statement No. 3 (‘‘SFAS 154’’). The statement requires retrospective application to prior periods’ ﬁnancial statements for a voluntary change in accounting principle unless it is deemed impracticable. It also requires that a change in the method of depreciation, amortization, or depletion for long- lived, non-ﬁnancial assets be accounted for as a change in accounting estimate rather than a change in accounting principle. SFAS 154 is effective for accounting changes and corrections of errors made in ﬁscal years beginning after December 15, 2005. The adoption of SFAS 154 did not have a material impact on the Company’s consolidated ﬁnancial statements. In December 2004, the FASB issued SFAS 123 (revised 2004), Share-Based Payment (‘‘SFAS 123(r)’’), which revised SFAS No. 123, Accounting for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees. SFAS 123(r) provides additional guidance on determining whether certain ﬁnancial instruments awarded in share-based payment transactions are liabilities. SFAS 123(r) also requires that MetLife, Inc. 41 the cost of all share-based transactions be measured at fair value and recognized over the period during which an employee is required to provide service in exchange for an award. The SEC issued a ﬁnal ruling in April 2005 allowing a public company that is not a small business issuer to implement SFAS 123(r) at the beginning of the next ﬁscal year after June 15, 2005. Thus, the revised pronouncement must be adopted by the Company by January 1, 2006. As permitted under SFAS 148, Accounting for Stock-Based Compensation — Transition and Disclosure — an amendment of FASB Statement No. 123, the Company elected to use the prospective method of accounting for stock options granted subsequent to December 31, 2002. Options granted prior to January 1, 2003 will continue to be accounted for under the intrinsic value method until the adoption of SFAS 123(r). In addition, the pro forma impact of accounting for these options at fair value continued to be accounted for under the intrinsic value method until the last of those options vested in 2005. As all stock options currently accounted for under the intrinsic value method vested prior to the effective date, implementation of SFAS 123(r) will not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. In December 2004, the FASB issued FSP 109-2, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004 (‘‘FSP 109-2’’). The American Jobs Creation Act of 2004 (‘‘AJCA’’) introduced a one-time dividend received deduction on the repatriation of certain earnings to a U.S. taxpayer. FSP 109-2 provides companies additional time beyond the ﬁnancial reporting period of enactment to evaluate the effects of the AJCA on their plans to repatriate foreign earnings for purposes of applying SFAS No. 109, Accounting for Income Taxes. During 2005, the Company recorded a $27 million income tax beneﬁt related to the repatriation of foreign earnings pursuant to Internal Revenue Code Section 965 for which a U.S. deferred income tax provision had previously been recorded. Effective July 1, 2004, the Company prospectively adopted FSP No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (‘‘FSP 106-2’’). FSP 106-2 provides accounting guidance to employers that sponsor postretirement health care plans that provide prescription drug beneﬁts. The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 based on the Company’s determination that the prescription drug beneﬁts offered under certain postretirement plans are actuarially equivalent to the beneﬁts offered under Medicare Part D. The postretirement beneﬁt plan assets and accumulated beneﬁt obligation were remeasured to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation was reduced by $213 million at July 1, 2004. Effective July 1, 2004, the Company adopted EITF Issue No. 03-16, Accounting for Investments in Limited Liability Companies (‘‘EITF 03-16’’). EITF 03-16 provides guidance regarding whether a limited liability company should be viewed as similar to a corporation or similar to a partnership for purposes of determining whether a noncontrolling investment should be accounted for using the cost method or the equity method of accounting. EITF 03-16 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective April 1, 2004, the Company adopted EITF Issue No. 03-6, Participating Securities and the Two — Class Method under FASB Statement No. 128 (‘‘EITF 03-6’’). EITF 03-6 provides guidance on determining whether a security should be considered a participating security for purposes of computing earnings per common share and how earnings should be allocated to the participating security. EITF 03-6 did not have an impact on the Company’s earnings per common share calculations or amounts. Effective January 1, 2004, the Company adopted SOP 03-1, as interpreted by a Technical Practice Aid (‘‘TPA’’), issued by the AICPA. SOP 03-1 provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. In June 2004, the FASB released FSP No. 97-1, Situations in Which Paragraphs 17(b) and 20 of FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments, Permit or Require Accrual of an Unearned Revenue Liability (‘‘FSP 97-1’’), which included clariﬁcation that unearned revenue liabilities should be considered in determining the necessary insurance beneﬁt liability required under SOP 03-1. Since the Company had considered unearned revenue in determining its SOP 03-1 beneﬁt liabilities, FSP 97-1 did not impact its consolidated ﬁnancial statements. As a result of the adoption of SOP 03-1, effective January 1, 2004, the Company decreased the liability for future policyholder beneﬁts for changes in the methodology relating to various guaranteed death and annuitization beneﬁts and for determining liabilities for certain universal life insurance contracts by $4 million, which has been reported as a cumulative effect of a change in accounting. This amount is net of corresponding changes in DAC, including VOBA and unearned revenue liability (‘‘offsets’’), under certain variable annuity and life contracts and income taxes. Certain other contracts sold by the Company provide for a return through periodic crediting rates, surrender adjustments or termination adjustments based on the total return of a contractually referenced pool of assets owned by the Company. To the extent that such contracts are not accounted for as derivatives under the provisions of SFAS No. 133 and not already credited to the contract account balance, under SOP 03-1 the change relating to the fair value of the referenced pool of assets is recorded as a liability with the change in the liability recorded as policyholder beneﬁts and claims. Prior to the adoption of SOP 03-1, the Company recorded the change in such liability as other comprehensive income. At adoption, this change decreased net income and increased other comprehensive income by $63 million, net of income taxes, which were recorded as cumulative effects of changes in accounting. Effective with the adoption of SOP 03-1, costs associated with enhanced or bonus crediting rates to contractholders must be deferred and amortized over the life of the related contract using assumptions consistent with the amortization of DAC. Since the Company followed a similar approach prior to adoption of SOP 03-1, the provisions of SOP 03-1 relating to sales inducements had no signiﬁcant impact on the Company’s consolidated ﬁnancial statements. In accordance with SOP 03-1’s guidance for the reporting of certain separate accounts, at adoption, the Company also reclassiﬁed $1.7 billion of separate account assets to general account investments and $1.7 billion of separate account liabilities to future policy beneﬁts and policyholder account balances. This reclassiﬁcation decreased net income and increased other comprehensive income by $27 million, net of income taxes, which were reported as cumulative effects of changes in accounting. Due to the adoption of SOP 03-1, the Company recorded a cumulative effect of a change in accounting of $86 million, net of income taxes of $46 million, for the year ended December 31, 2004. In December 2003, FASB revised SFAS No. 132, Employers’ Disclosures about Pensions and Other Postretirement Beneﬁts — an Amendment of FASB Statements No. 87, 88 and 106 (‘‘SFAS 132(r)’’). SFAS 132(r) retains most of the disclosure requirements of SFAS 132 and requires additional disclosure about assets, obligations, cash ﬂows and net periodic beneﬁt cost of deﬁned beneﬁt pension plans and other postretirement plans. SFAS 132(r) was primarily effective for ﬁscal years ending after December 15, 2003; however, certain disclosures about foreign plans and estimated future beneﬁt payments were effective for ﬁscal years ending after June 15, 2004. The Company’s adoption of SFAS 132(r) did not have a signiﬁcant impact on its consolidated ﬁnancial statements since it only revised disclosure requirements. During 2003, the Company adopted FASB Interpretation (‘‘FIN’’) No. 46, Consolidation of Variable Interest Entities — An Interpretation of Accounting Research Bulletin (‘‘ARB’’) No. 51 (‘‘FIN 46’’), and its December 2003 revision (‘‘FIN 46(r)’’). Certain of the Company’s investments in real estate joint ventures and other limited partnership interests meet the deﬁnition of a variable interest entity (‘‘VIE’’) and have been consolidated, in accordance with the transition rules and effective dates, because the Company is deemed to be the primary beneﬁciary. A VIE is deﬁned as (i) any entity in which the equity investments at risk in such entity do not have the characteristics of a controlling ﬁnancial interest; or (ii) any entity that does not have sufﬁcient equity at risk 42 MetLife, Inc. to ﬁnance its activities without additional subordinated support from other parties. Effective February 1, 2003, the Company adopted FIN 46 for VIEs created or acquired on or after February 1, 2003 and, effective December 31, 2003, the Company adopted FIN 46(r) with respect to interests in entities formerly considered special purpose entities (‘‘SPEs’’), including interests in asset-backed securities and collateralized debt obligations. The adoption of FIN 46 as of February 1, 2003 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. The adoption of the provisions of FIN 46(r) at December 31, 2003 did not require the Company to consolidate any additional VIEs that were not previously consolidated. In accordance with the provisions of FIN 46(r), the Company elected to defer until March 31, 2004 the consolidation of interests in VIEs for non-SPEs acquired prior to February 1, 2003 for which it is the primary beneﬁciary. As of March 31, 2004, the Company consolidated assets and liabilities relating to real estate joint ventures of $78 million and $11 million, respectively, and assets and liabilities relating to other limited partnerships of $29 million and less than $1 million, respectively, for VIEs for which the Company was deemed to be the primary beneﬁciary. There was no impact to net income from the adoption of FIN 46. Effective January 1, 2003, the Company adopted FIN No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (‘‘FIN 45’’). FIN 45 requires entities to establish liabilities for certain types of guarantees and expands ﬁnancial statement disclosures for others. The initial recognition and initial measurement provisions of FIN 45 were applicable on a prospective basis to guarantees issued or modiﬁed after December 31, 2002. The adoption of FIN 45 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (‘‘SFAS 146’’). SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recorded and measured initially at fair value only when the liability is incurred rather than at the date of an entity’s commitment to an exit plan as required by EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Beneﬁts and Other Costs to Exit an Activity Including Certain Costs Incurred in a Restructuring (‘‘EITF 94-3’’). As required by SFAS 146, the Company adopted this guidance on a prospective basis which had no material impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections (‘‘SFAS 145’’). In addition to amending or rescinding other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions, SFAS 145 generally precludes companies from recording gains and losses from the extinguishment of debt as an extraordinary item. SFAS 145 also requires sale-leaseback treatment for certain modiﬁcations of a capital lease that result in the lease being classiﬁed as an operating lease. The adoption of SFAS 145 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Investments The Company’s primary investment objective is to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that assets and liabilities are managed on a cash ﬂow and duration basis. The Company is exposed to three primary sources of investment risk: ) Credit risk, relating to the uncertainty associated with the continued ability of a given obligor to make timely payments of principal and interest; ) Interest rate risk, relating to the market price and cash ﬂow variability associated with changes in market interest rates; and ) Market valuation risk. The Company manages risk through in-house fundamental analysis of the underlying obligors, issuers, transaction structures and real estate properties. The Company also manages credit risk and market valuation risk through industry and issuer diversiﬁcation and asset allocation. For real estate and agricultural assets, the Company manages credit risk and valuation risk through geographic, property type and product type diversiﬁcation and asset allocation. The Company manages interest rate risk as part of its asset and liability management strategies, product design, such as the use of market value adjustment features and surrender charges, and proactive monitoring and management of certain non-guaranteed elements of its products, such as the resetting of credited interest and dividend rates for policies that permit such adjustments. The Company also uses certain derivative instruments in the management of credit and interest rate risks. MetLife, Inc. 43 Composition of Portfolio and Investment Results The following table illustrates the net investment income and annualized yields on average assets for each of the components of the Company’s investment portfolio for the years ended December 31, 2005, 2004 and 2003. December 31, 2005 2004 2003 (In millions) 6.02% 6.81% 10.59% 467 2,139 4,665 FIXED MATURITIES Yield(2) **************************************************************************** Investment income(3)***************************************************************** $ 10,424 Net investment gains (losses) ********************************************************** $ (868) Ending assets(3)********************************************************************* $230,875 MORTGAGE AND CONSUMER LOANS Yield(2) **************************************************************************** Investment income(4)***************************************************************** $ 2,236 Net investment gains (losses) ********************************************************** $ 17 Ending assets*********************************************************************** $ 37,190 REAL ESTATE AND REAL ESTATE JOINT VENTURES(5) Yield(2) **************************************************************************** Investment income******************************************************************* $ Net investment gains (losses) ********************************************************** $ Ending assets*********************************************************************** $ POLICY LOANS Yield(2) **************************************************************************** Investment income******************************************************************* $ Ending assets*********************************************************************** $ EQUITY SECURITIES AND OTHER LIMITED PARTNERSHIP INTERESTS Yield(2) **************************************************************************** Investment income******************************************************************* $ Net investment gains (losses) ********************************************************** $ Ending assets*********************************************************************** $ CASH AND SHORT-TERM INVESTMENTS Yield(2) **************************************************************************** Investment income******************************************************************* $ Net investment gains (losses) ********************************************************** $ Ending assets*********************************************************************** $ OTHER INVESTED ASSETS(6) Yield(2) **************************************************************************** Investment income******************************************************************* $ Net investment gains (losses)(7) ******************************************************** $ Ending assets*********************************************************************** $ TOTAL INVESTMENTS Gross investment income yield(2) ****************************************************** Investment fees and expenses yield **************************************************** NET INVESTMENT INCOME YIELD ************************************************* 3.66% 362 (2) 7,324 8.96% 570 502 8,078 12.44% 774 159 7,614 6.00% 572 9,981 6.35% (0.14)% 6.21% 6.53% 6.91% 9,015 $ $ 71 $176,377 8,480 $ $ (398) $167,382 6.99% 7.49% 1,951 $ $ (47) $ 32,406 1,902 $ $ (56) $ 26,249 11.69% 515 162 4,233 6.15% 541 8,899 9.96% 404 208 5,095 3.00% 153 (1) 6,710 6.55% 290 (149) 5,295 $ $ $ $ $ $ $ $ $ $ $ $ $ $ 10.88% 513 440 4,677 6.40% 554 8,750 3.03% 111 (43) 4,183 2.45% 160 1 5,483 9.65% 324 (159) 4,998 $ $ $ $ $ $ $ $ $ $ $ $ $ $ 6.69% (0.14)% 6.55% 6.88% (0.16)% 6.72% Gross investment income ************************************************************* $ 15,405 Investment fees and expenses********************************************************* $ (339) NET INVESTMENT INCOME(1)(5)(6)(7) *********************************************** $ 15,066 $ 12,869 (260) $ $ 12,044 (276) $ $ 12,609 $ 11,768 Ending assets(1)********************************************************************* $305,727 $239,015 $221,722 Net investment gains (losses)(1)(5)(6)(7) ************************************************* $ 1,947 $ 244 $ (215) (1) Included in ending assets, investment income and investment gains (losses) is $7,102 million, $213 million and $8 million, respectively, related to the consolidation of separate accounts under SOP 03-1 for the year ended December 31, 2005. Included in ending assets, investment income and investment gains (losses) is $2,139 million, $86 million and $25 million, respectively, related to the consolidation of separate accounts under SOP 03-1 for the year ended December 31, 2004. (2) Yields are based on quarterly average asset carrying values, excluding recognized and unrealized investment gains (losses), and for yield calculation purposes, average assets exclude collateral associated with the Company’s securities lending program. (3) Fixed maturities include $825 million in ending assets and $14 million in investment income relating to trading securities for the year ended December 31, 2005. The annualized yield on trading securities was 2.74% for the year ended December 31, 2005. The Company did not have any trading securities during the years ended December 31, 2004 and 2003. Investment income from mortgage and consumer loans includes prepayment fees. (4) (5) Real estate and real estate joint venture income includes amounts classiﬁed as discontinued operations of $58 million, $169 million and $212 million for the years ended December 31, 2005, 2004 and 2003, respectively. Net investment gains (losses) include $2,125 million, $146 million and $420 million of gains classiﬁed as discontinued operations for the years ended December 31, 2005, 2004 and 2003, respectively. 44 MetLife, Inc. (6) (7) Investment income from other invested assets includes scheduled periodic settlement payments on derivative instruments that do not qualify for hedge accounting under SFAS 133 of $99 million, $51 million and $84 million for the years ended December 31, 2005, 2004 and 2003, respectively. These amounts are excluded from net investment gains (losses). Additionally, excluded from net investment gains (losses) for year ended December 31, 2005 is ($13) million related to revaluation losses on derivatives used to hedge interest rate and currency risk on policyholder account balances that do not qualify for hedge accounting. Included in net investment gains (losses) from other invested assets for the year ended December 31, 2004 is a charge of $26 million related to a funds withheld reinsurance treaty that was converted to a coinsurance agreement. This amount is classiﬁed in net investment income in the consolidated statements of income. Fixed Maturities and Equity Securities Available-for-Sale Fixed maturities consist principally of publicly traded and privately placed debt securities, and represented 75.2% and 73.8% of total cash and invested assets at December 31, 2005 and 2004, respectively. Based on estimated fair value, public ﬁxed maturities represented $200,177 million, or 87.0%, and $154,439 million, or 87.6%, of total ﬁxed maturities at December 31, 2005 and 2004, respectively. Based on estimated fair value, private ﬁxed maturities represented $29,873 million, or 13.0%, and $21,938 million, or 12.4%, of total ﬁxed maturities at December 31, 2005 and 2004, respectively. In cases where quoted market prices are not available, fair values are estimated using present value or valuation techniques. The fair value estimates are made at a speciﬁc point in time, based on available market information and judgments about the ﬁnancial instruments, including estimates of the timing and amounts of expected future cash ﬂows and the credit standing of the issuer or counterparty. Factors considered in estimating fair value include: coupon rate, maturity, estimated duration, call provisions, sinking fund requirements, credit rating, industry sector of the issuer and quoted market prices of comparable securities. The Securities Valuation Ofﬁce of the NAIC evaluates the ﬁxed maturity investments of insurers for regulatory reporting purposes and assigns securities to one of six investment categories called ‘‘NAIC designations.’’ The NAIC ratings are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC ratings 1 and 2 include bonds generally considered investment grade (rated ‘‘Baa3’’ or higher by Moody’s Investors Services (‘‘Moody’s’’), or rated ‘‘BBB—’’ or higher by Standard & Poor’s (‘‘S&P’’) and Fitch Ratings Insurance Group (‘‘Fitch’’)), by such rating organizations. NAIC ratings 3 through 6 include bonds generally considered below investment grade (rated ‘‘Ba1’’ or lower by Moody’s, or rated ‘‘BB+’’ or lower by S&P and Fitch). The following table presents the Company’s total ﬁxed maturities by Nationally Recognized Statistical Rating Organizations designation and the equivalent ratings of the NAIC, as well as the percentage, based on estimated fair value, that each designation is comprised of at: NAIC Rating Rating Agency Designation (1) 1 2 3 4 5 6 Aaa/Aa/A ******************************* Baa ************************************ Ba ************************************* B ************************************** Caa and lower *************************** In or near default ************************* Subtotal ******************************** Redeemable preferred stock *************** Total ﬁxed maturities ********************** December 31, 2005 December 31, 2004 Cost or Amortized Cost $161,256 47,712 8,794 5,666 287 18 223,733 193 Estimated Fair Value % of Total Cost or Amortized Cost Estimated Fair Value % of Total $165,577 49,124 9,142 5,710 290 15 229,858 192 (In millions) 72.0% $112,702 42,165 21.3 6,907 4.0 4,081 2.5 329 0.1 101 — 99.9 0.1 166,285 326 $118,410 45,311 7,500 4,397 366 90 176,074 303 67.1% 25.7 4.2 2.5 0.2 0.1 99.8 0.2 $223,926 $230,050 100.0% $166,611 $176,377 100.0% (1) Amounts presented are based on rating agency designations. Comparisons between NAIC ratings and rating agency designations are published by the NAIC. The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch at December 31, 2005 and the lower of the applicable ratings between Moody’s and S&P at December 31, 2004. Beginning in the third quarter of 2005, the Company incorporated Fitch into its rating agency designations to be consistent with the Lehman Brothers’ ratings convention. If no rating is available from a rating agency, then the MetLife rating is used. The following table shows the cost or amortized cost and estimated fair value of ﬁxed maturities, by contractual maturity dates (excluding scheduled sinking funds) at: Due in one year or less ************************************************** $ Due after one year through ﬁve years *************************************** Due after ﬁve years through ten years ************************************** Due after ten years ****************************************************** Subtotal ************************************************************* Mortgage-backed, commercial mortgage-backed and other asset-backed December 31, 2005 2004 Cost or Amortized Cost Estimated Fair Value Cost or Amortized Cost (In millions) 7,083 36,100 45,303 58,667 $ 7,124 36,557 46,256 63,404 $ 6,749 29,846 33,531 41,593 Estimated Fair Value $ 6,844 31,164 35,996 46,463 147,153 153,341 111,719 120,467 securities ************************************************************ Subtotal ************************************************************* Redeemable preferred stock ********************************************** 223,733 193 Total ﬁxed maturities *************************************************** $223,926 76,580 76,517 229,858 192 54,566 166,285 326 55,607 176,074 303 $230,050 $166,611 $176,377 MetLife, Inc. 45 Bonds not due at a single maturity date have been included in the above table in the year of ﬁnal contractual maturity. Actual maturities may differ from contractual maturities due to the exercise of prepayment options. The following tables set forth the cost or amortized cost, gross unrealized gain and loss, and estimated fair value of the Company’s ﬁxed maturities by sector and equity securities, the percentage of the total ﬁxed maturities holdings that each sector represents and the percentage of the total equity securities at: Cost or Amortized Cost December 31, 2005 Gross Unrealized Gain Loss (In millions) Estimated Fair Value % of Total U.S. corporate securities********************************************* $ 72,339 Residential mortgage-backed securities********************************* 47,365 Foreign corporate securities ****************************************** 33,578 U.S. treasury/agency securities *************************************** 25,643 Commercial mortgage-backed securities******************************** 17,682 Asset-backed securities ********************************************* 11,533 Foreign government securities **************************************** 10,080 State and political subdivision securities ******************************** 4,601 Other ﬁxed maturity securities ***************************************** 912 Total bonds ****************************************************** Redeemable preferred stocks***************************************** 223,733 193 Total ﬁxed maturities********************************************* $223,926 $2,814 353 1,842 1,401 223 91 1,401 185 17 8,327 2 $ 835 472 439 86 207 51 35 36 41 2,202 3 $ 74,318 47,246 34,981 26,958 17,698 11,573 11,446 4,750 888 229,858 192 32.3% 20.5 15.2 11.7 7.7 5.0 5.0 2.1 0.4 99.9 0.1 $8,329 $2,205 $230,050 100.0% Common stocks**************************************************** $ Non-redeemable preferred stocks ************************************* Total equity securities(1)****************************************** $ 2,004 1,080 3,084 $ 250 45 $ 295 $ $ 30 11 41 $ $ 2,224 1,114 3,338 66.6% 33.4 100.0% Cost or Amortized Cost December 31, 2004 Gross Unrealized Gain Loss (In millions) Estimated Fair Value % of Total U.S. corporate securities ********************************************* $ 58,022 Residential mortgage-backed securities ********************************* 31,683 Foreign corporate securities ******************************************* 24,972 U.S. treasury/agency securities **************************************** 16,534 Commercial mortgage-backed securities ******************************** 12,099 Asset-backed securities ********************************************** 10,784 Foreign government securities ***************************************** 7,621 State and political subdivision securities ********************************* 3,683 Other ﬁxed maturity securities ***************************************** 887 Total bonds **************************************************** Redeemable preferred stocks ***************************************** 166,285 326 Total ﬁxed maturities *********************************************** $166,611 Common stocks **************************************************** $ Non-redeemable preferred stocks ************************************** Total equity securities(1) ******************************************** $ 1,412 501 1,913 $ 3,870 612 2,582 1,314 440 125 973 220 131 10,267 — $10,267 $ $ 244 39 283 $172 65 85 22 38 33 26 4 33 478 23 $501 $ 5 3 $ 8 $ 61,720 32,230 27,469 17,826 12,501 10,876 8,568 3,899 985 176,074 303 34.9% 18.3 15.6 10.1 7.1 6.2 4.8 2.2 0.6 99.8 0.2 $176,377 100.0% $ $ 1,651 537 2,188 75.5% 24.5 100.0% (1) Equity securities primarily consist of investments in common and preferred stocks and mutual fund interests. Such securities include private equity securities with an estimated fair value of $472 million and $332 million at December 31, 2005 and 2004, respectively. Fixed Maturity and Equity Security Impairment. The Company classiﬁes all of its ﬁxed maturities and equity securities as available-for-sale and marks them to market through other comprehensive income, except for non-marketable private equities, which are generally carried at cost. All securities with gross unrealized losses at the consolidated balance sheet date are subjected to the Company’s process for identifying other- than-temporary impairments. The Company writes down to fair value securities that it deems to be other-than-temporarily impaired in the period the securities are deemed to be so impaired. The assessment of whether such impairment has occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors, as described in ‘‘— Summary of Critical Accounting Estimates — Investments,’’ about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. The Company’s review of its ﬁxed maturities and equity securities for impairments includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for six months or greater. While all of these securities are monitored for potential impairment, the Company’s experience indicates that the ﬁrst two categories do not present as great a risk of impairment, and often, fair values recover over time as the factors that caused the declines improve. 46 MetLife, Inc. The Company records impairments as investment losses and adjusts the cost basis of the ﬁxed maturities and equity securities accordingly. The Company does not change the revised cost basis for subsequent recoveries in value. Impairments of ﬁxed maturities and equity securities were $64 million, $102 million and $355 million for the years ended December 31, 2005, 2004 and 2003, respectively. The Company’s three largest impairments totaled $40 million, $53 million and $125 million for the years ended December 31, 2005, 2004 and 2003, respectively. The circumstances that gave rise to these impairments were either ﬁnancial restructurings or bankruptcy ﬁlings. During the years ended December 31, 2005, 2004 and 2003, the Company sold or disposed of ﬁxed maturities and equity securities at a loss that had a fair value of $93,872 million, $29,939 million and $21,984 million, respectively. Gross losses excluding impairments for ﬁxed maturities and equity securities were $1,391 million, $516 million and $500 million for the years ended December 31, 2005, 2004 and 2003, respectively. The following tables present the cost or amortized cost, gross unrealized losses and number of securities for ﬁxed maturities and equity securities, at December 31, 2005 and December 31, 2004, where the estimated fair value had declined and remained below cost or amortized cost by less than 20%, or 20% or more for: Cost or Amortized Cost December 31, 2005 Gross Unrealized Losses Number of Securities Less than 20% 20% or more Less than 20% 20% or more Less than 20% 20% or more (In millions, except number of securities) Less than six months *************************************** $ 92,512 Six months or greater but less than nine months***************** 3,704 Nine months or greater but less than twelve months ************* 5,006 Twelve months or greater ************************************ 7,555 Total **************************************************** $108,777 $213 5 — 23 $241 $1,707 108 133 240 $2,188 $51 2 — 5 $58 11,441 456 573 924 13,394 308 7 2 8 325 Cost or Amortized Cost December 31, 2004 Gross Unrealized Losses Number of Securities Less than 20% 20% or more Less than 20% 20% or more Less than 20% 20% or more (In millions, except number of securities) Less than six months***************************************** $27,175 Six months or greater but less than nine months****************** 8,477 Nine months or greater but less than twelve months*************** 1,595 Twelve months or greater ************************************* 2,798 Total ***************************************************** $40,045 $ 79 9 19 19 $126 $246 111 33 80 $470 $18 2 4 15 $39 3,186 687 206 395 4,474 117 5 5 7 134 The gross unrealized loss related to the Company’s ﬁxed maturities and equity securities at December 31, 2005 was $2,246 million. These securities are concentrated by sector in U.S. corporates (37%); residential mortgage-backed (21%); and foreign corporates (20%); and are concentrated by industry in mortgage-backed (30%); industrial (22%); and ﬁnance (11%) (calculated as a percentage of gross unrealized loss). Non-investment grade securities represent 5% of the $106,772 million fair value and 8% of the $2,246 million gross unrealized loss. The Company held one ﬁxed maturity with a gross unrealized loss at December 31, 2005 greater than $10 million. This security represented less than 1% of the gross unrealized loss on ﬁxed maturities and equity securities. Corporate Fixed Maturities. The table below shows the major industry types that comprise the corporate ﬁxed maturity holdings at: December 31, 2005 December 31, 2004 Estimated Fair Value % of Total Estimated Fair Value % of Total Industrial*********************************************************************** $ 41,322 Foreign(1) ********************************************************************** 34,981 Finance *********************************************************************** 19,189 Utility************************************************************************** 12,633 Other ************************************************************************* 1,174 Total ************************************************************************ $109,299 (In millions) 37.8% $35,785 27,469 32.0 14,481 17.5 10,800 11.6 654 1.1 40.1% 30.8 16.3 12.1 0.7 100.0% $89,189 100.0% (1) Includes U.S. dollar-denominated debt obligations of foreign obligors, and other foreign investments. The Company maintains a diversiﬁed corporate ﬁxed maturity portfolio across industries and issuers. The portfolio does not have exposure to any single issuer in excess of 1% of the total invested assets of the portfolio. At December 31, 2005 and 2004, the Company’s combined holdings in the ten issuers to which it had the greatest exposure totaled $6,215 million and $4,967 million, respectively, each less than 3% of the Company’s total invested assets at such dates. The exposure to the largest single issuer of corporate ﬁxed maturities held at December 31, 2005 and 2004 was $943 million and $631 million, respectively. The Company has hedged all of its material exposure to foreign currency risk in its corporate ﬁxed maturity portfolio. In the Company’s international insurance operations, both its assets and liabilities are generally denominated in local currencies. MetLife, Inc. 47 Structured Securities. The following table shows the types of structured securities the Company held at: December 31, 2005 December 31, 2004 Estimated Fair Value % of Total Estimated Fair Value % of Total (In millions) Residential mortgage-backed securities: Collateralized mortgage obligations ************************************************ $29,679 Pass-through securities ********************************************************* 17,567 Total residential mortgage-backed securities ****************************************** Commercial mortgage-backed securities ********************************************* Asset-backed securities *********************************************************** 47,246 17,698 11,573 Total *********************************************************************** $76,517 38.8% $19,752 12,478 23.0 61.8 23.1 15.1 32,230 12,501 10,876 35.5% 22.4 57.9 22.5 19.6 100.0% $55,607 100.0% The majority of the residential mortgage-backed securities are guaranteed or otherwise supported by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation or the Government National Mortgage Association. At December 31, 2005, $46,304 million, or 98.0%, of the residential mortgage-backed securities were rated Aaa/AAA by Moody’s, S&P or Fitch. At December 31, 2004, $31,768 million, or 98.6%, of the residential mortgage-backed securities were rated Aaa/AAA by Moody’s or S&P. At December 31, 2005, $13,272 million, or 75%, of the commercial mortgage-backed securities were rated Aaa/AAA by Moody’s, S&P or Fitch. At December 31, 2004, $8,750 million, or 70.0%, of the commercial mortgage-backed securities were rated Aaa/AAA by Moody’s or S&P. The Company’s asset-backed securities are diversiﬁed both by sector and by issuer. Home equity loan and credit card receivables, accounting for about 31% and 26% of the total holdings, respectively, constitute the largest exposures in the Company’s asset-backed securities portfolio. At December 31, 2005, $6,084 million, or 52.6%, of total asset-backed securities were rated Aaa/AAA by Moody’s, S&P or Fitch. At December 31, 2004, $6,775 million, or 62.3%, of the total asset-backed securities were rated Aaa/AAA by Moody’s or S&P. Structured Investment Transactions. The Company participates in structured investment transactions, primarily asset securitizations and structured notes. These transactions enhance the Company’s total return on its investment portfolio principally by generating management fee income on asset securitizations and by providing equity-based returns on debt securities through structured notes and similar instruments. The Company sponsors ﬁnancial asset securitizations of high yield debt securities, investment grade bonds and structured ﬁnance securities and also is the collateral manager and a beneﬁcial interest holder in such transactions. As the collateral manager, the Company earns management fees on the outstanding securitized asset balance, which are recorded in income as earned. When the Company transfers assets to bankruptcy-remote SPEs and surrenders control over the transferred assets, the transaction is accounted for as a sale. Gains or losses on securitizations are determined with reference to the carrying amount of the ﬁnancial assets transferred, which is allocated to the assets sold and the beneﬁcial interests retained based on relative fair values at the date of transfer. Beneﬁcial interests in securitizations are carried at fair value in ﬁxed maturities. Income on these beneﬁcial interests is recognized using the prospective method. The SPEs used to securitize assets are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities. The Company purchases or receives beneﬁcial interests in SPEs, which generally acquire ﬁnancial assets, including corporate equities, debt securities and purchased options. The Company has not guaranteed the performance, liquidity or obligations of the SPEs and the Company’s exposure to loss is limited to its carrying value of the beneﬁcial interests in the SPEs. The Company uses the beneﬁcial interests as part of its risk management strategy, including asset-liability management. These SPEs are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities. These beneﬁcial interests are generally structured notes, which are included in ﬁxed maturities, and their income is recognized using the retrospective interest method or the level yield method, as appropriate. Impairments of these beneﬁcial interests are included in net investment gains (losses). The Company invests in structured notes and similar type instruments, which generally provide equity-based returns on debt securities. The carrying value of such investments was approximately $362 million and $666 million at December 31, 2005 and 2004, respectively. The related net investment income recognized was $28 million, $45 million and $78 million for the years ended December 31, 2005, 2004 and 2003, respectively. Trading Securities During 2005, the Company established a trading securities portfolio to support investment strategies that involve the active and frequent purchase and sale of securities. Trading securities are recorded at fair value with subsequent changes in fair value recognized in net investment income. Net investment income for the year ended December 31, 2005 includes $37 million of gains (losses) on securities classiﬁed as trading. Of this amount, $42 million relates to net gains (losses) recognized on trading securities sold during the year ended December 31, 2005. The remaining ($5) million for the year ended December 31, 2005 relates to changes in fair value on trading securities held at December 31, 2005. The Company did not have any trading securities during the years ended December 31, 2004 and 2003. As part of the acquisition of Travelers on July 1, 2005, the Company acquired Travelers’ investment in Tribeca Citigroup Investments Ltd. (‘‘Tribeca’’). Tribeca is a feeder fund investment structure whereby the feeder fund invests substantially all of its assets in the master fund, Tribeca Global Convertible Instruments Ltd. The primary investment objective of the master fund is to achieve enhanced risk-adjusted return by investing in domestic and foreign equities and equity-related securities utilizing such strategies as convertible securities arbitrage. MetLife is the majority owner of the feeder fund and consolidates the fund within its consolidated ﬁnancial statements. Approximately $452 million of Tribeca’s investments are reported as trading securities in the accompanying consolidated ﬁnancial statements with changes in fair value recognized in net investment income. Mortgage and Consumer Loans The Company’s mortgage and consumer loans are principally collateralized by commercial, agricultural and residential properties, as well as automobiles. Mortgage and consumer loans comprised 12.2% and 13.6% of the Company’s total cash and invested assets at December 31, 2005 and 48 MetLife, Inc. 2004, respectively. The carrying value of mortgage and consumer loans is stated at original cost net of repayments, amortization of premiums, accretion of discounts and valuation allowances. The following table shows the carrying value of the Company’s mortgage and consumer loans by type at: Commercial mortgage loans ******************************************************* $28,022 Agricultural mortgage loans ******************************************************** 7,700 Consumer loans ***************************************************************** 1,468 Total ************************************************************************* $37,190 (In millions) 75.4% $24,990 5,907 20.7 1,509 3.9 77.1% 18.2 4.7 100.0% $32,406 100.0% December 31, 2005 December 31, 2004 Carrying Value % of Total Carrying Value % of Total Commercial Mortgage Loans. The Company diversiﬁes its commercial mortgage loans by both geographic region and property type. The following table presents the distribution across geographic regions and property types for commercial mortgage loans at: December 31, 2005 December 31, 2004 Carrying Value % of Total Carrying Value % of Total (In millions) Region Paciﬁc************************************************************************** $ 6,818 South Atlantic ******************************************************************* 6,093 Middle Atlantic ******************************************************************* 4,689 East North Central**************************************************************** 3,078 West South Central*************************************************************** 2,069 New England ******************************************************************** 1,295 International ********************************************************************* 1,817 Mountain *********************************************************************** 861 West North Central *************************************************************** 825 East South Central *************************************************************** 381 Other ************************************************************************** 96 Total ************************************************************************* $28,022 Property Type Ofﬁce ************************************************************************** $13,453 Retail*************************************************************************** 6,398 Apartments********************************************************************** 3,102 Industrial ************************************************************************ 2,656 Hotel *************************************************************************** 1,355 Other ************************************************************************** 1,058 Total ************************************************************************* $28,022 The following table presents the scheduled maturities for the Company’s commercial mortgage loans at: 24.3% $ 6,075 5,696 21.8 4,057 16.7 2,550 11.0 2,024 7.4 1,412 4.6 1,364 6.5 778 3.1 667 2.9 268 1.4 99 0.3 24.3% 22.8 16.2 10.2 8.1 5.6 5.5 3.1 2.7 1.1 0.4 100.0% $24,990 100.0% 48.0% $11,500 5,698 22.8 3,264 11.1 2,499 9.5 1,245 4.8 784 3.8 46.0% 22.8 13.1 10.0 5.0 3.1 100.0% $24,990 100.0% Due in one year or less *********************************************************** $ 1,052 Due after one year through two years *********************************************** 2,138 Due after two years through three years ********************************************* 2,640 Due after three years through four years ********************************************* 4,037 Due after four years through ﬁve years *********************************************** 3,946 Due after ﬁve years *************************************************************** 14,209 Total ************************************************************************* $28,022 (In millions) 3.8% $ 7.6 9.4 14.4 14.1 50.7 939 1,800 2,372 2,943 4,578 12,358 3.7% 7.2 9.5 11.8 18.3 49.5 100.0% $24,990 100.0% December 31, 2005 December 31, 2004 Carrying Value % of Total Carrying Value % of Total Restructured, Potentially Delinquent, Delinquent or Under Foreclosure. The Company monitors its mortgage loan investments on an ongoing basis, including reviewing loans that are restructured, potentially delinquent, delinquent or under foreclosure. These loan classiﬁcations are consistent with those used in industry practice. The Company deﬁnes restructured mortgage loans as loans in which the Company, for economic or legal reasons related to the debtor’s ﬁnancial difﬁculties, grants a concession to the debtor that it would not otherwise consider. The Company deﬁnes potentially delinquent loans as loans that, in management’s opinion, have a high probability of becoming delinquent. The Company deﬁnes delinquent mortgage loans, consistent with industry practice, as loans in which two or more interest or principal payments are past due. The Company deﬁnes mortgage loans under foreclosure as loans in which foreclosure proceedings have formally commenced. The Company reviews all mortgage loans on an ongoing basis. These reviews may include an analysis of the property ﬁnancial statements and rent roll, lease rollover analysis, property inspections, market analysis and tenant creditworthiness. The Company records valuation allowances for certain of the loans that it deems impaired. The Company’s valuation allowances are established both on a loan speciﬁc basis for those loans where a property or market speciﬁc risk has been identiﬁed that could likely result in a future default, as well MetLife, Inc. 49 as for pools of loans with similar high risk characteristics where a property speciﬁc or market risk has not been identiﬁed. Loan speciﬁc valuation allowances are established for the excess carrying value of the mortgage loan over the present value of expected future cash ﬂows discounted at the loan’s original effective interest rate, the value of the loan’s collateral or the loan’s market value if the loan is being sold. Valuation allowances for pools of loans are established based on property types and loan to value risk factors. The Company records valuation allowances as investment losses. The Company records subsequent adjustments to allowances as investment gains (losses). The following table presents the amortized cost and valuation allowance for commercial mortgage loans distributed by loan classiﬁcation at: December 31, 2005 December 31, 2004 Amortized Cost(1) % of Total Valuation Allowance % of Amortized Cost Amortized Cost(1) % of Total Valuation Allowance % of Amortized Cost Performing ************************** $28,158 Restructured ************************ — Potentially delinquent ***************** 3 Delinquent or under foreclosure ******** 8 Total ***************************** $28,169 100% — — — 100.0% $147 — — — $147 (In millions) 0.5% —% —% —% 0.5% $25,077 55 7 — 99.8% 0.2 — — $25,139 100.0% $128 18 3 — $149 0.5% 32.7% 42.9% —% 0.6% (1) Amortized cost is equal to carrying value before valuation allowances. The following table presents the changes in valuation allowances for commercial mortgage loans for the: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year************************************************************************ $149 Additions ************************************************************************************** 43 Deductions************************************************************************************* (45) Balance, end of year***************************************************************************** $147 $122 53 (26) $149 $119 51 (48) $122 Agricultural Mortgage Loans. The Company diversiﬁes its agricultural mortgage loans by both geographic region and product type. Approximately 67% of the $7,700 million of agricultural mortgage loans outstanding at December 31, 2005 were subject to rate resets prior to maturity. A substantial portion of these loans is successfully renegotiated and remains outstanding to maturity. The process and policies for monitoring the agricultural mortgage loans and classifying them by performance status are generally the same as those for the commercial loans. The following table presents the amortized cost and valuation allowances for agricultural mortgage loans distributed by loan classiﬁcation at: December 31, 2005 December 31, 2004 Amortized Cost(1) % of Total Valuation Allowance % of Amortized Cost Amortized Cost (1) % of Total Valuation Allowance Performing ************************** Restructured ************************ Potentially delinquent ***************** Delinquent or under foreclosure ******** Total ***************************** $7,635 36 3 37 $7,711 99.0% 0.5 — 0.5 100.0% $ 8 — 1 2 $11 (In millions) 0.1% —% 33.3% 5.4% 0.1% $5,803 67 4 40 $5,914 98.1% 1.1 0.1 0.7 100.0% $4 — 1 2 $7 % of Amortized Cost 0.1% —% 25.0% 5.0% 0.1% (1) Amortized cost is equal to carrying value before valuation allowances. The following table presents the changes in valuation allowances for agricultural mortgage loans for the: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year *************************************************************************** $ 7 Additions ****************************************************************************************** 4 Deductions **************************************************************************************** — Balance, end of year ******************************************************************************** $11 $ 6 5 (4) $ 7 $ 6 1 (1) $ 6 Consumer Loans. Consumer loans consist of residential mortgages and auto loans. Real Estate and Real Estate Joint Ventures The Company’s real estate and real estate joint venture investments consist of commercial properties located primarily in the United States. At December 31, 2005 and 2004, the carrying value of the Company’s real estate, real estate joint ventures and real estate held-for-sale was $4,665 million and $4,233 million, respectively, or 1.5% and 1.8%, of total cash and invested assets, respectively. The carrying value of real estate is stated at depreciated cost net of impairments and valuation allowances. The carrying value of real estate joint ventures is stated at the Company’s equity in the real 50 MetLife, Inc. 63.5% 9.1 0.1 72.7 27.3 — 27.3 4,665 100.0 3,076 1,156 1 1,157 — — — 100.0% $4,233 100.0% estate joint ventures net of impairments and valuation allowances. The following table presents the carrying value of the Company’s real estate, real estate joint ventures, real estate held-for-sale and real estate acquired upon foreclosure at: Type December 31, 2005 December 31, 2004 Carrying Value % of Total Carrying Value % of Total Real estate held-for-investment ******************************************************* $3,735 Real estate joint ventures held-for-investment ******************************************* 926 Foreclosed real estate held-for-investment ********************************************** 4 (In millions) 80.1% $2,687 386 19.8 3 0.1 Real estate held-for-sale ************************************************************* Foreclosed real estate held-for-sale**************************************************** — — — Total real estate, real estate joint ventures and real estate held-for-sale ********************** $4,665 The Company’s carrying value of real estate held-for-sale, including real estate acquired upon foreclosure of commercial and agricultural mortgage loans, in the amounts of $0 million and $1,157 million at December 31, 2005 and 2004, respectively, are net of valuation allowances of $0 million and $4 million, respectively, and net of impairments of $0 million and $12 million at December 31, 2005 and 2004, respectively. The Company records real estate acquired upon foreclosure of commercial and agricultural mortgage loans at the lower of estimated fair value or the carrying value of the mortgage loan at the date of foreclosure. Certain of the Company’s investments in real estate joint ventures meet the deﬁnition of a VIE under FIN 46(r). See ‘‘— Investments — Variable Interest Entities.’’ In the second quarter of 2005, the Company sold its One Madison Avenue and 200 Park Avenue properties in Manhattan, New York for $918 million and $1.72 billion, respectively, resulting in gains, net of income taxes, of $431 million and $762 million, respectively. The gains are included in income from discontinued operations in the accompanying consolidated statements of income. In connection with the sale of the 200 Park Avenue property, the Company has retained rights to existing signage and is leasing space for associates in the property for 20 years with optional renewal periods through 2205. In 2004, the Company sold one of its real estate investments, Sears Tower, resulting in a gain of $85 million, net of income taxes. Other Limited Partnership Interests The carrying value of other limited partnership interests (which primarily represent ownership interests in pooled investment funds that make private equity investments in companies in the United States and overseas) was $4,276 million and $2,907 million at December 31, 2005 and 2004, respectively. The Company uses the equity method of accounting for investments in limited partnership interests in which it has more than a minor interest, has inﬂuence over the partnership’s operating and ﬁnancial policies, does not have a controlling interest and is not the primary beneﬁciary. The Company uses the cost method for minor interest investments and when it has virtually no inﬂuence over the partnership’s operating and ﬁnancial policies. The Company’s investments in other limited partnerships represented 1.4% and 1.2% of cash and invested assets at December 31, 2005 and 2004, respectively. Some of the Company’s investments in other limited partnership interests meet the deﬁnition of a VIE under FIN 46(r). See ‘‘— Investments — Variable Interest Entities.’’ Other Invested Assets The Company’s other invested assets consist principally of leveraged leases and funds withheld at interest of $4,573 million and $3,916 million at December 31, 2005 and 2004, respectively. The leveraged leases are recorded net of non-recourse debt. The Company participates in lease transactions, which are diversiﬁed by industry, asset type and geographic area. The Company regularly reviews residual values and writes down residuals to expected values as needed. Funds withheld represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. For agreements written on a modiﬁed coinsurance basis and certain agreements written on a coinsurance basis, assets supporting the reinsured policies equal to the net statutory reserves are withheld and continue to be legally owned by the ceding company. Other invested assets also includes derivative revaluation gains and the fair value of embedded derivatives related to funds withheld and modiﬁed coinsurance contracts. Interest accrues to these funds withheld at rates deﬁned by the treaty terms and may be contractually speciﬁed or directly related to the investment portfolio. The Company’s other invested assets represented 2.6% and 2.2% of cash and invested assets at December 31, 2005 and 2004, respectively. Derivative Financial Instruments The Company uses a variety of derivatives, including swaps, forwards, futures and option contracts, to manage its various risks. Additionally, the Company enters into income generation and replication derivative transactions as permitted by its insurance subsidiaries’ Derivatives Use Plans approved by the applicable state insurance departments. MetLife, Inc. 51 The table below provides a summary of the notional amount and current market or fair value of derivative ﬁnancial instruments held at: December 31, 2005 December 31, 2004 Notional Amount Current Market or Fair Value Assets Liabilities Notional Amount Current Market or Fair Value Assets Liabilities Interest rate swaps***************************************** $20,444 Interest rate ﬂoors****************************************** 10,975 Interest rate caps ****************************************** 27,990 Financial futures ******************************************* 1,159 Foreign currency swaps ************************************ 14,274 Foreign currency forwards*********************************** 4,622 Options ************************************************** 815 Financial forwards****************************************** 2,452 Credit default swaps *************************************** 5,882 Synthetic GICs ******************************************** 5,477 Other **************************************************** 250 Total *************************************************** $94,340 $ 653 134 242 12 527 64 356 13 13 — 9 $2,023 (In millions) $ 69 — — 8 991 92 6 4 11 — — $12,681 3,325 7,045 611 8,214 1,013 263 326 1,897 5,869 450 $1,181 $41,694 $284 38 12 — 150 5 37 — 11 — 1 $538 $ 22 — — 13 1,302 57 7 — 5 — 1 $1,407 The above table does not include notional values for equity futures, equity ﬁnancial forwards, and equity options. At December 31, 2005 and 2004, the Company owned 3,305 and 776 equity futures contracts, respectively. Equity futures market values are included in ﬁnancial futures in the preceding table. At December 31, 2005 and 2004, the Company owned 213,000 and no equity ﬁnancial forwards, respectively. Equity ﬁnancial forwards market values are included in ﬁnancial forwards in the preceding table. At December 31, 2005 and 2004, the Company owned 4,720,254 and 493,358 equity options, respectively. Equity options market values are included in options in the preceding table. The notional amount of $562 million, related to equity options for 2004 has been removed from the above table to conform with the 2005 presentation. Credit Risk. The Company may be exposed to credit related losses in the event of nonperformance by counterparties to derivative ﬁnancial instruments. Generally, the current credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date. The credit exposure of the Company’s derivative transactions is represented by the fair value of contracts with a net positive fair value at the reporting date. The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. Because exchange traded futures are effected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit related losses in the event of nonperformance by counterparties to such derivative instruments. The Company enters into various collateral arrangements, which require both the pledging and accepting of collateral in connection with its derivative instruments. As of December 31, 2005, the Company was obligated to return cash collateral under its control of $195 million. This unrestricted cash collateral is included in cash and cash equivalents and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheet. As of December 31, 2005, the Company had also accepted collateral consisting of various securities with a fair market value of $427 million, which is held in separate custodial accounts. Such collateral is included in other assets and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheet. The Company is permitted by contract to sell or repledge this collateral, but as of December 31, 2005, none of the collateral had been sold or repledged. As of December 31, 2005, the Company provided collateral of $4 million, which is included in other assets in the consolidated balance sheet. The counterparties are permitted by contract to sell or repledge this collateral. The Company did not have any cash or other collateral related to derivative instruments at December 31, 2004. Variable Interest Entities The following table presents the total assets of and maximum exposure to loss relating to VIEs for which the Company has concluded that (i) it is the primary beneﬁciary and which are consolidated in the Company’s consolidated ﬁnancial statements at December 31, 2005; and (ii) it holds signiﬁcant variable interests but it is not the primary beneﬁciary and which have not been consolidated: December 31, 2005 Primary Beneﬁciary Not Primary Beneﬁciary Total Assets(1) Maximum Exposure to Loss(2) Total Assets(1) Maximum Exposure to Loss(2) Asset-backed securitizations and collateralized debt obligations ******************* Real estate joint ventures(3) ************************************************* Other limited partnerships(4) ************************************************* Other investments(5) ******************************************************* Total******************************************************************* $ — 304 48 — $352 (In millions) $ — 114 35 — $149 $ 3,728 246 15,760 3,722 $23,456 $ 463 19 2,109 242 $2,833 (1) The assets of the asset-backed securitizations and collateralized debt obligations are reﬂected at fair value at December 31, 2005. The assets of the real estate joint ventures, other limited partnerships and other investments are reﬂected at the carrying amounts at which such assets would have been reﬂected on the Company’s balance sheet had the Company consolidated the VIE from the date of its initial investment in the entity. (2) The maximum exposure to loss of the asset-backed securitizations and collateralized debt obligations is equal to the carrying amounts of participation or retained interests. In addition, the Company provides collateral management services for certain of these structures for which it collects a 52 MetLife, Inc. management fee. The maximum exposure to loss relating to real estate joint ventures, other limited partnerships and other investments is equal to the carrying amounts plus any unfunded commitments, reduced by amounts guaranteed by other partners. (3) Real estate joint ventures include partnerships and other ventures which engage in the acquisition, development, management and disposal of real estate investments. (4) Other limited partnerships include partnerships established for the purpose of investing in real estate funds, public and private debt and equity securities, as well as limited partnerships established for the purpose of investing in low-income housing that qualiﬁes for federal tax credits. (5) Other investments include securities that are not asset-backed securitizations or collateralized debt obligations. Securities Lending The Company participates in a securities lending program whereby blocks of securities, which are included in ﬁxed maturity securities, are loaned to third parties, primarily major brokerage ﬁrms. The Company requires a minimum of 102% of the fair value of the loaned securities to be separately maintained as collateral for the loans. Securities with a cost or amortized cost of $32,068 million and $26,564 million and an estimated fair value of $32,954 million and $27,974 million were on loan under the program at December 31, 2005 and 2004, respectively. Securities loaned under such transactions may be sold or repledged by the transferee. The Company was liable for cash collateral under its control of $33,893 million and $28,678 million at December 31, 2005 and 2004, respectively. Securities loaned transactions are accounted for as ﬁnancing arrangements on the Company’s consolidated balance sheets and consolidated statements of cash ﬂows and the income and expenses associated with the program are reported in net investment income as investment income and investment expenses, respectively. Security collateral of $207 million and $17 million, respectively, at December 31, 2005 and 2004 on deposit from customers in connection with the securities lending transactions may not be sold or repledged and is not reﬂected in the consolidated ﬁnancial statements. Separate Accounts The Company had $127.9 billion and $86.8 billion held in its separate accounts, for which the Company generally does not bear investment risk, as of December 31, 2005 and 2004, respectively. The Company manages each separate account’s assets in accordance with the prescribed investment policy that applies to that speciﬁc separate account. The Company establishes separate accounts on a single client and multi-client commingled basis in compliance with insurance laws. Effective with the adoption of SOP 03-1, on January 1, 2004, the Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if (i) such separate accounts are legally recognized; (ii) assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities; (iii) investments are directed by the contractholder; and (iv) all investment performance, net of contract fees and assessments, is passed through to the contractholder. The Company reports separate account assets meeting such criteria at their fair value. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the consolidated statements of income. The Company’s revenues reﬂect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Separate accounts not meeting the above criteria are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. Quantitative and Qualitative Disclosures About Market Risk. The Company must effectively manage, measure and monitor the market risk associated with its invested assets and interest rate sensitive insurance contracts. It has developed an integrated process for managing risk, which it conducts through its Corporate Risk Management Department, Asset/Liability Management Committees (‘‘ALM Committees’’) and additional specialists at the business segment level. The Company has established and implemented comprehensive policies and procedures at both the corporate and business segment level to minimize the effects of potential market volatility. The Company regularly analyzes its exposure to interest rate, equity market and foreign currency exchange risk. As a result of that analysis, the Company has determined that the fair value of its interest rate sensitive invested assets is materially exposed to changes in interest rates. The equity and foreign currency portfolios do not expose the Company to material market risk. The Company analyzes interest rate risk using various models including multi-scenario cash ﬂow projection models that forecast cash ﬂows of the liabilities and their supporting investments, including derivative instruments. The Company uses a variety of strategies to manage interest rate, equity market, and foreign currency exchange risk, including the use of derivative instruments. The Travelers acquisition has increased the Company’s exposure to market risk. The Travelers acquisition has not changed management’s processes for measuring, managing and monitoring market risk; however, some of those processes are utilizing interim manual reporting and estimation techniques while the Company integrates the operations acquired. During the second half of 2005, management restructured the portfolio of assets that were acquired, generally reducing the amount of market risk associated with the acquired block, in line with the Company’s overall investment strategy. The acquisition also changed the proﬁle of the Company’s foreign currency exchange rate risk, although management still deems the aggregate sensitivity to foreign currency exchange rate risk to be immaterial. Market Risk Exposures The Company has exposure to market risk through its insurance operations and investment activities. For purposes of this disclosure, ‘‘market risk’’ is deﬁned as the risk of loss resulting from changes in interest rates, equity market prices and foreign currency exchange rates. Interest rates. The Company’s exposure to interest rate changes results from its signiﬁcant holdings of ﬁxed maturities, as well as its interest rate sensitive liabilities. The ﬁxed maturities include U.S. and foreign government bonds, securities issued by government agencies, corporate bonds and mortgage-backed securities, all of which are mainly exposed to changes in medium- and long-term treasury rates. The interest rate sensitive liabilities for purposes of this disclosure include guaranteed interest contracts and ﬁxed annuities, which have the same type of interest rate exposure (medium- and long-term treasury rates) as the ﬁxed maturities. The Company employs product design, pricing and asset/liability management strategies to reduce the adverse effects of interest rate movements. Product design and pricing strategies include the use of surrender charges or restrictions on withdrawals in some products. Asset/liability management strategies include the use of derivatives, the purchase of securities structured to protect against prepay- MetLife, Inc. 53 ments, and prepayment restrictions and related fees on mortgage loans and consistent monitoring of the pricing of the Company’s products in order to better match the duration of the assets and the liabilities they support. Equity market prices. The Company’s investments in equity securities expose it to changes in equity prices, as do certain liabilities that involve long-term guarantees on equity performance. It manages this risk on an integrated basis with other risks through its asset/liability management strategies. The Company also manages equity market price risk through industry and issuer diversiﬁcation, asset allocation techniques and the use of derivatives. Foreign currency exchange rates. The Company’s exposure to ﬂuctuations in foreign currency exchange rates against the U.S. dollar results from its holdings in non-U.S. dollar denominated ﬁxed maturity securities, equity securities and liabilities, as well as through its investments in foreign subsidiaries. The principal currencies that create foreign currency exchange rate risk in the Company’s investment portfolios are the Euro, the Canadian dollar and the British pound. The Company mitigates the majority of its ﬁxed maturities’ foreign currency exchange rate risk through the utilization of foreign currency swaps and forward contracts. Through its investments in foreign subsidiaries, the Company is primarily exposed to the Canadian dollar, the Mexican peso, the Australian dollar, the Argentinean peso, the South Korean won, the Chilean peso, the Taiwanese dollar and the Japanese Yen. The Company has matched substantially all of its foreign currency liabilities in its foreign subsidiaries with their respective foreign currency assets, thereby reducing its risk to currency exchange rate ﬂuctuation. Selectively, the Company uses U.S. dollar assets to support certain long duration foreign currency liabilities. Additionally, in some countries, local surplus is held entirely or in part in U.S. dollar assets which further minimizes exposure to exchange rate ﬂuctuation risk. Risk Management Corporate risk management. MetLife has established several ﬁnancial and non-ﬁnancial senior management committees as part of its risk management process. These committees manage capital and risk positions, approve asset/liability management strategies and establish appropriate corporate business standards. MetLife also has a separate Corporate Risk Management Department, which is responsible for risk throughout MetLife and reports to MetLife’s Chief Financial Ofﬁcer. The Corporate Risk Management Department’s primary responsibilities consist of: ) implementing a board of directors-approved corporate risk framework, which outlines the Company’s approach for managing risk on an enterprise-wide basis; ) developing policies and procedures for managing, measuring and monitoring those risks identiﬁed in the corporate risk framework; ) establishing appropriate corporate risk tolerance levels; ) deploying capital on an economic capital basis; and ) reporting on a periodic basis to the Governance Committee of the Holding Company’s board of directors and various ﬁnancial and non-ﬁnancial senior management committees. Asset/liability management. The Company actively manages its assets using an approach that balances quality, diversiﬁcation, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that the assets and liabilities are managed on a cash ﬂow and duration basis. The asset/liability management process is the shared responsibility of the Portfolio Management Unit, the Business Finance Asset/Liability Management Unit, and the operating business segments under the supervision of the various product line speciﬁc ALM Committees. The ALM Committees’ duties include reviewing and approving target portfolios on a periodic basis, establishing investment guidelines and limits and providing oversight of the asset/liability management process. The portfolio managers and asset sector specialists, who have responsibility on a day-to-day basis for risk management of their respective investing activities, implement the goals and objectives established by the ALM Committees. Each of MetLife’s business segments has an asset/liability ofﬁcer who works with portfolio managers in the investment department to monitor investment, product pricing, hedge strategy and liability management issues. MetLife establishes target asset portfolios for each major insurance product, which represent the investment strategies used to proﬁtably fund its liabilities within acceptable levels of risk. These strategies include objectives for effective duration, yield curve sensitivity, convexity, liquidity, asset sector concentration and credit quality. To manage interest rate risk, the Company performs periodic projections of asset and liability cash ﬂows to evaluate the potential sensitivity of its securities investments and liabilities to interest rate movements. These projections involve evaluating the potential gain or loss on most of the Company’s in-force business under various increasing and decreasing interest rate environments. New York State Department of Insurance regulations require that MetLife perform some of these analyses annually as part of MetLife’s review of the sufﬁciency of its regulatory reserves. For several of its legal entities, the Company maintains segmented operating and surplus asset portfolios for the purpose of asset/liability management and the allocation of investment income to product lines. For each segment, invested assets greater than or equal to the GAAP liabilities less the DAC asset and any non-invested assets allocated to the segment are maintained, with any excess swept to the surplus segment. The operating segments may reﬂect differences in legal entity, statutory line of business and any product market characteristic which may drive a distinct investment strategy with respect to duration, liquidity or credit quality of the invested assets. Certain smaller entities make use of unsegmented general accounts for which the investment strategy reﬂects the aggregate characteristics of liabilities in those entities. The Company measures relative sensitivities of the value of its assets and liabilities to changes in key assumptions utilizing Company models. These models reﬂect speciﬁc product characteristics and include assumptions based on current and anticipated experience regarding lapse, mortality and interest crediting rates. In addition, these models include asset cash ﬂow projections reﬂecting interest payments, sinking fund payments, principal payments, bond calls, mortgage prepayments and defaults. Common industry metrics, such as duration and convexity, are also used to measure the relative sensitivity of assets and liability values to changes in interest rates. In computing the duration of liabilities, consideration is given to all policyholder guarantees and to how the Company intends to set indeterminate policy elements such as interest credits or dividends. Each operating asset segment has a duration constraint based on the liability duration and the investment objectives of that portfolio. Where a liability cash ﬂow may exceed the maturity of available assets, as is the case with certain retirement and non-medical health products, the Company may support such liabilities with equity investments or curve mismatch strategies. Hedging activities. To reduce interest rate risk, MetLife’s risk management strategies incorporate the use of various interest rate derivatives to adjust the overall duration and cash ﬂow proﬁle of its invested asset portfolios to better match the duration and cash ﬂow proﬁle of its liabilities. Such instruments include ﬁnancial futures, ﬁnancial forwards, interest rate and credit default swaps, caps, ﬂoors and options. MetLife also uses foreign currency swaps and 54 MetLife, Inc. forwards to hedge its foreign currency denominated ﬁxed income investments. In 2004, MetLife initiated a hedging strategy for certain equity price risks within its liabilities using equity futures and options. Risk Measurement; Sensitivity Analysis The Company measures market risk related to its holdings of invested assets and other ﬁnancial instruments, including certain market risk sensitive insurance contracts, based on changes in interest rates, equity market prices and currency exchange rates, utilizing a sensitivity analysis. This analysis estimates the potential changes in fair value, cash ﬂows and earnings based on a hypothetical 10% change (increase or decrease) in interest rates, equity market prices and currency exchange rates. The Company believes that a 10% change (increase or decrease) in these market rates and prices is reasonably possible in the near-term. In performing this analysis, the Company used market rates at December 31, 2005 to re-price its invested assets and other ﬁnancial instruments. The sensitivity analysis separately calculated each of MetLife’s market risk exposures (interest rate, equity market price and foreign currency exchange rate) related to its trading and non-trading invested assets and other ﬁnancial instruments. The sensitivity analysis performed included the market risk sensitive holdings described above. The Company modeled the impact of changes in market rates and prices on the fair values of its invested assets, earnings and cash ﬂows as follows: Fair values. The Company bases its potential change in fair values on an immediate change (increase or decrease) in: ) the net present values of its interest rate sensitive exposures resulting from a 10% change (increase or decrease) in interest rates; ) the market value of its equity positions due to a 10% change (increase or decrease) in equity prices; and ) the U.S. dollar equivalent balances of the Company’s currency exposures due to a 10% change (increase or decrease) in currency exchange rates. Earnings and cash ﬂows. MetLife calculates the potential change in earnings and cash ﬂows on the change in its earnings and cash ﬂows over a one-year period based on an immediate 10% change (increase or decrease) in interest rates and equity prices. The following factors were incorporated into the earnings and cash ﬂows sensitivity analyses: ) the reinvestment of ﬁxed maturity securities; ) the reinvestment of payments and prepayments of principal related to mortgage-backed securities; ) the re-estimation of prepayment rates on mortgage-backed securities for each 10% change (increase or decrease) in the interest rates; and ) the expected turnover (sales) of ﬁxed maturities and equity securities, including the reinvestment of the resulting proceeds. The sensitivity analysis is an estimate and should not be viewed as predictive of the Company’s future ﬁnancial performance. The Company cannot assure that its actual losses in any particular year will not exceed the amounts indicated in the table below. Limitations related to this sensitivity analysis include: ) the market risk information is limited by the assumptions and parameters established in creating the related sensitivity analysis, including the impact of prepayment rates on mortgages; ) for derivatives that qualify as hedges, the impact on reported earnings may be materially different from the change in market values; ) the analysis excludes other signiﬁcant real estate holdings and liabilities pursuant to insurance contracts; and ) the model assumes that the composition of assets and liabilities remains unchanged throughout the year. Accordingly, the Company uses such models as tools and not substitutes for the experience and judgment of its corporate risk and asset/liability management personnel. Based on its analysis of the impact of a 10% change (increase or decrease) in market rates and prices, MetLife has determined that such a change could have a material adverse effect on the fair value of its interest rate sensitive invested assets. The equity and foreign currency portfolios do not expose the Company to material market risk. The table below illustrates the potential loss in fair value of the Company’s interest rate sensitive ﬁnancial instruments at December 31, 2005. In addition, the potential loss with respect to the fair value of currency exchange rates and the Company’s equity price sensitive positions at December 31, 2005 is set forth in the table below. The potential loss in fair value for each market risk exposure of the Company’s portfolio, as of the period indicated was: December 31, 2005 (In millions) Non-trading: Interest rate risk ************************************************************************************** Equity price risk ************************************************************************************** Foreign currency exchange rate risk ********************************************************************* Trading: Interest rate risk ************************************************************************************** $5,570 $ 556 $ 728 $ 6 MetLife, Inc. 55 The table below provides additional detail regarding the potential loss in fair value of the Company’s non-trading interest sensitive ﬁnancial instruments at December 31, 2005 by type of asset or liability. As of December 31, 2005 Notional Amount Assets Fixed maturities *************************************************************************** Equity securities*************************************************************************** Mortgage and consumer loans ************************************************************** Policy loans ****************************************************************************** Short-term investments********************************************************************* Cash and cash equivalents ***************************************************************** Mortgage loan commitments **************************************************************** Total assets **************************************************************************** Liabilities Policyholder account balances ************************************************************** Short-term debt *************************************************************************** Long-term debt *************************************************************************** Junior subordinated debt securities underlying common equity units ******************************* Shares subject to mandatory redemption****************************************************** Payables for collateral under securities loaned and other transactions ****************************** Total liabilities *************************************************************************** Other Derivative instruments (designated hedges or otherwise) Interest rate swaps ********************************************************************** $20,444 Interest rate ﬂoors *********************************************************************** 10,975 Interest rate caps************************************************************************ 27,990 Financial futures************************************************************************* 1,159 Foreign currency swaps ****************************************************************** 14,274 Foreign currency forwards **************************************************************** 4,622 Options******************************************************************************** 815 Financial forwards *********************************************************************** 2,452 Credit default swaps ********************************************************************* 5,882 Synthetic GICs************************************************************************** 5,477 Other********************************************************************************** 250 Total other *************************************************************************** Net change ******************************************************************************* Fair Value (In millions) $230,050 3,338 37,820 9,981 3,306 4,018 (4) $107,083 1,414 10,296 2,098 362 34,515 $ 584 134 242 4 (464) (28) 350 9 2 — 9 Assuming a 10% increase in the yield curve. $(5,633) — (616) (324) (18) — (14) $(6,605) $ 917 — 395 23 — — $ 1,335 $ (76) (39) 101 (12) (227) — — — — — — $ (253) $(5,570) This quantitative measure of risk has increased by $1,920 million, or 53%, at December 31, 2005, from $3,650 million at December 31, 2004. The primary reasons for the increase are growth in assets exposed to interest rate risk in increasing interest scenarios including ﬁxed maturity instruments and interest rate ﬂoors, and the increase in the yield curve since December 31, 2004. Subsequent to the restructuring of assets to comply with MetLife’s investment guidelines, the Travelers acquisition represents $702 million of the increase. Approximately $600 million of the increase is due to asset growth other than from the Travelers acquisition and approximately $200 million is due to the lengthening of the asset portfolio during 2005. The major contributor to the remainder of the change is movements in the yield curve. In addition to the analysis above, as part of its asset liability management program, the Company also performs an analysis of the sensitivity to changes in interest rates, including both insurance liabilities and ﬁnancial instruments. As of December 31, 2005, a hypothetical instantaneous 10% decrease in interest rates applied to the Company’s liabilities, insurance and associated asset portfolios would reduce the fair value of equity by $390 million. Management does not expect that this sensitivity would produce a liquidity strain on the Company. 56 MetLife, Inc. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure None. Management’s Annual Report on Internal Control Over Financial Reporting Management of MetLife, Inc. and subsidiaries is responsible for establishing and maintaining adequate internal control over ﬁnancial reporting. In fulﬁlling this responsibility, estimates and judgments by management are required to assess the expected beneﬁts and related costs of control procedures. The objectives of internal control include providing management with reasonable, but not absolute, assurance that assets are safeguarded against loss from unauthorized use or disposition, and that transactions are executed in accordance with management’s authorization and recorded properly to permit the preparation of consolidated ﬁnancial statements in conformity with accounting principles generally accepted in the United States of America. Financial management has documented and evaluated the effectiveness of the internal control of the Company as of December 31, 2005 pertaining to ﬁnancial reporting in accordance with the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. In the opinion of management, MetLife, Inc. maintained effective internal control over ﬁnancial reporting as of December 31, 2005. Deloitte & Touche LLP, an independent registered public accounting ﬁrm, has audited the consolidated ﬁnancial statements and consolidated ﬁnancial statement schedules included in the Annual Report on Form 10-K for the year ended December 31, 2005. The Report of the Independent Registered Public Accounting Firm on their audit of the consolidated ﬁnancial statements is included at page F-1. Attestation Report of the Company’s Registered Public Accounting Firm The Company’s independent registered public accounting ﬁrm, Deloitte & Touche LLP, has issued their attestation report on management’s assessment of internal control over ﬁnancial reporting which is set forth below. MetLife, Inc. 57 Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of MetLife, Inc. We have audited management’s assessment, included in management’s annual report on internal control over ﬁnancial reporting, that MetLife, Inc. and subsidiaries (the ‘‘Company’’) maintained effective internal control over ﬁnancial reporting as of December 31, 2005, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company’s manage- ment is responsible for maintaining effective internal control over ﬁnancial reporting and for its assessment of the effectiveness of internal control over ﬁnancial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over ﬁnancial reporting based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over ﬁnancial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over ﬁnancial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions. A company’s internal control over ﬁnancial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal ﬁnancial ofﬁcers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of ﬁnancial reporting and the preparation of ﬁnancial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over ﬁnancial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reﬂect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of ﬁnancial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the ﬁnancial statements. Because of the inherent limitations of internal control over ﬁnancial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over ﬁnancial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, management’s assessment that the Company maintained effective internal control over ﬁnancial reporting as of December 31, 2005, is fairly stated, in all material respects, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Also in our opinion, the Company maintained, in all material respects, effective internal control over ﬁnancial reporting as of December 31, 2005, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated ﬁnancial statements as of and for the year ended December 31, 2005, of the Company, and our report dated February 28, 2006, expressed an unqualiﬁed opinion on those consolidated ﬁnancial statements. /s/ DELOITTE & TOUCHE LLP DELOITTE & TOUCHE LLP New York, New York February 28, 2006 58 MetLife, Inc. Financial Statements INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm **************************************************************** Financial Statements at December 31, 2005 and 2004 and for the years ended December 31, 2005, 2004 and 2003: Consolidated Balance Sheets **************************************************************************************** Consolidated Statements of Income*********************************************************************************** Consolidated Statements of Stockholders’ Equity ********************************************************************** Consolidated Statements of Cash Flows ****************************************************************************** Notes to Consolidated Financial Statements *************************************************************************** Page F-1 F-2 F-3 F-4 F-5 F-7 MetLife, Inc. 59 Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of MetLife, Inc.: We have audited the accompanying consolidated balance sheets of MetLife, Inc. and subsidiaries (the ‘‘Company’’) as of December 31, 2005 and 2004, and the related consolidated statements of income, stockholders’ equity, and cash ﬂows for each of the three years in the period ended December 31, 2005. These ﬁnancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these ﬁnancial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated ﬁnancial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated ﬁnancial statements. An audit also includes assessing the accounting principles used and signiﬁcant estimates made by management, as well as evaluating the overall consolidated ﬁnancial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, such consolidated ﬁnancial statements present fairly, in all material respects, the consolidated ﬁnancial position of MetLife, Inc. and subsidiaries as of December 31, 2005 and 2004, and the results of their operations and their cash ﬂows for each of the three years in the period ended December 31, 2005, in conformity with accounting principles generally accepted in the United States of America. As discussed in Note 1, the Company changed its method of accounting for certain non-traditional long duration contracts and separate accounts, and for embedded derivatives in certain insurance products as required by accounting guidance which became effective on January 1, 2004 and October 1, 2003, respectively, and recorded the impact as cumulative effects of changes in accounting principles. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company’s internal control over ﬁnancial reporting as of December 31, 2005, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report, dated February 28, 2006, expressed an unqualiﬁed opinion on management’s assessment of the effectiveness of the Company’s internal control over ﬁnancial reporting and an unqualiﬁed opinion on the effectiveness of the Company’s internal control over ﬁnancial reporting. /s/ DELOITTE & TOUCHE LLP DELOITTE & TOUCHE LLP New York, New York February 28, 2006 MetLife, Inc. F-1 METLIFE, INC. CONSOLIDATED BALANCE SHEETS DECEMBER 31, 2005 AND 2004 (In millions, except share and per share data) 2005 2004 ASSETS Investments: Fixed maturities available-for-sale, at fair value (amortized cost: $223,926 and $166,611, respectively) *************** $230,050 Trading securities, at fair value (cost: $830 and $0, respectively) *********************************************** 825 Equity securities available-for-sale, at fair value (cost: $3,084 and $1,913, respectively)**************************** 3,338 Mortgage and consumer loans *************************************************************************** 37,190 Policy loans ******************************************************************************************* 9,981 Real estate and real estate joint ventures held-for-investment************************************************** 4,665 Real estate held-for-sale ******************************************************************************** — Other limited partnership interests************************************************************************* 4,276 Short-term investments ********************************************************************************* 3,306 Other invested assets ********************************************************************************** 8,078 Total investments ******************************************************************************** Cash and cash equivalents ******************************************************************************** Accrued investment income ******************************************************************************* Premiums and other receivables **************************************************************************** Deferred policy acquisition costs and value of business acquired ************************************************ Assets of subsidiaries held-for-sale ************************************************************************* Goodwill************************************************************************************************ Other assets ******************************************************************************************** Separate account assets ********************************************************************************** 301,709 4,018 3,036 12,186 19,641 — 4,797 8,389 127,869 Total assets ************************************************************************************* $481,645 LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities: Future policy beneﬁts *********************************************************************************** $123,204 Policyholder account balances *************************************************************************** 128,312 Other policyholder funds ******************************************************************************** 8,331 Policyholder dividends payable *************************************************************************** 917 Policyholder dividend obligation*************************************************************************** 1,607 Short-term debt *************************************************************************************** 1,414 Long-term debt **************************************************************************************** 9,888 Junior subordinated debt securities underlying common equity units ******************************************** 2,134 Shares subject to mandatory redemption ****************************************************************** 278 Liabilities of subsidiaries held-for-sale ********************************************************************** — Current income taxes payable**************************************************************************** 69 Deferred income taxes payable*************************************************************************** 1,706 Payables for collateral under securities loaned and other transactions ******************************************* 34,515 Other liabilities ***************************************************************************************** 12,300 Separate account liabilities******************************************************************************* 127,869 Total liabilities************************************************************************************ 452,544 $176,377 — 2,188 32,406 8,899 3,076 1,157 2,907 2,662 5,295 234,967 4,048 2,338 6,695 14,327 410 633 6,621 86,769 $356,808 $100,154 86,246 7,251 898 2,243 1,445 7,412 — 278 268 421 2,473 28,678 9,448 86,769 333,984 Stockholders’ Equity: Preferred stock, par value $0.01 per share; 200,000,000 shares authorized; 84,000,000 shares issued and outstanding at December 31, 2005; none issued and outstanding at December 31, 2004; $2,100 aggregate liquidation preference Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 786,766,664 shares issued at 1 — December 31, 2005 and 2004; 757,537,064 shares and 732,487,999 shares outstanding at December 31, 2005 and 2004, respectively********************************************************************************** Additional paid-in capital ********************************************************************************** Retained earnings **************************************************************************************** Treasury stock, at cost; 29,229,600 shares and 54,278,665 shares at December 31, 2005 and 2004, respectively ***** Accumulated other comprehensive income******************************************************************* Total stockholders’ equity************************************************************************** 29,101 Total liabilities and stockholders’ equity ************************************************************** $481,645 8 17,274 10,865 (959) 1,912 8 15,037 6,608 (1,785) 2,956 22,824 $356,808 See accompanying notes to consolidated ﬁnancial statements. F-2 MetLife, Inc. METLIFE, INC. CONSOLIDATED STATEMENTS OF INCOME FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003 (In millions, except per common share data) REVENUES Premiums************************************************************************************** $24,860 Universal life and investment-type product policy fees ************************************************* 3,828 Net investment income ************************************************************************** 14,910 Other revenues ********************************************************************************* 1,271 Net investment gains (losses) ********************************************************************* (93) Total revenues ************************************************************************** 44,776 $22,200 2,867 12,364 1,198 175 $20,575 2,495 11,472 1,199 (551) 38,804 35,190 2005 2004 2003 EXPENSES Policyholder beneﬁts and claims ******************************************************************* Interest credited to policyholder account balances **************************************************** Policyholder dividends *************************************************************************** Other expenses ******************************************************************************** Total expenses ************************************************************************* Income from continuing operations before provision for income taxes ************************************ Provision for income taxes************************************************************************ Income from continuing operations***************************************************************** Income from discontinued operations, net of income taxes********************************************* Income before cumulative effect of a change in accounting, net of income taxes ************************** Cumulative effect of a change in accounting, net of income taxes ************************************** Net income ************************************************************************************ 4,714 Preferred stock dividends ************************************************************************ 63 Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust********** — Net income available to common shareholders******************************************************* $ 4,651 25,506 3,925 1,679 9,267 3,139 1,575 4,714 — 4,399 1,260 40,377 22,662 2,997 1,666 7,813 35,138 3,666 1,029 2,637 207 2,844 (86) 2,758 — — 20,811 3,035 1,731 7,168 32,745 2,445 616 1,829 414 2,243 (26) 2,217 — 21 $ 2,758 $ 2,196 Income from continuing operations available to common shareholders per common share Basic *************************************************************************************** $ 4.19 $ 3.51 $ 2.45 Diluted ************************************************************************************** $ 4.16 $ 3.49 $ 2.42 Net income available to common shareholders per common share Basic *************************************************************************************** $ 6.21 $ 3.67 $ 2.97 Diluted ************************************************************************************** $ 6.16 $ 3.65 $ 2.94 Cash dividends per common share **************************************************************** $ 0.52 $ 0.46 $ 0.23 See accompanying notes to consolidated ﬁnancial statements. MetLife, Inc. F-3 METLIFE, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003 (In millions) Balance at January 1, 2003 ************************ Treasury stock transactions, net ********************* Issuance of shares — by subsidiary ****************** Dividends on common stock************************ Settlement of common stock purchase contracts ****** Premium on conversion of company-obligated mandatorily redeemable securities of a subsidiary trust Comprehensive income (loss): Net income ************************************ Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************* Unrealized investment gains (losses), net of related offsets and income taxes********************* Foreign currency translation adjustments ********** Minimum pension liability adjustment ************* Other comprehensive income (loss) ************** Comprehensive income (loss) ********************* Balance at December 31, 2003 ********************* Treasury stock transactions, net ********************* Dividends on common stock************************ Comprehensive income (loss): Net income ************************************ Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************* Unrealized investment gains (losses), net of related offsets and income taxes********************* Cumulative effect of a change in accounting, net of income taxes******************************* Foreign currency translation adjustments ********** Minimum pension liability adjustment ************* Other comprehensive income (loss) ************** Comprehensive income (loss) ********************* Balance at December 31, 2004 ********************* Treasury stock transactions, net ********************* Common stock issued in connection with acquisition *** Issuance of preferred stock ************************* Issuance of stock purchase contracts related to common equity units **************************** Dividends on preferred stock *********************** Dividends on common stock************************ Comprehensive income (loss): Net income ************************************ Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************* Unrealized investment gains (losses), net of related offsets and income taxes********************* Foreign currency translation adjustments, net of income taxes******************************* Minimum pension liability adjustment, net of income taxes ************************************* Other comprehensive income (loss) ************** Comprehensive income (loss) ********************* Balance at December 31, 2005 ********************* Preferred Common Stock Stock Additional Paid-In Capital Treasury Retained Stock at Earnings Cost $ — $8 $14,968 $ 2,807 $(2,405) (92) 20 24 (175) (656) 1,662 Accumulated Other Comprehensive Income (Loss) Net Unrealized Investment Foreign Currency Translation Minimum Pension Liability Gains (Losses) Adjustment Adjustment Total $ 2,282 $(229) $ (46) $17,385 (72) 24 (175) 1,006 (21) 2,217 — 8 14,991 46 (835) (950) 4,193 (343) 2,758 8 — 1 15,037 58 283 2,042 (146) 6,608 (1,785) 99 727 (63) (394) 4,714 (250) 940 177 (82) 2,972 (52) (128) (62) (6) 90 144 (2) 2,994 92 (130) 233 (1,285) (81) 89 (21) 2,217 (250) 940 177 (82) 785 3,002 21,149 (904) (343) 2,758 (62) (6) 90 144 (2) 164 2,922 22,824 157 1,010 2,043 (146) (63) (394) 4,714 233 (1,285) (81) 89 (1,044) 3,670 $ 1 $8 $17,274 $10,865 $ (959) $ 1,942 $ 11 $ (41) $29,101 See accompanying notes to consolidated ﬁnancial statements. F-4 MetLife, Inc. METLIFE, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003 (In millions) 2005 2004 2003 4,714 $ 2,758 $ 2,217 Cash ﬂows from operating activities Net income ******************************************************************************** $ Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization expenses***************************************************** Amortization of premiums and accretion of discounts associated with investments, net ************* (Gains) losses from sales of investments and businesses, net ********************************** Interest credited to policyholder account balances ******************************************** Interest credited to bank deposits ********************************************************** Universal life and investment-type product policy fees ***************************************** Change in accrued investment income ***************************************************** Change in premiums and other receivables ************************************************** Change in deferred policy acquisition costs, net ********************************************** Change in insurance-related liabilities ******************************************************* Change in trading securities*************************************************************** Change in income taxes payable ********************************************************** Change in other assets ****************************************************************** Change in other liabilities ***************************************************************** Other, net****************************************************************************** Net cash provided by operating activities ******************************************************** Cash ﬂows from investing activities Sales, maturities and repayments of: Fixed maturities ************************************************************************* Equity securities************************************************************************* Mortgage and consumer loans ************************************************************ Real estate and real estate joint ventures **************************************************** Other limited partnership interests ********************************************************** 352 (201) (2,271) 3,925 106 (3,828) (170) (37) (1,043) 5,709 (244) 528 346 506 (387) 8,005 155,689 1,062 8,462 3,668 1,132 Purchases of: Fixed maturities ************************************************************************* Equity securities************************************************************************* Mortgage and consumer loans ************************************************************ Real estate and real estate joint ventures **************************************************** Other limited partnership interests ********************************************************** Net change in short-term investments ******************************************************** Purchase of businesses, net of cash received of $852, $0 and $27, respectively******************** Proceeds from sales of businesses, net of cash disposed of $43, $103 and $0, respectively ********* Net change in other invested assets********************************************************** Other, net******************************************************************************** (169,102) (1,509) (10,902) (1,451) (1,105) 2,267 (10,160) 260 (426) (495) Net cash used in investing activities ************************************************************ $ (22,610) 444 (110) (302) 2,998 38 (2,867) (142) 78 (1,331) 5,346 — (135) (497) 356 (124) 6,510 87,451 1,686 3,954 1,268 799 (94,266) (2,178) (9,931) (872) (894) (740) (7) 29 (575) (141) 486 (180) 122 3,035 17 (2,495) (155) (334) (1,333) 4,698 — 241 (471) 320 (41) 6,127 76,200 612 3,483 1,088 331 (101,526) (232) (4,975) (312) (643) 98 18 5 (803) (222) $(14,417) $ (26,878) See accompanying notes to consolidated ﬁnancial statements. MetLife, Inc. F-5 METLIFE, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued) FOR THE YEARS ENDED DECEMBER 31, 2005, 2004 AND 2003 (Dollars in millions) Cash ﬂows from ﬁnancing activities 2005 2004 2003 Policyholder account balances: Deposits ******************************************************************************* $ 52,077 Withdrawals **************************************************************************** (47,827) Net change in payables for collateral under securities loaned and other transactions****************** 4,138 Net change in short-term debt*************************************************************** (56) Long-term debt issued ********************************************************************* 3,940 Long-term debt repaid ********************************************************************* (1,430) Preferred stock issued ********************************************************************* 2,100 Dividends on preferred stock **************************************************************** (63) Junior subordinated debt securities issued **************************************************** 2,134 Treasury stock acquired ******************************************************************** — Settlement of common stock purchase contracts *********************************************** — Proceeds from offering of common stock by subsidiary, net ************************************** — Dividends on common stock **************************************************************** (394) Stock options exercised ******************************************************************** 72 Debt and equity issuance costs ************************************************************* (128) Other, net******************************************************************************** (46) Net cash provided by ﬁnancing activities ******************************************************** Change in cash and cash equivalents ********************************************************** Cash and cash equivalents, beginning of year *************************************************** Cash and cash equivalents, end of year **************************************************** $ Cash and cash equivalents, subsidiaries held-for-sale, beginning of year ***************************** $ Cash and cash equivalents, subsidiaries held-for-sale, end of year ************************** $ Cash and cash equivalents, from continuing operations, beginning of year **************************** $ Cash and cash equivalents, from continuing operations, end of year************************* $ (88) 4,106 14,517 4,018 4,018 4,048 58 — Supplemental disclosures of cash ﬂow information: Net cash paid during the year for: Interest ******************************************************************************** $ Income taxes *************************************************************************** $ 579 1,391 Non-cash transactions during the year: Business acquisitions: Assets acquired*********************************************************************** $ 102,112 Less: liabilities assumed **************************************************************** 90,090 Net assets acquired ******************************************************************* Less: cash paid*********************************************************************** Business acquisition, common stock issued *********************************************** $ 12,022 11,012 1,010 Business Dispositions: Assets disposed ********************************************************************** $ Less: liabilities disposed **************************************************************** Net assets disposed******************************************************************* Plus: equity securities received ********************************************************** Less: cash disposed ****************************************************************** Business disposition, net of cash disposed ************************************************ $ Contribution of equity securities to MetLife Foundation ******************************************* $ Accrual for stock purchase contracts related to common equity units ****************************** $ Purchase money mortgage on real estate sale ************************************************* $ MetLife Capital Trust I transactions *********************************************************** $ Real estate acquired in satisfaction of debt **************************************************** $ Transfer from funds withheld at interest to ﬁxed maturities **************************************** $ 366 269 97 43 43 97 1 97 — — 1 — See accompanying notes to consolidated ﬁnancial statements. F-6 $ 39,506 (31,057) 1,595 (2,178) 1,822 (119) — — — (1,000) — — (343) 51 — 3 8,280 373 3,733 $ 4,106 $ $ 57 58 $ 3,676 $ 4,048 $ $ $ $ $ $ $ $ $ $ $ $ 362 977 20 13 7 7 — 923 820 103 — 103 — 50 — 2 — 7 606 $ 40,371 (31,135) 9,221 2,481 926 (763) — — — (97) 1,006 317 (175) 1 — 8 22,161 1,410 2,323 3,733 66 57 2,257 3,676 468 702 153 144 9 9 — 8 5 3 — — 3 — — 196 1,037 14 — $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ MetLife, Inc. METLIFE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. Summary of Accounting Policies Business ‘‘MetLife’’ or the ‘‘Company’’ refers to MetLife, Inc., a Delaware corporation incorporated in 1999 (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). MetLife, Inc. is a leading provider of insurance and other ﬁnancial services to millions of individual and institutional customers throughout the United States. Through its subsidiaries and afﬁliates, MetLife, Inc. offers life insurance, annuities, automobile and homeowners insurance and retail banking services to individuals, as well as group insurance, reinsurance and retirement & savings products and services to corporations and other institutions. Outside the United States, the MetLife companies have direct insurance operations in Asia Paciﬁc, Latin America and Europe. Basis of Presentation The accompanying consolidated ﬁnancial statements include the accounts of (i) the Holding Company and its subsidiaries; (ii) partnerships and joint ventures in which the Company has control; and (iii) variable interest entities (‘‘VIEs’’) for which the Company is deemed to be the primary beneﬁciary. Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item (see Note 7). Assets, liabilities, revenues and expenses of the general account for 2005 and 2004 include amounts related to certain separate accounts previously reported in separate account assets and liabilities. See ‘‘— Application of Recent Accounting Pronouncements.’’ Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in equity securities in which it has more than a 20% interest and for real estate joint ventures and other limited partnership interests in which it has more than a minor equity interest or more than minor inﬂuence over the partnership’s operations, but does not have a controlling interest and is not the primary beneﬁciary. The Company uses the cost method of accounting for real estate joint ventures and other limited partnership interests in which it has a minor equity investment and virtually no inﬂuence over the partnership’s operations. Minority interest related to consolidated entities included in other liabilities was $1,291 million and $1,145 million at December 31, 2005 and 2004, respectively. Certain amounts in the prior year periods’ consolidated ﬁnancial statements have been reclassiﬁed to conform with the 2005 presentation. Such reclassiﬁcations include $1,397 million and $880 million relating to net bank deposits reclassiﬁed from net cash provided by operating activities to cash ﬂows from ﬁnancing activities for the years ended December 31, 2004 and 2003, respectively. This reclassiﬁcation resulted from the reclassiﬁcation of bank deposit balances from other liabilities to policyholder account balances on the consolidated balance sheet at December 31, 2004. In addition, $1,595 million and $9,221 million relating to the net change in payable for collateral under securities loaned and other transactions was reclassiﬁed from cash ﬂows from investing activities to cash ﬂows from ﬁnancing activities on the consolidated statements of cash ﬂows for the years ended December 31, 2004 and 2003, respectively. On July 1, 2005, the Holding Company completed the acquisition of The Travelers Insurance Company (‘‘TIC’’), excluding certain assets, most signiﬁcantly, Primerica, from Citigroup Inc. (‘‘Citigroup’’), and substantially all of Citigroup’s international insurance businesses (collectively, ‘‘Travelers’’), which is more fully described in Note 2. The acquisition is being accounted for using the purchase method of accounting. Travelers’ assets, liabilities and results of operations are included in the Company’s results beginning July 1, 2005. The accounting policies of Travelers were conformed to MetLife upon acquisition. Summary of Critical Accounting Estimates The preparation of ﬁnancial statements in conformity with accounting principles generally accepted in the United States of America (‘‘GAAP’’) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated ﬁnancial statements. The most critical estimates include those used in determining: (i) investment impairments; (ii) the fair value of investments in the absence of quoted market values; (iii) application of the consolidation rules to certain investments; (iv) the fair value of and accounting for derivatives; (v) the capitalization and amortization of deferred policy acquisition costs (‘‘DAC’’), including value of business acquired (‘‘VOBA’’); (vi) the measurement of goodwill and related impairment, if any; (vii) the liability for future policyholder beneﬁts; (viii) accounting for reinsurance transactions; (ix) the liability for litigation and regulatory matters; and (x) accounting for employee beneﬁt plans. The application of purchase accounting requires the use of estimation techniques in determining the fair value of the assets acquired and liabilities assumed — the most signiﬁcant of which relate to the aforementioned critical estimates. In applying these policies, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and ﬁnancial services industries; others are speciﬁc to the Company’s businesses and operations. Actual results could differ from these estimates. Investments The Company’s principal investments are in ﬁxed maturities, mortgage and consumer loans, other limited partnerships, and real estate and real estate joint ventures, all of which are exposed to three primary sources of investment risk: credit, interest rate and market valuation. The ﬁnancial statement risks are those associated with the recognition of impairments and income, as well as the determination of fair values. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used by the Company in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the market value has been below cost or amortized cost; (ii) the potential for impairments of securities when the issuer is experiencing signiﬁcant ﬁnancial difﬁculties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources; (vi) the Company’s ability and intent to hold the security for a period of time sufﬁcient to allow for the recovery of its value to an amount equal to or greater than cost or amortized cost; (vii) unfavorable changes in forecasted cash ﬂows on asset-backed securities; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. In addition, the earnings on certain investments are dependent upon market conditions, which could result in prepayments and changes in amounts to be earned due to changing interest rates or equity markets. The determination of fair values in the absence of quoted market values is based on: (i) valuation methodologies; (ii) securities the Company deems to be comparable; and MetLife, Inc. F-7 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. (iii) assumptions deemed appropriate given the circumstances. The use of different methodologies and assumptions may have a material effect on the estimated fair value amounts. In addition, the Company enters into certain structured investment transactions, real estate joint ventures and limited partnerships for which the Company may be deemed to be the primary beneﬁciary and, therefore, may be required to consolidate such investments. The accounting rules for the determination of the primary beneﬁciary are complex and require evaluation of the contractual rights and obligations associated with each party involved in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party. Derivatives The Company enters into freestanding derivative transactions primarily to manage the risk associated with variability in cash ﬂows or changes in fair values related to the Company’s ﬁnancial assets and liabilities. The Company also uses derivative instruments to hedge its currency exposure associated with net investments in certain foreign operations. The Company also purchases investment securities, issues certain insurance policies and engages in certain reinsurance contracts that have embedded derivatives. The associated ﬁnancial statement risk is the volatility in net income which can result from (i) changes in fair value of derivatives not qualifying as accounting hedges; (ii) ineffectiveness of designated hedges; and (iii) counterparty default. In addition, there is a risk that embedded derivatives requiring bifurcation are not identiﬁed and reported at fair value in the consolidated ﬁnancial statements. Accounting for derivatives is complex, as evidenced by signiﬁcant authoritative interpretations of the primary accounting standards which continue to evolve, as well as the signiﬁcant judgments and estimates involved in determining fair value in the absence of quoted market values. These estimates are based on valuation methodologies and assumptions deemed appropriate under the circumstances. Such assumptions include estimated volatility and interest rates used in the determination of fair value where quoted market values are not available. The use of different assumptions may have a material effect on the estimated fair value amounts. Deferred Policy Acquisition Costs and Value of Business Acquired The Company incurs signiﬁcant costs in connection with acquiring new and renewal insurance business. These costs, which vary with and are primarily related to the production of that business, are deferred. The recovery of DAC is dependent upon the future proﬁtability of the related business. The amount of future proﬁt is dependent principally on investment returns in excess of the amounts credited to policyholders, mortality, morbidity, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inﬂation. Of these factors, the Company anticipates that investment returns are most likely to impact the rate of amortization of such costs. The aforementioned factors enter into management’s estimates of gross margins and proﬁts, which generally are used to amortize such costs. VOBA, included in DAC, reﬂects the estimated fair value of in-force contracts in a life insurance company acquisition and represents the portion of the purchase price that is allocated to the value of the right to receive future cash ﬂows from the insurance and annuity contracts in force at the acquisition date. VOBA is based on actuarially determined projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns and other factors. Actual experience on the purchased business may vary from these projections. Revisions to estimates result in changes to the amounts expensed in the reporting period in which the revisions are made and could result in the impairment of the asset and a charge to income if estimated future gross margins and proﬁts are less than amounts deferred. In addition, the Company utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC. This practice assumes that the expectation for long-term appreciation in equity markets is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Goodwill Goodwill is the excess of cost over the fair value of net assets acquired. The Company tests goodwill for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justiﬁcation for conducting an interim test. Impairment testing is performed using the fair value approach, which requires the use of estimates and judgment, at the ‘‘reporting unit’’ level. A reporting unit is the operating segment, or a business that is one level below the operating segment if discrete ﬁnancial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, goodwill within Corporate & Other is allocated to reporting units within the Company’s business segments. If the carrying value of a reporting unit’s goodwill exceeds its fair value, the excess is recognized as an impairment and recorded as a charge against net income. The fair values of the reporting units are determined using a market multiple or discounted cash ﬂow model. The critical estimates necessary in determining fair value are projected earnings, comparative market multiples and the discount rate. Liability for Future Policy Beneﬁts and Unpaid Claims and Claim Expenses The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities and non- medical health insurance. Generally, amounts are payable over an extended period of time and liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy beneﬁts are mortality, morbidity, expenses, persistency, investment returns and inﬂation. Utilizing these assumptions, liabilities are estab- lished on a block of business basis. The Company also establishes liabilities for unpaid claims and claim expenses for property and casualty claim insurance which represent the amount estimated for claims that have been reported but not settled and claims incurred but not reported. Liabilities for unpaid claims are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation. Differences between actual experience and the assumptions used in pricing these policies and in the establishment of liabilities result in variances in proﬁt and could result in losses. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur. Reinsurance The Company enters into reinsurance transactions as both a provider and a purchaser of reinsurance. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit F-8 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the ﬁnancial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Additionally, for each of its reinsurance contracts, the Company must determine if the contract provides indemniﬁcation against loss or liability relating to insurance risk, in accordance with applicable accounting standards. The Company must review all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. If the Company determines that a reinsurance contract does not expose the reinsurer to a reasonable possibility of a signiﬁcant loss from insurance risk, the Company records the contract using the deposit method of accounting. Litigation The Company is a party to a number of legal actions and regulatory investigations. Given the inherent unpredictability of these matters, it is difﬁcult to estimate the impact on the Company’s consolidated ﬁnancial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities related to certain lawsuits, including the Company’s asbestos-related liability, are especially difﬁcult to estimate due to the limitation of available data and uncertainty regarding numerous variables used to determine amounts recorded. The data and variables that impact the assumptions used to estimate the Company’s asbestos-related liability include the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. It is possible that an adverse outcome in certain of the Company’s litigation and regulatory investigations, including asbestos- related cases, or the use of different assumptions in the determination of amounts recorded could have a material effect upon the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Employee Beneﬁt Plans Certain subsidiaries of the Holding Company sponsor pension and other retirement plans in various forms covering employees who meet speciﬁed eligibility requirements. The reported expense and liability associated with these plans require an extensive use of assumptions which include the discount rate, expected return on plan assets and rate of future compensation increases as determined by the Company. Management determines these assumptions based upon currently available market and industry data, historical performance of the plan and its assets, and consultation with an independent consulting actuarial ﬁrm. These assumptions used by the Company may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of the participants. These differences may have a signiﬁcant effect on the Company’s consolidated ﬁnancial statements and liquidity. Signiﬁcant Accounting Policies Investments The Company’s ﬁxed maturity and equity securities are classiﬁed as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on securities are recorded as a separate component of other comprehensive income or loss, net of policyholder related amounts and deferred income taxes. The cost of ﬁxed maturity and equity securities is adjusted for impairments in value deemed to be other-than- temporary in the period in which the determination is made. These adjustments are recorded as investment losses. The assessment of whether such impairment has occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors, as described in ‘‘— Summary of Critical Accounting Estimates-Investments,’’ about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. The Company’s review of its ﬁxed maturities and equity securities for impairments also includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for six months or greater. Investment gains and losses on sales of securities are determined on a speciﬁc identiﬁcation basis. All security transactions are recorded on a trade date basis. Amortization of premium and accretion of discount on ﬁxed maturity securities is recorded using the effective interest method. Mortgage and consumer loans are stated at amortized cost, net of valuation allowances. Loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the contractual terms of the loan agreement. Valuation allowances are established for the excess carrying value of the loan over the present value of expected future cash ﬂows discounted at the loan’s original effective interest rate, the value of the loan’s collateral or the loan’s market value if the loan is being sold. The Company also establishes allowances for loan loss when a loss contingency exists for pools of loans with similar characteristics, for example, mortgage loans based on similar property types and loan to value risk factors. A loss contingency exists when the likelihood that a future event will occur is probable based on past events. Changes in valuation allowances are included in net investment gains and losses. Interest income earned on impaired loans is accrued on the principal amount of the loan based on the loan’s contractual interest rate. However, interest ceases to be accrued for loans on which interest is generally more than 60 days past due and/or where the collection of interest is not considered probable. Cash receipts on impaired loans are recorded as a reduction of the recorded investment. Real estate held-for-investment, including related improvements, is stated at cost less accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Once the Company identiﬁes a property that is expected to be sold within one year and commences a ﬁrm plan for marketing the property, the Company, if applicable, classiﬁes the property as held-for-sale and reports the related net investment income and any resulting investment gains and losses as discontinued operations. Real estate held-for-sale is stated at the lower of depreciated cost or fair value less expected disposition costs. Real estate is not depreciated while it is classiﬁed as held-for-sale. Cost of real estate held-for-investment is adjusted for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Impaired real estate is written down to estimated fair value with the impairment loss being included in net investment gains and losses. MetLife, Inc. F-9 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Impairment losses are based upon the estimated fair value of real estate, which is generally computed using the present value of expected future cash ﬂows from the real estate discounted at a rate commensurate with the underlying risks. Real estate acquired upon foreclosure of commercial and agricultural mortgage loans is recorded at the lower of estimated fair value or the carrying value of the mortgage loan at the date of foreclosure. Policy loans are stated at unpaid principal balances. Short-term investments are stated at amortized cost, which approximates fair value. Other invested assets consist principally of leveraged leases and funds withheld at interest. The leveraged leases are recorded net of non-recourse debt. The Company participates in lease transactions which are diversiﬁed by industry, asset type and geographic area. The Company regularly reviews residual values and impairs residuals to expected values as needed. Funds withheld represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. For agreements written on a modiﬁed coinsurance basis and certain agreements written on a coinsurance basis, assets supporting the reinsured policies and equal to the net statutory reserves are withheld and continue to be legally owned by the ceding companies. Other invested assets also includes derivative revaluation gains and the fair value of embedded derivatives related to funds withheld and modiﬁed coinsurance contracts. The Company recognizes interest on funds withheld in accordance with the treaty terms as investment income is earned on the assets supporting the reinsured policies. Interest on funds withheld is reported in net investment income in the consolidated ﬁnancial statements. The Company participates in structured investment transactions, primarily asset securitizations and structured notes. These transactions enhance the Company’s total return on its investment portfolio principally by generating management fee income on asset securitizations and by providing equity- based returns on debt securities through structured notes and similar instruments. The Company sponsors ﬁnancial asset securitizations of high yield debt securities, investment grade bonds and structured ﬁnance securities and also is the collateral manager and a beneﬁcial interest holder in such transactions. As the collateral manager, the Company earns management fees on the outstanding securitized asset balance, which are recorded in income as earned. When the Company transfers assets to a bankruptcy-remote special purpose entity (‘‘SPE’’) and surrenders control over the transferred assets, the transaction is accounted for as a sale. Gains or losses on securitizations are determined with reference to the carrying amount of the ﬁnancial assets transferred, which is allocated to the assets sold and the beneﬁcial interests retained based on relative fair values at the date of transfer. Beneﬁcial interests in securitizations are carried at fair value in ﬁxed maturities. Income on these beneﬁcial interests is recognized using the prospective method. The SPEs used to securitize assets are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities. Prior to the adoption of Financial Accounting Standards Board (‘‘FASB’’) Interpretation (‘‘FIN’’) No. 46, Consolidation of Variable Interest Entities — An Interpretation of Accounting Research Bulletin (‘‘ARB’’) No. 51 (‘‘FIN 46’’), and its December 2003 revision (‘‘FIN 46(r)’’), such SPEs were not consolidated because they did not meet the criteria for consolidation under previous accounting guidance. The Company purchases or receives beneﬁcial interests in SPEs, which generally acquire ﬁnancial assets, including corporate equities, debt securities and purchased options. The Company has not guaranteed the performance, liquidity or obligations of the SPEs and the Company’s exposure to loss is limited to its carrying value of the beneﬁcial interests in the SPEs. The Company uses the beneﬁcial interests as part of its risk management strategy, including asset-liability management. These SPEs are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities based on the framework provided in FIN 46(r). These beneﬁcial interests are generally structured notes, which are included in ﬁxed maturities, and their income is recognized using the retrospective interest method or the level yield method, as appropriate. Impairments of these beneﬁcial interests are included in net investment gains (losses). Trading Securities During 2005, the Company established a trading securities portfolio to support investment strategies that involve the active and frequent purchase and sale of securities. Trading securities are recorded at fair value with subsequent changes in fair value recognized in net investment income. Derivative Financial Instruments Derivatives are ﬁnancial instruments whose values are derived from interest rates, foreign exchange rates, or other ﬁnancial indices. Derivatives may be exchange traded or contracted in the over-the-counter market. The Company uses a variety of derivatives, including swaps, forwards, futures and option contracts, to manage its various risks. Additionally, the Company enters into income generation and replication derivatives as permitted by its insurance subsidiaries’ Derivatives Use Plans approved by the applicable state insurance departments. Freestanding derivatives are carried on the Company’s consolidated balance sheet either as assets within other invested assets or as liabilities within other liabilities at fair value as determined by quoted market prices or through the use of pricing models. Values can be affected by changes in interest rates, foreign exchange rates, ﬁnancial indices, credit spreads, market volatility, and liquidity. Values can also be affected by changes in estimates and assumptions used in pricing models. If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting pursuant to Statement of Financial Accounting Standards (‘‘SFAS’’) No. 133, Accounting for Derivative Instruments and Hedging Activities (‘‘SFAS 133’’), as amended, changes in the fair value of the derivative are reported in net investment gains (losses), in interest credited to policyholder account balances for economic hedges of liabilities embedded in certain variable annuity products offered by the Company or in net investment income for economic hedges of equity method investments in joint ventures. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge as either (i) a hedge of the fair value of a recognized asset or liability or an unrecognized ﬁrm commitment (‘‘fair value hedge’’); (ii) a hedge of a forecasted transaction or of the variability of cash ﬂows to be received or paid related to a recognized asset or liability (‘‘cash ﬂow hedge’’); or (iii) a hedge of a net investment in a foreign operation. In this documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method which will be used to measure ineffective- ness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and periodically throughout the life of the designated hedging relationship. Under a fair value hedge, changes in the fair value of the hedging derivative, including amounts measured as ineffectiveness, and changes in the fair value of the hedged item related to the designated risk being hedged, are reported within net investment gains (losses). The fair values of the hedging F-10 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. derivatives are exclusive of any accruals that are separately reported in the consolidated statement of income within interest income or interest expense to match the location of the hedged item. Under a cash ﬂow hedge, changes in the fair value of the hedging derivative measured as effective are reported within other comprehensive income (loss), a separate component of shareholders’ equity, and the deferred gains or losses on the derivative are reclassiﬁed into the consolidated statement of income when the Company’s earnings are affected by the variability in cash ﬂows of the hedged item. Changes in the fair value of the hedging instrument measured as ineffectiveness are reported within net investment gains (losses). The fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the consolidated statement of income within interest income or interest expense to match the location of the hedged item. In a hedge of a net investment in a foreign operation, changes in the fair value of the hedging derivative that are measured as effective are reported within other comprehensive income (loss) consistent with the translation adjustment for the hedged net investment in the foreign operation. Changes in the fair value of the hedging instrument measured as ineffectiveness are reported within net investment gains (losses). The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the fair value or cash ﬂows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; (iv) a hedged ﬁrm commitment no longer meets the deﬁnition of a ﬁrm commitment; or (v) the derivative is de- designated as a hedging instrument. When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the fair value or cash ﬂows of a hedged item, the derivative continues to be carried on the consolidated balance sheet at its fair value, with changes in fair value recognized currently in net investment gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in fair value of derivatives recorded in other comprehensive income (loss) related to discontinued cash ﬂow hedges are released into the consolidated statement of income when the Company’s earnings are affected by the variability in cash ﬂows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur by the end of the speciﬁed time period or the hedged item no longer meets the deﬁnition of a ﬁrm commitment, the derivative continues to be carried on the consolidated balance sheet at its fair value, with changes in fair value recognized currently in net investment gains (losses). Any asset or liability associated with a recognized ﬁrm commitment is derecognized from the consolidated balance sheet, and recorded currently in net investment gains (losses). Deferred gains and losses of a derivative recorded in other comprehensive income (loss) pursuant to the cash ﬂow hedge of a forecasted transaction are recognized immediately in net investment gains (losses). In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value on the consolidated balance sheet, with changes in its fair value recognized in the current period as net investment gains (losses). The Company is also a party to ﬁnancial instruments that contain terms which are deemed to be embedded derivatives. The Company assesses each identiﬁed embedded derivative to determine whether it is required to be bifurcated under SFAS 133. If the instrument would not be accounted for in its entirety at fair value and it is determined that the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative. Such embedded derivatives are carried on the consolidated balance sheet at fair value with the host contract and changes in their fair value are reported currently in net investment gains (losses). If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at fair value, with changes in fair value recognized in the current period in net investment gains (losses). Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Property, Equipment, Leasehold Improvements and Computer Software Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using either the straight-line or sum-of-the-years-digits method over the estimated useful lives of the assets, as appropriate. The estimated life for company occupied real estate property is generally 40 years. Estimated lives generally range from ﬁve to ten years for leasehold improvements and three to seven years for all other property and equipment. The cost basis of the property, equipment and leasehold improvements was $1,418 million and $1,258 million at December 31, 2005 and 2004, respectively. Accumulated depreciation and amortization of property, equipment and leasehold improvements was $625 million and $565 million at December 31, 2005 and 2004, respectively. Related depreciation and amortization expense was $117 million, $112 million and $117 million for the years ended December 31, 2005, 2004 and 2003, respectively. Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $1,010 million and $868 million at December 31, 2005 and 2004, respectively. Accumulated amortization of capitalized software was $661 million and $552 million at December 31, 2005 and 2004, respectively. Related amortization expense was $111 million, $139 million and $154 million for the years ended December 31, 2005, 2004 and 2003, respectively. Deferred Policy Acquisition Costs and Value of Business Acquired The costs of acquiring new and renewal insurance business that vary with, and are primarily related to, the production of that business are deferred. Such costs consist principally of commissions and agency and policy issue expenses. VOBA, included as part of DAC, represents the present value of estimated future proﬁts to be generated from existing insurance contracts in-force at the date of acquisition. DAC is amortized with interest over the expected life of the contract for participating traditional life, universal life and investment-type products. Generally, DAC is amortized in proportion to the present value of estimated gross margins or proﬁts from investment, mortality, expense margins and MetLife, Inc. F-11 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. surrender charges. Interest rates used to compute the present value of estimated gross margins and proﬁts are based on rates in effect at the inception or acquisition of the contracts. Actual gross margins or proﬁts can vary from management’s estimates resulting in increases or decreases in the rate of amortization. Management utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC. This practice assumes that the expectation for long-term equity investment appreciation is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Management periodically updates these estimates and evaluates the recoverability of DAC. When appropriate, management revises its assumptions of the estimated gross margins or proﬁts of these contracts, and the cumulative amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. DAC for non-participating traditional life, non-medical health and annuity policies with life contingencies is amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are made at the date of policy issuance or acquisition and are consistently applied during the lives of the contracts. Deviations from estimated experience are included in operations when they occur. For these contracts, the amortization period is typically the estimated life of the policy. Policy acquisition costs related to internally replaced contracts are expensed at the date of replacement. DAC for property and casualty insurance contracts, which is primarily comprised of commissions and certain underwriting expenses, are deferred and amortized on a pro rata basis over the applicable contract term or reinsurance treaty. Sales Inducements The Company has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a speciﬁed percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. Goodwill Goodwill is the excess of cost over the fair value of net assets acquired. Changes in goodwill are as follows: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year************************************************************************ $ 633 Acquisitions ************************************************************************************ 4,180 Dispositions and other *************************************************************************** (16) Balance, end of year **************************************************************************** $4,797 $628 4 1 $633 $ 750 3 (125) $ 628 Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justiﬁcation for conducting an interim test. Impairment testing is performed using the fair value approach, which requires the use of estimates and judgment, at the ‘‘reporting unit’’ level. A reporting unit is the operating segment, or a business one level below that operating segment if discrete ﬁnancial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, goodwill within Corporate & Other is allocated to reporting units within the Company’s business segments. If the carrying value of a reporting unit’s goodwill exceeds its fair value, the excess is recognized as an impairment and recorded as a charge against net income. The fair values of the reporting units are determined using a market multiple or a discounted cash ﬂow model. Liability for Future Policy Beneﬁts and Policyholder Account Balances Future policy beneﬁt liabilities for participating traditional life insurance policies are equal to the aggregate of (i) net level premium reserves for death and endowment policy beneﬁts (calculated based upon the non-forfeiture interest rate, ranging from 3% to 7% for domestic business and 3% to 12% for international business, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends. Future policy beneﬁts for non-participating traditional life insurance policies are equal to the aggregate of the present value of future beneﬁt payments and related expenses less the present value of future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rates for the aggregate future policy beneﬁt liabilities range from 4% to 7% for domestic business and 2% to 10% for international business. Participating business represented approximately 11% and 14% of the Company’s life insurance in-force, and 41% and 56% of the number of life insurance policies in-force, at December 31, 2005 and 2004, respectively. Participating policies represented approximately 31% and 30%, 35% and 34%, and 38% and 38% of gross and net life insurance premiums for the years ended December 31, 2005, 2004 and 2003, respectively. The percentages indicated are calculated excluding the business of the Reinsurance segment. Future policy beneﬁt liabilities for individual and group traditional ﬁxed annuities after annuitization are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 2% to 11% and for domestic business and 2% to 10% for international business. Future policy beneﬁt liabilities for non-medical health insurance are calculated using the net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rates used in establishing such liabilities range from 3% to 7% for domestic business and 2% to 10% for international business. Future policy beneﬁt liabilities for disabled lives are estimated using the present value of beneﬁts method and experience assumptions as to claim terminations, expenses and interest. Interest rates used in establishing such liabilities range from 3% to 8% for domestic business and 2% to 10% for international business. Liabilities for unpaid claims and claim expenses for property and casualty insurance are included in future policyholder beneﬁts and are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends F-12 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. and risk management programs, reduced for anticipated salvage and subrogation. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur. Policyholder account balances relate to investment-type contracts and universal life-type policies. Investment-type contracts principally include traditional individual ﬁxed annuities in the accumulation phase and non-variable group annuity contracts. Policyholder account balances are equal to (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from 0.3% to 14% for domestic business and 1% to 18% for international business, less expenses, mortality charges, and withdrawals; and (iii) fair value adjustments relating to business combinations. Bank deposits are also included in policyholder account balances. The Company issues ﬁxed and ﬂoating rate obligations under its guaranteed interest contract (‘‘GIC’’) program which are denominated in either U.S. dollars or foreign currencies. During the years ended December 31, 2005, 2004 and 2003, the Company issued $4,018 million, $3,958 million and $4,349 million, respectively, in such obligations. During the years ended December 31, 2005, 2004 and 2003, there were repayments of $1,052 million, $150 million and $47 million, respectively, of GICs under this program. In addition, the acquisition of Travelers increased the balance by $5,293 million in GICs as of December 31, 2005. Accordingly, the GICs outstanding, which are included in policyholder account balances in the accompanying consolidated balance sheets, were $17,442 million and $9,017 million at December 31, 2005 and 2004, respectively. Interest credited on the contracts for the years ended December 31, 2005, 2004 and 2003 was $464 million, $142 million and $58 million, respectively. The Company establishes future policy beneﬁt liabilities for minimum death and income beneﬁt guarantees relating to certain annuity contracts and secondary and paid up guarantees relating to certain life policies as follows: ) Annuity guaranteed death beneﬁt liabilities are determined by estimating the expected value of death beneﬁts in excess of the projected account balance and recognizing the excess ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used in estimating the liabilities are consistent with those used for amortizing DAC, including the mean reversion assumption. The assumptions of investment performance and volatility are consistent with the historical experience of the Standard & Poor’s 500 Index (‘‘S&P’’). The beneﬁts used in calculating the liabilities are based on the average beneﬁts payable over a range of scenarios. ) Guaranteed income beneﬁt liabilities are determined by estimating the expected value of the income beneﬁts in excess of the projected account balance at the date of annuitization and recognizing the excess ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used for calculating such guaranteed income beneﬁt liabilities are consistent with those used for calculating the guaranteed death beneﬁt liabilities. In addition, the calculation of guaranteed annuitization beneﬁt liabilities incorporates a percentage of the potential annuitizations that may be elected by the contractholder. ) Liabilities for universal and variable life secondary guarantees and paid-up guarantees are determined by estimating the expected value of death beneﬁts payable when the account balance is projected to be zero and recognizing those beneﬁts ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balances, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used in estimating the secondary and paid up guarantee liabilities are consistent with those used for amortizing DAC. The assumptions of investment performance and volatility for variable products are consistent with historical S&P experience. The beneﬁts used in calculating the liabilities are based on the average beneﬁts payable over a range of scenarios. The Company offers certain variable annuity products with guaranteed minimum beneﬁt riders as follows: ) Guaranteed minimum withdrawal beneﬁt riders (‘‘GMWB’’s) guarantee a policyholder return of the purchase payment plus a bonus amount via partial withdrawals, even if the account value is reduced to zero, provided that the policyholder’s cumulative withdrawals in a contract year do not exceed a certain limit. The initial guaranteed withdrawal amount is equal to the initial beneﬁt base as deﬁned in the contract. When an additional purchase payment is made, the guaranteed withdrawal amount is set equal to the greater of (i) the guaranteed withdrawal amount before the purchase payment or (ii) the beneﬁt base after the purchase payment. The beneﬁt base increases by additional purchase payments plus a bonus amount and decreases by beneﬁts paid and/or withdrawal amounts. After a speciﬁed period of time, the beneﬁt base may also change as a result of an optional reset as deﬁned in the contract. The beneﬁt base can be reset to the account balance on the date of the reset if greater than the beneﬁt base before the reset. The GMWB is an embedded derivative, which is measured at fair value separately from the host variable annuity product. ) Guaranteed minimum accumulation beneﬁt riders (‘‘GMAB’’s) provide the contract holder with a minimum accumulation of their purchase payments deposited within a speciﬁc time period, adjusted proportionately for withdrawals, after a speciﬁed period of time determined at the time of issuance of the variable annuity contract. The GMAB is also an embedded derivative, which is measured at fair value separately from the host variable annuity product. ) The fair value of the GMWBs and GMABs is calculated based on actuarial and capital market assumptions related to the projected cash ﬂows, including beneﬁts and related contract charges, over the lives of the contracts, incorporating expectations concerning policyholder behavior. In measuring the fair value of GMWBs and GMABs, the Company attributes a portion of the fees collected from the policyholder equal to the present value of expected future guaranteed minimum withdrawal and accumulation beneﬁts. GMWBs and GMABs are reported in policyholder account balances and the changes in fair value are reported in net investment gains (losses). Any additional fees represent ‘‘excess’’ fees and are reported in universal life and investment-type product policy fees. Other Policyholder Funds Other policyholder funds includes policy and contract claims and unearned policy and contract fees. Recognition of Insurance Revenue and Related Beneﬁts Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due. Beneﬁts and expenses are provided against such revenues to recognize proﬁts over the estimated lives of the policies. When premiums are due over a signiﬁcantly shorter period MetLife, Inc. F-13 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. than the period over which beneﬁts are provided, any excess proﬁt is deferred and recognized into operations in a constant relationship to insurance in- force or, for annuities, the amount of expected future policy beneﬁt payments. Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term. Deposits related to universal life-type and investment-type products are credited to policyholder account balances. Revenues from such contracts consist of amounts assessed against policyholder account balances for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to operations include interest credited and beneﬁt claims incurred in excess of related policyholder account balances. Premiums related to property and casualty contracts are recognized as revenue on a pro rata basis over the applicable contract term. Unearned premiums are included in future policy beneﬁts. Other Revenues Other revenues include advisory fees, broker/dealer commissions and fees, and administrative service fees. Such fees and commissions are recognized in the period in which services are performed. Other revenues also include changes in account value relating to corporate-owned life insurance (‘‘COLI’’). Under certain COLI contracts, if the Company reports certain unlikely adverse results in its consolidated ﬁnancial statements, withdrawals would not be immediately available and would be subject to market value adjustment, which could result in a reduction of the account value. Policyholder Dividends Policyholder dividends are approved annually by the insurance subsidiaries’ boards of directors. The aggregate amount of policyholder dividends is related to actual interest, mortality, morbidity and expense experience for the year, as well as management’s judgment as to the appropriate level of statutory surplus to be retained by the insurance subsidiaries. Federal Income Taxes The Holding Company and its includable life insurance and non-life insurance subsidiaries ﬁle a consolidated U.S. federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended (the ‘‘Code’’). Non-includable subsidiaries ﬁle either separate tax returns or separate consolidated tax returns. The future tax consequences of temporary differences between ﬁnancial reporting and tax bases of assets and liabilities are measured at the balance sheet dates and are recorded as deferred income tax assets and liabilities. Valuation allowances are established when management assesses, based on available information, that it is more likely than not that deferred income tax assets will not be realized. For federal income tax purposes, the Company has made an election under Internal Revenue Code Section 338 as it relates to the Travelers acquisition. As a result of this election, the tax basis in the acquired assets and liabilities were adjusted as of the acquisition date resulting in a change to the related deferred income taxes. Reinsurance The Company has reinsured certain of its life insurance and property and casualty insurance contracts with other insurance companies under various agreements. For reinsurance contracts that transfer sufﬁcient underwriting risk, reinsurance premiums, commissions, expense reimbursements, beneﬁts and liabilities related to reinsured long-duration contracts are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. The cost of reinsurance related to short-duration contracts is accounted for over the reinsurance contract period. Amounts due from reinsurers, for both short- and long-duration arrangements, are estimated based upon assumptions consistent with those used in establishing the liabilities related to the underlying reinsured contracts. Policy and contract liabilities are reported gross of reinsurance credits. DAC is reduced by amounts recovered under reinsurance contracts. Amounts received from reinsurers for policy administration are reported in other revenues. The Company assumes and retrocedes ﬁnancial reinsurance contracts, which represent low mortality risk reinsurance treaties. These contracts are reported as deposits and are included in other assets. The amount of revenue reported on these contracts represents fees and the cost of insurance under the terms of the reinsurance agreement and is reported in other revenues. Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. Effective with the adoption of Statement of Position 03-1, Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts (‘‘SOP 03-1’’), on January 1, 2004, the Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if (i) such separate accounts are legally recognized; (ii) assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities; (iii) investments are directed by the contractholder; and (iv) all investment performance, net of contact fees and assessments, is passed through to the contractholder. The Company reports separate account assets meeting such criteria at their fair value. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the consolidated statements of income. In connection with the adoption of SOP 03-1, separate account assets with a fair value of $1.7 billion were reclassiﬁed to general account investments with a corresponding transfer of separate account liabilities to future policy beneﬁts and policyholder account balances. See ‘‘— Application of Recent Accounting Pronouncements.’’ The Company’s revenues reﬂect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Separate accounts not meeting the above criteria are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. Stock-Based Compensation The Company accounts for stock-based compensation plans using the prospective fair value accounting method prescribed by SFAS No. 123, Accounting for Stock-Based Compensation (‘‘SFAS 123’’), as amended by SFAS No. 148, Accounting for Stock-Based Compensation — Transition and F-14 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Disclosure (‘‘SFAS 148’’). The fair value method requires compensation cost to be measured based on the fair value of the equity instrument at the grant or award date. Stock-based compensation grants prior to January 1, 2003 are accounted for using the intrinsic value method prescribed by Accounting Principles Board (‘‘APB’’) Opinion No. 25, Accounting for Stock Issued to Employees (‘‘APB 25’’). Note 14 includes the pro forma disclosures required by SFAS No. 123, as amended. The intrinsic value method represents the quoted market price or fair value of the equity award at the measurement date less the amount, if any, the employee is required to pay. Stock-based compensation is accrued over the vesting period of the grant or award. Foreign Currency Balance sheet accounts of foreign operations are translated at the exchange rates in effect at each year-end and income and expense accounts are translated at the average rates of exchange prevailing during the year. The local currencies of foreign operations are the functional currencies unless the local economy is highly inﬂationary. Translation adjustments are charged or credited directly to other comprehensive income or loss. Gains and losses from foreign currency transactions are reported as gains (losses) in the period in which they occur. Discontinued Operations The results of operations of a component of the Company that either has been disposed of or is classiﬁed as held-for-sale are reported in discontinued operations if the operations and cash ﬂows of the component have been or will be eliminated from the ongoing operations of the Company as a result of the disposal transaction and the Company will not have any signiﬁcant continuing involvement in the operations of the component after the disposal transaction. Earnings Per Common Share Basic earnings per common share is computed based on the weighted average number of common shares outstanding during the period. Diluted earnings per common share includes the dilutive effect of the assumed: (i) conversion of forward purchase contracts; (ii) exercise of stock options; and (iii) issuance under deferred stock compensation using the treasury stock method. Under the treasury stock method, conversion of forward purchase contracts, exercise of the stock options and issuance under deferred stock compensation is assumed with the proceeds used to purchase common stock at the average market price for the period. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares, including the effects, if any, of the stock purchase contracts on common equity units. See Note 9. Application of Recent Accounting Pronouncements In February 2006, the FASB issued SFAS No. 155, Accounting for Certain Hybrid Instruments (‘‘SFAS 155’’). SFAS 155 amends SFAS 133 and SFAS No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities (‘‘SFAS 140’’). SFAS 155 allows ﬁnancial instruments that have embedded derivatives to be accounted for as a whole, eliminating the need to bifurcate the derivative from its host, if the holder elects to account for the whole instrument on a fair value basis. In addition, among other changes, SFAS 155 (i) clariﬁes which interest-only strips and principal-only strips are not subject to the requirements of SFAS 133; (ii) establishes a requirement to evaluate interests in securitized ﬁnancial assets to identify interests that are freestanding derivatives or that are hybrid ﬁnancial instruments that contain an embedded derivative requiring bifurcation; (iii) clariﬁes that concentrations of credit risk in the form of subordination are not embedded derivatives; and (iv) eliminates the prohibition on a qualifying special-purpose entity (‘‘QSPE’’) from holding a derivative ﬁnancial instrument that pertains to a beneﬁcial interest other than another derivative ﬁnancial interest. SFAS 155 will be applied prospectively and is effective for all ﬁnancial instruments acquired or issued for ﬁscal years beginning after September 15, 2006. SFAS 155 is not expected to have a material impact on the Company’s consolidated ﬁnancial statements. The FASB has issued additional guidance relating to derivative ﬁnancial instruments as follows: ) In June 2005, the FASB cleared SFAS 133 Implementation Issue No. B38, Embedded Derivatives: Evaluation of Net Settlement with Respect to the Settlement of a Debt Instrument through Exercise of an Embedded Put Option or Call Option (‘‘Issue B38’’) and SFAS 133 Implementation Issue No. B39, Embedded Derivatives: Application of Paragraph 13(b) to Call Options That Are Exercisable Only by the Debtor (‘‘Issue B39’’). Issue B38 clariﬁed that the potential settlement of a debtor’s obligation to a creditor occurring upon exercise of a put or call option meets the net settlement criteria of SFAS No. 133. Issue B39 clariﬁed that an embedded call option, in which the underlying is an interest rate or interest rate index, that can accelerate the settlement of a debt host ﬁnancial instrument should not be bifurcated and fair valued if the right to accelerate the settlement can be exercised only by the debtor (issuer/borrower) and the investor will recover substantially all of its initial net investment. Issues B38 and B39, which must be adopted as of the ﬁrst day of the ﬁrst ﬁscal quarter beginning after December 15, 2005, did not have a material impact on the Company’s consolidated ﬁnancial statements. ) Effective October 1, 2003, the Company adopted SFAS 133 Implementation Issue No. B36, Embedded Derivatives: Modiﬁed Coinsurance Arrangements and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to the Creditworthiness of the Obligor under Those Instruments (‘‘Issue B36’’). Issue B36 concluded that (i) a company’s funds withheld payable and/or receivable under certain reinsurance arrangements; and (ii) a debt instrument that incorporates credit risk exposures that are unrelated or only partially related to the creditworthiness of the obligor include an embedded derivative feature that is not clearly and closely related to the host contract. Therefore, the embedded derivative feature is measured at fair value on the balance sheet and changes in fair value are reported in income. As a result of the adoption of Issue B36, the Company recorded a cumulative effect of a change in accounting of $26 million, net of income taxes, for the year ended December 31, 2003. ) Effective July 1, 2003, the Company adopted SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities (‘‘SFAS 149’’). SFAS 149 amended and clariﬁed the accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Except for certain previously issued and effective guidance, SFAS 149 was effective for contracts entered into or modiﬁed after June 30, 2003. The Company’s adoption of SFAS 149 did not have a signiﬁcant impact on its consolidated ﬁnancial statements. Effective November 9, 2005, the Company prospectively adopted the guidance in FASB Staff Position (‘‘FSP’’) FAS 140-2, Clariﬁcation of the Application of Paragraphs 40(b) and 40(c) of FAS 140 (‘‘FSP 140-2’’). FSP 140-2 clariﬁed certain criteria relating to derivatives and beneﬁcial interests MetLife, Inc. F-15 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. when considering whether an entity qualiﬁes as a QSPE. Under FSP 140-2, the criteria must only be met at the date the QSPE issues beneﬁcial interests or when a derivative ﬁnancial instrument needs to be replaced upon the occurrence of a speciﬁed event outside the control of the transferor. FSP 140-2 did not have a material impact on the Company’s consolidated ﬁnancial statements. In September 2005, the American Institute of Certiﬁed Public Accountants (‘‘AICPA’’) issued SOP 05-1, Accounting by Insurance Enterprises for Deferred Acquisition Costs in Connection with Modiﬁcations or Exchanges of Insurance Contracts (‘‘SOP 05-1’’). SOP 05-1 provides guidance on accounting by insurance enterprises for deferred acquisition costs on internal replacements of insurance and investment contracts other than those speciﬁcally described in SFAS No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and For Realized Gains and Losses from the Sale of Investments. SOP 05-1 deﬁnes an internal replacement as a modiﬁcation in product beneﬁts, features, rights, or coverages that occurs by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. Under SOP 05-1, modiﬁcations that result in a substantially unchanged contract will be accounted for as a continuation of the replaced contract. A replacement contract that is substantially changed will be accounted for as an extinguishment of the replaced contract resulting in a release of unamortized deferred acquisition costs, unearned revenue and deferred sales inducements associated with the replaced contract. The guidance in SOP 05-1 will be applied prospectively and is effective for internal replacements occurring in ﬁscal years beginning after December 15, 2006. The Company is currently evaluating the impact of SOP 05-1 and does not expect that the pronouncement will have a material impact on the Company’s consolidated ﬁnancial statements. In September 2005, the Emerging Issues Task Force (‘‘EITF’’) reached consensus on Issue No. 05-7, Accounting for Modiﬁcations to Conversion Options Embedded in Debt Instruments and Related Issues (‘‘EITF 05-7’’). EITF 05-7 provides guidance on whether a modiﬁcation of conversion options embedded in debt results in an extinguishment of that debt. In certain situations, companies may change the terms of an embedded conversion option as part of a debt modiﬁcation. The EITF concluded that the change in the fair value of an embedded conversion option upon modiﬁcation should be included in the analysis of EITF Issue No. 96-19, Debtor’s Accounting for a Modiﬁcation or Exchange of Debt Instruments, to determine whether a modiﬁcation or extinguishment has occurred and that a change in the fair value of a conversion option should be recognized upon the modiﬁcation as a discount (or premium) associated with the debt, and an increase (or decrease) in additional paid-in capital. EITF 05-7 will be applied prospectively and is effective for all debt modiﬁcations occurring in periods beginning after December 15, 2005. EITF 05-7 did not have a material impact on the Company’s consolidated ﬁnancial statements. In September 2005, the EITF reached consensus on Issue No. 05-8, Income Tax Consequences of Issuing Convertible Debt with a Beneﬁcial Conversion Feature (‘‘EITF 05-8’’). EITF 05-8 concludes that (i) the issuance of convertible debt with a beneﬁcial conversion feature results in a basis difference that should be accounted for as a temporary difference and (ii) the establishment of the deferred tax liability for the basis difference should result in an adjustment to additional paid in capital. EITF 05-8 will be applied retrospectively for all instruments with a beneﬁcial conversion feature accounted for in accordance with EITF Issue No. 98-5, Accounting for Convertible Securities with Beneﬁcial Conversion Features or Contingently Adjustable Conversion Ratios, and EITF Issue No. 00-27, Application of Issue No. 98-5 to Certain Convertible Instruments, and is effective for periods beginning after December 15, 2005. EITF 05-8 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective July 1, 2005, the Company adopted SFAS No. 153, Exchanges of Nonmonetary Assets, an amendment of APB Opinion No. 29 (‘‘SFAS 153’’). SFAS 153 amended prior guidance to eliminate the exception for nonmonetary exchanges of similar productive assets and replaced it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial substance if the future cash ﬂows of the entity are expected to change signiﬁcantly as a result of the exchange. The provisions of SFAS 153 were required to be applied prospectively for ﬁscal periods beginning after June 15, 2005. The adoption of SFAS 153 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective July 1, 2005, the Company adopted EITF Issue No. 05-6, Determining the Amortization Period for Leasehold Improvements (‘‘EITF 05-6’’). EITF 05-6 provides guidance on determining the amortization period for leasehold improvements acquired in a business combination or acquired subsequent to lease inception. As required by EITF 05-6, the Company adopted this guidance on a prospective basis which had no material impact on the Company’s consolidated ﬁnancial statements. In June 2005, the FASB completed its review of EITF Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments (‘‘EITF 03-1’’). EITF 03-1 provides accounting guidance regarding the determination of when an impairment of debt and marketable equity securities and investments accounted for under the cost method should be considered other-than-temporary and recognized in income. EITF 03-1 also requires certain quantitative and qualitative disclosures for debt and marketable equity securities classiﬁed as available-for-sale or held-to- maturity under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities (‘‘SFAS 115’’), that are impaired at the balance sheet date but for which an other-than-temporary impairment has not been recognized. The FASB decided not to provide additional guidance on the meaning of other-than-temporary impairment but has issued FSP 115-1, The Meaning of Other-Than-Temporary Impairment and its Application to Certain Invest- ments (‘‘FSP 115-1’’), which nulliﬁes the accounting guidance on the determination of whether an investment is other-than-temporarily impaired as set forth in EITF 03-1. As required by FSP 115-1, the Company adopted this guidance on a prospective basis, which had no material impact on the Company’s consolidated ﬁnancial statements, and has provided the required disclosures. In June 2005, the EITF reached consensus on Issue No. 04-5, Determining Whether a General Partner, or the General Partners as a Group, Controls a Limited Partnership or Similar Entity When the Limited Partners Have Certain Rights (‘‘EITF 04-5’’). EITF 04-5 provides a framework for determining whether a general partner controls and should consolidate a limited partnership or a similar entity in light of certain rights held by the limited partners. The consensus also provides additional guidance on substantive rights. EITF 04-5 was effective after June 29, 2005 for all newly formed partnerships and for any pre-existing limited partnerships that modiﬁed their partnership agreements after that date. EITF 04-5 must be adopted by January 1, 2006 for all other limited partnerships through a cumulative effect of a change in accounting principle recorded in opening equity or it may be applied retrospectively by adjusting prior period ﬁnancial statements. The adoption of this provision of EITF 04-5 did not have a material impact on the Company’s consolidated ﬁnancial statements. In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, a replacement of APB Opinion No. 20 and FASB Statement No. 3 (‘‘SFAS 154’’). The statement requires retrospective application to prior periods’ ﬁnancial statements for a voluntary change in accounting principle unless it is deemed impracticable. It also requires that a change in the method of depreciation, amortization, or depletion for long- lived, non-ﬁnancial assets be accounted for as a change in accounting estimate rather than a change in accounting principle. SFAS 154 is effective for F-16 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. accounting changes and corrections of errors made in ﬁscal years beginning after December 15, 2005. The adoption of SFAS 154 did not have a material impact on the Company’s consolidated ﬁnancial statements. In December 2004, the FASB issued SFAS 123 (revised 2004), Share-Based Payment (‘‘SFAS 123(r)’’), which revised SFAS 123 and supersedes APB 25. SFAS 123(r) provides additional guidance on determining whether certain ﬁnancial instruments awarded in share-based payment transactions are liabilities. SFAS 123(r) also requires that the cost of all share-based transactions be measured at fair value and recognized over the period during which an employee is required to provide service in exchange for an award. The SEC issued a ﬁnal ruling in April 2005 allowing a public company that is not a small business issuer to implement SFAS 123(r) at the beginning of the next ﬁscal year after June 15, 2005. Thus, the revised pronouncement must be adopted by the Company by January 1, 2006. As permitted under SFAS 148, Accounting for Stock-Based Compensation — Transition and Disclosure — an amendment of FASB Statement No. 123, the Company elected to use the prospective method of accounting for stock options granted subsequent to December 31, 2002. Options granted prior to January 1, 2003 will continue to be accounted for under the intrinsic value method until the adoption of SFAS 123(r). In addition, the pro forma impact of accounting for these options at fair value continued to be accounted for under the intrinsic value method until the last of those options vested in 2005. As all stock options currently accounted for under the intrinsic value method vested prior to the effective date, implementation of SFAS 123(r) will not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. See Note 14. In December 2004, the FASB issued FSP 109-2, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004 (‘‘FSP 109-2’’). The American Jobs Creation Act of 2004 (‘‘AJCA’’) introduced a one-time dividend received deduction on the repatriation of certain earnings to a U.S. taxpayer. FSP 109-2 provides companies additional time beyond the ﬁnancial reporting period of enactment to evaluate the effects of the AJCA on their plans to repatriate foreign earnings for purposes of applying SFAS No. 109, Accounting for Income Taxes. During 2005, the Company recorded a $27 million income tax beneﬁt related to the repatriation of foreign earnings pursuant to Internal Revenue Code Section 965 for which a U.S. deferred income tax provision had previously been recorded. Effective July 1, 2004, the Company prospectively adopted FSP No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (‘‘FSP 106-2’’). FSP 106-2 provides accounting guidance to employers that sponsor postretirement health care plans that provide prescription drug beneﬁts. The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 based on the Company’s determination that the prescription drug beneﬁts offered under certain postretirement plans are actuarially equivalent to the beneﬁts offered under Medicare Part D. The postretirement beneﬁt plan assets and accumulated beneﬁt obligation were remeasured to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation was reduced by $213 million at July 1, 2004. See Note 13. Effective July 1, 2004, the Company adopted EITF Issue No. 03-16, Accounting for Investments in Limited Liability Companies (‘‘EITF 03-16’’). EITF 03-16 provides guidance regarding whether a limited liability company should be viewed as similar to a corporation or similar to a partnership for purposes of determining whether a noncontrolling investment should be accounted for using the cost method or the equity method of accounting. EITF 03-16 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective April 1, 2004, the Company adopted EITF Issue No. 03-6, Participating Securities and the Two — Class Method under FASB Statement No. 128 (‘‘EITF 03-6’’). EITF 03-6 provides guidance on determining whether a security should be considered a participating security for purposes of computing earnings per common share and how earnings should be allocated to the participating security. EITF 03-6 did not have an impact on the Company’s earnings per common share calculations or amounts. Effective January 1, 2004, the Company adopted SOP 03-1, as interpreted by a Technical Practice Aid (‘‘TPA’’), issued by the AICPA. SOP 03-1 provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. In June 2004, the FASB released FSP No. 97-1, Situations in Which Paragraphs 17(b) and 20 of FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments, Permit or Require Accrual of an Unearned Revenue Liability (‘‘FSP 97-1’’), which included clariﬁcation that unearned revenue liabilities should be considered in determining the necessary insurance beneﬁt liability required under SOP 03-1. Since the Company had considered unearned revenue in determining its SOP 03-1 beneﬁt liabilities, FSP 97-1 did not impact its consolidated ﬁnancial statements. As a result of the adoption of SOP 03-1, effective January 1, 2004, the Company decreased the liability for future policyholder beneﬁts for changes in the methodology relating to various guaranteed death and annuitization beneﬁts and for determining liabilities for certain universal life insurance contracts by $4 million, which has been reported as a cumulative effect of a change in accounting. This amount is net of corresponding changes in DAC, including VOBA and unearned revenue liability (‘‘offsets’’), under certain variable annuity and life contracts and income taxes. Certain other contracts sold by the Company provide for a return through periodic crediting rates, surrender adjustments or termination adjustments based on the total return of a contractually referenced pool of assets owned by the Company. To the extent that such contracts are not accounted for as derivatives under the provisions of SFAS No. 133 and not already credited to the contract account balance, under SOP 03-1 the change relating to the fair value of the referenced pool of assets is recorded as a liability with the change in the liability recorded as policyholder beneﬁts and claims. Prior to the adoption of SOP 03-1, the Company recorded the change in such liability as other comprehensive income. At adoption, this change decreased net income and increased other comprehensive income by $63 million, net of income taxes, which were recorded as cumulative effects of changes in accounting. Effective with the adoption of SOP 03-1, costs associated with enhanced or bonus crediting rates to contractholders must be deferred and amortized over the life of the related contract using assumptions consistent with the amortization of DAC. Since the Company followed a similar approach prior to adoption of SOP 03-1, the provisions of SOP 03-1 relating to sales inducements had no signiﬁcant impact on the Company’s consolidated ﬁnancial statements. In accordance with SOP 03-1’s guidance for the reporting of certain separate accounts, at adoption, the Company also reclassiﬁed $1.7 billion of separate account assets to general account investments and $1.7 billion of separate account liabilities to future policy beneﬁts and policyholder account balances. This reclassiﬁcation decreased net income and increased other comprehensive income by $27 million, net of income taxes, which were reported as cumulative effects of changes in accounting. Due to the adoption of SOP 03-1, the Company recorded a cumulative effect of a change in accounting of $86 million, net of income taxes of $46 million, for the year ended December 31, 2004. In December 2003, FASB revised SFAS No. 132, Employers’ Disclosures about Pensions and Other Postretirement Beneﬁts — an Amendment of FASB Statements No. 87, 88 and 106 (‘‘SFAS 132(r)’’). SFAS 132(r) retains most of the disclosure requirements of SFAS 132 and requires additional disclosure about assets, obligations, cash ﬂows and net periodic beneﬁt cost of deﬁned beneﬁt pension plans and other postretirement plans. SFAS 132(r) was primarily effective for ﬁscal years ending after December 15, 2003; however, certain disclosures about foreign plans and estimated MetLife, Inc. F-17 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. future beneﬁt payments were effective for ﬁscal years ending after June 15, 2004. The Company’s adoption of SFAS 132(r) did not have a signiﬁcant impact on its consolidated ﬁnancial statements since it only revised disclosure requirements. During 2003, the Company adopted FIN 46 and FIN 46(r). Certain of the Company’s investments in real estate joint ventures and other limited partnership interests meet the deﬁnition of a variable interest entity (‘‘VIE’’) and have been consolidated, in accordance with the transition rules and effective dates, because the Company is deemed to be the primary beneﬁciary. A VIE is deﬁned as (i) any entity in which the equity investments at risk in such entity do not have the characteristics of a controlling ﬁnancial interest; or (ii) any entity that does not have sufﬁcient equity at risk to ﬁnance its activities without additional subordinated support from other parties. Effective February 1, 2003, the Company adopted FIN 46 for VIEs created or acquired on or after February 1, 2003 and, effective December 31, 2003, the Company adopted FIN 46(r) with respect to interests in entities formerly considered special purpose entities (‘‘SPEs’’), including interests in asset-backed securities and collateralized debt obligations. The adoption of FIN 46 as of February 1, 2003 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. The adoption of the provisions of FIN 46(r) at December 31, 2003 did not require the Company to consolidate any additional VIEs that were not previously consolidated. In accordance with the provisions of FIN 46(r), the Company elected to defer until March 31, 2004 the consolidation of interests in VIEs for non-SPEs acquired prior to February 1, 2003 for which it is the primary beneﬁciary. As of March 31, 2004, the Company consolidated assets and liabilities relating to real estate joint ventures of $78 million and $11 million, respectively, and assets and liabilities relating to other limited partnerships of $29 million and less than $1 million, respectively, for VIEs for which the Company was deemed to be the primary beneﬁciary. There was no impact to net income from the adoption of FIN 46. Effective January 1, 2003, the Company adopted FIN No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (‘‘FIN 45’’). FIN 45 requires entities to establish liabilities for certain types of guarantees and expands ﬁnancial statement disclosures for others. The initial recognition and initial measurement provisions of FIN 45 were applicable on a prospective basis to guarantees issued or modiﬁed after December 31, 2002. The adoption of FIN 45 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. See Note 12. Effective January 1, 2003, the Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (‘‘SFAS 146’’). SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recorded and measured initially at fair value only when the liability is incurred rather than at the date of an entity’s commitment to an exit plan as required by EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Beneﬁts and Other Costs to Exit an Activity Including Certain Costs Incurred in a Restructuring (‘‘EITF 94-3’’). As required by SFAS 146, the Company adopted this guidance on a prospective basis which had no material impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections (‘‘SFAS 145’’). In addition to amending or rescinding other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions, SFAS 145 generally precludes companies from recording gains and losses from the extinguishment of debt as an extraordinary item. SFAS 145 also requires sale-leaseback treatment for certain modiﬁcations of a capital lease that result in the lease being classiﬁed as an operating lease. The adoption of SFAS 145 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. 2. Acquisitions and Dispositions Travelers On July 1, 2005, the Holding Company completed the acquisition of Travelers for $12.0 billion. The results of Travelers’ operations were included in the Company’s consolidated ﬁnancial statements beginning July 1, 2005. As a result of the acquisition, management of the Company increased signiﬁcantly the size and scale of the Company’s core insurance and annuity products and expanded the Company’s presence in both the retirement & savings domestic and international markets. The distribution agreements executed with Citigroup as part of the acquisition will provide the Company with one of the broadest distribution networks in the industry. Consideration paid by the Holding Company for the purchase consisted of approximately $10.9 billion in cash and 22,436,617 shares of the Holding Company’s common stock with a market value of approximately $1.0 billion to Citigroup and approximately $100 million in other transaction costs. Consideration paid to Citigroup will be ﬁnalized subject to review of the June 30, 2005 ﬁnancial statements of Travelers by both the Company and Citigroup and interpretation of the provisions of the acquisition agreement by both parties. In addition to cash on-hand, the purchase price was ﬁnanced through the issuance of common stock as described above, debt securities as described in Note 8, common equity units as described in Note 9 and preferred shares as described in Note 14. The acquisition is being accounted for using the purchase method of accounting, which requires that the assets and liabilities of Travelers be measured at their fair value as of July 1, 2005. Purchase Price Allocation and Goodwill — Preliminary The purchase price has been allocated to the assets acquired and liabilities assumed using management’s best estimate of their fair values as of the acquisition date. The computation of the purchase price and the allocation of the purchase price to the net assets acquired based upon their respective fair values as of July 1, 2005, and the resulting goodwill, as revised, are presented below. During the fourth quarter of 2005, the Company revised the purchase price allocation as a result of reviews of Travelers underwriting criteria performed in order to reﬁne the estimate of fair values of assumed future policy beneﬁt liabilities. As a result of these reviews and actuarial analyses, and to be consistent with MetLife’s reserving methodologies, the Company increased its estimate of fair value liabilities relating to a speciﬁc group of acquired life insurance policies. Consequently, the fair value of future policy beneﬁts assumed, deferred tax assets acquired and goodwill increased by $360 million, $126 million and $234 million, respectively. The Company expects to complete its reviews and, if required, further reﬁne its estimate of fair value of such liabilities by June 30, 2006. Additionally, the Company received updated information regarding the fair values of certain assets and liabilities such as its investments in other limited partnerships, mortgage loans, other assets and other liabilities resulting in a net increase of goodwill of $54 million. The fair value of certain other assets acquired and liabilities assumed, including goodwill, may also be adjusted during the allocation period due to ﬁnalization of the purchase price to be paid to Citigroup as noted previously, agreement between Citigroup and MetLife as to the tax basis purchase price to be allocated to the acquired subsidiaries, and receipt of information regarding the estimation of certain fair values. In no case will the adjustments extend beyond one year from the acquisition date. F-18 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. As of July 1, 2005 (In millions) Sources: Cash ********************************************************************************************* $4,198 Debt ********************************************************************************************* 2,716 Junior subordinated debt securities associated with common equity units *********************************** 2,134 Preferred stock ************************************************************************************ 2,100 Common stock ************************************************************************************ 1,010 Total sources of funds**************************************************************************** Uses: Debt and equity issuance costs ********************************************************************** Investment in MetLife Capital Trusts II and III ************************************************************ Acquisition costs *********************************************************************************** 113 Purchase price paid to Citigroup ********************************************************************** 11,853 Total purchase price****************************************************************************** Total uses of funds ******************************************************************************* $12,158 $ 128 64 11,966 $12,158 As of July 1, 2005 (In millions) Total purchase price******************************************************************************** Net assets acquired from Travelers ***************************************************************** $9,412 Adjustments to reﬂect assets acquired at fair value: $11,966 Fixed maturities available-for-sale********************************************************************** Mortgage and consumer loans *********************************************************************** Real estate and real estate joint ventures held-for-investment ********************************************** Real estate held-for-sale***************************************************************************** Other limited partnerships**************************************************************************** Other invested assets ******************************************************************************* Premiums and other receivables ********************************************************************** Elimination of historical deferred policy acquisition costs ************************************************** Value of business acquired ************************************************************************** Value of distribution agreement acquired *************************************************************** Value of customer relationships acquired *************************************************************** Elimination of historical goodwill *********************************************************************** Net deferred income tax assets*********************************************************************** Other assets ************************************************************************************** Adjustments to reﬂect liabilities assumed at fair value: Future policy beneﬁts ******************************************************************************* Policyholder account balances *********************************************************************** Other liabilities ************************************************************************************* Net fair value of assets and liabilities assumed ****************************************************** Goodwill resulting from the acquisition ************************************************************** (31) 72 17 22 51 201 1,008 (3,210) 3,780 645 17 (197) 2,098 (88) (4,070) (1,904) (34) 7,789 $ 4,177 Goodwill resulting from the acquisition has been allocated to the Company’s segments, as well as Corporate & Other, that are expected to beneﬁt from the acquisition as follows: Institutional********************************************************************************************* Individual ********************************************************************************************** International ******************************************************************************************** Corporate & Other ************************************************************************************** Total *********************************************************************************************** $ 894 2,702 193 388 $4,177 Of the goodwill of $4.2 billion, approximately $1.5 billion is estimated to be deductible for income tax purposes. As of July 1, 2005 (In millions) MetLife, Inc. F-19 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Condensed Statement of Net Assets Acquired The condensed statement of net assets acquired reﬂects the fair value of Travelers net assets as of July 1, 2005 as follows: Assets: Fixed maturities available-for-sale***************************************************************************** Trading securities ****************************************************************************************** Equity securities available-for-sale **************************************************************************** Mortgage and consumer loans ****************************************************************************** Policy loans ********************************************************************************************** Real estate and real estate joint ventures held-for-investment ***************************************************** Real estate held-for-sale ************************************************************************************ Other limited partnership interests **************************************************************************** Short-term investments ************************************************************************************* Other invested assets ************************************************************************************** Total investments **************************************************************************************** Cash and cash equivalents ********************************************************************************* Accrued investment income ********************************************************************************* Premiums and other receivables ***************************************************************************** Value of business acquired ********************************************************************************* Goodwill ************************************************************************************************* Other intangible assets ************************************************************************************* Deferred tax assets **************************************************************************************** Other assets ********************************************************************************************* Separate account assets *********************************************************************************** Total assets acquired ************************************************************************************ Liabilities: Future policy beneﬁts ************************************************************************************** Policyholder account balances******************************************************************************* Other policyholder funds************************************************************************************ Short-term debt ******************************************************************************************* Current income taxes payable ******************************************************************************* Other liabilities ******************************************************************************************** Separate account liabilities ********************************************************************************** Total liabilities assumed *********************************************************************************** Net assets acquired ************************************************************************************* As of July 1, 2005 (In millions) $44,346 555 641 2,365 884 77 49 1,124 2,801 1,686 54,528 844 539 4,886 3,780 4,177 662 1,087 737 30,799 102,039 18,501 36,633 324 25 66 3,725 30,799 90,073 $11,966 Other Intangible Assets VOBA reﬂects the estimated fair value of in-force contracts acquired and represents the portion of the purchase price that is allocated to the value of the right to receive future cash ﬂows from the life insurance and annuity contracts in force at the acquisition date. VOBA is based on actuarially determined projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns and other factors. Actual experience on the purchased business may vary from these projections. If estimated gross proﬁts or premiums differ from expectations, the amortization of VOBA is adjusted to reﬂect actual experience. The value of the other identiﬁable intangibles reﬂects the estimated fair value of Citigroup/Travelers distribution agreement and customer relationships acquired at July 1, 2005 and will be amortized in relation to the expected economic beneﬁts of the agreement. If actual experience under the distribution agreements or with customer relationships differs from expectations, the amortization of these intangibles will be adjusted to reﬂect actual experience. The use of discount rates was necessary to establish the fair value of VOBA, as well as the other identiﬁable intangible assets. In selecting the appropriate discount rates, management considered its weighted average cost of capital as well as the weighted average cost of capital required by market participants. A discount rate of 11.5% was used to value these intangible assets. The fair values of business acquired, distribution agreements and customer relationships acquired are as follows: Value of business acquired ******************************************************************* Value of distribution agreements and customer relationships acquired****************************** Total value of amortizable intangible assets acquired ****************************************** Non-amortizable intangible assets acquired **************************************************** Total value of intangible assets acquired, excluding goodwill************************************ $3,780 662 4,442 — $4,442 16 16 16 F-20 MetLife, Inc. As of July 1, 2005 Weighted Average Amortization Period (In millions) (In years) NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The estimated future amortization of the values of business acquired, distribution agreements and customer relationships acquired from 2006 to 2010 is as follows: As of December 31, 2005 (In millions) 2006 ************************************************************************************************ 2007 ************************************************************************************************ 2008 ************************************************************************************************ 2009 ************************************************************************************************ 2010 ************************************************************************************************ $376 $363 $347 $330 $307 Unaudited Pro Forma Condensed Consolidated Financial Information The following unaudited pro forma condensed consolidated ﬁnancial information presents the results of operations for the Company assuming the Travelers acquisition had occurred at the beginning of the respective periods presented. Discontinued operations and the cumulative effects of changes in accounting and the related earnings per share have been excluded from the presentation of the unaudited pro forma condensed consolidated statements of income as these are non-recurring in nature. Additionally, the unaudited pro forma condensed consolidated statements of income reﬂect the reduction in investment income from the sale of ﬁxed maturity securities, but does not reﬂect a reduction of investment income from the sale of real estate property as such investment income is reported as discontinued operations. The unaudited pro forma condensed consolidated statements of income do not reﬂect the gains (losses) on the sale of real estate property or ﬁxed maturity securities as such gains (losses) would be reported as discontinued operations or are sales that would not be part of the normal course of business. This unaudited pro forma information does not necessarily represent what the Company’s actual results of operations would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods. Year Ended December 31, 2005 2004 (In millions, except per share data) Revenues Premiums ****************************************************************************************** $25,339 Universal life and investment-type product policy fees ***************************************************** 4,255 Net investment income******************************************************************************* 16,405 Other revenues ************************************************************************************* 1,435 Net investment gains (losses) ************************************************************************* (52) Total revenues ********************************************************************************** 47,382 Expenses Policyholder beneﬁts and claims *********************************************************************** Interest credited to policyholder account balances ******************************************************** Policyholder dividends ******************************************************************************* Other expenses************************************************************************************* Total expenses ********************************************************************************* Income from continuing operations before provision for income taxes **************************************** 5,189 Provision for income taxes **************************************************************************** 1,510 Income from continuing operations ********************************************************************* $ 3,679 26,099 4,495 1,679 9,920 42,193 $23,514 3,612 14,864 1,276 189 43,455 24,155 4,156 1,666 8,953 38,930 4,525 1,308 $ 3,217 Income from continuing operations per common share Basic ******************************************************************************************* $ 4.84 $ 4.16 Diluted ****************************************************************************************** $ 4.80 $ 4.14 Weighted average number of common shares outstanding Basic ******************************************************************************************* Diluted ****************************************************************************************** 760.2 766.5 773.3 777.4 The weighted average number of common shares outstanding in the preceding table assumes the 22.4 million shares issued in connection with the Travelers acquisition were outstanding as of the beginning of the periods presented. Income from continuing operations per common share as presented in the preceding table does not include a deduction for the impact of the preferred stock dividend of approximately $123 million, assuming that such preferred shares had been issued as of the beginning of the periods presented, for the years ended December 31, 2005 and 2004. Income from continuing operations available to common shareholders per common share would have been $4.68 and $4.00 for the years ended December 31, 2005 and 2004, respectively, deducting the impact of the preferred stock dividend. Restructuring Costs and Other Charges During 2005, as part of the integration of Travelers’ operations, management approved and initiated plans to reduce approximately 1,000 domestic and international Travelers employees which is expected to be completed by December 2006. MetLife, Inc. F-21 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. For the year ended December 31, 2005, MetLife recorded restructuring costs, including severance, relocation and outplacement services of Travelers’ employees, as liabilities assumed in the purchase business combination. Management currently estimates total restructuring costs associated with such actions to approximate $48 million. Estimated restructuring expenses may change as management continues to execute the approved plan. Decreases to these estimates are recorded as an adjustment to goodwill. Increases to these estimates are recorded as an adjustment to goodwill during the purchase price allocation period (generally within one year of the acquisition date) and will be recorded as operating expenses thereafter. The restructuring costs associated with the Travelers acquisition are as follows: Accrued Restructuring at July 1, 2005 Cash Payments for Year Ended December 31, 2005 Accrued Restructuring at December 31, 2005 Total Costs Incurred at December 31, 2005 (In millions) Total restructuring costs ********************************* $49 The liability for restructuring costs was reduced by $1 million due to a reduction in the estimate of severance beneﬁts to be paid to Travelers $(20) $28 $48 employees. The adjustment was recorded against the acquisition costs included in the determination of the purchase price. Additional Acquisitions and Dispositions On September 1, 2005, the Company completed the acquisition of CitiStreet Associates, a division of CitiStreet LLC, that is primarily involved in the distribution of annuity products and retirement plans to the education, healthcare, and not-for-proﬁt markets, for approximately $56 million, of which $2 million was allocated to goodwill and $54 million to other identiﬁable intangibles, speciﬁcally the value of customer relationships acquired, which has a weighted average amortization period of 16 years. CitiStreet Associates will be integrated with MetLife Resources, a division of MetLife dedicated to providing retirement plans and ﬁnancial services to the same markets. In 2003, a subsidiary of MetLife, Inc., Reinsurance Group of America, Incorporated (‘‘RGA’’), entered into a coinsurance agreement under which it assumed the traditional U.S. life reinsurance business of Allianz Life Insurance Company of North America (‘‘Allianz Life’’). The transaction added approximately $278 billion of life reinsurance in-force, $246 million of premiums and $11 million of income before income tax expense, excluding minority interest expense, in 2003. The effects of such transaction are included within the Reinsurance segment. In 2002, the Company acquired Aseguradora Hidalgo S.A. (‘‘Hidalgo’’), an insurance company based in Mexico with approximately $2.5 billion in assets as of the date of acquisition (June 20, 2002). During the second quarter of 2003, as a part of its acquisition and integration strategy, the International segment completed the legal merger of Hidalgo into its original Mexican subsidiary, Seguro Genesis, S.A., forming MetLife Mexico, S.A. As a result of the merger of these companies, the Company recorded $62 million of earnings, net of income taxes, from the merger and a reduction in policyholder liabilities resulting from a change in methodology in determining the liability for future policy beneﬁts. Such beneﬁt was recorded in the second quarter of 2003 in the International segment. See Note 19 for information on the disposition of P.T. Sejahtera (‘‘MetLife Indonesia’’) and SSRM Holdings, Inc. (‘‘SSRM’’). 3. Investments Fixed Maturities by Sector and Equity Securities Available-for-Sale The following tables set forth the cost or amortized cost, gross unrealized gain and loss, and estimated fair value of the Company’s ﬁxed maturities by sector and equity securities, the percentage of the total ﬁxed maturities holdings that each sector represents and the percentage of the total equity securities at: Cost or Amortized Cost December 31, 2005 Gross Unrealized Gain Loss (In millions) Estimated Fair Value % of Total U.S. corporate securities************************************************* $ 72,339 Residential mortgage-backed securities************************************* 47,365 Foreign corporate securities ********************************************** 33,578 U.S. treasury/agency securities ******************************************* 25,643 Commercial mortgage-backed securities************************************ 17,682 Asset-backed securities ************************************************* 11,533 Foreign government securities ******************************************** 10,080 State and political subdivision securities ************************************ 4,601 Other ﬁxed maturity securities ********************************************* 912 Total bonds ********************************************************** Redeemable preferred stocks********************************************* 223,733 193 Total ﬁxed maturities*************************************************** $223,926 $2,814 353 1,842 1,401 223 91 1,401 185 17 8,327 2 $ 835 472 439 86 207 51 35 36 41 2,202 3 $ 74,318 47,246 34,981 26,958 17,698 11,573 11,446 4,750 888 229,858 192 32.3% 20.5 15.2 11.7 7.7 5.0 5.0 2.1 0.4 99.9 0.1 $8,329 $2,205 $230,050 100.0% Common stocks******************************************************** $ Non-redeemable preferred stocks ***************************************** 2,004 1,080 $ 250 45 Total equity securities************************************************** $ 3,084 $ 295 $ $ 30 11 41 $ $ 2,224 1,114 66.6% 33.4 3,338 100.0% F-22 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. December 31, 2004 Cost or Amortized Cost Gross Unrealized Gain Loss (In millions) Estimated Fair Value % of Total U.S. corporate securities ************************************************* $ 58,022 Residential mortgage-backed securities ************************************* 31,683 Foreign corporate securities *********************************************** 24,972 U.S. treasury/agency securities ******************************************** 16,534 Commercial mortgage-backed securities ************************************ 12,099 Asset-backed securities ************************************************** 10,784 Foreign government securities ********************************************* 7,621 State and political subdivision securities ************************************* 3,683 Other ﬁxed maturity securities ********************************************* 887 Total bonds ********************************************************** Redeemable preferred stocks ********************************************* 166,285 326 Total ﬁxed maturities *************************************************** $166,611 $ 3,870 612 2,582 1,314 440 125 973 220 131 10,267 — $172 65 85 22 38 33 26 4 33 478 23 $ 61,720 32,230 27,469 17,826 12,501 10,876 8,568 3,899 985 176,074 303 34.9% 18.3 15.6 10.1 7.1 6.2 4.8 2.2 0.6 99.8 0.2 $10,267 $501 $176,377 100.0% Common stocks ******************************************************** $ Non-redeemable preferred stocks ****************************************** Total equity securities ************************************************** $ 1,412 501 1,913 $ $ 244 39 283 $ 5 3 $ 8 $ $ 1,651 537 75.5% 24.5 2,188 100.0% The Company held foreign currency derivatives with notional amounts of $5,695 million and $4,720 million to hedge the exchange rate risk associated with foreign bonds and loans at December 31, 2005 and 2004, respectively. Excluding investments in U.S. Treasury securities and obligations of U.S. government corporations and agencies, the Company is not exposed to any signiﬁcant concentration of credit risk in its ﬁxed maturities portfolio. The Company held ﬁxed maturities at estimated fair values that were below investment grade or not rated by an independent rating agency that totaled $15,157 million and $12,353 million at December 31, 2005 and 2004, respectively. These securities had a net unrealized gain of $392 million and $935 million at December 31, 2005 and 2004, respectively. Non-income producing ﬁxed maturities were $15 million and $90 million at December 31, 2005 and 2004, respectively. Unrealized losses associated with non-income producing ﬁxed maturities were $3 million and $11 million at December 31, 2005 and 2004, respectively. The cost or amortized cost and estimated fair value of bonds at December 31, 2005 and 2004, by contractual maturity date (excluding scheduled sinking funds), are shown below: December 31, 2005 2004 Cost or Amortized Cost Estimated Fair Value Cost or Amortized Cost Estimated Fair Value Due in one year or less ***************************************************** $ Due after one year through ﬁve years ****************************************** Due after ﬁve years through ten years ***************************************** Due after ten years ********************************************************* Subtotal **************************************************************** Mortgage-backed, commercial mortgage-backed and other asset-backed securities ** Subtotal **************************************************************** Redeemable preferred stock ************************************************* 223,733 193 Total ﬁxed maturities ****************************************************** $223,926 7,083 36,100 45,303 58,667 147,153 76,580 (In millions) $ 7,124 36,557 46,256 63,404 153,341 76,517 229,858 192 $ 6,749 29,846 33,531 41,593 111,719 54,566 166,285 326 $ 6,844 31,164 35,996 46,463 120,467 55,607 176,074 303 $230,050 $166,611 $176,377 Bonds not due at a single maturity date have been included in the above table in the year of ﬁnal contractual maturity. Actual maturities may differ from contractual maturities due to the exercise of prepayment options. Sales or disposals of ﬁxed maturities and equity securities classiﬁed as available-for-sale were as follows: Proceeds ******************************************************************************* $127,709 Gross investment gains ******************************************************************* $ 704 Gross investment losses ****************************************************************** $ (1,391) $57,604 844 $ (516) $ $54,801 498 $ (500) $ Gross investment losses above exclude writedowns recorded during 2005, 2004 and 2003 for other-than-temporarily impaired available-for-sale ﬁxed maturities and equity securities of $64 million, $102 million and $355 million, respectively. The Company periodically disposes of ﬁxed maturity and equity securities at a loss. Generally, such losses are insigniﬁcant in amount or in relation to the cost basis of the investment or are attributable to declines in fair value occurring in the period of disposition. Years Ended December 31, 2005 2004 2003 (In millions) MetLife, Inc. F-23 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Unrealized Losses for Fixed Maturities and Equity Securities Available-for-Sale The following tables show the estimated fair values and gross unrealized losses of the Company’s ﬁxed maturities (aggregated by sector) and equity securities in an unrealized loss position, aggregated by length of time that the securities have been in a continuous unrealized loss position at December 31, 2005 and 2004: Less than 12 Months December 31, 2005 Equal to or Greater than 12 Months Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions, except number of securities) U.S. corporate securities ****************************************** $29,018 Residential mortgage-backed securities ****************************** 31,258 Foreign corporate securities**************************************** 13,185 U.S. treasury/agency securities************************************* 7,759 Commercial mortgage-backed securities ***************************** 10,190 Asset-backed securities ******************************************* 4,709 Foreign government securities************************************** 1,203 State and political subdivision securities****************************** 1,050 Other ﬁxed maturity securities ************************************** 319 Total bonds *************************************************** Redeemable preferred stocks ************************************** 98,691 77 Total ﬁxed maturities ******************************************** $98,768 $ 737 434 378 85 185 42 31 36 36 1,964 3 $2,685 1,291 1,728 113 685 305 327 16 52 7,202 — $1,967 $7,202 Equity securities ************************************************* $ 671 $ 34 $ 131 $ 98 38 61 1 22 9 4 — 5 238 — $238 $ 7 $ 31,703 32,549 14,913 7,872 10,875 5,014 1,530 1,066 371 105,893 77 $ 835 472 439 86 207 51 35 36 41 2,202 3 $105,970 $2,205 $ 802 $ 41 Total number of securities in an unrealized loss position **************** 12,787 932 13,719 Less than 12 Months December 31, 2004 Equal to or Greater than 12 Months Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions, except number of securities) U.S. corporate securities ******************************************* $ 9,963 Residential mortgage-backed securities ******************************* 8,545 Foreign corporate securities***************************************** 3,979 U.S. treasury/agency securities ************************************** 5,014 Commercial mortgage-backed securities ****************************** 3,920 Asset-backed securities ******************************************** 3,927 Foreign government securities *************************************** 896 State and political subdivision securities******************************* 211 Other ﬁxed maturity securities *************************************** 46 Total bonds **************************************************** 36,501 Redeemable preferred stocks *************************************** 303 Total ﬁxed maturities *********************************************** $36,804 Equity securities ************************************************** $ 136 Total number of securities in an unrealized loss position ***************** 4,206 $120 58 71 22 33 25 21 2 33 385 23 $408 $ 6 $1,211 375 456 4 225 209 117 72 26 2,695 — $2,695 $ 27 402 $52 7 14 — 5 8 5 2 — 93 — $93 $ 2 $11,174 8,920 4,435 5,018 4,145 4,136 1,013 283 72 39,196 303 $39,499 $ 163 4,608 $172 65 85 22 38 33 26 4 33 478 23 $501 $ 8 F-24 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Aging of Gross Unrealized Losses for Fixed Maturities and Equity Securities Available-for-Sale The following tables present the cost or amortized cost, gross unrealized losses and number of securities for ﬁxed maturities and equity securities at December 31, 2005 and December 31, 2004, where the estimated fair value had declined and remained below cost or amortized cost by less than 20%, or 20% or more for: Cost or Amortized Cost December 31, 2005 Gross Unrealized Losses Number of Securities Less than 20% 20% or more Less than 20% 20% or more Less than 20% 20% or more (In millions, except number of securities) Less than six months ******************************************** $ 92,512 Six months or greater but less than nine months********************** 3,704 Nine months or greater but less than twelve months ****************** 5,006 Twelve months or greater ***************************************** 7,555 Total ********************************************************* $108,777 $213 5 — 23 $241 $1,707 108 133 240 $2,188 $51 2 — 5 $58 11,441 456 573 924 13,394 308 7 2 8 325 Cost or Amortized Cost December 31, 2004 Gross Unrealized Losses Number of Securities Less than 20% 20% or more Less than 20% 20% or more Less than 20% 20% or more (In millions, except number of securities) Less than six months********************************************** $27,175 Six months or greater but less than nine months*********************** 8,477 Nine months or greater but less than twelve months******************** 1,595 Twelve months or greater ****************************************** 2,798 Total ********************************************************** $40,045 $ 79 9 19 19 $126 $246 111 33 80 $470 $18 2 4 15 $39 3,186 687 206 395 4,474 117 5 5 7 134 As of December 31, 2005, $2,188 million of unrealized losses related to securities with an unrealized loss position less than 20% of cost or amortized cost, which represented 2% of the cost or amortized cost of such securities. As of December 31, 2004, $470 million of unrealized losses related to securities with an unrealized loss position less than 20% of cost or amortized cost, which represented 1% of the cost or amortized cost of such securities. As of December 31, 2005, $58 million of unrealized losses related to securities with an unrealized loss position greater than 20% of cost or amortized cost, which represented 24% of the cost or amortized cost of such securities. Of such unrealized losses of $58 million, $51 million have been in an unrealized loss position for a period of less than six months. As of December 31, 2004, $39 million of unrealized losses related to securities with an unrealized loss position greater than 20% of cost or amortized cost, which represented 31% of the cost or amortized cost of such securities. Of such unrealized losses of $39 million, $18 million have been in an unrealized loss position for a period of less than six months. As described more fully in Note 1, the Company performs a regular evaluation, on a security-by-security basis, of its investment holdings in accordance with its impairment policy in order to evaluate whether such securities are other-than-temporarily impaired. The increase in the unrealized losses during 2005 is principally driven by an increase in interest rates during the year. Based upon the Company’s evaluation of the securities in accordance with its impairment policy, the cause of the decline being principally attributable to the general rise in rates during the year, and the Company’s intent and ability to hold the ﬁxed income and equity securities with unrealized losses for a period of time sufﬁcient for them to recover; the Company has concluded that the aforementioned securities are not other-than-temporarily impaired. Securities Lending Program The Company participates in a securities lending program whereby blocks of securities, which are included in ﬁxed maturity securities, are loaned to third parties, primarily major brokerage ﬁrms. The Company requires a minimum of 102% of the fair value of the loaned securities to be separately maintained as collateral for the loans. Securities with a cost or amortized cost of $32,068 million and $26,564 million and an estimated fair value of $32,954 million and $27,974 million were on loan under the program at December 31, 2005 and 2004, respectively. Securities loaned under such transactions may be sold or repledged by the transferee. The Company was liable for cash collateral under its control of $33,893 million and $28,678 million at December 31, 2005 and 2004, respectively. Securities loaned transactions are accounted for as ﬁnancing arrangements on the Company’s consolidated balance sheets and consolidated statements of cash ﬂows and the income and expenses associated with the program are reported in net investment income as investment income and investment expenses, respectively. Security collateral of $207 million and $17 million, respectively, at December 31, 2005 and 2004 on deposit from customers in connection with the securities lending transactions may not be sold or repledged and is not reﬂected in the consolidated ﬁnancial statements. Assets on Deposit and Held in Trust The Company had investment assets on deposit with regulatory agencies with a fair market value of $1,597 million and $1,390 million at December 31, 2005 and 2004, respectively, consisting primarily of ﬁxed maturity securities. Company securities held in trust to satisfy collateral requirements had an amortized cost of $1,863 million and $2,473 million at December 31, 2005 and 2004, respectively, consisting primarily of ﬁxed maturity and equity securities. MetLife, Inc. F-25 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Mortgage and Consumer Loans Mortgage and consumer loans were categorized as follows: December 31, 2005 2004 Amount Percent Amount Percent Commercial mortgage loans ********************************************************* $28,169 Agricultural mortgage loans ********************************************************** 7,711 Consumer loans ******************************************************************* 1,482 Total *************************************************************************** 37,362 (In millions) 75% $25,139 5,914 21 1,510 4 77% 18 5 100% 32,563 100% Less: Valuation allowances ********************************************************** 172 Mortgage and consumer loans ******************************************************* $37,190 157 $32,406 Mortgage loans are collateralized by properties primarily located in the United States. At December 31, 2005, approximately 22%, 9% and 7% of the properties were located in California, New York and Illinois, respectively. Generally, the Company (as the lender) requires that a minimum of one-fourth of the purchase price of the underlying real estate be paid by the borrower. Certain of the Company’s real estate joint ventures have mortgage loans with the Company. The carrying values of such mortgages were $379 million and $641 million at December 31, 2005 and 2004, respectively. Changes in loan valuation allowances for mortgage and consumer loans were as follows: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year************************************************************************** $157 Additions **************************************************************************************** 64 Deductions*************************************************************************************** (49) Balance, end of year******************************************************************************* $172 $129 57 (29) $126 52 (49) $157 $129 A portion of the Company’s mortgage and consumer loans was impaired and consisted of the following: December 31, 2005 2004 (In millions) Impaired loans with valuation allowances********************************************************************** $ 22 Impaired loans without valuation allowances ******************************************************************* 116 Total ************************************************************************************************** Less: Valuation allowances on impaired loans ***************************************************************** 138 4 Impaired loans ***************************************************************************************** $134 $185 133 318 41 $277 The average investment in impaired loans was $187 million, $404 million and $652 million for the years ended December 31, 2005, 2004 and 2003, respectively. Interest income on impaired loans was $12 million, $29 million and $58 million for the years ended December 31, 2005, 2004 and 2003, respectively. The investment in restructured loans was $37 million and $125 million at December 31, 2005 and 2004, respectively. Interest income of $2 million, $9 million and $19 million was recognized on restructured loans for the years ended December 31, 2005, 2004 and 2003, respectively. Gross interest income that would have been recorded in accordance with the original terms of such loans amounted to $3 million, $12 million and $24 million for the years ended December 31, 2005, 2004 and 2003, respectively. Mortgage and consumer loans with scheduled payments of 60 days (90 days for agricultural mortgages) or more past due or in foreclosure had an amortized cost of $60 million and $58 million at December 31, 2005 and 2004, respectively. Real Estate and Real Estate Joint Ventures Real estate and real estate joint ventures consisted of the following: December 31, 2005 2004 (In millions) Real estate and real estate joint ventures held-for-investment ************************************************* $4,783 Impairments ****************************************************************************************** (118) Total ********************************************************************************************** Real estate held-for-sale ******************************************************************************** Impairments ****************************************************************************************** Total ********************************************************************************************** — Real estate and real estate joint ventures ****************************************************************** $4,665 4,665 — — $3,194 (118) 3,076 1,173 (16) 1,157 $4,233 MetLife, Inc. F-26 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Accumulated depreciation on real estate was $1,326 million and $2,005 million at December 31, 2005 and 2004, respectively. Related depreciation expense was $136 million, $179 million and $183 million for the years ended December 31, 2005, 2004 and 2003, respectively. These amounts include $15 million, $76 million and $86 million of depreciation expense related to discontinued operations for the years ended December 31, 2005, 2004 and 2003, respectively. Real estate and real estate joint ventures were categorized as follows: December 31, 2005 2004 Amount Percent Amount Percent Ofﬁce ****************************************************************************** $2,597 Apartments************************************************************************** 892 Retail******************************************************************************* 614 Other******************************************************************************* 469 Land ******************************************************************************* 60 Agriculture ************************************************************************** 33 Total ***************************************************************************** $4,665 (In millions) 56% $2,297 918 19 558 13 403 10 56 1 1 1 54% 22 13 10 1 — 100% $4,233 100% The Company’s real estate holdings are primarily located in the United States. At December 31, 2005, approximately 23%, 22% and 16% of the Company’s real estate holdings were located in California, New York and Texas, respectively. Changes in the real estate and real estate joint ventures held-for-sale valuation allowance were as follows: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year**************************************************************************** $ 4 $ 12 Additions ****************************************************************************************** 13 5 Deductions***************************************************************************************** (21) (9) Balance, end of year ******************************************************************************** $ — $ 4 $ 11 17 (16) $ 12 Investment income related to impaired real estate and real estate joint ventures held-for-investment was $7 million, $15 million and $34 million for the years ended December 31, 2005, 2004 and 2003, respectively. There was no investment income (expense) related to impaired real estate and real estate joint ventures held-for-sale for the year ended December 31, 2005. Investment income (expense) related to impaired real estate and real estate joint ventures held-for-sale was ($1) million and $1 million for the years ended December 31, 2004 and 2003, respectively. The carrying value of non- income producing real estate and real estate joint ventures was $37 million and $41 million at December 31, 2005 and 2004, respectively. The Company owned real estate acquired in satisfaction of debt of $4 million at December 31, 2005 and 2004. Leveraged Leases Leveraged leases, included in other invested assets, consisted of the following: December 31, 2005 2004 (In millions) Investment ******************************************************************************************* $ 991 Estimated residual values ******************************************************************************* 735 Total ********************************************************************************************** Unearned income ************************************************************************************* 1,726 (645) Leveraged leases *********************************************************************************** $1,081 $1,059 480 1,539 (424) $1,115 The investment amounts set forth above are generally due in monthly installments. The payment periods generally range from one to 15 years, but in certain circumstances are as long as 30 years. These receivables are generally collateralized by the related property. The Company’s deferred income tax liability related to leveraged leases was $605 million and $757 million at December 31, 2005 and 2004, respectively. Funds Withheld at Interest Included in other invested assets at December 31, 2005 and 2004, were funds withheld at interest of $3,492 million and $2,801 million, respectively. MetLife, Inc. F-27 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Net Investment Income The components of net investment income were as follows: Years Ended December 31, 2005 2004 2003 Fixed maturities *************************************************************************** $11,414 Equity securities ************************************************************************** 65 Mortgage and consumer loans ************************************************************** 2,302 Real estate and real estate joint ventures ***************************************************** 804 Policy loans ****************************************************************************** 572 Other limited partnership interests************************************************************ 709 Cash, cash equivalents and short-term investments ******************************************** 400 Other *********************************************************************************** 472 Total ********************************************************************************** Less: Investment expenses ***************************************************************** 16,738 1,828 Net investment income ****************************************************************** $14,910 Net Investment Gains (Losses) Net investment gains (losses) were as follows: (In millions) $ 9,397 80 1,963 680 541 324 167 219 13,371 1,007 $ 8,789 31 1,903 606 554 80 171 224 12,358 886 $12,364 $11,472 Years Ended December 31, 2005 2004 2003 (In millions) Fixed maturities ********************************************************************************** $(868) Equity securities ********************************************************************************* 117 Mortgage and consumer loans ********************************************************************* 17 Real estate and real estate joint ventures ************************************************************ 14 Other limited partnership interests ****************************************************************** 42 Sales of businesses ****************************************************************************** 8 Derivatives ************************************************************************************** 381 Other ****************************************************************************************** 196 Net investment gains (losses) ******************************************************************** $ (93) $ 71 155 (47) 16 53 23 (255) 159 $(398) 41 (56) 19 (84) — (103) 30 $ 175 $(551) Net Unrealized Investment Gains (Losses) The components of net unrealized investment gains (losses), included in accumulated other comprehensive income, were as follows: Fixed maturities ***************************************************************************** $ 6,132 Equity securities **************************************************************************** 247 Derivatives ********************************************************************************* (142) Minority interest***************************************************************************** (171) Other ************************************************************************************* (102) Total ************************************************************************************ 5,964 (In millions) $ 9,602 287 (503) (104) 39 $ 9,204 376 (427) (51) 18 9,321 9,120 Amounts allocated from: Years Ended December 31, 2005 2004 2003 Future policy beneﬁt loss recognition ********************************************************* DAC and VOBA ************************************************************************** Participating contracts ********************************************************************* Policyholder dividend obligation *************************************************************** Total ************************************************************************************ Deferred income taxes*********************************************************************** Total ************************************************************************************ (4,022) Net unrealized investment gains (losses) **************************************************** $ 1,942 (1,410) (79) — (1,492) (1,991) (541) — (2,119) (1,482) (674) (183) (2,130) (2,981) (4,651) (4,469) (1,041) (1,676) (1,679) (6,327) (6,148) $ 2,994 $ 2,972 F-28 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The changes in net unrealized investment gains (losses) were as follows: Years Ended December 31, 2005 2004 2003 (In millions) Balance, beginning of year ******************************************************************** $ 2,994 Unrealized investment gains (losses) during the year *********************************************** (3,372) Unrealized investment gains of subsidiaries at the date of sale ************************************** 15 Unrealized investment gains (losses) relating to: Future policy beneﬁt gains (losses) recognition ************************************************** Deferred policy acquisition costs ************************************************************* Participating contracts ********************************************************************** Policyholder dividend obligation ************************************************************** Deferred income taxes********************************************************************** 581 462 — 627 635 Balance, end of year ************************************************************************* $ 1,942 $2,972 201 — $2,282 1,711 — (509) 133 183 11 3 (213) (115) (30) (248) (415) $2,994 $2,972 Net change in unrealized investment gains (losses) ************************************************ $(1,052) $ 22 $ 690 Trading Securities Net investment income for the year ended December 31, 2005 includes $37 million of gains (losses) on securities classiﬁed as trading. Of this amount, $42 million relates to net gains (losses) recognized on trading securities sold during the year ended December 31, 2005. The remaining ($5) million for the year ended December 31, 2005 relates to changes in fair value on trading securities held at December 31, 2005. The Company did not have any trading securities during the years ended December 31, 2004 and 2003. As part of the acquisition of Travelers on July 1, 2005, the Company acquired Travelers’ investment in Tribeca. Tribeca is a feeder fund investment structure whereby the feeder fund invests substantially all of its assets in the master fund, Tribeca Global Convertible Instruments Ltd. The primary investment objective of the master fund is to achieve enhanced risk-adjusted return by investing in domestic and foreign equities and equity-related securities utilizing such strategies as convertible securities arbitrage. MetLife is the majority owner of the feeder fund and consolidates the fund within its consolidated ﬁnancial statements. Approximately $452 million of Tribeca’s investments are reported as trading securities in the accompanying consoli- dated ﬁnancial statements with changes in fair value recognized in net investment income. Structured Investment Transactions The Company invests in structured notes and similar type instruments, which generally provide equity-based returns on debt securities. The carrying value of such investments was approximately $362 million and $666 million at December 31, 2005 and 2004, respectively. The related net investment income recognized was $28 million, $45 million and $78 million for the years ended December 31, 2005, 2004 and 2003, respectively. Variable Interest Entities The following table presents the total assets of and maximum exposure to loss relating to VIEs for which the Company has concluded that (i) it is the primary beneﬁciary and which are consolidated in the Company’s consolidated ﬁnancial statements at December 31, 2005; and (ii) it holds signiﬁcant variable interests but it is not the primary beneﬁciary and which have not been consolidated: December 31, 2005 Primary Beneﬁciary Not Primary Beneﬁciary Total Assets(1) Maximum Exposure to Loss(2) Total Assets(1) Maximum Exposure to Loss(2) Asset-backed securitizations and collateralized debt obligations ********************** Real estate joint ventures(3) **************************************************** Other limited partnerships(4) **************************************************** Other investments(5) ********************************************************** Total************************************************************************ $ — 304 48 — $352 (In millions) $ — 114 35 — $149 $ 3,728 246 15,760 3,722 $23,456 $ 463 19 2,109 242 $2,833 (1) The assets of the asset-backed securitizations and collateralized debt obligations are reﬂected at fair value at December 31, 2005. The assets of the real estate joint ventures, other limited partnerships and other investments are reﬂected at the carrying amounts at which such assets would have been reﬂected on the Company’s balance sheet had the Company consolidated the VIE from the date of its initial investment in the entity. (2) The maximum exposure to loss of the asset-backed securitizations and collateralized debt obligations is equal to the carrying amounts of participation or retained interests. In addition, the Company provides collateral management services for certain of these structures for which it collects a management fee. The maximum exposure to loss relating to real estate joint ventures, other limited partnerships and other investments is equal to the carrying amounts plus any unfunded commitments, reduced by amounts guaranteed by other partners. (3) Real estate joint ventures include partnerships and other ventures which engage in the acquisition, development, management and disposal of real estate investments. (4) Other limited partnerships include partnerships established for the purpose of investing in real estate funds, public and private debt and equity securities, as well as limited partnerships established for the purpose of investing in low-income housing that qualiﬁes for federal tax credits. (5) Other investments include securities that are not asset-backed securitizations or collateralized debt obligations. MetLife, Inc. F-29 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 4. Derivative Financial Instruments Types of Derivative Instruments The following table provides a summary of the notional amounts and current market or fair value of derivative ﬁnancial instruments held at: December 31, 2005 December 31, 2004 Notional Amount Current Market or Fair Value Assets Liabilities Notional Amount Current Market or Fair Value Assets Liabilities Interest rate swaps********************************************** $20,444 Interest rate ﬂoors*********************************************** 10,975 Interest rate caps *********************************************** 27,990 Financial futures ************************************************ 1,159 Foreign currency swaps ***************************************** 14,274 Foreign currency forwards**************************************** 4,622 Options ******************************************************* 815 Financial forwards*********************************************** 2,452 Credit default swaps ******************************************** 5,882 Synthetic GICs ************************************************* 5,477 Other ********************************************************* 250 Total ******************************************************** $94,340 $ 653 134 242 12 527 64 356 13 13 — 9 (In millions) $ 69 — — 8 991 92 6 4 11 — — $12,681 3,325 7,045 611 8,214 1,013 263 326 1,897 5,869 450 $2,023 $1,181 $41,694 $284 38 12 — 150 5 37 — 11 — 1 $538 $ 22 — — 13 1,302 57 7 — 5 — 1 $1,407 The above table does not include notional values for equity futures, equity ﬁnancial forwards, and equity options. At December 31, 2005 and 2004, the Company owned 3,305 and 776 equity futures contracts, respectively. Equity futures market values are included in ﬁnancial futures in the preceding table. At December 31, 2005 and 2004, the Company owned 213,000 and no equity ﬁnancial forwards, respectively. Equity ﬁnancial forwards market values are included in ﬁnancial forwards in the preceding table. At December 31, 2005 and 2004, the Company owned 4,720,254 and 493,358 equity options, respectively. Equity options market values are included in options in the preceding table. The notional amount of $562 million related to equity options for 2004 has been removed from the above table to conform with the 2005 presentation. The following table provides a summary of the notional amounts of derivative ﬁnancial instruments by maturity at December 31, 2005: Interest rate swaps ************************************************* Interest rate ﬂoors ************************************************** Interest rate caps ************************************************** Financial futures *************************************************** Foreign currency swaps********************************************* Foreign currency forwards ******************************************* Options ********************************************************** Financial forwards ************************************************** Credit default swaps *********************************************** Synthetic GICs **************************************************** Other ************************************************************ Total *********************************************************** After One Year Through Five Years $ 6,955 325 13,090 — 4,811 — 594 — 4,931 726 — Remaining Life After Five Years Through Ten Years (In millions) $ 5,100 10,650 — — 6,316 — 1 — 276 — — One Year or Less $ 5,021 — 14,900 1,159 751 4,622 220 452 675 4,751 250 After Ten Years Total $3,368 — — — 2,396 — — 2,000 — — — $20,444 10,975 27,990 1,159 14,274 4,622 815 2,452 5,882 5,477 250 $32,801 $31,432 $22,343 $7,764 $94,340 Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at speciﬁed intervals, the difference between ﬁxed rate and ﬂoating rate interest amounts as calculated by reference to an agreed notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. The Company also enters into basis swaps to better match the cash ﬂows from assets and related liabilities. In a basis swap, both legs of the swap are ﬂoating with each based on a different index. Generally, no cash is exchanged at the outset of the contract and no principal payments are made by either party. A single net payment is usually made by one counterparty at each due date. Basis swaps are included in interest rate swaps in the preceding table. Interest rate caps and ﬂoors are used by the Company primarily to protect its ﬂoating rate liabilities against rises in interest rates above a speciﬁed level, and against interest rate exposure arising from mismatches between assets and liabilities (duration mismatches), as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a speciﬁed level, respectively. In exchange-traded interest rate (Treasury and swap) and equity futures transactions, the Company agrees to purchase or sell a speciﬁed number of contracts, the value of which is determined by the different classes of interest rate and equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. F-30 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance. The value of interest rate futures is substantially impacted in interest rates and they can be used to modify or hedge existing interest rate risk. Exchange-traded equity futures are used primarily to hedge liabilities embedded in certain variable annuity products offered by the Company. Foreign currency derivatives, including foreign currency swaps, foreign currency forwards and currency option contracts, are used by the Company to reduce the risk from ﬂuctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. The Company also uses foreign currency forwards and swaps to hedge the foreign currency risk associated with certain of its net investments in foreign operations. In a foreign currency swap transaction, the Company agrees with another party to exchange, at speciﬁed intervals, the difference between one currency and another at a forward exchange rate calculated by reference to an agreed upon principal amount. The principal amount of each currency is exchanged at the inception and termination of the currency swap by each party. In a foreign currency forward transaction, the Company agrees with another party to deliver a speciﬁed amount of an identiﬁed currency at a speciﬁed future date. The price is agreed upon at the time of the contract and payment for such a contract is made in a different currency at the speciﬁed future date. The Company enters into currency option contracts that give it the right, but not the obligation, to sell the foreign currency amount in exchange for a functional currency amount within a limited time at a contracted price. The contracts may also be net settled in cash, based on differentials in the foreign exchange rate and the strike price. Currency option contracts are included in options in the preceding table. Swaptions are used by the Company primarily to sell, or monetize, embedded call options in its ﬁxed rate liabilities. A swaption is an option to enter into a swap with an effective date equal to the exercise date of the embedded call and a maturity date equal to the maturity date of the underlying liability. The Company receives a premium for entering into the swaption. Swaptions are included in options in the preceding table. Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at time of exercise and the strike price. Equity index options are included in options in the preceding table. The Company enters into ﬁnancial forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a speciﬁed future date. Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a deﬁned period. Equity variance swaps are included in ﬁnancial forwards in the preceding table. Swap spread locks are used by the Company to hedge invested assets on an economic basis against the risk of changes in credit spreads. Swap spread locks are forward starting swaps where the Company agrees to pay a coupon based on a predetermined reference swap spread in exchange for receiving a coupon based on a ﬂoating rate. The Company has the option to cash settle with the counterparty in lieu of maintaining the swap after the effective date. Swap spread locks are included in ﬁnancial forwards in the preceding table. Certain credit default swaps are used by the Company to hedge against credit-related changes in the value of its investments and to diversify its credit risk exposure in certain portfolios. In a credit default swap transaction, the Company agrees with another party, at specified intervals, to pay a premium to insure credit risk. If a credit event, as defined by the contract, occurs, generally the contract will require the swap to be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit default swaps are also used in replication synthetic asset transactions (‘‘RSATs’’) to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. RSATs are a combination of a derivative and usually a U.S. Treasury or Agency security. RSATs that involve the use of credit default swaps are included in such classiﬁcation in the preceding table. Total rate of return swaps (‘‘TRRs’’) are swaps whereby the Company agrees with another party to exchange, at speciﬁed intervals, the difference between the economic risk and reward of an asset or a market index and LIBOR, calculated by reference to an agreed notional principal amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. TRRs can be used as hedges or RSATs and are included in the other classiﬁcation in the preceding table. A synthetic GIC is a contract that simulates the performance of a traditional GIC through the use of ﬁnancial instruments. Under a synthetic GIC, the policyholder owns the underlying assets. The Company guarantees a rate return on those assets for a premium. Hedging The table below provides a summary of the notional amount and fair value of derivatives by type of hedge designation at: December 31, 2005 December 31, 2004 Notional Amount Fair Value Assets Liabilities Notional Amount Fair Value Assets Liabilities (In millions) Fair value****************************************************** $ 4,506 Cash ﬂow ***************************************************** 8,301 Foreign operations ********************************************** 2,005 Non-qualifying ************************************************** 79,528 Total ******************************************************** $94,340 $ 51 31 13 1,928 $ 104 505 70 502 $ 4,879 8,787 535 27,493 $2,023 $1,181 $41,694 $173 41 — 324 $538 $ 234 689 47 437 $1,407 MetLife, Inc. F-31 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The following table provides the settlement payments recorded in income for the: Years Ended December 31, 2005 2004 2003 (In millions) Qualifying hedges: Net investment income *************************************************************************** $ 42 Interest credited to policyholder account balances **************************************************** 17 Other expenses ********************************************************************************* (8) $(147) 45 — $(63) — — Non-qualifying hedges: Net investment gains (losses)********************************************************************** 86 Total***************************************************************************************** $137 51 84 $ (51) $ 21 Fair Value Hedges The Company designates and accounts for the following as fair value hedges when they have met the requirements of SFAS 133: (i) interest rate swaps to convert ﬁxed rate investments to ﬂoating rate investments; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated investments and liabilities; and (iii) interest rate futures to hedge against changes in value of ﬁxed rate securities. The Company recognized net investment gains (losses) representing the ineffective portion of all fair value hedges as follows: Years Ended December 31, 2005 2004 2003 (In millions) Changes in the fair value of derivatives *************************************************************** $(118) Changes in the fair value of the items hedged ********************************************************* 115 Net ineffectiveness of fair value hedging activities******************************************************* $ (3) $ 62 (48) $(191) 159 $ 14 $ (32) All components of each derivative’s gain or loss were included in the assessment of hedge ineffectiveness. There were no instances in which the Company discontinued fair value hedge accounting due to a hedged ﬁrm commitment no longer qualifying as a fair value hedge. Cash Flow Hedges The Company designates and accounts for the following as cash ﬂow hedges, when they have met the requirements of SFAS 133: (i) interest rate swaps to convert ﬂoating rate investments to ﬁxed rate investments; (ii) interest rate swaps to convert ﬂoating rate liabilities into ﬁxed rate liabilities; (iii) foreign currency swaps to hedge the foreign currency cash ﬂow exposure of foreign currency denominated investments and liabilities; (iv) interest rate futures to hedge against changes in value of securities to be acquired; (v) interest rate futures to hedge against changes in interest rates on liabilities to be issued; and (vi) ﬁnancial forwards to buy and sell securities. For the years ended December 31, 2005, 2004 and 2003, the Company recognized net investment gains (losses) of ($25) million, ($45) million, and ($68) million, respectively, which represented the ineffective portion of all cash ﬂow hedges. All components of each derivative’s gains or loss were included in the assessment of hedge ineffectiveness. In certain instances, the Company discontinued cash ﬂow hedge accounting because the forecasted transactions did not occur on the anticipated date or in the additional time period permitted by SFAS 133. The net amounts reclassiﬁed into net investment gains (losses) for the years ended December 31, 2005, 2004 and 2003 related to such discontinued cash ﬂow hedges were losses of $42 million, $51 million and $0 million, respectively. There were no hedged forecasted transactions, other than the receipt or payment of variable interest payments. Presented below is a roll forward of the components of other comprehensive income (loss), before income taxes, related to cash ﬂow hedges: Years Ended December 31, 2005 2004 2003 (In millions) Other comprehensive income (loss) balance at the beginning of the year********************************** $(456) Gains (losses) deferred in other comprehensive income (loss) on the effective portion of cash ﬂow hedges ***** 270 Amounts reclassiﬁed to net investment gains (losses) ************************************************** 44 Amounts reclassiﬁed to net investment income ******************************************************* 2 Amortization of transition adjustment **************************************************************** (2) Other comprehensive income (losses) balance at the end of the year ************************************ $(142) $(417) (97) 63 2 (7) $ (24) (399) 12 2 (8) $(456) $(417) At December 31, 2005, approximately $23 million of the deferred net loss on derivatives accumulated in other comprehensive income (loss) is expected to be reclassiﬁed to earnings during the year ending December 31, 2006. Hedges of Net Investments in Foreign Operations The Company uses forward exchange contracts, foreign currency swaps and options to hedge portions of its net investment in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on the forward exchange contracts based upon the change in forward rates. There was no ineffectiveness recorded in 2005, 2004 or 2003. The Company’s consolidated statements of stockholders’ equity for the years ended December 31, 2005, 2004 and 2003 include losses of $115 million, $47 million and $10 million, respectively, related to foreign currency contracts used to hedge its net investments in foreign operations. At December 31, 2005 and 2004, the cumulative foreign currency translation loss recorded in AOCI related to these hedges was approximately $172 million and $57 million, respectively. When substantially all of the net investments in foreign operations are sold or liquidated, the amounts in AOCI F-32 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. are reclassiﬁed to the consolidated statements of income, while a pro rata portion will be reclassiﬁed upon partial sale of the net investments in foreign operations. Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging The Company enters into the following derivatives that do not qualify for hedge accounting under SFAS 133 or for purposes other than hedging: (i) interest rate swaps, purchased caps and ﬂoors, and interest rate futures to minimize its exposure to interest rate volatility; (ii) foreign currency forwards, swaps and option contracts to minimize its exposure to adverse movements in exchange rates; (iii) swaptions to sell embedded call options in ﬁxed rate liabilities; (iv) credit default swaps to minimize its exposure to adverse movements in credit; (v) credit default swaps to diversify its credit risk exposure in certain portfolios; (vi) equity futures, equity index options, interest rate futures and equity variance swaps to economically hedge liabilities embedded in certain variable annuity products; (vii) swap spread locks to hedge invested assets against the risk of changes in credit spreads; (viii) ﬁnancial forwards to buy and sell securities; (ix) synthetic GICs to synthetically create traditional GICs; (x) RSATs and TRRs to synthetically create investments; and (xi) basis swaps to better match the cash ﬂows from assets and related liabilities. Effective at the date of acquisition, the Travelers’ derivative positions which previously qualiﬁed for hedge accounting were dedesignated in accordance with SFAS 133. Such derivative positions were not redesignated and were included with the Company’s other nonqualifying derivative positions from the date of acquisition through December 31, 2005. For the years ended December 31, 2005, 2004 and 2003, the Company recognized as net investment gains (losses) changes in fair value of $368 million, ($157) million and ($114) million, respectively, related to derivatives that do not qualify for hedge accounting. For the year ended December 31, 2005, the Company recorded changes in fair value of ($2) million, as interest credited to policyholder account balances related to derivatives that do not qualify for hedge accounting. The Company did not have interest credited to policyholder account balances related to such derivatives for the years ended December 31, 2004 and 2003. For the year ended December 31, 2005, the Company recorded changes in fair value of ($38) million, as net investment income related to derivatives that do not qualify for hedge accounting. The Company did not have net investment income related to such derivatives for the years ended December 31, 2004 and 2003. Embedded Derivatives The Company has certain embedded derivatives which are required to be separated from their host contracts and accounted for as derivatives. These host contracts include guaranteed rate of return contracts, guaranteed minimum withdrawal, accumulation, and interest beneﬁt contracts, and modiﬁed coinsurance contracts. The fair value of the Company’s embedded derivative assets was $50 million and $46 million at December 31, 2005 and 2004, respectively. The fair value of the Company’s embedded derivative liabilities was $45 million and $26 million at December 31, 2005 and 2004, respectively. The amounts recorded in net investment gains (losses) during the years ended December 31, 2005, 2004 and 2003 were gains of $69 million, $37 million and $19 million, respectively. Credit Risk The Company may be exposed to credit related losses in the event of nonperformance by counterparties to derivative ﬁnancial instruments. Generally, the current credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date. The credit exposure of the Company’s derivative transactions is represented by the fair value of contracts with a net positive fair value at the reporting date. As noted above, the Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. Because exchange traded futures are effected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit related losses in the event of nonperformance by counterparties to such derivative instruments. The Company enters into various collateral arrangements, which require both the pledging and accepting of collateral in connection with its derivative instruments. As of December 31, 2005, the Company was obligated to return cash collateral under its control of $195 million. This unrestricted cash collateral is included in cash and cash equivalents and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheet. As of December 31, 2005, the Company had also accepted collateral consisting of various securities with a fair market value of $427 million, which is held in separate custodial accounts. Such collateral is included in other assets and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheet. The Company is permitted by contract to sell or repledge this collateral, but as of December 31, 2005, none of the collateral had been sold or repledged. As of December 31, 2005, the Company provided collateral of $4 million, which is included in other assets in the consolidated balance sheet. The counterparties are permitted by contract to sell or repledge this collateral. The Company did not have any cash or other collateral related to derivative instruments at December 31, 2004. MetLife, Inc. F-33 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 5. Insurance Deferred Policy Acquisition Costs and Value of Business Acquired Information regarding DAC and VOBA for the years ended December 31, 2005, 2004 and 2003 is as follows: Deferred Policy Value of Acquisition Business Acquired Costs Total Balance at January 1, 2003***************************************************************** Capitalizations ************************************************************************** Acquisitions **************************************************************************** Total ****************************************************************************** $ 9,983 2,792 218 $1,739 — 40 $11,722 2,792 258 12,993 1,779 14,772 (In millions) Less: Amortization related to: Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Less: Dispositions and other ************************************************************** Balance at December 31, 2003 ************************************************************* Capitalizations ************************************************************************** Acquisitions **************************************************************************** Total ****************************************************************************** Less: Amortization related to: Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Less: Dispositions and other ************************************************************** Balance at December 31, 2004 ************************************************************* Capitalizations ************************************************************************** Acquisitions **************************************************************************** Total ****************************************************************************** Less: Amortization related to: Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Less: Dispositions and other ************************************************************** Balance at December 31, 2005 ************************************************************* 7 146 1,658 1,811 (98) 11,280 3,101 — 14,381 7 (41) 1,757 1,723 (85) (7) (31) 162 124 (2) 1,657 — 6 1,663 4 (92) 140 52 27 12,743 3,604 1,584 — — 3,780 16,347 5,364 12 (323) 2,128 1,817 102 (25) (139) 336 172 (21) — 115 1,820 1,935 (100) 12,937 3,101 6 16,044 11 (133) 1,897 1,775 (58) 14,327 3,604 3,780 21,711 (13) (462) 2,464 1,989 81 $14,428 $5,213 $19,641 The estimated future amortization expense for the next ﬁve years allocated to other expenses for VOBA is $506 million in 2006, $477 million in 2007, $449 million in 2008, $422 million in 2009 and $392 million in 2010. Amortization of VOBA and DAC is related to (i) investment gains and losses and the impact of such gains and losses on the amount of the amortization; (ii) unrealized investment gains and losses to provide information regarding the amount that would have been amortized if such gains and losses had been recognized; and (iii) other expenses to provide amounts related to the gross margins or proﬁts originating from transactions other than investment gains and losses. Value of Distribution Agreements and Customer Relationships Acquired Changes in value of distribution agreements (‘‘VODA’’), and value of customer relationships acquired (‘‘VOCRA’’), which are reported within other assets in the consolidated balance sheet, are as follows: Years Ended December 31, 2005 2004 (In millions) Balance at January 1 *************************************************************************************** $ — $ — Acquisitions *********************************************************************************************** — Amortization*********************************************************************************************** (1) — Less: Dispositions and other********************************************************************************* — — Balance at December 31 *********************************************************************************** $715 716 $ — F-34 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The estimated future amortization expense allocated to other expenses for the next ﬁve years for VODA and VOCRA is $6 million in 2006, $13 million in 2007, $20 million in 2008, $26 million in 2009 and $31 million in 2010. Sales Inducements Changes in deferred sales inducements, which are reported within other assets in the consolidated balance sheet, are as follows: Years Ended December 31, 2005 2004 (In millions) Balance at January 1************************************************************************************** $294 Capitalization ********************************************************************************************* 140 Amortization********************************************************************************************** (20) Balance at December 31 ********************************************************************************** $414 $196 121 (23) $294 Liabilities for Unpaid Claims and Claim Expenses The following table provides an analysis of the activity in the liability for unpaid claims and claim expenses relating to property and casualty, group accident and non-medical health policies and contracts, which are reported within future policyholder beneﬁts in the consolidated balance sheet: Years Ended December 31, 2005 2004 2003 (In millions) Balance at January 1 ************************************************************************ $ 5,824 (486) Less: Reinsurance recoverables ************************************************************* Net balance at January 1 ******************************************************************** Acquisitions, net **************************************************************************** Incurred related to: Current year ***************************************************************************** Prior years ******************************************************************************* $ 5,412 (525) $ 4,885 (498) 5,338 4,887 4,387 120 — — 4,954 (197) 4,757 4,591 (29) 4,562 4,483 45 4,528 Paid related to: Current year ***************************************************************************** Prior years ******************************************************************************* (2,841) (1,373) (2,717) (1,394) (2,676) (1,352) (4,214) (4,111) (4,028) Net Balance at December 31 ***************************************************************** Add: Reinsurance recoverables ************************************************************* 6,001 589 Balance at December 31 ******************************************************************** $ 6,590 5,338 486 4,887 525 $ 5,824 $ 5,412 As a result of changes in estimates of insured events in the prior years, the claims and claim adjustment expenses decreased $197 million in 2005 due to a reduction in prior year automobile bodily injury and homeowners severity as well as reﬁnement in the estimation methodology for non-medical health long-term care claim reserves. In 2004, the claims and claim adjustment expenses decreased by $29 million due to a decrease in property an casualty prior year unallocated expense reserves and improved loss ratios in non-medical health long-term care. In 2003, the claims and claim adjustment expenses increased by $45 million as a result of higher than anticipated losses and related claims expenses in automobile bodily injury coverage driven by actual inﬂation factors being greater than assumed inﬂation factors for these claims. The increases were partially offset by improved claims management on non-medical health long-term care. Guarantees The Company issues annuity contracts which may include contractual guarantees to the contractholder for: (i) return of no less than total deposits made to the contract less any partial withdrawals (‘‘return of net deposits’’) and (ii) the highest contract value on a speciﬁed anniversary date minus any withdrawals following the contract anniversary, or total deposits made to the contract less any partial withdrawals plus a minimum return (‘‘anniversary contract value’’ or ‘‘minimum return’’). The Company also issues annuity contracts that apply a lower rate of funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize (‘‘two tier annuities’’). These guarantees include beneﬁts that are payable in the event of death or at annuitization. The Company also issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid up beneﬁt. MetLife, Inc. F-35 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The Company had the following types of guarantees relating to annuity and universal and variable life contracts at: Annuity Contracts December 31, 2005 2004 In the Event of Death At Annuitization In the Event of Death At Annuitization (In millions) Return of Net Deposits Separate account value ******************************************** Net amount at risk ************************************************* Average attained age of contractholders******************************* $ $ 9,577 3(1) 60 years N/A N/A N/A $ $ 6,925 22(1) 60 years N/A N/A N/A Anniversary Contract Value or Minimum Return Separate account value ******************************************** Net amount at risk ************************************************* Average attained age of contractholders******************************* $ 80,368 $ 1,614(1) $ 18,936 $ 85(2) $ 43,414 $ 990(1) $ 14,297 $ 51(2) 61 years 59 years 61 years 58 years Two Tier Annuities General account value ********************************************* Net amount at risk ************************************************* Average attained age of contractholders******************************* N/A N/A N/A $ $ 299 36(3) 58 years N/A N/A N/A $ $ 301 36(3) 58 Years Universal and Variable Life Contracts December 31, 2005 2004 Secondary Guarantees Paid Up Guarantees Secondary Guarantees Paid Up Guarantees (In millions) Account value (general and separate account) ********************************** $ Net amount at risk ********************************************************** $124,702(1) $39,979(1) $94,163(1) $42,318(1) Average attained age of policyholders****************************************** 48 years 54 years 45 years 52 years $ 4,570 $ 4,505 $ 4,715 7,357 (1) The net amount at risk for guarantees of amounts in the event of death is deﬁned as the current guaranteed minimum death beneﬁt in excess of the current account balance at the balance sheet date. (2) The net amount at risk for guarantees of amounts at annuitization is deﬁned as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. (3) The net amount at risk for two tier annuities is based on the excess of the upper tier, adjusted for a proﬁt margin, less the lower tier. The net amount at risk is based on the direct amount at risk (excluding reinsurance). The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. Liabilities for guarantees (excluding base policy liabilities) relating to annuity and universal and variable life contracts are as follows: Annuity Contracts Guaranteed Death Beneﬁts Guaranteed Annuitization Beneﬁts Universal and Variable Life Contracts Secondary Guarantees Paid Up Guarantees (In millions) Balance at January 1, 2004 *************************************** Incurred guaranteed beneﬁts ************************************** Paid guaranteed beneﬁts****************************************** Balance at December 31, 2004 *********************************** Incurred guaranteed beneﬁts ************************************** Paid guaranteed beneﬁts****************************************** Balance at December 31, 2005 *********************************** $ 9 23 (8) 24 22 (5) $41 $17 2 — 19 10 — $29 $ 6 4 (4) 6 10 (1) $15 Account balances of contracts with insurance guarantees are invested in separate account asset classes as follows at: $25 4 — 29 10 — Total $ 57 33 (12) 78 52 (6) $39 $124 December 31, 2005 2004 (In millions) Mutual Fund Groupings Equity ******************************************************************************************* $58,461 Bond******************************************************************************************** 6,133 Balanced **************************************************************************************** 4,804 Money Market ************************************************************************************ 1,075 Specialty***************************************************************************************** 1,004 Total ***************************************************************************************** $71,477 $31,829 3,621 1,730 383 245 $37,808 F-36 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Separate Accounts Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $111,155 million and $71,623 million at December 31, 2005 and 2004, respectively, for which the policyholder assumes all investment risk, and separate accounts with a minimum return or account value for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $16,714 million and $15,146 million at December 31, 2005 and 2004, respectively. The latter category consisted primarily of Met Managed Guaranteed Interest Contracts and participating close-out contracts. The average interest rates credited on these contracts were 5.1% and 4.7% at December 31, 2005 and 2004, respectively. Fees charged to the separate accounts by the Company (including mortality charges, policy administration fees and surrender charges) are reﬂected in the Company’s revenues as universal life and investment-type product policy fees and totaled $1,720 million, $1,333 million and $1,082 million for the years ended December 31, 2005, 2004 and 2003, respectively. At December 31, 2005, ﬁxed maturities, equity securities, and cash and cash equivalents reported on the consolidated balance sheet include $29 million, $34 million and $6 million, respectively, of the Company’s proportional interest in separate accounts. At December 31, 2004, ﬁxed maturities, equity securities, and cash and cash equivalents reported on the consolidated balance sheet include $47 million, $20 million and $2 million, respectively, of the Company’s proportional interest in separate accounts. For both the years ended December 31, 2005 and 2004, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts. 6. Reinsurance The Company’s life insurance operations participate in reinsurance activities in order to limit losses, minimize exposure to large risks, and provide additional capacity for future growth. The Company has historically reinsured the mortality risk on new life insurance policies primarily on an excess of retention basis or a quota share basis. Until 2005, the Company reinsured up to 90% of the mortality risk for all new individual life insurance policies that it wrote through its various franchises. This practice was initiated by the different franchises for different products starting at various points in time between 1992 and 2000. During 2005, the Company changed its retention practices for individual life insurance. Amounts reinsured in prior years remain reinsured under the original reinsurance; however, under the new retention guidelines, the Company reinsures up to 90% of the mortality risk in excess of $1 million for most new life insurance policies that it writes through its various franchises and for certain individual life policies the retention limits remained unchanged. On a case by case basis, the Company may retain up to $25 million per life on single life policies and $30 million per life on survivorship policies and reinsure 100% of amounts in excess of the Company’s retention limits. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time. In addition, the Company reinsures a signiﬁcant portion of the mortality risk on its universal life policies issued since 1983. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with speciﬁc characteristics. In addition to reinsuring mortality risk, the Company reinsures other risks and speciﬁc coverages. The Company routinely reinsures certain classes of risks in order to limit its exposure to particular travel, avocation and lifestyle hazards. The Company has exposure to catastrophes, which are an inherent risk of the property and casualty business and could contribute to signiﬁcant ﬂuctuations in the Company’s results of operations. The Company uses excess of loss and quota share reinsurance arrangements to limit its maximum loss, provide greater diversiﬁcation of risk and minimize exposure to larger risks. The Company had also protected itself through the purchase of combination risk coverage. This reinsurance coverage pooled risks from several lines of business and included individual and group life claims in excess of $2 million per policy, as well as excess property and casualty losses, among others. This combination risk coverage was commuted during 2005. The Company reinsures its business through a diversiﬁed group of reinsurers. No single unafﬁliated reinsurer has a material obligation to the Company nor is the Company’s business substantially dependent upon any reinsurance contracts. The Company is contingently liable with respect to ceded reinsurance should any reinsurer be unable to meet its obligations under these agreements. In the Reinsurance Segment, RGA retains a maximum of $6 million of coverage per individual life with respect to its assumed reinsurance business. The amounts in the consolidated statements of income are presented net of reinsurance ceded. The effects of reinsurance were as follows: Years Ended December 31, 2005 2004 2003 Direct premiums ************************************************************************** $22,232 Reinsurance assumed ********************************************************************* 5,316 Reinsurance ceded *********************************************************************** (2,688) Net premiums **************************************************************************** $24,860 (In millions) $20,126 4,488 (2,414) $19,300 3,702 (2,427) $22,200 $20,575 Reinsurance recoveries netted against policyholder beneﬁts and claims **************************** $ 2,255 $ 1,850 $ 2,292 Reinsurance recoverables, included in premiums and other receivables, were $8,602 million and $4,104 million at December 31, 2005 and 2004, respectively, including $1,261 million and $1,302 million, respectively, relating to reinsurance of long-term guaranteed interest contracts and structured settlement lump sum contracts accounted for as a ﬁnancing transaction; $2,772 million at December 31, 2005 relating to reinsurance on the runoff of long-term care business written by Travelers; and $1,356 million at December 31, 2005 relating to reinsurance on the runoff of workers compensation business written by Travelers. Reinsurance and ceded commissions payables, included in other liabilities, were $319 million and $110 million at December 31, 2005 and 2004, respectively. For the years ended December 31, 2005, 2004 and 2003, reinsurance ceded and assumed include afﬁliated transactions of $670 million, $570 million, and $559 million, respectively. 7. Closed Block On April 7, 2000 (the ‘‘date of demutualization’’), Metropolitan Life established a closed block for the beneﬁt of holders of certain individual life insurance policies of Metropolitan Life. Assets have been allocated to the closed block in an amount that has been determined to produce cash ﬂows which, together with anticipated revenues from the policies included in the closed block, are reasonably expected to be sufﬁcient to support obligations MetLife, Inc. F-37 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. and liabilities relating to these policies, including, but not limited to, provisions for the payment of claims and certain expenses and taxes, and to provide for the continuation of policyholder dividend scales in effect for 1999, if the experience underlying such dividend scales continues, and for appropriate adjustments in such scales if the experience changes. At least annually, the Company compares actual and projected experience against the experience assumed in the then-current dividend scales. Dividend scales are adjusted periodically to give effect to changes in experience. The closed block assets, the cash ﬂows generated by the closed block assets and the anticipated revenues from the policies in the closed block will beneﬁt only the holders of the policies in the closed block. To the extent that, over time, cash ﬂows from the assets allocated to the closed block and claims and other experience related to the closed block are, in the aggregate, more or less favorable than what was assumed when the closed block was established, total dividends paid to closed block policyholders in the future may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect for 1999 had been continued. Any cash ﬂows in excess of amounts assumed will be available for distribution over time to closed block policyholders and will not be available to stockholders. If the closed block has insufﬁcient funds to make guaranteed policy beneﬁt payments, such payments will be made from assets outside of the closed block. The closed block will continue in effect as long as any policy in the closed block remains in-force. The expected life of the closed block is over 100 years. The Company uses the same accounting principles to account for the participating policies included in the closed block as it used prior to the date of demutualization. However, the Company establishes a policyholder dividend obligation for earnings that will be paid to policyholders as additional dividends as described below. The excess of closed block liabilities over closed block assets at the effective date of the demutualization (adjusted to eliminate the impact of related amounts in accumulated other comprehensive income) represents the estimated maximum future earnings from the closed block expected to result from operations attributed to the closed block after income taxes. Earnings of the closed block are recognized in income over the period the policies and contracts in the closed block remain in-force. Management believes that over time the actual cumulative earnings of the closed block will approximately equal the expected cumulative earnings due to the effect of dividend changes. If, over the period the closed block remains in existence, the actual cumulative earnings of the closed block is greater than the expected cumulative earnings of the closed block, the Company will pay the excess of the actual cumulative earnings of the closed block over the expected cumulative earnings to closed block policyholders as additional policyholder dividends unless offset by future unfavorable experience of the closed block and, accordingly, will recognize only the expected cumulative earnings in income with the excess recorded as a policyholder dividend obligation. If over such period, the actual cumulative earnings of the closed block is less than the expected cumulative earnings of the closed block, the Company will recognize only the actual earnings in income. However, the Company may change policyholder dividend scales in the future, which would be intended to increase future actual earnings until the actual cumulative earnings equal the expected cumulative earnings. Closed block liabilities and assets designated to the closed block are as follows: Closed Block Liabilities Future policy beneﬁts **************************************************************************************** $42,759 Other policyholder funds ************************************************************************************* 257 Policyholder dividends payable ******************************************************************************** 693 Policyholder dividend obligation ******************************************************************************** 1,607 Payables for collateral under securities loaned and other transactions ************************************************ 4,289 Other liabilities ********************************************************************************************** 200 Total closed block liabilities ********************************************************************************* 49,805 $42,348 258 690 2,243 4,287 199 50,025 December 31, 2005 2004 (In millions) Assets Designated to the Closed Block Investments: Fixed maturities available-for-sale, at fair value (amortized cost: $27,892 and $27,757, respectively) ******************** Trading securities, at fair value (cost: $3 and $0, respectively) **************************************************** Equity securities available-for-sale, at fair value (cost: $1,180 and $898, respectively) ******************************** Mortgage loans on real estate ******************************************************************************* Policy loans ********************************************************************************************** Short-term investments************************************************************************************* Other invested assets************************************************************************************** Total investments**************************************************************************************** Cash and cash equivalents *********************************************************************************** Accrued investment income*********************************************************************************** Deferred income taxes *************************************************************************************** Premiums and other receivables ******************************************************************************* Total assets designated to the closed block ******************************************************************* Excess of closed block liabilities over assets designated to the closed block****************************************** Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains, net of deferred income tax of $554 and $752, respectively ************************** Unrealized derivative gains (losses), net of deferred income tax beneﬁt of ($17) and ($31), respectively ****************** Allocated to policyholder dividend obligation, net of deferred income tax beneﬁt of ($538) and ($763), respectively ******** Total amounts included in accumulated other comprehensive income (loss) ***************************************** — Maximum future earnings to be recognized from closed block assets and liabilities************************************* $ 4,545 29,270 3 1,341 7,790 4,148 41 477 43,070 512 506 902 270 45,260 4,545 985 (31) (954) 29,766 — 979 8,165 4,067 101 221 43,299 325 511 1,002 103 45,240 4,785 1,338 (55) (1,356) (73) $ 4,712 MetLife, Inc. F-38 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Information regarding the policyholder dividend obligation is as follows: Balance at beginning of year ******************************************************************* $2,243 Impact on revenues, net of expenses and income taxes ******************************************** (9) Change in unrealized investment and derivative gains (losses) *************************************** (627) Balance at end of year ************************************************************************ $1,607 $2,130 124 (11) $1,882 — 248 $2,243 $2,130 Closed block revenues and expenses were as follows: Years Ended December 31, 2005 2004 2003 (In millions) Years Ended December 31, 2005 2004 2003 (In millions) Revenues Premiums *********************************************************************************** $3,062 Net investment income and other revenues******************************************************* 2,382 Net investment gains (losses) ****************************************************************** 10 Total revenues ***************************************************************************** 5,454 Expenses Policyholder beneﬁts and claims **************************************************************** Policyholder dividends************************************************************************* Change in policyholder dividend obligation******************************************************** Other expenses ****************************************************************************** Total expenses***************************************************************************** Revenues, net of expenses before income taxes ************************************************** 257 Income taxes ******************************************************************************** 90 Revenues, net of expenses and income taxes **************************************************** $ 167 3,478 1,465 (9) 263 5,197 $3,156 2,504 (19) $3,365 2,554 (128) 5,641 5,791 3,480 1,458 124 275 5,337 304 109 3,660 1,509 — 297 5,466 325 118 $ 195 $ 207 The change in maximum future earnings of the closed block is as follows: Years Ended December 31, 2005 2004 2003 (In millions) Balance at end of year ************************************************************************ $4,545 Balance at beginning of year ******************************************************************* 4,712 Change during year*************************************************************************** $ (167) $4,712 4,907 $4,907 5,114 $ (195) $ (207) Metropolitan Life charges the closed block with federal income taxes, state and local premium taxes, and other additive state or local taxes, as well as investment management expenses relating to the closed block as provided in the plan of demutualization. Metropolitan Life also charges the closed block for expenses of maintaining the policies included in the closed block. 8. Debt At December 31, 2005 and 2004, debt outstanding is as follows: Interest Rates Range Weighted Average Maturity 2005 2004 December 31, (In millions) Senior notes*************************************************** Repurchase agreements***************************************** Surplus notes************************************************** Junior subordinated debentures ********************************** Fixed rate notes************************************************ 4.20%-10.50% Other notes with varying interest rates ***************************** 3.44%-5.89% Capital lease obligations ***************************************** — Total long-term debt ******************************************** Total short-term debt******************************************** Total ***************************************************** 5.00%-7.25% 2.18%-5.65% 7.63%-7.88% 6.75% 5.66% 2006-2035 3.99% 2006-2013 7.76% 2015-2025 6.75% 5.10% 2006-2010 4.86% 2006-2012 2065 — — $ 7,616 855 696 399 104 145 73 9,888 1,414 $6,017 105 946 — 110 168 66 7,412 1,445 $11,302 $8,857 Long-term Debt In connection with ﬁnancing the acquisition of Travelers on July 1, 2005, which is more fully described in Note 2, the Holding Company issued the following debt: On June 23, 2005, the Holding Company issued in the United States public market $1,000 million aggregate principal amount of 5.00% senior notes due June 15, 2015 at a discount of $2.7 million ($997.3 million) and $1,000 million aggregate principal amount of 5.70% senior notes due MetLife, Inc. F-39 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. June 15, 2035 at a discount of $2.4 million ($997.6 million). In connection with the offering, the Holding Company incurred approximately $12.4 million of issuance costs which have been capitalized and included in other assets. These costs are being amortized using the effective interest method over the respective term of the related senior notes. On June 29, 2005, the Holding Company issued 400 million pounds sterling ($729.2 million at issuance) aggregate principal amount of 5.25% senior notes due June 29, 2020 at a discount of 4.5 million pounds sterling ($8.1 million at issuance), for aggregate proceeds of 395.5 million pounds sterling ($721.1 million at issuance). The senior notes were initially offered and sold outside the United States in reliance upon Regulation S under the Securities Act of 1933, as amended. In connection with the offering, the Holding Company incurred approximately $3.7 million of issuance costs which have been capitalized and included in other assets. These costs are being amortized using the effective interest method over the term of the related senior notes. MetLife Bank National Association (‘‘MetLife Bank’’ or ‘‘MetLife Bank, N.A.’’) is a member of the Federal Home Loan Bank of New York (the ‘‘FHLB of NY’’) and holds $43 million and $7 million of common stock of the FHLB of NY, which is included in equity securities on the Company’s consolidated balance sheets at December 31, 2005 and 2004, respectively. MetLife Bank has also entered into repurchase agreements with the FHLB of NY whereby MetLife Bank has issued repurchase agreements in exchange for cash and for which the FHLB of NY has been granted a blanket lien on MetLife Bank’s residential mortgages and mortgage-backed securities to collateralize MetLife Bank’s obligations under the repurchase agreements. MetLife Bank maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualiﬁed collateral is sufﬁcient to satisfy the collateral maintenance level. The repurchase agreements and the related security agreement represented by this blanket lien, provide that upon any event of default by MetLife Bank, the FHLB of NY’s recovery is limited to the amount of MetLife Bank’s liability under the outstanding repurchase agreements. The amount of the Company’s liability for repurchase agreements with the FHLB of NY as of December 31, 2005 and 2004 are $855 million and $105 million, respectively, which is included in long-term debt. On December 8, 2005, RGA issued junior subordinated debentures with a face amount of $400 million. Interest is payable semi-annually at a ﬁxed rate of 6.75% until December 15, 2015. Subsequent to December 15, 2015, interest on these debentures will accrue at an annual rate of 3-month LIBOR plus a margin equal to 266.5 basis points, payable quarterly until maturity in 2065. Collateralized debt, which consists of repurchase agreements and capital lease obligations, ranks highest in priority, followed by unsecured senior debt which consists of senior notes, ﬁxed rate notes, other notes with varying interest rates, followed by subordinated debt which consists of junior subordinated debentures and surplus notes. Payments of interest and principal on the Company’s surplus notes, which are subordinate to all other debt, may be made only with the prior approval of the insurance department of the state of domicile. The Company repaid a $250 million 7% surplus note which matured on November 1, 2005 and a $1,006 million, 3.911% senior note which matured on May 15, 2005. The aggregate maturities of long-term debt as of December 31, 2005 for the next ﬁve years are $803 million in 2006, $113 million in 2007, $384 million in 2008, $147 million in 2009, $240 million in 2010 and $8,201 million thereafter. Short-term Debt At December 31, 2005 and 2004, the Company’s short-term debt consisted of commercial paper with a weighted average interest rate of 3.4% and 2.3%, respectively. The debt was outstanding for an average of 53 days and 27 days at December 31, 2005 and 2004, respectively. Credit Facilities and Letters of Credit The Company maintains committed and unsecured credit facilities aggregating $3.85 billion as of December 31, 2005. When drawn upon, these facilities bear interest at varying rates in accordance with the respective agreements. The facilities can be used for general corporate purposes and $3.0 billion of the facilities also serve as back-up lines of credit for the Company’s commercial paper programs. The following table provides details on these facilities as of December 31, 2005: Borrower(s) Expiration Capacity Letter of Credit Issuances Drawdowns Unused Commitments (In millions) MetLife, Inc., MetLife Funding, Inc. and Metropolitan Life Insurance Company *********************************************** April 2009 MetLife, Inc. and MetLife Funding, Inc. ************************ April 2010 MetLife Bank, N.A. ***************************************** July 2006 Reinsurance Group of America, Incorporated ******************* January 2006 Reinsurance Group of America, Incorporated ******************* May 2007 Reinsurance Group of America, Incorporated ******************* September 2010 Total ***************************************************** $1,500 1,500 200 26 26 600 $3,852 $374 — — — — 320 $694 $ — — — 26 26 50 $102 $1,126 1,500 200 — — 230 $3,056 On July 1, 2005, in connection with the closing of the acquisition of Travelers, the $2.0 billion amended and restated ﬁve-year letter of credit and reimbursement agreement (the ‘‘L/C Agreement’’) entered into by The Travelers Life and Annuity Reinsurance Company (‘‘TLARC’’) and various institutional lenders on April 25, 2005 became effective. Under the L/C Agreement, the Holding Company agreed to unconditionally guarantee reimbursement obligations of TLARC with respect to reinsurance letters of credit issued pursuant to the L/C Agreement and replaced Citigroup Insurance Holding Company as guarantor upon closing of the Travelers acquisition. The L/C Agreement expires ﬁve years after the closing of the acquisition. Also during 2005, Exeter Reassurance Company Ltd. (‘‘Exeter’’) entered into three ten-year letter of credit and reimbursement agreements totaling $800 mil- lion with an institutional lender, and the Holding Company and Exeter entered into a $500 million ten-year letter of credit and reimbursement agreement F-40 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. with another institutional lender. The following table provides details on the capacity and outstanding balances of such committed facilities as of December 31, 2005: Account Party Expiration Capacity The Travelers Life and Annuity Reinsurance Company ********************** July 2010 Exeter Reassurance Company Ltd. ************************************* March 2015 Exeter Reassurance Company Ltd. ************************************* June 2015 Exeter Reassurance Company Ltd. ************************************* September 2015 Exeter Reassurance Company Ltd. and MetLife, Inc. *********************** December 2015 Total**************************************************************** $2,000 225 250 325 500 $3,300 Letter of Credit Issuances (In millions) $1,930 225 250 — 280 $2,685 Unused Commitments $ 70 — — 325 220 $615 Note: The Holding Company is a guarantor under the ﬁrst four agreements and a party to the ﬁfth agreement above. At December 31, 2005 and 2004, the Company had outstanding $3.6 billion and $961 million, respectively, in letters of credit from various banks, of which $3.4 billion and $470 million, respectively, were part of committed facilities. The letters of credit outstanding at December 31, 2005 and 2004 all automatically renew for one year periods except for $755 million in the current period which expires in ten years. Since commitments associated with letters of credit and ﬁnancing arrangements may expire unused, these amounts do not necessarily reﬂect the Company’s actual future cash funding requirements. Other Interest expense related to the Company’s indebtedness included in other expenses was $544 million, $428 million and $420 million for the years ended December 31, 2005, 2004 and 2003, respectively. See also Note 9 for a description of junior subordinated debentures of $2,134 million issued in connection with the common equity units. 9. Common Equity Units Summary In connection with ﬁnancing the acquisition of Travelers on July 1, 2005, which is more fully described in Note 2, the Company distributed and sold 82.8 million 6.375% common equity units for $2,070 million in proceeds in a registered public offering on June 21, 2005. As described below, the common equity units consist of interests in trust preferred securities issued by MetLife Capital Trusts II and III, and stock purchase contracts issued by the Holding Company. The only assets of MetLife Capital Trusts II and III are junior subordinated debentures issued by the Holding Company. Common Equity Units Each common equity unit has an initial stated amount of $25 per unit and consists of: ) A 1/80 or 1.25% ($12.50), undivided beneﬁcial ownership interest in a series A trust preferred security of MetLife Capital Trust II (‘‘Series A Trust’’), with an initial liquidation amount of $1,000. ) A 1/80 or 1.25% ($12.50), undivided beneﬁcial ownership interest in a series B trust preferred security of MetLife Capital Trust III (‘‘Series B Trust’’ and, together with the Series A Trust, the ‘‘Trusts’’), with an initial liquidation amount of $1,000. ) A stock purchase contract under which the holder of the common equity unit will purchase and the Holding Company will sell, on each of the initial stock purchase date and the subsequent stock purchase date, a variable number of shares of the Holding Company’s common stock, par value $0.01 per share, for a purchase price of $12.50. Junior Subordinated Debentures Issued to Support Trust Common and Preferred Securities The Holding Company issued $1,067 million 4.82% Series A and $1,067 million 4.91% Series B junior subordinated debt securities due no later than February 15, 2039 and February 15, 2040, respectively, for a total of $2,134 million, in exchange for $2,070 million in aggregate proceeds from the sale of the trust preferred securities by the Trusts and $64 million in trust common securities issued equally by the Trusts. The common and preferred securities of the Trusts, totaling $2,134 million, represent undivided beneﬁcial ownership interests in the assets of the Trusts, have no stated maturity and must be redeemed upon maturity of the corresponding series of junior subordinated debt securities — the sole assets of the respective Trusts. The Series A and Series B Trusts will make quarterly distributions on the common and preferred securities at an annual rate of 4.82% and 4.91%, respectively. The trust common securities, which are held by the Holding Company, represent a 3% interest in the Trusts and are reﬂected as ﬁxed maturities in the accompanying consolidated balance sheet of MetLife, Inc. The Trusts are VIEs in accordance with FIN 46 and FIN 46(r), and the Company does not consolidate its interest in MetLife Capital Trusts II and III as it is not the primary beneﬁciary of either of the Trusts. The Holding Company has directly guaranteed the repayment of the trust preferred securities to the holders thereof to the extent that there are funds available in the Trusts. The guarantee will remain in place until the full redemption of the trust preferred securities. The trust preferred securities held by the common equity unit holders are pledged to the Holding Company to collateralize the obligation of the common equity unit holders under the related stock purchase contracts. The common equity unit holder may substitute certain zero coupon treasury securities in place of the trust preferred securities as collateral under the stock purchase contract. The trust preferred securities have remarketing dates which correspond with the initial and subsequent stock purchase dates to provide the holders of the common equity units with the proceeds to exercise the stock purchase contracts. The initial stock purchase date is expected to be August 15, 2008, but could be deferred for quarterly periods until February 15, 2009, and the subsequent stock purchase date is expected to be February 15, 2009, but could be deferred for quarterly periods until February 15, 2010. At the remarketing date, the remarketing agent will have the ability to reset the interest rate on the trust preferred securities to generate sufﬁcient remarketing proceeds to satisfy the common equity unit holder’s obligation under the stock purchase contract, subject to a reset cap for each of the ﬁrst two attempted remarketings of each series. The interest rate on the supporting junior subordinated debt securities issued by the Holding Company will be reset at a commensurate rate. If the initial remarketing is unsuccessful, the remarketing agent will attempt to remarket the trust preferred securities, as necessary, in subsequent quarters through February 15, 2009 for the Series A MetLife, Inc. F-41 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. trust preferred securities and through February 15, 2010 for the Series B trust preferred securities. The ﬁnal attempt at remarketing will not be subject to the reset cap. If all remarketing attempts are unsuccessful, the Holding Company has the right, as a secured party, to apply the liquidation amount on the trust preferred securities to the common equity unit holders obligation under the stock purchase contract and to deliver to the common equity unit holder a junior subordinated debt security payable on August 15, 2010 at an annual rate of 4.82% and 4.91% on the Series A and Series B trust preferred securities, respectively, in payment of any accrued and unpaid distributions. Interest expense related to the junior subordinated debentures underlying common equity units was $55 million for the year ended December 31, 2005. Stock Purchase Contracts Each stock purchase contract requires the holder of the common equity unit to purchase, and the Holding Company to sell, for $12.50, on each of the initial stock purchase date and the subsequent stock purchase date, a number of newly issued or treasury shares of the Holding Company’s common stock, par value $0.01 per share, equal to the applicable settlement rate. The settlement rate at the respective stock purchase date will be calculated based on the closing price of the common stock during a speciﬁed 20-day period immediately preceding the applicable stock purchase date. If the market value of the Holding Company’s common stock is less than the threshold appreciation price of $53.10 but greater than $43.35, the reference price, the settlement rate will be a number of the Holding Company’s common stock equal to the stated amount of $12.50 divided by the market value. If the market value is less than or equal to the reference price, the settlement rate will be 0.28835 shares of the Holding Company’s common stock. If the market value is greater than or equal to the threshold appreciation price, the settlement rate will be 0.23540 shares of the Holding Company’s common stock. Accordingly, upon settlement in the aggregate, the Holding Company will receive proceeds of $2,070 million and issue between 39.0 million and 47.8 million shares of its common stock. The stock purchase contract may be exercised at the option of the holder at any time prior to the settlement date. However, upon early settlement, the holder will receive the minimum settlement rate. The stock purchase contracts further require the Holding Company to pay the holder of the common equity unit quarterly contract payments on the stock purchase contracts at the annual rate of 1.510% on the stated amount of $25 per stock purchase contract until the initial stock purchase date and at the annual rate of 1.465% on the remaining stated amount of $12.50 per stock purchase contract thereafter. The quarterly distributions on the Series A and Series B trust preferred securities of 4.82% and 4.91%, respectively, combined with the contract payments on the stock purchase contract of 1.510%, (1.465% after the initial stock purchase date) result in the 6.375% yield on the common equity units. If the Holding Company defers any of the contract payments on the stock purchase contract, then it will accrue additional amounts on the deferred amounts at the annual rate of 6.375% until paid, to the extent permitted by law. The value of the stock purchase contracts at issuance, $96.6 million, were calculated as the present value of the future contract payments due under the stock purchase contract of 1.510% through the initial stock purchase date, and 1.465% up to the subsequent stock purchase date, discounted at the interest rate on the supporting junior subordinated debt securities issued by the Holding Company, 4.82% or 4.91% on the Series A and Series B trust preferred securities, respectively. The value of the stock purchase contracts were recorded in other liabilities with an offsetting decrease in additional paid-in capital. The other liability balance related to the stock purchase contracts will accrue interest at the discount rate of 4.82% or 4.91%, as applicable, with an offsetting increase to interest expense. When the contract payments are made under the stock purchase contracts they will reduce the other liability balance. During the year ended December 31, 2005, the Holding Company increased the other liability balance for the accretion of the discount on the contract payment of $2 million and made contract payments of $13 million. Issuance Costs In connection with the offering of common equity units, the Holding Company incurred approximately $55.3 million of issuance costs of which $5.8 million relate to the issuance of the junior subordinated debt securities underlying common equity notes which fund the Series A and Series B trust preferred securities and $49.5 million relate to the expected issuance of the common stock under the stock purchase contracts. The $5.8 million in debt issuance costs have been capitalized, are included in other assets, and will be amortized using the effective interest method over the period from issuance date of the common equity units to the initial and subsequent stock purchase date. The remaining $49.5 million of costs relate to the common stock issuance under the stock purchase contracts and have been recorded as a reduction of additional paid-in capital. Earnings Per Common Share The stock purchase contracts are reﬂected in diluted earnings per common share using the treasury stock method, and are dilutive when the weighted average market price of the Holding Company’s common stock is greater than or equal to the threshold appreciation price. During the period from the date of issuance through December 31, 2005, the weighted average market price of the Holding Company’s common stock was less than the threshold appreciation price. Accordingly, the stock purchase contracts did not have an impact on diluted earnings common per share. See Note 16. 10. Shares Subject to Mandatory Redemption and Company-Obligated Mandatorily Redeemable Securities of Subsidiary Trusts MetLife Capital Trust I. In connection with MetLife, Inc.’s, initial public offering in April 2000, the Holding Company and MetLife Capital Trust I, a wholly-owned trust (the ‘‘Trust’’), issued equity security units (the ‘‘units’’). Each unit originally consisted of (i) a contract to purchase, for $50, shares of the Holding Company’s common stock (the ‘‘purchase contracts’’) on May 15, 2003; and (ii) a capital security of the Trust, with a stated liquidation amount of $50. In accordance with the terms of the units, the Trust was dissolved on February 5, 2003, and $1,006 million aggregate principal amount of 8.00% debentures of the Holding Company (the ‘‘MetLife debentures’’), the sole assets of the Trust, were distributed to the owners of the Trust’s capital securities in exchange for their capital securities. The MetLife debentures were remarketed on behalf of the debenture owners on February 12, 2003 and the interest rate on the MetLife debentures was reset as of February 15, 2003 to 3.911% per annum. As a result of the remarketing, the debenture owners received $21 million ($0.03 per diluted common share) in excess of the carrying value of the capital securities. This excess was recorded by the Company as a charge to additional paid-in capital and, for the purpose of calculating earnings per share, is subtracted from net income to arrive at net income available to common shareholders. On May 15, 2003, the purchase contracts associated with the units were settled. In exchange for $1,006 million, the Company issued 2.97 shares of MetLife, Inc. common stock per purchase contract, or 59.8 million shares of treasury stock. The excess of the Company’s cost of the treasury stock F-42 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. ($1,662 million) over the contract price of the stock issued to the purchase contract holders ($1,006 million) was $656 million, which was recorded as a direct reduction to retained earnings. Due to the dissolution of the Trust in 2003, there was no interest expense on capital securities for the years ended December 31, 2005 and 2004. Interest expense on the capital securities is included in other expenses and was $10 million for the year ended December 31, 2003. GenAmerica Capital I. In June 1997, GenAmerica Corporation (‘‘GenAmerica’’) issued $125 million of 8.525% capital securities through a wholly- owned subsidiary trust, GenAmerica Capital I. GenAmerica has fully and unconditionally guaranteed, on a subordinated basis, the obligation of the trust under the capital securities and is obligated to mandatorily redeem the securities on June 30, 2027. GenAmerica may prepay the securities any time after June 30, 2007. Capital securities outstanding were $119 million, net of unamortized discounts of $6 million, at both December 31, 2005 and 2004. Interest expense on these instruments is included in other expenses and was $11 million for each of the years ended December 31, 2005, 2004, and 2003. RGA Capital Trust I. In December 2001, RGA, through its wholly-owned trust, RGA Capital Trust I (the ‘‘Trust’’), issued 4,500,000 Preferred Income Equity Redeemable Securities (‘‘PIERS’’) Units. Each PIERS unit consists of (i) a preferred security issued by the Trust, having a stated liquidation amount of $50 per unit, representing an undivided beneﬁcial ownership interest in the assets of the Trust, which consist solely of junior subordinated debentures issued by RGA which have a principal amount at maturity of $50 and a stated maturity of March 18, 2051; and (ii) a warrant to purchase, at any time prior to December 15, 2050, 1.2508 shares of RGA stock at an exercise price of $50. The fair market value of the warrant on the issuance date was $14.87 and is detachable from the preferred security. RGA fully and unconditionally guarantees, on a subordinated basis, the obligations of the Trust under the preferred securities. The preferred securities and subordinated debentures were issued at a discount (original issue discount) to the face or liquidation value of $14.87 per security. The securities will accrete to their $50 face/liquidation value over the life of the security on a level yield basis. The weighted average effective interest rate on the preferred securities and the subordinated debentures is 8.25% per annum. Capital securities outstanding were $159 million, net of unamortized discounts of $66 million, at both December 31, 2005 and 2004. 11. Income Taxes The provision for income taxes from continuing operations was as follows: Years Ended December 31, 2005 2004 2003 (In millions) Current: Federal ************************************************************************************* $ 328 State and local ****************************************************************************** 63 Foreign************************************************************************************* 111 $ 691 51 154 502 896 $301 22 47 370 Deferred: Federal ************************************************************************************* $ 733 State and local ****************************************************************************** 14 Foreign************************************************************************************* 11 $ 191 6 (64) $231 27 (12) 758 Provision for income taxes*********************************************************************** $1,260 133 246 $1,029 $616 Reconciliations of the income tax provision at the U.S. statutory rate to the provision for income taxes as reported for continuing operations were as follows: Years Ended December 31, 2005 2004 2003 (In millions) Tax provision at U.S. statutory rate **************************************************************** $1,540 Tax effect of: Tax exempt investment income ***************************************************************** State and local income taxes ****************************************************************** Prior year taxes ****************************************************************************** Foreign operations net of foreign income taxes**************************************************** Foreign operations repatriation ***************************************************************** Other, net ********************************************************************************** (169) 35 (31) (44) (27) (44) Provision for income taxes*********************************************************************** $1,260 $1,283 $855 (131) 37 (105) (36) — (19) (118) 44 (26) (81) — (58) $1,029 $616 Included in the 2005 total tax provision is a $27 million tax beneﬁt related to the repatriation of foreign earnings pursuant to Internal Revenue Code Section 965 for which a U.S. deferred tax position had previously been recorded. The Company is under continuous examination by the Internal Revenue Service (‘‘IRS’’) and other tax authorities in jurisdictions in which the Company has signiﬁcant business operations. The income tax years under examination vary by jurisdiction. In 2004 the Company recorded an adjustment of $91 million for the settlement of all federal income tax issues relating to the IRS’s audit of the Company’s tax returns for the years 1997- 1999. Such settlement is reﬂected in the 2004 tax expense as an adjustment to prior year taxes. The Company also received $22 million in interest on such settlement and incurred an $8 million tax expense on such settlement for a total impact to net income of $105 million. The current IRS examination covers the years 2000-2002 and the Company expects it to be completed in 2006. The Company regularly assesses the likelihood of additional assessments in each taxing jurisdiction resulting from current and subsequent years’ examinations. Liabilities for income taxes have been established for MetLife, Inc. F-43 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. future income tax assessments when it is probable there will be future assessments and the amount thereof can be reasonably estimated. Once established, liabilities for uncertain tax positions are adjusted only when there is more information available or when an event occurs necessitating a change to the liabilities. The Company believes that the resolution of income tax matters for open years will not have a material effect on its consolidated ﬁnancial statements although the resolution of income tax matters could impact the Company’s effective tax rate for a particular future period. Deferred income taxes represent the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following: December 31, 2005 2004 (In millions) Deferred income tax assets: Policyholder liabilities and receivables ****************************************************************** $ 5,049 Net operating loss carryforwards ********************************************************************** 1,017 Capital loss carryforwards**************************************************************************** 75 Tax credit carryforwards ***************************************************************************** 102 Intangibles***************************************************************************************** 82 Litigation related ************************************************************************************ 64 Other********************************************************************************************* 178 Less: Valuation allowance **************************************************************************** Deferred income tax liabilities: Investments *************************************************************************************** Deferred policy acquisition costs ********************************************************************** Net unrealized investment gains*********************************************************************** Other********************************************************************************************* 6,567 199 6,368 1,838 4,989 1,041 206 8,074 Net deferred income tax (liability) asset ******************************************************************* $(1,706) $ 3,982 434 118 30 112 85 152 4,913 23 4,890 1,544 3,965 1,676 178 7,363 $(2,473) Domestic net operating loss carryforwards amount to $2,580 million at December 31, 2005 and will expire beginning in 2015. Foreign net operating loss carryforwards amount to $392 million at December 31, 2005 and were generated in various foreign countries with expiration periods of ﬁve years to inﬁnity. Capital loss carryforwards amount to $213 million at December 31, 2005 and will expire beginning in 2006. Tax credit carryforwards amount to $102 million at December 31, 2005 and will expire beginning in 2006. The Company has recorded a valuation allowance related to tax beneﬁts of certain foreign net operating loss carryforwards. The valuation allowance reﬂects management’s assessment, based on available information, that it is more likely than not that the deferred income tax asset for certain foreign net operating loss carryforwards will not be realized. The tax beneﬁt will be recognized when management believes that it is more likely than not that these deferred income tax assets are realizable. In 2005, the Company recorded $176 million of additional deferred income tax valuation allowance related to certain foreign net operating loss carryforwards. 12. Contingencies, Commitments, and Guarantees Contingencies Litigation The Company is a defendant in a large number of litigation matters. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the United States permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufﬁcient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrate to management that the monetary relief which may be speciﬁed in a lawsuit or claim bears little relevance to its merits or disposition value. Thus, unless stated below, the speciﬁc monetary relief sought is not noted. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be inherently impossible to ascertain with any degree of certainty. Inherent uncertainties can include how fact ﬁnders will view individually and in their totality documentary evidence, the credibility and effectiveness of witnesses’ testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. On a quarterly and yearly basis, the Company reviews relevant information with respect to liabilities for litigation and contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. Unless stated below, estimates of possible additional losses or ranges of loss for particular matters cannot in the ordinary course be made with a reasonable degree of certainty. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities have been established for a number of the matters noted below. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of December 31, 2005. F-44 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Sales Practices Claims Over the past several years, Metropolitan Life, New England Mutual Life Insurance Company (‘‘New England Mutual’’) and General American Life Insurance Company (‘‘General American’’) have faced numerous claims, including class action lawsuits, alleging improper marketing and sales of individual life insurance policies or annuities. These lawsuits generally are referred to as ‘‘sales practices claims.’’ In December 1999, a federal court approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies and annuity contracts or certiﬁcates issued pursuant to individual sales in the United States by Metropolitan Life, Metropolitan Insurance and Annuity Company or Metropolitan Tower Life Insurance Company between January 1, 1982 and December 31, 1997. Similar sales practices class actions against New England Mutual, with which Metropolitan Life merged in 1996, and General American, which was acquired in 2000, have been settled. In October 2000, a federal court approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies issued by New England Mutual between January 1, 1983 through August 31, 1996. A federal court has approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies issued by General American between January 1, 1982 through December 31, 1996. An appellate court has afﬁrmed the order approving the settlement. Certain class members have opted out of the class action settlements noted above and have brought or continued non-class action sales practices lawsuits. In addition, other sales practices lawsuits, including lawsuits or other proceedings relating to the sale of mutual funds and other products, have been brought. As of December 31, 2005, there are approximately 338 sales practices litigation matters pending against Metropolitan Life; approximately 45 sales practices litigation matters pending against New England Mutual, New England Life Insurance Company, and New England Securities Corporation (collectively, ‘‘New England’’); approximately 34 sales practices litigation matters pending against General American; and approximately 35 sales practices litigation matters pending against Walnut Street Securities, Inc. (‘‘Walnut Street’’). In addition, similar litigation matters are pending against MetLife Securities, Inc. (‘‘MSI’’). Metropolitan Life, New England, General American, MSI and Walnut Street continue to defend themselves vigorously against these litigation matters. Some individual sales practices claims have been resolved through settlement, won by dispositive motions, or, in a few instances, have gone to trial. Most of the current cases seek substantial damages, including in some cases punitive and treble damages and attorneys’ fees. Additional litigation relating to the Company’s marketing and sales of individual life insurance, mutual funds and other products may be commenced in the future. The Metropolitan Life class action settlement did not resolve two putative class actions involving sales practices claims ﬁled against Metropolitan Life in Canada, and these actions remain pending. The Company believes adequate provision has been made in its consolidated ﬁnancial statements for all probable and reasonably estimable losses for sales practices claims against Metropolitan Life, New England, General American, MSI and Walnut Street. Regulatory authorities in a small number of states have had investigations or inquiries relating to Metropolitan Life’s, New England’s, General American’s, MSI’s or Walnut Street’s sales of individual life insurance policies or annuities or other products. Over the past several years, these and a number of investigations by other regulatory authorities were resolved for monetary payments and certain other relief. The Company may continue to resolve investigations in a similar manner. Asbestos-Related Claims Metropolitan Life is also a defendant in thousands of lawsuits seeking compensatory and punitive damages for personal injuries allegedly caused by exposure to asbestos or asbestos-containing products. Metropolitan Life has never engaged in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products nor has Metropolitan Life issued liability or workers’ compensation insurance to companies in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products. Rather, these lawsuits principally have been based upon allegations relating to certain research, publication and other activities of one or more of Metropolitan Life’s employees during the period from the 1920’s through approximately the 1950’s and have alleged that Metropolitan Life learned or should have learned of certain health risks posed by asbestos and, among other things, improperly publicized or failed to disclose those health risks. Metropolitan Life believes that it should not have legal liability in such cases. Legal theories asserted against Metropolitan Life have included negligence, intentional tort claims and conspiracy claims concerning the health risks associated with asbestos. Although Metropolitan Life believes it has meritorious defenses to these claims, and has not suffered any adverse monetary judgments in respect of these claims, due to the risks and expenses of litigation, almost all past cases have been resolved by settlements. Metropolitan Life’s defenses (beyond denial of certain factual allegations) to plaintiffs’ claims include that: (i) Metropolitan Life owed no duty to the plaintiffs — it had no special relationship with the plaintiffs and did not manufacture, produce, distribute or sell the asbestos products that allegedly injured plaintiffs; (ii) plaintiffs cannot demonstrate justiﬁable detrimental reliance; and (iii) plaintiffs cannot demonstrate proximate causation. In defending asbestos cases, Metropolitan Life selects various strategies depending upon the jurisdictions in which such cases are brought and other factors which, in Metropolitan Life’s judgment, best protect Metropolitan Life’s interests. Strategies include seeking to settle or compromise claims, motions challenging the legal or factual basis for such claims or defending on the merits at trial. Since 2002, trial courts in California, Utah, Georgia, New York, Texas, and Ohio granted motions dismissing claims against Metropolitan Life on some or all of the above grounds. Other courts have denied motions brought by Metropolitan Life to dismiss cases without the necessity of trial. There can be no assurance that Metropolitan Life will receive favorable decisions on motions in the future. Metropolitan Life intends to continue to exercise its best judgment regarding settlement or defense of such cases, including when trials of these cases are appropriate. Metropolitan Life continues to study its claims experience, review external literature regarding asbestos claims experience in the United States and consider numerous variables that can affect its asbestos liability exposure, including bankruptcies of other companies involved in asbestos litigation and legislative and judicial developments, to identify trends and to assess their impact on the recorded asbestos liability. Bankruptcies of other companies involved in asbestos litigation, as well as advertising by plaintiffs’ asbestos lawyers, may be resulting in an increase in the cost of resolving claims and could result in an increase in the number of trials and possible adverse verdicts Metropolitan Life may experience. Plaintiffs are seeking additional funds from defendants, including Metropolitan Life, in light of such bankruptcies by certain other defendants. In addition, publicity regarding legislative reform efforts may result in an increase or decrease in the number of claims. Metropolitan Life previously reported that it had received approximately 23,500 asbestos-related claims in 2004. In the context of reviewing in the third quarter of 2005 certain pleadings received in 2004, it was determined that there was a small undercount of Metropolitan Life’s asbestos-related MetLife, Inc. F-45 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. claims in 2004. Accordingly, Metropolitan Life now reports that it received approximately 23,900 asbestos-related claims in 2004. The total number of asbestos personal injury claims pending against Metropolitan Life as of the dates indicated, the number of new claims during the years ended on those dates and the total settlement payments made to resolve asbestos personal injury claims during those years are set forth in the following table: At or For the Years Ended December 31, 2005 2004 2003 (Dollars in millions) Asbestos personal injury claims at year end (approximate) ************************************ Number of new claims during the year (approximate) **************************************** Settlement payments during the year(1) *************************************************** $ 100,250 18,500 74.3 108,000 23,900 85.5 $ 111,700 58,750 84.2 $ (1) Settlement payments represent payments made by Metropolitan Life during the year in connection with settlements made in that year and in prior years. Amounts do not include Metropolitan Life’s attorneys’ fees and expenses and do not reﬂect amounts received from insurance carriers. The Company believes adequate provision has been made in its consolidated ﬁnancial statements for all probable and reasonably estimable losses for asbestos-related claims. The ability of Metropolitan Life to estimate its ultimate asbestos exposure is subject to considerable uncertainty due to numerous factors. The availability of data is limited and it is difﬁcult to predict with any certainty numerous variables that can affect liability estimates, including the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. The number of asbestos cases that may be brought or the aggregate amount of any liability that Metropolitan Life may ultimately incur is uncertain. Accordingly, it is reasonably possible that the Company’s total exposure to asbestos claims may be greater than the liability recorded by the Company in its consolidated ﬁnancial statements and that future charges to income may be necessary. While the potential future charges could be material in particular quarterly or annual periods in which they are recorded, based on information currently known by management, management does not believe any such charges are likely to have a material adverse effect on the Company’s consolidated ﬁnancial position. Metropolitan Life increased its recorded liability for asbestos-related claims by $402 million from approximately $820 million to $1,225 million at December 31, 2002. This total recorded asbestos-related liability (after the self-insured retention) was within the coverage of the excess insurance policies discussed below. Metropolitan Life regularly reevaluates its exposure from asbestos litigation and has updated its liability analysis for asbestos- related claims through December 31, 2005. During 1998, Metropolitan Life paid $878 million in premiums for excess insurance policies for asbestos-related claims. The excess insurance policies for asbestos-related claims provide for recovery of losses up to $1,500 million, which is in excess of a $400 million self-insured retention. The asbestos-related policies are also subject to annual and per-claim sublimits. Amounts are recoverable under the policies annually with respect to claims paid during the prior calendar year. Although amounts paid by Metropolitan Life in any given year that may be recoverable in the next calendar year under the policies will be reﬂected as a reduction in the Company’s operating cash ﬂows for the year in which they are paid, management believes that the payments will not have a material adverse effect on the Company’s liquidity. Each asbestos-related policy contains an experience fund and a reference fund that provides for payments to Metropolitan Life at the commutation date if the reference fund is greater than zero at commutation or pro rata reductions from time to time in the loss reimbursements to Metropolitan Life if the cumulative return on the reference fund is less than the return speciﬁed in the experience fund. The return in the reference fund is tied to performance of the Standard & Poor’s 500 Index and the Lehman Brothers Aggregate Bond Index. A claim with respect to the prior year was made under the excess insurance policies in 2003, 2004 and 2005 for the amounts paid with respect to asbestos litigation in excess of the retention. As the performance of the indices impacts the return in the reference fund, it is possible that loss reimbursements to the Company and the recoverable with respect to later periods may be less than the amount of the recorded losses. Such foregone loss reimbursements may be recovered upon commutation depending upon future performance of the reference fund. If at some point in the future, the Company believes the liability for probable and reasonably estimable losses for asbestos-related claims should be increased, an expense would be recorded and the insurance recoverable would be adjusted subject to the terms, conditions and limits of the excess insurance policies. Portions of the change in the insurance recoverable would be recorded as a deferred gain and amortized into income over the estimated remaining settlement period of the insurance policies. The foregone loss reimbursements were approximately $8.3 million with respect to 2002 claims, $15.5 million with respect to 2003 claims and $15.1 million with respect to 2004 claims and estimated as of December 31, 2005, to be approximately $45.4 million in the aggregate, including future years. Property and Casualty Actions A purported class action has been ﬁled against Metropolitan Property and Casualty Insurance Company’s (‘‘MPC’’) subsidiary, Metropolitan Casualty Insurance Company, in Florida alleging breach of contract and unfair trade practices with respect to allowing the use of parts not made by the original manufacturer to repair damaged automobiles. Discovery is ongoing and a motion for class certiﬁcation is pending. Two purported nationwide class actions have been ﬁled against MPC in Illinois. One suit claims breach of contract and fraud due to the alleged underpayment of medical claims arising from the use of a purportedly biased provider fee pricing system. A motion for class certiﬁcation has been ﬁled and discovery is ongoing. The second suit claims breach of contract and fraud arising from the alleged use of preferred provider organizations to reduce medical provider fees covered by the medical claims portion of the insurance policy. The court recently granted MPC’s motion to dismiss the fraud claim in the second suit. A purported class action has been ﬁled against MPC in Montana. This suit alleges breach of contract and bad faith for not aggregating medical payment and uninsured coverages provided in connection with the several vehicles identiﬁed in insureds’ motor vehicle policies. A recent decision by the Montana Supreme Court in a suit involving another insurer determined that aggregation is required. The parties have reached an agreement to settle this suit. MPC has recorded a liability in an amount the Company believes is adequate to resolve the claims underlying this matter. The amount to be paid will not be material to MPC. Certain plaintiffs’ lawyers in another action have alleged that the use of certain automated databases to provide total loss vehicle valuation methods was improper. MPC, along with a number of other insurers, agreed in July 2005 to resolve this issue in a class action format. Management believes that the amount to be paid in resolution of this matter will not be material to MPC. In December 2005, a purported class action was ﬁled against MPC in Louisiana federal court on behalf of insureds who incurred total property losses as a result of Hurricane Katrina. Plaintiffs claim they are entitled to coverage for all of their claims. A lawsuit was ﬁled against MPC in November 2005 in Mississippi federal court by two policyholders challenging the denial of a claim under their homeowners policy for damage caused to their F-46 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. property during Hurricane Katrina. In 2006, MPC was sued in two additional Hurricane Katrina-related actions, one in Louisiana and one in Mississippi and it is reasonably possible other actions will be ﬁled. The Company intends to vigorously defend these matters. Demutualization Actions Several lawsuits were brought in 2000 challenging the fairness of Metropolitan Life’s plan of reorganization, as amended (the ‘‘plan’’) and the adequacy and accuracy of Metropolitan Life’s disclosure to policyholders regarding the plan. These actions named as defendants some or all of Metropolitan Life, the Holding Company, the individual directors, the New York Superintendent of Insurance (the ‘‘Superintendent’’) and the underwriters for MetLife, Inc.’s initial public offering, Goldman Sachs & Company and Credit Suisse First Boston. In 2003, a trial court within the commercial part of the New York State court granted the defendants’ motions to dismiss two purported class actions. In 2004, the appellate court modiﬁed the trial court’s order by reinstating certain claims against Metropolitan Life, the Holding Company and the individual directors. Plaintiffs in these actions have ﬁled a consolidated amended complaint. Plaintiffs’ motion to certify a litigation class is pending. Another purported class action ﬁled in New York State court in Kings County has been consolidated with this action. The plaintiffs in the state court class actions seek compensatory relief and punitive damages. Five persons brought a proceeding under Article 78 of New York’s Civil Practice Law and Rules challenging the Opinion and Decision of the Superintendent who approved the plan. In this proceeding, petitioners sought to vacate the Superintendent’s Opinion and Decision and enjoin him from granting ﬁnal approval of the plan. On November 10, 2005, the trial court granted respondents’ motions to dismiss this proceeding. Petitioners have ﬁled a notice of appeal. In a class action against Metropolitan Life and the Holding Company pending in the United States District Court for the Eastern District of New York, plaintiffs served a second consolidated amended complaint in 2004. In this action, plaintiffs assert violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 in connection with the plan, claiming that the Policyholder Information Booklets failed to disclose certain material facts and contained certain material misstatements. They seek rescission and compensatory damages. On June 22, 2004, the court denied the defendants’ motion to dismiss the claim of violation of the Securities Exchange Act of 1934. The court had previously denied defendants’ motion to dismiss the claim for violation of the Securities Act of 1933. In 2004, the court reafﬁrmed its earlier decision denying defendants’ motion for summary judgment as premature. On July 19, 2005, this federal trial court certiﬁed a class action against Metropolitan Life and the Holding Company. Metropolitan Life and the Holding Company have ﬁled a petition seeking permission for an interlocutory appeal from this order. Metropolitan Life, the Holding Company and the individual defendants believe they have meritorious defenses to the plaintiffs’ claims and are contesting vigorously all of the plaintiffs’ claims in these actions. In 2001, a lawsuit was ﬁled in the Superior Court of Justice, Ontario, Canada on behalf of a proposed class of certain former Canadian policyholders against the Holding Company, Metropolitan Life, and Metropolitan Life Insurance Company of Canada. Plaintiffs’ allegations concern the way that their policies were treated in connection with the demutualization of Metropolitan Life; they seek damages, declarations, and other non-pecuniary relief. The defendants believe they have meritorious defenses to the plaintiffs’ claims and will contest vigorously all of plaintiffs’ claims in this matter. On April 30, 2004, a lawsuit was ﬁled in New York state court in New York County against the Holding Company and Metropolitan Life on behalf of a proposed class comprised of the settlement class in the Metropolitan Life sales practices class action settlement approved in December 1999 by the United States District Court for the Western District of Pennsylvania. In their amended complaint, plaintiffs challenged the treatment of the cost of the sales practices settlement in the demutualization of Metropolitan Life and asserted claims of breach of ﬁduciary duty, common law fraud, and unjust enrichment. In an order dated July 13, 2005, the court granted the defendants’ motion to dismiss the action and the plaintiffs have ﬁled a notice of appeal. Other A putative class action lawsuit which commenced in October 2000 is pending in the United States District Court for the District of Columbia, in which plaintiffs allege that they were denied certain ad hoc pension increases awarded to retirees under the Metropolitan Life retirement plan. The ad hoc pension increases were awarded only to retirees (i.e., individuals who were entitled to an immediate retirement beneﬁt upon their termination of employment) and not available to individuals like these plaintiffs whose employment, or whose spouses’ employment, had terminated before they became eligible for an immediate retirement beneﬁt. The plaintiffs seek to represent a class consisting of former Metropolitan Life employees, or their surviving spouses, who are receiving deferred vested annuity payments under the retirement plan and who were allegedly eligible to receive the ad hoc pension increases. In September 2005, Metropolitan Life’s motion for summary judgment was granted. Plaintiffs have moved for reconsideration. On February 21, 2006, the SEC and New England Securities Corporation (‘‘NES’’), a subsidiary of NELICO, resolved a formal investigation of NES that arose in response to NES informing the SEC that certain systems and controls relating to one NES advisory program were not operating effectively. NES previously provided restitution to the affected clients and the settlement includes additional client payments to be made by NES in the total amount of approximately $2,615,000. No penalties were imposed. In May 2003, the American Dental Association and three individual providers sued MetLife and Cigna in a purported class action lawsuit brought in a Florida federal district court. The plaintiffs purport to represent a nationwide class of in-network providers who allege that their claims are being wrongfully reduced by downcoding, bundling, and the improper use and programming of software. The complaint alleges federal racketeering and various state law theories of liability. MetLife is vigorously defending the matter. The district court has granted in part and denied in part MetLife’s motion to dismiss. MetLife has ﬁled another motion to dismiss. The court has issued a tag-along order, related to a medical managed care trial, which will stay the lawsuit indeﬁnitely. In a lawsuit commenced in June 1998, a New York state court granted in 2004 plaintiffs’ motion to certify a litigation class of owners of certain participating life insurance policies and a sub-class of New York owners of such policies in an action asserting that Metropolitan Life breached their policies and violated New York’s General Business Law in the manner in which it allocated investment income across lines of business during a period ending with the 2000 demutualization. Plaintiffs sought compensatory damages. In January 2006, the appellate court reversed the class certiﬁcation order. On November 23, 2005, the trial court issued a Memorandum Decision granting Metropolitan Life’s motion for summary judgment. The plaintiffs’ time to appeal the trial court’s decision has not yet expired. Regulatory bodies have contacted the Company and have requested information relating to market timing and late trading of mutual funds and variable insurance products and, generally, the marketing of products. The Company believes that many of these inquiries are similar to those made to many ﬁnancial services companies as part of industry-wide investigations by various regulatory agencies. The SEC has commenced an investigation with respect to market timing and late trading in a limited number of privately-placed variable insurance contracts that were sold through General American. As previously reported, in May 2004, General American received a Wells Notice stating that the SEC staff is considering recommending that the SEC bring a MetLife, Inc. F-47 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. civil action alleging violations of the U.S. securities laws against General American. Under the SEC procedures, General American can avail itself of the opportunity to respond to the SEC staff before it makes a formal recommendation regarding whether any action alleging violations of the U.S. securities laws should be considered. General American has responded to the Wells Notice. The Company is fully cooperating with regard to these information requests and investigations. The Company at the present time is not aware of any systemic problems with respect to such matters that may have a material adverse effect on the Company’s consolidated ﬁnancial position. As anticipated, the SEC issued a formal order of investigation related to certain sales by a former MetLife sales representative to the Sheriff’s Department of Fulton County, Georgia. The Company is fully cooperating with respect to inquiries from the SEC. The Company has received a number of subpoenas and other requests from the Ofﬁce of the Attorney General of the State of New York seeking, among other things, information regarding and relating to compensation agreements between insurance brokers and the Company, whether MetLife has provided or is aware of the provision of ‘‘ﬁctitious’’ or ‘‘inﬂated’’ quotes, and information regarding tying arrangements with respect to reinsurance. Based upon an internal review, the Company advised the Attorney General for the State of New York that MetLife was not aware of any instance in which MetLife had provided a ‘‘ﬁctitious’’ or ‘‘inﬂated’’ quote. MetLife also has received subpoenas, including sets of interrogatories, from the Ofﬁce of the Attorney General of the State of Connecticut seeking information and documents including contingent commission payments to brokers and MetLife’s awareness of any ‘‘sham’’ bids for business. MetLife also has received a Civil Investigative Demand from the Ofﬁce of the Attorney General for the State of Massachusetts seeking information and documents concerning bids and quotes that the Company submitted to potential customers in Massachusetts, the identity of agents, brokers, and producers to whom the Company submitted such bids or quotes, and communications with a certain broker. The Company has received two subpoenas from the District Attorney of the County of San Diego, California. The subpoenas seek numerous documents including incentive agreements entered into with brokers. The Florida Department of Financial Services and the Florida Ofﬁce of Insurance Regulation also have served subpoenas on the Company asking for answers to interrogatories and document requests concerning topics that include compensation paid to intermediaries. The Ofﬁce of the Attorney General for the State of Florida has also served a subpoena on the Company seeking, among other things, copies of materials produced in response to the subpoenas discussed above. The Company has received a subpoena from the Ofﬁce of the U.S. Attorney for the Southern District of California asking for documents regarding the insurance broker, Universal Life Resources. The Insurance Commissioner of Oklahoma has served a subpoena, including a set of interrogatories, on the Company seeking, among other things, documents and information concerning the compensation of insurance producers for insurance covering Oklahoma entities and persons. The Ohio Department of Insurance has requested documents regarding a broker and certain Ohio public entity groups. The Company continues to cooperate fully with these inquiries and is responding to the subpoenas and other requests. MetLife is continuing to conduct an internal review of its commission payment practices. Approximately sixteen broker-related lawsuits in which the Company was named as a defendant were ﬁled. Voluntary dismissals and consolidations have reduced the number of pending actions to four. In one of these, the California Insurance Commissioner is suing in California state court Metropolitan Life, Paragon Life Insurance Company and other companies alleging that the defendants violated certain provisions of the California Insurance Code. Another of these actions is pending in a multi-district proceeding established in the federal district court in the District of New Jersey. In this proceeding, plaintiffs have ﬁled an amended class action complaint consolidating the claims from separate actions that had been ﬁled in or transferred to the District of New Jersey. The consolidated amended complaint alleges that the Holding Company, Metropolitan Life, several other insurance companies and several insurance brokers violated RICO, ERISA, and antitrust laws and committed other misconduct in the context of providing insurance to employee beneﬁt plans and to persons who participate in such employee beneﬁt plans. Plaintiffs seek to represent classes of employers that established employee beneﬁt plans and persons who participated in such employee beneﬁt plans. A motion for class certiﬁcation has been ﬁled. Plaintiffs in several other actions have voluntarily dismissed their claims. The Company intends to vigorously defend these cases. In addition to those discussed above, regulators and others have made a number of inquiries of the insurance industry regarding industry brokerage practices and related matters and other inquiries may begin. It is reasonably possible that MetLife will receive additional subpoenas, interrogatories, requests and lawsuits. MetLife will fully cooperate with all regulatory inquiries and intends to vigorously defend all lawsuits. The Company has received a subpoena from the Connecticut Attorney General requesting information regarding its participation in any ﬁnite reinsurance transactions. MetLife has also received information requests relating to ﬁnite insurance or reinsurance from other regulatory and governmental authorities. MetLife believes it has appropriately accounted for its transactions of this type and intends to cooperate fully with these information requests. The Company believes that a number of other industry participants have received similar requests from various regulatory and governmental authorities. It is reasonably possible that MetLife or its subsidiaries may receive additional requests. MetLife and any such subsidiaries will fully cooperate with all such requests. As previously disclosed, the NASD staff notiﬁed MSI, NES and Walnut Street, all direct or indirect subsidiaries of MetLife, Inc., that it has made a preliminary determination to ﬁle charges of violations of the NASD’s and the SEC’s rules against the ﬁrms. The pending investigation was initiated after the ﬁrms reported to the NASD that a limited number of mutual fund transactions processed by ﬁrm representatives and at the ﬁrms’ consolidated trading desk, during the period April through December 2003, had been received from customers after 4:00 p.m., Eastern time, and received the same day’s net asset value. The potential charges of violations of the NASD’s and the SEC’s rules relate to the processing of transactions received after 4:00 p.m., the ﬁrms’ maintenance of books and records, supervisory procedures and responses to the NASD’s information requests. Under the NASD’s procedures, the ﬁrms have submitted a response to the NASD staff. The NASD staff has not made a formal recommendation regarding whether any action alleging violations of the rules should be ﬁled. MetLife continues to cooperate fully with the NASD. Following an inquiry commencing in March 2004, the staff of the NASD has notiﬁed MSI that it has made a preliminary determination to recommend charging MSI with the failure to adopt, maintain and enforce written supervisory procedures reasonably designed to achieve compliance with suitability requirements regarding the sale of college savings plans, also known as 529 plans. This notiﬁcation follows an industry-wide inquiry by the NASD examining sales of 529 plans. Under the NASD’s procedures, MSI submitted its written explanation of why it believes charges should not be ﬁled. The NASD staff has not made a formal recommendation regarding whether any action alleging violations of applicable rules should be ﬁled. MSI continues to cooperate fully with the NASD. In February 2006, the Company learned that the SEC has commenced a formal investigation of NES in connection with the suitability of its sales of various universal life insurance policies. The Company believes that others in the insurance industry are the subject of similar investigations by the SEC. NES is cooperating fully with the SEC. F-48 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. MSI received in 2005 a notice from the Illinois Department of Securities asserting possible violations of the Illinois Securities Act in connection with sales of a former afﬁliate’s mutual funds. A response has been submitted and MSI intends to cooperate fully with the Illinois Department of Securities. In August 1999, an amended putative class action complaint was ﬁled in Connecticut state court against The Travelers Life and Annuity Company (‘‘TLAC’’), Travelers Equity Sales, Inc. and certain former afﬁliates. The amended complaint alleges Travelers Property Casualty Corporation, a former TLAC afﬁliate, purchased structured settlement annuities from TLAC and spent less on the purchase of those structured settlement annuities than agreed with claimants, and that commissions paid to brokers for the structured settlement annuities, including an afﬁliate of TLAC, were paid in part to Travelers Property Casualty Corporation. On May 26, 2004, the Connecticut Superior Court certiﬁed a nationwide class action involving the following claims against TLAC: violation of the Connecticut Unfair Trade Practice Statute, unjust enrichment, and civil conspiracy. On June 15, 2004, the defendants appealed the class certiﬁcation order and the appeal is now pending before the Connecticut Supreme Court. A former registered representative of Tower Square Securities, Inc. (‘‘Tower Square’’), a broker-dealer subsidiary of The Travelers Insurance Company (‘‘TIC’’), is alleged to have defrauded individuals by diverting funds for his personal use. In June 2005, the SEC issued a formal order of investigation with respect to Tower Square and served Tower Square with a subpoena. The Securities and Business Investments Division of the Connecticut Department of Banking and the NASD are also reviewing this matter. Tower Square intends to fully cooperate with the SEC, the NASD and the Connecticut Department of Banking. In the context of the above, two arbitration matters were commenced in 2005 against Tower Square. In one of the matters, defendants include other unafﬁliated broker-dealers with whom the registered representative was formerly registered. It is reasonably possible that other actions will be brought regarding this matter. Tower Square intends to defend itself vigorously in all such cases. Metropolitan Life also has been named as a defendant in a number of silicosis, welding and mixed dust cases in various states. The Company intends to defend itself vigorously against these cases. Various litigation, including purported or certiﬁed class actions, and various claims and assessments against the Company, in addition to those discussed above and those otherwise provided for in the Company’s consolidated ﬁnancial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. Summary It is not feasible to predict or determine the ultimate outcome of all pending investigations and legal proceedings or provide reasonable ranges of potential losses, except as noted above in connection with speciﬁc matters. In some of the matters referred to above, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s consolidated ﬁnancial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require life insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual beneﬁts owed pursuant to insurance policies issued by impaired, insolvent or failed life insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assessments levied against the Company were $4 million, $10 million and $6 million for the years ended December 31, 2005, 2004 and 2003, respectively. The Company maintained a liability of $90 million, and a related asset for premium tax offsets of $54 million, at December 31, 2005 for undiscounted future assessments in respect of currently impaired, insolvent or failed insurers. Impact of Hurricanes On August 29, 2005, Hurricane Katrina made landfall in the states of Louisiana, Mississippi and Alabama causing catastrophic damage to these coastal regions. As of December 31, 2005, the Company recognized total net losses related to the catastrophe of $134 million, net of income taxes and reinsurance recoverables and including reinstatement premiums and other reinsurance-related premium adjustments, which impacted the Auto & Home and Institutional segments. The Auto & Home and Institutional segments recorded net losses related to the catastrophe of $120 million and $14 million, each net of income taxes and reinsurance recoverables and including reinstatement premiums and other reinsurance-related premium adjustments, respectively. MetLife’s gross losses from Katrina were approximately $335 million, primarily arising from the Company’s homeowners business. On October 24, 2005, Hurricane Wilma made landfall across the state of Florida. As of December 31, 2005, the Company’s Auto & Home segment recognized total losses related to the catastrophe of $32 million, net of income taxes and reinsurance recoverables. MetLife’s gross losses from Hurricane Wilma were approximately $57 million arising from the Company’s homeowners and automobile businesses. Additional hurricane-related losses may be recorded in future periods as claims are received from insureds and claims to reinsurers are processed. Reinsurance recoveries are dependent on the continued creditworthiness of the reinsurers, which may be affected by their other reinsured losses in connection with Hurricanes Katrina and Wilma and otherwise. In addition, lawsuits, including purported class actions, have been ﬁled in Mississippi and Louisiana challenging denial of claims for damages caused to their property during Hurricane Katrina. MPC is a named party in some of these lawsuits. In addition, rulings in cases in which MPC is not a party may affect interpretation of its policies. MPC intends to vigorously defend these matters. However, any adverse rulings could result in an increase in the Company’s hurricane-related claim exposure and losses. Based on information currently known by management, it does not believe that additional claim losses resulting from Hurricane Katrina will have a material adverse impact on the Company’s consolidated ﬁnancial statements. MetLife, Inc. F-49 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Argentina As a part of the Travelers acquisition, the Company acquired Citigroup’s insurance operations in Argentina. The Argentinean economic, regulatory and legal environment, including interpretations of laws and regulations by regulators and courts, is uncertain. Potential legal or governmental actions related to pension reform, ﬁduciary responsibilities, performance guarantees and tax rulings could adversely affect the results of the Company. Upon acquisition, the Company established liabilities related to insurance liabilities, most signiﬁcantly death and disability policy liabilities, based upon its interpretation of Argentinean law and the Company’s best estimate of its obligations under such law. Additionally, the Company has established certain liabilities related to its estimated obligations associated with litigation and tax rulings related to pesiﬁcation. Commitments Leases In accordance with industry practice, certain of the Company’s income from lease agreements with retail tenants is contingent upon the level of the tenants’ sales revenues. Additionally, the Company, as lessee, has entered into various lease and sublease agreements for ofﬁce space, data processing and other equipment. Future minimum rental and sublease income, and minimum gross rental payments relating to these lease agreements were as follows: Rental Income Sublease Income (In millions) Gross Rental Payments 2006 *************************************************************************************** $440 2007 *************************************************************************************** $398 2008 *************************************************************************************** $329 2009 *************************************************************************************** $270 2010 *************************************************************************************** $218 Thereafter *********************************************************************************** $737 $20 $17 $14 $ 7 $ 6 $17 $218 $196 $165 $131 $104 $524 Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commit- ments were $2,684 million and $1,324 million at December 31, 2005 and 2004, respectively. The Company anticipates that these amounts will be invested in partnerships over the next ﬁve years. Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $2,974 million and $1,189 million at December 31, 2005 and 2004, respectively. Other Commitments TIC is a member of the Federal Home Loan Bank of Boston (the ‘‘FHLB of Boston’’) and holds $70 million of common stock of the FHLB of Boston, which is included in equity securities on the Company’s balance sheets. TIC has also entered into several funding agreements with the FHLB of Boston whereby TIC has issued such funding agreements in exchange for cash and for which the FHLB of Boston has been granted a blanket lien on TIC’s residential mortgages and mortgage-backed securities to collateralize TIC’s obligations under the funding agreements. TIC maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualiﬁed collateral is sufﬁcient to satisfy the collateral maintenance level. The funding agreements and the related security agreement represented by this blanket lien, provide that upon any event of default by TIC, the FHLB of Boston’s recovery is limited to the amount of TIC’s liability under the outstanding funding agreements. The amount of the Company’s liability for funding agreements with the Bank as of December 31, 2005 is $1.1 billion, which is included in policyholder account balances. On December 12, 2005, RGA repurchased 1.6 million shares of its outstanding common stock at an aggregate price of approximately $76 million under an accelerated share repurchase agreement with a major bank. The bank borrowed the stock sold to RGA from third parties and is purchasing the shares in the open market over the subsequent few months to return to the lenders. RGA will either pay or receive an amount based on the actual amount paid by the bank to purchase the shares. These repurchases resulted in an increase in the Company’s ownership percentage of RGA to approximately to 53% at December 31, 2005 from approximately 52% at December 31, 2004. In February 2006, the ﬁnal purchase price was determined resulting in a cash settlement substantially equal to the aggregate cost. RGA recorded the initial repurchase of shares as treasury stock and recorded the amount received as an adjustment to the cost of the treasury stock. Guarantees In the course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties pursuant to which it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other speciﬁc liabilities, and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemniﬁcations to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $2 billion, with a cumulative maximum of $5.2 billion, while in other cases such limitations are not speciﬁed or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In addition, the Company indemniﬁes its directors and ofﬁcers as provided in its charters and by-laws. Also, the Company indemniﬁes other of its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation F-50 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these indemnities in the future. The Company has also guaranteed minimum investment returns on certain international retirement funds in accordance with local laws. Since these guarantees are not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In the ﬁrst quarter of 2005, the Company recorded a liability of $4 million with respect to indemnities provided in connection with a certain disposition. The approximate term for this liability is 18 months. The maximum potential amount of future payments the Company could be required to pay under these indemnities is approximately $500 million. Due to the uncertainty in assessing changes to the liability over the term, the liability on the Company’s consolidated balance sheet will remain until either expiration or settlement of the guarantee unless evidence clearly indicates that the estimates should be revised. In the third quarter of 2005, the Company released $6 million of a liability due to the expiration of indemnities provided in a prior year disposition. The Company’s recorded liabilities at December 31, 2005 and 2004 for indemnities, guarantees and commitments were $9 million and $10 million, respectively. In connection with RSATs, the Company writes credit default swap obligations requiring payment of principal due in exchange for the reference credit obligation, depending on the nature or occurrence of speciﬁed credit events for the referenced entities. In the event of a speciﬁed credit event, the Company’s maximum amount at risk, assuming the value of the referenced credits becomes worthless, is $593 million at December 31, 2005. The credit default swaps expire at various times during the next six years. 13. Employee Beneﬁt Plans Pension and Other Postretirement Beneﬁt Plans Certain subsidiaries of the Holding Company (the ‘‘Subsidiaries’’) are sponsors and/or administrators of deﬁned beneﬁt pension plans covering eligible employees and sales representatives. Retirement beneﬁts are based upon years of credited service and ﬁnal average or career average earnings history. The Subsidiaries also provide certain postemployment beneﬁts and certain postretirement health care and life insurance beneﬁts for retired employees. Employees of the Subsidiaries who were hired prior to 2003 (or, in certain cases, rehired during or after 2003) and meet age and service criteria while working for a covered subsidiary, may become eligible for these postretirement beneﬁts, at various levels, in accordance with the applicable plans. The Subsidiaries have issued group annuity and life insurance contracts supporting approximately 98% of all pension and postretirement employee beneﬁt plans assets sponsored by the Subsidiaries. In connection with the acquisition of Travelers, the employees of Travelers and any other Citigroup afﬁliate in the United States who became employees of certain Subsidiaries in connection with that acquisition (including those who remained employees of companies acquired in that acquisition) will be credited with service recognized by Citigroup for purposes of determining eligibility and vesting under The Metropolitan Life Retirement Plan for United States Employees (the ‘‘Plan’’), a noncontributory qualiﬁed deﬁned beneﬁt pension plan, with respect to beneﬁts earned under the Plan subsequent to the closing date of the acquisition. Neither the Holding Company nor its subsidiaries assumed an obligation for beneﬁts earned under deﬁned beneﬁt plans of Citigroup or Travelers prior to the acquisition. A December 31 measurement date is used for all of the Subsidiaries’ deﬁned beneﬁt pension and other postretirement beneﬁt plans. MetLife, Inc. F-51 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Obligations, Funded Status and Net Periodic Beneﬁt Costs December 31, Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2005 2004 (In millions) Change in projected beneﬁt obligation: Projected beneﬁt obligation at beginning of year ****************************************** $5,523 142 318 — (1) 90 — 6 (312) Service cost********************************************************************** Interest cost ********************************************************************** Plan participants’ contributions******************************************************* Acquisitions and divestitures ******************************************************** Actuarial losses (gains) ************************************************************* Change in beneﬁts **************************************************************** Transfers in (out) of controlled group************************************************** Beneﬁts paid ********************************************************************* Projected beneﬁt obligation at end of year *********************************************** $5,269 129 311 — (3) 147 — — (330) $1,975 37 121 28 1 172 7 (5) (160) $2,090 32 119 25 — (139) 1 — (153) 5,766 5,523 2,176 1,975 Change in plan assets: Fair value of plan assets at beginning of year ******************************************** Actual return on plan assets ******************************************************** Acquisitions and divestitures ******************************************************** Employer contribution ************************************************************** Beneﬁts paid ********************************************************************* Fair value of plan assets at end of year ************************************************* Underfunded *********************************************************************** (248) Unrecognized net asset at transition **************************************************** — Unrecognized net actuarial losses****************************************************** 1,528 Unrecognized prior service cost ******************************************************* 54 Prepaid (accrued) beneﬁt cost ********************************************************* $1,334 5,392 404 (1) 4 (281) 5,518 4,728 416 (3) 526 (275) 5,392 (131) 1 1,510 67 1,062 60 — 2 (31) 1,093 (1,083) 1 377 (122) 1,005 93 — 2 (38) 1,062 (913) — 199 (165) $1,447 $ (827) $ (879) Qualiﬁed plan prepaid pension cost **************************************************** $1,691 Non-qualiﬁed plan accrued pension cost ************************************************ (435) Intangible assets ******************************************************************** 12 Accumulated other comprehensive loss************************************************* 66 Prepaid (accrued) beneﬁt cost ********************************************************* $1,334 $1,782 (478) 13 130 $ — $ — (879) — — (827) — — $1,447 $ (827) $ (879) The prepaid (accrued) beneﬁt cost for pension beneﬁts presented in the above table consists of prepaid beneﬁt costs of $1,696 million and $1,785 million as of December 31, 2005 and 2004, respectively, and accrued beneﬁt costs of $362 million and $338 million as of December 31, 2005 and 2004, respectively. The aggregate projected beneﬁt obligation and aggregate fair value of plan assets for the pension plans were as follows: Qualiﬁed Plan Non-Qualiﬁed Plan Total 2005 2004 2005 2004 2005 2004 (In millions) Aggregate fair value of plan assets (principally Company contracts) ********** $5,518 Aggregate projected beneﬁt obligation ********************************** 5,258 Over (under) funded ************************************************* $ 260 $5,392 4,999 $ — $ — $5,518 5,766 524 508 $5,392 5,523 $ 393 $(508) $(524) $ (248) $ (131) The accumulated beneﬁt obligation for all deﬁned beneﬁt pension plans was $5,349 million and $5,149 million at December 31, 2005 and 2004, respectively. Information for pension plans with an accumulated beneﬁt obligation in excess of plan assets: Projected beneﬁt obligation ********************************************************************************* $538 Accumulated beneﬁt obligation ****************************************************************************** $449 Fair value of plan assets *********************************************************************************** $ 19 $550 $482 $ 17 December 31, 2005 2004 (In millions) F-52 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Information for pension and other postretirement plans with a projected beneﬁt obligation in excess of plan assets: December 31, Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2005 2004 Projected beneﬁt obligation*************************************************************** $538 Fair value of plan assets ***************************************************************** $ 19 The components of net periodic beneﬁt cost were as follows: (In millions) $550 $ 17 $2,176 $1,093 $1,975 $1,062 Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2003 2005 2004 2003 Service cost **************************************************************** $ 142 Interest cost **************************************************************** 318 Expected return on plan assets ************************************************ (446) Amortization of prior actuarial losses ******************************************** 116 Amortization of prior service cost *********************************************** 16 Curtailment cost************************************************************* — Net periodic beneﬁt cost****************************************************** $ 146 (In millions) $ 123 314 (335) 86 16 10 $ 37 121 (79) 15 (17) — $ 129 311 (428) 101 16 — $ 32 119 (77) 7 (19) — $ 39 123 (72) 8 (20) 3 $ 129 $ 214 $ 77 $ 62 $ 81 The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the ‘‘Prescription Drug Act’’). The other postretirement beneﬁt plan accumulated beneﬁt obligation were remeasured effective July 1, 2004 in order to determine the effect of the expected subsidies on net periodic other postretirement beneﬁt cost. As a result, the accumulated other postretirement beneﬁt obligation was reduced by $213 million at July 1, 2004 and net periodic other postretirement beneﬁt cost from July 1, 2004 through December 31, 2004 was reduced by $17 million. The reduction of net periodic beneﬁt cost was due to reductions in service cost of $3 million, interest cost of $6 million, and amortization of prior actuarial loss of $8 million. The reduction in the accumulated postretirement beneﬁt obligation related to the Prescription Drug Act was $298 million and $230 million as of December 31, 2005 and 2004, respectively. For the year ended December 31, 2005, the reduction of net periodic postretirement beneﬁt cost was $45 million, which was due to reductions in service cost of $6 million, interest cost of $16 million and amortization of prior actuarial loss of $23 million. An additional $23 million reduction in the December 31, 2005 accumulated other postretirement beneﬁt obligation is the result of an actuarial loss recognized during the year resulting from updated assumptions including a January 1, 2005 participant census and new claims cost experience and the effect of a December 31, 2005 change in the discount rate. Assumptions Assumptions used in determining beneﬁt obligations were as follows: December 31, Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2005 2004 Weighted average discount rate ************************************************************ Rate of compensation increase************************************************************* 3% – 8% 3% – 8% N/A Assumptions used in determining net periodic beneﬁt cost were as follows: 5.82% 5.87% 5.82% 5.88% N/A December 31, Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2003 2005 2004 2003 Weighted average discount rate *********************************** 5.83% Weighted average expected rate of return on plan assets ************* 8.50% Rate of compensation increase *********************************** 3% – 8% The discount rate is based on the yield of a hypothetical portfolio of high-quality debt instruments available on the valuation date, measured on a yield to worst basis, which would provide the necessary future cash ﬂows to pay the aggregate projected beneﬁt obligation when due. The expected rate of return on plan assets is based on anticipated performance of the various asset sectors in which the plan invests, weighted by target allocation percentages. Anticipated future performance is based on long-term historical returns of the plan assets by sector, adjusted for the Subsidiaries’ long-term expectations on the performance of the markets. While the precise expected return derived using this approach will ﬂuctuate from year to year, the Subsidiaries’ policy is to hold this long-term assumption constant as long as it remains within reasonable tolerance from the derived rate. The weighted expected return on plan assets for use in that plan’s valuation in 2006 is currently anticipated to be 8.25% for pension beneﬁts and other postretirement medical beneﬁts and 6.25% for other postretirement life beneﬁts. 6.74% 5.98% 6.20% 6.82% 8.51% 7.51% 7.91% 7.79% N/A 6.10% 8.50% 3% – 8% 3% – 8% N/A N/A The assumed health care cost trend rates used in measuring the accumulated other postretirement beneﬁt obligation were as follows: December 31, 2005 2004 Pre-Medicare eligible claims ******************************************* 9.5% down to 5% in 2014 Medicare eligible claims *********************************************** 11.5% down to 5% in 2018 8% down to 5% in 2010 10% down to 5% in 2014 MetLife, Inc. F-53 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Assumed health care cost trend rates may have a signiﬁcant effect on the amounts reported for health care plans. A one-percentage point change in assumed health care cost trend rates would have the following effects: Effect on total of service and interest cost components ************************************************ Effect of accumulated postretirement beneﬁt obligation ************************************************* $ 15 $182 $ (12) $(153) Plan Assets The weighted average allocation of pension plan and other postretirement beneﬁt plan assets is as follows: One Percent Increase One Percent Decrease (In millions) December 31, Pension Beneﬁts Other Postretirement Beneﬁts 2005 2004 2005 2004 Asset Category Equity securities******************************************************************************** Fixed maturities ******************************************************************************** Other (Real Estate and Alternative Investments) ****************************************************** 47% 50% 42% 41% 37% 36% 53% 57% 2% 16% 14% Total *************************************************************************************** 100% 100% 100% 100% 5% The weighted average target allocation of pension plan and other postretirement beneﬁt plan assets for 2006 is as follows: Pension Beneﬁts Other Postretirement Beneﬁts Asset Category Equity securities ******************************************************************************* 30% - 65% Fixed maturities******************************************************************************** 20% - 70% Other (Real Estate and Alternative Investments) ***************************************************** 0% - 25% Target allocations of assets are determined with the objective of maximizing returns and minimizing volatility of net assets through adequate asset 30% - 45% 45% - 70% 0% - 10% diversiﬁcation. Adjustments are made to target allocations based on an assessment of the impact of economic factors and market conditions. The account values of the group annuity and life insurance contracts issued by the Subsidiaries and held as assets of the pension and postretirement beneﬁt plans, were $6,471 million and $6,335 million as of December 31, 2005 and 2004, respectively. The majority of such account values are held in separate accounts established by the Subsidiaries. Total revenue from these contracts recognized in the consolidated statements of income was $28 million, $28 million and $90 million for the years ended December 31, 2005, 2004 and 2003, respectively, and includes policy charges, net investment income from investments backing the contracts and administrative fees. Total investment income, including realized and unrealized gains and losses, credited to the account balances were $460 million, $519 million and $776 million for the years ended December 31, 2005, 2004 and 2003, respectively. The terms of these contracts are consistent in all material respects with what the Subsidiaries offer to unafﬁliated parties which are similarly situated. Cash Flows The Subsidiaries expect to contribute $187 million to its pension plans and $128 million to its other postretirement beneﬁt plans during 2006. Gross beneﬁt payments for the next ten years, which reﬂect expected future service as appropriate, are expected to be as follows: 2006 ******************************************************************************************* $ 320 2007 ******************************************************************************************* $ 325 2008 ******************************************************************************************* $ 337 2009 ******************************************************************************************* $ 351 2010 ******************************************************************************************* $ 355 2011-2015 ************************************************************************************** $1,984 Gross subsidy payments expected to be received for the next ten years under the Medicare Prescription Drug, Improvement and Modernization Act $128 $133 $138 $144 $150 $833 of 2003 are as follows: Pension Beneﬁts Other Postretirement Beneﬁts (In millions) 2006 *************************************************************************************************** 2007 *************************************************************************************************** 2008 *************************************************************************************************** 2009 *************************************************************************************************** 2010 *************************************************************************************************** 2011-2015 ********************************************************************************************** $11 $12 $13 $13 $14 $83 F-54 MetLife, Inc. Other Postretirement Beneﬁts (In millions) NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Savings and Investment Plans The Subsidiaries sponsor savings and investment plans for substantially all employees under which a portion of employee contributions are matched. The Subsidiaries contributed $71 million, $64 million and $59 million for the years ended December 31, 2005, 2004 and 2003, respectively. 14. Equity Preferred Stock On September 29, 1999, the Holding Company adopted a stockholder rights plan (the ‘‘rights plan’’) under which each outstanding share of common stock issued between April 4, 2000 and the distribution date (as deﬁned in the rights plan) will be coupled with a stockholder right. Each right will entitle the holder to purchase one one-hundredth of a share of Series A Junior Participating Preferred Stock. Each one one-hundredth of a share of Series A Junior Participating Preferred Stock will have economic and voting terms equivalent to one share of common stock. Until it is exercised, the right itself will not entitle the holder thereof to any rights as a stockholder, including the right to receive dividends or to vote at stockholder meetings. Stockholder rights are not exercisable until the distribution date, and will expire at the close of business on April 4, 2010, unless earlier redeemed or exchanged by the Holding Company. The rights plan is designed to protect stockholders in the event of unsolicited offers to acquire the Holding Company and other coercive takeover tactics. In connection with ﬁnancing the acquisition of Travelers on July 1, 2005, which is more fully described in Note 2, the Company issued preferred shares as follows: On June 13, 2005, the Holding Company issued 24 million shares of Floating Rate Non-Cumulative Preferred Stock, Series A (the ‘‘Series A preferred shares’’) with a $0.01 par value per share, and a liquidation preference of $25 per share for aggregate proceeds of $600 million. On June 16, 2005, the Holding Company issued 60 million shares of 6.50% Non-Cumulative Preferred Stock, Series B (the ‘‘Series B preferred shares’’), with a $0.01 par value per share, and a liquidation preference of $25 per share, for aggregate proceeds of $1.5 billion. The Series A and Series B preferred shares (the ‘‘Preferred Shares’’) rank senior to the common stock with respect to dividends and liquidation rights. Dividends on the Preferred Shares are not cumulative. Holders of the Preferred Shares will be entitled to receive dividend payments only when, as and if declared by the Holding Company’s board of directors or a duly authorized committee of the board. If dividends are declared on the Series A preferred shares, they will be payable quarterly, in arrears, at an annual rate of the greater of (i) 1.00% above three-month LIBOR on the related LIBOR determination date; or (ii) 4.00%. Any dividends declared on the Series B preferred shares will be payable quarterly, in arrears, at an annual ﬁxed rate of 6.50%. Accordingly, in the event that dividends are not declared on the Preferred Shares for payment on any dividend payment date, then those dividends will cease to accrue and be payable. If a dividend is not declared before the dividend payment date, the Holding Company has no obligation to pay dividends accrued for that dividend period whether or not dividends are declared and paid in future periods. No dividends may, however, be paid or declared on the Holding Company’s common stock — or any other securities ranking junior to the Preferred Shares — unless the full dividends for the latest completed dividend period on all Preferred Shares, and any parity stock, have been declared and paid or provided for. The Holding Company is prohibited from declaring dividends on the Preferred Shares if it fails to meet speciﬁed capital adequacy, net income and shareholders’ equity levels. In addition, under Federal Reserve Board policy, the Holding Company may not be able to pay dividends if it does not earn sufﬁcient operating income. The Preferred Shares do not have voting rights except in certain circumstances where the dividends have not been paid for an equivalent of six or more dividend payment periods whether or not those periods are consecutive. Under such circumstances, the holders of the Preferred Shares have certain voting rights with respect to members of the board of directors of the Holding Company. The Preferred Shares are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. The Preferred Shares are redeemable but not prior to September 15, 2010. On and after that date, subject to regulatory approval, the Preferred Shares will be redeemable at the Holding Company’s option in whole or in part, at a redemption price of $25 per Preferred Share, plus declared and unpaid dividends. In connection with the offering of the Preferred Shares, the Holding Company incurred approximately $56.8 million of issuance costs which have been recorded as a reduction of additional paid-in capital. On November 15, 2005, the Holding Company’s board of directors declared dividends of $0.3077569 per share, for a total of $8 million, on the Series A preferred shares, and $0.4062500 per share, for a total of $24 million, on the Series B preferred shares. Both dividends were paid on December 15, 2005 to shareholders of record as of November 30, 2005. On August 22, 2005, the Holding Company’s board of directors declared dividends of $0.286569 per share, for a total of $7 million, on the Series A preferred shares, and $0.4017361 per share, for a total of $24 million, on the Series B preferred shares. Both dividends were paid on September 15, 2005 to shareholders of record as of August 31, 2005. See Note 21 for further information. Common Stock On October 26, 2004, the Holding Company’s board of directors authorized a $1 billion common stock repurchase program. Under this authorization, the Holding Company may purchase its common stock from the MetLife Policyholder Trust, in the open market and in privately negotiated transactions. As a result of the acquisition of Travelers (see Note 2), the Holding Company has suspended its common stock repurchase activity. Future common stock repurchases will be dependent upon several factors, including the Company’s capital position, its ﬁnancial strength and credit ratings, general market conditions and the price of the Holding Company’s common stock. On December 16, 2004, the Holding Company repurchased 7,281,553 shares of its outstanding common stock at an aggregate cost of $300 million under an accelerated common stock repurchase agreement with a major bank. The bank borrowed the stock sold to the Holding Company from third parties and purchased the common stock in the open market to return to such third parties. In April 2005, the Holding Company received a cash adjustment of approximately $7 million based on the actual amount paid by the bank to purchase the common stock, for a ﬁnal purchase price of approximately $293 million. The Holding Company recorded the shares initially repurchased as treasury stock and recorded the amount received as an adjustment to the cost of the treasury stock. See Note 9 regarding stock purchase contracts issued by the Company on June 21, 2005 in connection with the issuance of the common equity units. MetLife, Inc. F-55 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The Company did not acquire any shares of the Holding Company’s common stock during the year ended December 31, 2005. The Company acquired 26,373,952 and 2,997,200 shares of the Holding Company’s common stock for $1,000 million and $97 million during the years ended December 31, 2004 and 2003, respectively. During the years ended December 31, 2005, 2004 and 2003, 25,049,065, 1,675,814 and 59,904,925 shares of common stock were issued from treasury stock for $819 million, $50 million and $1,667 million, respectively, of which 22,436,617 shares for approximately $1 billion were issued in connection with the acquisition of Travelers on July 1, 2005 (see Note 2) and 59,771,221 shares were issued on May 15, 2003 in connection with the settlement of common stock purchase contracts (see Note 10) for $1,006 million in cash. At December 31, 2005, the Holding Company had approximately $716 million remaining on the October 26, 2004 common stock repurchase program. On October 25, 2005, the Holding Company’s board of directors approved an annual dividend for 2005 of $0.52 per share of common stock, for a total of $394 million, payable on December 15, 2005 to common shareholders of record on November 7, 2005. On September 28, 2004, the Holding Company’s board of directors approved an annual dividend for 2004 of $0.46 per share of common stock, for a total of $343 million, payable on December 13, 2004 to shareholders of record on November 5, 2004. On October 21, 2003, the Holding Company’s board of directors approved an annual dividend for 2003 of $0.23 per share of common stock, for a total of $175 million, payable on December 15, 2003 to shareholders of record on November 7, 2003. Dividend Restrictions Under New York State Insurance Law, Metropolitan Life is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to the Holding Company as long as the aggregate amount of all such dividends in any calendar year does not exceed the lesser of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). Metropolitan Life will be permitted to pay a cash dividend to the Holding Company in excess of the lesser of such two amounts only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Insurance (the ‘‘Superintendent’’) and the Superintendent does not disapprove the distribution within 30 days of its ﬁling. Under New York State Insurance Law, the Superintendent has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its shareholders. The New York State Department of Insurance has established informal guidelines for such determinations. The guidelines, among other things, focus on the insurer’s overall ﬁnancial condition and proﬁtability under statutory accounting practices. During the years ended December 31, 2005, 2004 and 2003, Metropolitan Life paid to the Holding Company $880 million, $797 million and $698 million, respectively, in ordinary dividends, the maximum amount which could be paid to the Holding Company without prior regulatory approval, and an additional $2,320 mil- lion, $0 million and $750 million, respectively, in special dividends, as approved by the Superintendent. The maximum amount of the dividend which Metropolitan Life may pay to the Holding Company in 2006 without prior regulatory approval is $863 million. Under Connecticut State Insurance Law, TIC is permitted, without prior insurance regulatory clearance, to pay shareholder dividends to its parent as long as the amount of such dividend, when aggregated with all other dividends in the preceding twelve months, does not exceed the greater of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year. TIC will be permitted to pay a cash dividend in excess of the greater of such two amounts only if it ﬁles notice of its declaration of such a dividend and the amount thereof with the Connecticut Commissioner of Insurance (‘‘Commissioner’’) and the Commissioner does not disapprove the payment within 30 days after notice or until the Commissioner has approved the dividend, whichever is sooner. In addition, any dividend that exceeds earned surplus (unassigned funds, reduced by 25% of unrealized appreciation in value or revaluation of assets or unrealized proﬁts on investments) as of the last ﬁled annual statutory statement requires insurance regulatory approval. Under Connecticut State Insurance Law, the Commissioner has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its shareholders. The Connecticut State Insurance Law requires prior approval for any dividends for a period of two years following a change in control. As a result of the acquisition of TIC by the Holding Company, under Connecticut State Insurance Law all dividend payments by TIC through June 30, 2007 require prior approval of the Commissioner. TIC has not paid any dividends since its acquisition by the Holding Company. Under Rhode Island State Insurance Law, MPC is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to the Holding Company as long as the aggregate amount of all such dividends in any twelve-month period does not exceed the lesser of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year; or (ii) net income, not including capital gains, for the immediately preceding calendar year. MPC will be permitted to pay a cash dividend to the Holding Company in excess of the lesser of such two amounts only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the Rhode Island Superintendent of Insurance (the ‘‘Rhode Island Superintendent’’) and the Rhode Island Superintendent does not disapprove the distribution within 30 days of its ﬁling. Under Rhode Island State Insurance Code, the Rhode Island Superintendent has broad discretion in determining whether the ﬁnancial condition of a stock property and casualty insurance company would support the payment of such dividends to its shareholders. During the years ended December 31, 2005, 2004 and 2003, MPC paid to the Holding Company $0 million, $0 million and $75 million, respectively, in ordinary dividends, the maximum amount which could be paid to the Holding Company without prior regulatory approval and an additional $400 million, $300 million and $0 million, respectively, in special dividends, as approved by the Rhode Island Superintendent. The maximum amount of the dividend which MPC may pay to the Holding Company in 2006 without prior regulatory approval is $178 million for dividends with a scheduled date of payment subsequent to June 1, 2006. Any dividend payment prior to June 1, 2006 will require prior regulatory approval. Under Delaware State Insurance Law, Metropolitan Tower Life Insurance Company (‘‘MTL’’) is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to the Holding Company as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding capital gains). MTL will be permitted to pay a cash dividend to the Holding Company in excess of the greater of such two amounts only if it ﬁles notice of the declaration of such a dividend and the amount thereof with the Delaware Superintendent of Insurance (the ‘‘Delaware Superintendent’’) and the Delaware Superintendent does not disapprove the distribution within 30 days of its ﬁling. In addition, any dividend that exceeds earned surplus (deﬁned as unassigned funds) as of the immediately preceding calendar year requires insurance regulatory approval. Under Delaware State Insurance Law, the Delaware Superintendent has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its shareholders. During the year ended December 31, 2005, MTL paid to the Holding Company $54 million in ordinary dividends, the maximum amount which could be paid to the Holding F-56 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Company as of the date of the dividend without prior regulatory approval, and an additional $873 million in special dividends, as approved by the Delaware Superintendent. On October 8, 2004, Metropolitan Insurance and Annuity Company (‘‘MIAC’’) was merged into MTL. Prior to the merger, MIAC paid the Holding Company $65 million in dividends for which prior insurance regulatory clearance was not required and paid no special dividends for the year ended December 31, 2004. For the year ended December 31, 2003, MIAC paid to the Holding Company $104 million in dividends for which prior insurance regulatory clearance was not required and $94 million in special dividends. MTL, exclusive of MIAC, paid no dividends to the Holding Company during the years ended December 31, 2004 and 2003. The maximum amount of dividends that may be paid to the Holding Company from MTL in 2006, without prior regulatory approval, is $85 million, for dividends with a scheduled date of payment subsequent to May 25, 2006. Stock Compensation Plans The MetLife, Inc. 2000 Stock Incentive Plan, as amended (the ‘‘Stock Incentive Plan’’), authorized the granting of awards in the form of non-qualiﬁed or incentive stock options qualifying under Section 422A of the Internal Revenue Code. The MetLife, Inc. 2000 Directors Stock Plan, as amended (the ‘‘Directors Stock Plan’’), authorized the granting of awards in the form of stock awards, non-qualiﬁed stock options, or a combination of the foregoing to outside Directors of the Holding Company. Under the MetLife, Inc. 2005 Stock and Incentive Compensation Plan, as amended (the ‘‘2005 Stock Plan’’), awards granted may be in the form of non-qualiﬁed stock options or incentive stock options qualifying under Section 422A of the Internal Revenue Code, Stock Appreciation Rights, Restricted Stock or Restricted Stock Units, Performance Shares or Performance Share Units, Cash-Based Awards, and Stock-Based Awards (each as deﬁned in the 2005 Stock Plan). Under the MetLife, Inc. 2005 Non-Management Director Stock Compensation Plan (the ‘‘2005 Directors Stock Plan’’), awards granted may be in the form of non-qualiﬁed stock options, Stock Appreciation Rights, Restricted Stock or Restricted Stock Units, or Stock-Based Awards (each as deﬁned in the 2005 Directors Stock Plan). The Stock Incentive Plan, Directors Stock Plan, 2005 Stock Plan, the 2005 Directors Stock Plan and the Long-Term Performance Compensation Plan (‘‘LTPCP’’), as described below, are hereinafter collectively referred to as the ‘‘Incentive Plans.’’ The aggregate number of shares reserved for issuance under the 2005 Stock Plan is 68,000,000 plus those shares available but not utilized under the Stock Incentive Plan and those shares utilized under the Stock Incentive Plan that are recovered due to forfeiture of stock options. At the commencement of the 2005 Stock Plan, additional shares carried forward from the Stock Incentive Plan and available for issuance under the 2005 Stock Plan were 11,917,472. Each share issued under the 2005 Stock Plan in connection with a stock option or Stock Appreciation Right reduces the number of shares remaining for issuance under that plan by one, and each share issued under the 2005 Stock Plan in connection with awards other than stock options or Stock Appreciation Rights reduces the number of shares remaining for issuance under that plan by 1.179 shares. The number of shares reserved for issuance under the 2005 Directors Stock Plan is 2,000,000. All stock options granted have an exercise price equal to the fair market value price of the Holding Company’s common stock on the date of grant, and a maximum term of ten years. Certain stock options granted under the Stock Incentive Plan and the 2005 Stock Plan become exercisable over a three year period commencing with the date of grant, while other stock options become exercisable three years after the date of grant. Stock options issued under the Directors Stock Plan are exercisable immediately. Exercise dates for stock options issued under the 2005 Directors Stock Plan will be determined at the time they are granted. A summary of the status of stock options issued pursuant to the Incentive Plans is presented below: Options Weighted Average Exercise Price Outstanding at January 1, 2003 *************************************** 16,259,630 Granted *********************************************************** 5,634,439 Exercised ********************************************************** (20,054) Cancelled/Expired*************************************************** (1,578,987) Outstanding at December 31, 2003 *********************************** 20,295,028 Granted *********************************************************** 5,074,206 Exercised ********************************************************** (1,464,865) Cancelled/Expired*************************************************** (642,268) Outstanding at December 31, 2004 *********************************** 23,262,101 Granted *********************************************************** 4,318,325 Exercised ********************************************************** (2,464,190) Cancelled/Expired*************************************************** (734,453) Outstanding at December 31, 2005 *********************************** 24,381,783 $30.10 $26.13 $30.02 $29.45 $29.05 $35.28 $29.70 $30.27 $30.33 $38.70 $29.68 $32.26 $31.83 The following table summarizes additional information about stock options outstanding at December 31, 2005: Options Exercisable 1,357,034 — — — 4,566,265 — — — 12,736,500 — — — 15,375,005 Weighted Average Exercise Price $30.01 $ — $ — $ — $30.15 $ — $ — $ — $29.57 $ — $ — $ — $29.85 Range of Exercise Prices $26.00 — $31.23********************************************** $31.24 — $37.33********************************************** $37.34 — $43.43********************************************** $43.44 — $49.53********************************************** $49.54 — $50.38********************************************** Number Outstanding at December 31, 2005 15,515,008 4,629,250 4,140,325 87,100 10,100 24,381,783 Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Number Exercisable at December 31, 2005 Weighted Average Exercise Price 5.93 8.12 9.23 9.63 9.87 $28.94 $35.22 $38.41 $48.15 $50.35 13,850,856 1,512,148 12,001 $29.26 $35.19 $38.00 — $ — — $ — 15,375,005 $29.85 MetLife, Inc. F-57 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Effective January 1, 2003, the Company elected to prospectively apply the fair value method of accounting for stock options granted by the Company subsequent to December 31, 2002. As permitted under SFAS 148, stock options granted prior to January 1, 2003 will continue to be accounted for under APB 25. Had compensation expense for grants awarded prior to January 1, 2003 been determined based on fair value at the date of grant in accordance with SFAS 123, the Company’s earnings and earnings per common share amounts would have been reduced to the following pro forma amounts: Years Ended December 31, 2005 2004 2003 (In millions, except per share data) Net income ********************************************************************************* $4,714 Preferred stock dividend *********************************************************************** 63 Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust(1) ***** — Net income available to common shareholders **************************************************** $4,651 $2,758 — — $2,217 — 21 $2,758 $2,196 Add: Stock option-based employee compensation expense included in reported net income, net of income taxes ************************************************************************************* $ 33 Deduct: Total stock option-based employee compensation determined under fair value based method for all awards, net of income taxes ***************************************************************** $ (35) Pro forma net income available to common shareholders(2) ***************************************** $4,649 $ $ 26 (44) $ $ 11 (40) $2,740 $2,167 Basic earnings per common share As reported ********************************************************************************* $ 6.21 $ 3.67 $ 2.97 Pro forma(2) ********************************************************************************* $ 6.21 $ 3.65 $ 2.93 Diluted earnings per common share As reported ********************************************************************************* $ 6.16 $ 3.65 $ 2.94 Pro forma(2) ********************************************************************************* $ 6.15 $ 3.63 $ 2.90 (1) See Note 10 for a discussion of this charge included in the calculation of net income available to common shareholders. (2) The pro forma earnings disclosures are not necessarily representative of the effects on net income and earnings per share in future years. Prior to January 1, 2005, the Black-Scholes model was used to determine the fair value of options granted as recognized in the ﬁnancial statements or as reported in the pro forma disclosure above. The fair value of stock options issued on or after January 1, 2005 was estimated on the date of grant using a binomial lattice model. The Company made this change because lattice models produce more accurate option values due to the ability to incorporate assumptions about employee exercise behavior resulting from changes in the price of the underlying shares. In addition, lattice models allow for changes in critical assumptions over the life of the option in comparison to closed-form models like Black-Scholes, which require single-value assumptions at the time of grant. The expected volatility used in the binomial lattice model is based on an analysis of historical prices of the Company’s common stock and options on the Company’s shares traded on the open market. The Company used a weighted-average of the implied volatility for traded call options with the longest remaining maturity nearest to the money as of each valuation date and the historical volatility, calculated using monthly share prices. The Company chose a monthly measurement interval for historical volatility as it believes this better depicts the nature of employee option exercise decisions being based on longer-term trends in the price of the Company’s shares rather than on daily price movements. The risk-free rate is based on observed interest rates for instruments with maturities similar to the expected term of the employee stock options. The Black-Scholes model requires a single spot rate, therefore the weighted-average of these rates for all grants in the year indicated is presented in the table below. The binomial lattice model allows for the use of different rates for different years. The table below presents the range of imputed forward rates for U.S. Treasury Strips that was input over the contractual term of the options. Dividend yield is determined based on historical dividend distributions compared to the price of the underlying shares as of the valuation date, adjusted for any expected future changes in the dividend rate. For options valued using the binomial lattice model during the year ended December 31, 2005, the dividend yield as of the measurement date was held constant throughout the life of the option. Use of the Black-Scholes model requires an input of the expected life of the options, or the average number of years before options will be exercised or expired. The Company estimated expected life using the historical average years to exercise or cancellation and average remaining years outstanding for vested options. Alternatively, the binomial model used by the Company incorporates the contractual term of the options and then considers expected exercise behavior and a post-vesting termination rate, or the rate at which vested options are exercised or expire prematurely due to termination of employment, to derive an expected life. Exercise behavior in the Company’s binomial lattice model is expressed using an exercise multiple, which reﬂects the ratio of exercise price to the strike price of options granted at which employees are expected to exercise. The exercise multiple is derived from actual historical exercise activity. F-58 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The following weighted-average assumptions, with the exception of risk-free rates used in 2005 which are expressed as a range, were used in the applicable option-pricing model to determine the fair value of stock options issued for the: Years Ended December 31, 2005 2004 2003 Dividend yield **************************************************************************** 1.20% 0.70% 0.68% Risk-free rate of return ********************************************************************* 3.33% - 4.70% 3.69% 5.07% Expected volatility ************************************************************************* 23.23% 34.85% 37.39% Expected life (years) *********************************************************************** Exercise multiple ************************************************************************** Post-vesting termination rate **************************************************************** Contractual term (years) ******************************************************************** 6 1.48% 5.19% 10 6 N/A N/A N/A 6 N/A N/A N/A Years Ended December 31, 2005 2004 2003 Weighted average fair value of options granted **************************************************** $10.09 $13.25 $10.41 The Company also awards long-term stock-based compensation to certain members of management. Under the LTPCP, awards are payable in their entirety at the end of a three-year performance period. Each participant was assigned a target compensation amount at the inception of the performance period with the ﬁnal compensation amount determined based on the total shareholder return on the Holding Company’s stock over the three-year performance period, subject to limited further adjustment approved by the Holding Company’s Board of Directors. Final awards may be paid in whole or in part with shares of the Holding Company’s stock, as approved by the Holding Company’s Board of Directors. Beginning in 2005, no further LTPCP target compensation amounts were set. Instead, certain members of management were awarded Performance Shares under the 2005 Stock Plan. Participants are awarded an initial target number of Performance Shares with the ﬁnal number of Performance Shares payable being determined by the product of the initial target multiplied by a factor of 0.0 to 2.0. The factor applied is based on measurements of the Holding Company’s performance with respect to (i) change in annual net operating earnings per share; and (ii) proportionate total shareholder return, as deﬁned, with reference to the three- year performance period relative to other companies in the Standard and Poor’s Insurance Index with reference to the same three-year period. Performance Share awards will normally vest in their entirety at the end of the three-year performance period (subject to certain contingencies) and will be payable entirely in shares of the Holding Company’s stock. On April 15, 2005, the Company granted 1,036,950 Performance Shares for which the total fair value on the date of grant was approximately $40 million. For the years ended December 31, 2005, 2004 and 2003, compensation expense related to the LTPCP and Performance Shares was $70 million, $49 million, and $45 million, respectively. For the years ended December 31, 2005, 2004 and 2003, the aggregate stock-based compensation expense related to the Incentive Plans was $120 million, $89 million and $63 million, respectively, including stock-based compensation for non-employees of $235 thousand, $468 thousand and $550 thousand, respectively. Statutory Equity and Income Each insurance company’s state of domicile imposes minimum risk-based capital requirements that were developed by the National Association of Insurance Commissioners (‘‘NAIC’’). The formulas for determining the amount of risk-based capital specify various weighting factors that are applied to ﬁnancial balances or various levels of activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of total adjusted capital, as deﬁned by the NAIC, to authorized control level risk-based capital, as deﬁned by the NAIC. Companies below speciﬁc trigger points or ratios are classiﬁed within certain levels, each of which requires speciﬁed corrective action. Each of the Holding Company’s U.S. insurance subsidiaries exceeded the minimum risk-based capital requirements for all periods presented herein. The NAIC adopted the Codiﬁcation of Statutory Accounting Principles (‘‘Codiﬁcation’’) in 2001. Codiﬁcation was intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. The New York State Department of Insurance has adopted Codiﬁcation with certain modiﬁcations for the preparation of statutory ﬁnancial statements of insurance companies domiciled in New York. Modiﬁcations by the various state insurance departments may impact the effect of Codiﬁcation on the statutory capital and surplus of the Holding Company’s insurance subsidiaries. Statutory accounting practices differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy beneﬁt liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt and valuing securities on a different basis. Statutory net income of Metropolitan Life, a New York domiciled insurer, was $2,155 million, $2,648 million and $2,169 million for the years ended December 31, 2005, 2004 and 2003, respectively. Statutory capital and surplus, as ﬁled with the New York State Department of Insurance, was $8,639 million and $8,804 million at December 31, 2005 and 2004, respectively. Statutory net income of TIC, a Connecticut domiciled insurer, from the date of purchase was $470 million for the six month period ended December 31, 2005. Statutory capital and surplus, as ﬁled with the Connecticut Insurance Department, was $4,081 million at December 31, 2005. Statutory net income of MPC, a Rhode Island domiciled insurer, was $289 million, $356 million and $329 million for the years ended December 31, 2005, 2004 and 2003, respectively. Statutory capital and surplus, as ﬁled with the Insurance Department of Rhode Island, was $1,783 million and $1,875 million at December 31, 2005 and 2004, respectively. Statutory net income of MTL (including MIAC), which was merged into MTL in 2004, as ﬁled with the Delaware Insurance Department, was $353 and $144 million for the years ended December 31, 2005 and 2004, respectively. Statutory net income of MIAC, as ﬁled with the Delaware Insurance Department, was $341 million for the year ended December 31, 2003. Statutory capital and surplus of MTL, as ﬁled, which includes MIAC, was $690 million and $1,195 million as of December 31, 2005 and 2004, respectively. MetLife, Inc. F-59 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Other Comprehensive Income The following table sets forth the reclassiﬁcation adjustments required for the years ended December 31, 2005, 2004 and 2003 in other comprehensive income (loss) that are included as part of net income for the current year that have been reported as a part of other comprehensive income (loss) in the current or prior year: Holding gains (losses) on investments arising during the year***************************************** $(3,329) Income tax effect of holding (losses) gains ******************************************************** 1,253 Reclassiﬁcation adjustments: $ 513 74 $1,528 (575) Years Ended December 31, 2005 2004 2003 (In millions) Recognized holding (gains) losses included in current year income ********************************** Amortization of premiums and accretion of discounts associated with investments ********************* Income tax effect *************************************************************************** Allocation of holding gains (losses) on investments relating to other policyholder amounts ***************** Income tax effect of allocation of holding gains (losses) to other policyholder amounts ******************** Unrealized investment gains of subsidiary at date of sale ******************************************** Deferred income taxes on unrealized investment gains of subsidiary at date of sale ********************** Net unrealized investment gains (losses) ********************************************************** Foreign currency translation adjustments arising during the year*************************************** Reclassiﬁcation adjustment for sale of investment in foreign operation ********************************** Foreign currency translation adjustment *********************************************************** (81) Minimum pension liability adjustment ************************************************************* 89 Other comprehensive income (losses) ************************************************************ $(1,044) 156 (199) 16 1,670 (629) 15 (5) (86) 5 (1,052) (218) (94) (45) (182) (26) — — 22 144 — 144 (2) 351 (168) (68) (606) 228 — — 690 177 — 177 (82) $ 164 $ 785 15. Other Expenses Other expenses were comprised of the following: Compensation****************************************************************************** $ 3,163 Commissions ****************************************************************************** 3,266 Interest and debt issue costs ***************************************************************** 659 Amortization of DAC and VOBA *************************************************************** 2,451 Capitalization of DAC ************************************************************************ (3,604) Rent, net of sublease income ***************************************************************** 296 Minority interest***************************************************************************** 154 Other ************************************************************************************* 2,882 Total other expenses ********************************************************************** $ 9,267 (In millions) $ 2,874 2,876 408 1,908 (3,101) 264 152 2,432 $ 2,707 2,473 478 1,820 (2,792) 254 110 2,118 $ 7,813 $ 7,168 Years Ended December 31, 2005 2004 2003 F-60 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 16. Earnings Per Common Share The following presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below: Weighted average common stock outstanding for basic earnings per common share Incremental shares from assumed: Conversion of forward purchase contracts *********************************** Exercise of stock options************************************************** Issuance under LTPCP**************************************************** Years Ended December 31, 2005 2004 2003 (In millions, except share and per share data) 749,022,816 750,924,982 738,597,047 — 6,139,695 173,845 — 4,053,813 — 8,293,269 68,111 — Weighted average common stock outstanding for diluted earnings per common share 755,336,356 754,978,795 746,958,427 Income from continuing operations *************************************** $ Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust(1) *************************************** Income from continuing operations per common share ******************** $ Basic ****************************************************************** $ Diluted ***************************************************************** $ Income from discontinued operations, net of income taxes, per common share****************************************************************** $ Basic ****************************************************************** $ Diluted ***************************************************************** $ Cumulative effect of a change in accounting, net of income taxes, per common share ******************************************************** $ Basic ****************************************************************** Diluted ***************************************************************** $ Net income available to common shareholders per common share ********* $ Basic ****************************************************************** $ Diluted ***************************************************************** $ 3,139 $ 2,637 $ 1,829 — 3,139 4.19 4.16 1,575 2.10 2.09 $ $ $ $ $ $ — $ — $ — $ 4,651 6.21 6.16 $ $ $ — 2,637 3.51 3.49 207 0.28 0.27 (86) (0.11) (0.11) 2,758 3.67 3.65 $ $ $ $ $ $ $ $ $ $ $ $ 21 1,808 2.45 2.42 414 0.56 0.55 (26) (0.04) (0.03) 2,196 2.97 2.94 (1) See Note 10 for a discussion of this charge included in the calculation of net income available to common shareholders. 17. Quarterly Results of Operations (Unaudited) The unaudited quarterly results of operations for 2005 and 2004 are summarized in the table below: Three Months Ended March 31, June 30, September 30, December 31, (In millions, except per share data) 2005 Total revenues ******************************************************************* $10,257 Total expenses ******************************************************************* $ 9,107 Income from continuing operations ************************************************** $ 800 Income from discontinued operations, net of income taxes ****************************** $ 187 Income before cumulative effect of a change in accounting, net of income taxes ************ $ 987 Net income available to common shareholders **************************************** $ 987 Basic earnings per share: Income from continuing operations, per common share ******************************* $ 1.09 Income from discontinued operations, net of income taxes, per common share *********** $ 0.25 Income before cumulative effect of a change in accounting, net of income taxes, per common share *************************************************************** $ 1.34 Net income available to common shareholders, per common share ********************* $ 1.34 Diluted earnings per share: Income from continuing operations, per common share ******************************* $ 1.08 Income from discontinued operations, net of income taxes, per common share *********** $ 0.25 Income before cumulative effect of a change in accounting, net of income taxes, per common share *************************************************************** $ 1.33 Net income available to common shareholders, per common share ********************* $ 1.33 $10,961 $ 9,500 $ 1,008 $ 1,237 $ 2,245 $ 2,245 $ 1.37 $ 1.68 $ 3.05 $ 3.05 $ 1.36 $ 1.66 $ 3.02 $ 3.02 $12,012 $11,027 739 $ 34 $ 773 $ 773 $ $ $ $ $ $ $ $ $ 0.97 0.04 1.02 0.98 0.96 0.04 1.01 0.97 MetLife, Inc. $11,546 $10,743 592 $ 117 $ 709 $ 709 $ $ $ $ $ $ $ $ $ 0.78 0.15 0.93 0.89 0.77 0.15 0.92 0.88 F-61 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Three Months Ended March 31, June 30, September 30, December 31, (In millions, except per share data) 2004 Total revenues ******************************************************************* $ 9,415 Total expenses ******************************************************************* $ 8,487 Income from continuing operations ************************************************** $ 638 Income from discontinued operations, net of income taxes ****************************** $ 46 Income before cumulative effect of a change in accounting, net of income taxes ************ $ 684 Net income available to common shareholders **************************************** $ 598 Basic earnings per share: Income from continuing operations, per common share ******************************* $ 0.84 Income from discontinued operations, net of income taxes, per common share *********** $ 0.06 Income before cumulative effect of a change in accounting, net of income taxes, per common share *************************************************************** $ 0.90 Net income available to common shareholders, per common share ********************* $ 0.79 Diluted earnings per share: Income from continuing operations, per common share ******************************* $ 0.84 Income from discontinued operations, net of income taxes, per common share *********** $ 0.06 Income before cumulative effect of a change in accounting, net of income taxes, per common share *************************************************************** $ 0.90 Net income available to common shareholders, per common share ********************* $ 0.79 $ 9,467 $ 8,402 828 $ 126 $ 954 $ 954 $ $ 1.10 $ 0.17 $ 1.26 $ 1.26 $ 1.09 $ 0.17 $ 1.26 $ 1.26 $ 9,972 $ 9,003 679 $ 16 $ 695 $ 695 $ $ $ $ $ $ $ $ $ 0.91 0.02 0.93 0.93 0.90 0.02 0.92 0.92 $ 9,950 $ 9,246 492 $ 19 $ 511 $ 511 $ $ $ $ $ $ $ $ $ 0.66 0.03 0.69 0.69 0.66 0.03 0.68 0.68 18. Business Segment Information The Company provides insurance and ﬁnancial services to customers in the United States, Asia Paciﬁc, Latin America, and Europe. The Company’s business is divided into ﬁve operating segments: Institutional, Individual, Auto & Home, International and Reinsurance, as well as Corporate & Other. These segments are managed separately because they either provide different products and services, require different strategies or have different technology requirements. As a part of the Travelers acquisition, management realigned certain products and services within several of the Company’s segments to better conform to the way it manages and assesses its business. Accordingly, all prior period segment results have been adjusted to reﬂect such product reclassiﬁcations. Also in connection with the Travelers acquisition, management has utilized its economic capital model to evaluate the deployment of capital based upon the unique and speciﬁc nature of the risks inherent in the Company’s existing and newly acquired businesses and has adjusted such allocations based upon this model. Economic Capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The Economic Capital model accounts for the unique and speciﬁc nature of the risks inherent in Metlife’s businesses. As a part of the economic capital process a portion of net investment income is credited to the segments based on the level of allocated equity. Institutional offers a broad range of group insurance and retirement & savings products and services, including group life insurance, non-medical health insurance, such as short and long-term disability, long-term care, and dental insurance, and other insurance products and services. Individual offers a wide variety of protection and asset accumulation products, including life insurance, annuities and mutual funds. Auto & Home provides personal lines property and casualty insurance, including private passenger automobile, homeowners and personal excess liability insurance. International provides life insurance, accident and health insurance, annuities and retirement & savings products to both individuals and groups. Through the Company’s majority-owned subsidiary, RGA, Reinsurance provides reinsurance of life and annuity policies in North America and various international markets. Additionally, reinsurance of critical illness policies is provided in select international markets. Corporate & Other contains the excess capital not allocated to the business segments, various start-up entities, including MetLife Bank and run-off entities, as well as interest expense related to the majority of the Company’s outstanding debt and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of all intersegment amounts, which generally relate to intersegment loans, which bear interest rates commensurate with related borrowings, as well as intersegment transactions. Additionally, the Company’s asset management business, including amounts reported as discontinued operations, is included in the results of operations for Corporate & Other. See Note 19 for disclosures regarding discontinued operations, including real estate. F-62 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Set forth in the tables below is certain ﬁnancial information with respect to the Company’s segments, as well as Corporate & Other, for the years ended December 31, 2005, 2004 and 2003. The accounting policies of the segments are the same as those of the Company, except for the method of capital allocation and the accounting for gains (losses) from intercompany sales, which are eliminated in consolidation. The Company allocates capital to each segment based upon the economic capital model that allows the Company to effectively manage its capital. The Company evaluates the performance of each operating segment based upon net income excluding net investment gains (losses), net of income taxes, adjustments related to net investment gains (losses), net of income taxes, the impact from the cumulative effect of changes in accounting, net of income taxes and discontinued operations, other than discontinued real estate, net of income taxes, less preferred stock dividends. Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting are included in net investment gains (losses). The Company allocates certain non-recurring items, such as expenses associated with certain legal proceedings, to Corporate & Other. For the Year Ended December 31, 2005 Institutional Individual Auto & Home International Reinsurance (In millions) Corporate & Other Total Premiums ************************************* $ 11,387 $ Universal life and investment-type product policy fees Net investment income ************************** Other revenues ******************************** Net investment gains (losses) ********************* Policyholder beneﬁts and claims ****************** Interest credited to policyholder account balances *** Policyholder dividends *************************** Other expenses ******************************** Income (loss) from continuing operations before 772 5,962 653 (10) 12,776 1,652 1 2,229 4,502 $2,911 — 2,476 181 6,535 33 477 (50) (12) 1,994 5,420 — 1,775 3 1,670 828 3,272 $ 2,186 579 844 20 5 2,128 278 5 1,000 $ 3,869 — 606 58 22 3,206 220 — 991 $ 5 1 782 30 (48) (18) — — 947 $ 24,860 3,828 14,910 1,271 (93) 25,506 3,925 1,679 9,267 provision (beneﬁt) for income taxes ************** Income from discontinued operations, net of income taxes *************************************** Cumulative effect of a change in accounting, net of income taxes ******************************** Net income************************************ Total assets *********************************** DAC and VOBA ******************************** Goodwill ************************************** Separate account assets ************************ Policyholder liabilities **************************** Separate account liabilities *********************** For the Year Ended December 31, 2004 2,106 1,803 288 223 138 (159) 4,399 162 295 — 5 — 1,113 1,575 — 1,562 176,401 1,259 959 45,239 105,998 45,239 — 1,503 228,325 13,540 2,903 81,070 120,031 81,070 Institutional Individual — 224 5,397 186 157 — 3,490 — Auto & Home — 192 18,624 1,841 288 1,546 13,260 1,546 — 92 16,049 2,815 96 14 11,751 14 — 1,141 36,849 — 394 — 4,714 481,645 19,641 4,797 — 127,869 262,371 — 127,869 7,841 International Reinsurance (In millions) Corporate & Other Total Premiums ************************************* $ 10,037 $ Universal life and investment-type product policy fees Net investment income ************************** Other revenues ******************************** Net investment gains (losses) ********************* Policyholder beneﬁts and claims ****************** Interest credited to policyholder account balances *** Policyholder dividends *************************** Other expenses ******************************** Income (loss) from continuing operations before 711 4,582 654 163 11,173 1,016 — 1,972 4,204 $2,948 — 1,805 171 6,031 35 422 91 (9) 2,079 5,107 — 1,618 2 1,657 795 2,879 $ 1,690 349 585 23 23 1,611 151 6 614 provision (beneﬁt) for income taxes ************** 1,986 1,292 269 288 Income from discontinued operations, net of income taxes *************************************** Cumulative effect of a change in accounting, net of income taxes ******************************** Net income************************************ Total assets *********************************** DAC and VOBA ******************************** Goodwill ************************************** Separate account assets ************************ Policyholder liabilities **************************** Separate account liabilities *********************** 19 21 — (9) (60) 1,267 133,441 997 64 40,462 72,967 40,462 — 885 170,554 9,297 200 45,384 100,332 45,384 — 208 6,410 185 157 — 3,180 — (30) 163 13,838 1,278 92 923 8,001 923 $ 3,348 — 538 56 59 2,694 212 1 957 137 — — 91 15,214 2,567 96 14 10,464 14 $ (27) 2 457 8 (152) (2) — — 596 $ 22,200 2,867 12,364 1,198 175 22,662 2,997 1,666 7,813 (306) 3,666 176 207 4 144 17,351 3 24 (14) 1,848 (14) (86) 2,758 356,808 14,327 633 86,769 196,792 86,769 MetLife, Inc. F-63 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. For the Year Ended December 31, 2003 Premiums **************************************** Universal life and investment-type product policy fees *** Net investment income***************************** Other revenues *********************************** Net investment gains (losses) *********************** Policyholder beneﬁts and claims ************************************* Interest credited to policyholder********************** account balances ******************************* Policyholder dividends ***************************** Other expenses*********************************** Income (loss) from continuing operations before provision (beneﬁt) for income taxes ************************* Income from discontinued operations, net of income taxes****************************************** Cumulative effect of a change in accounting, net of Institutional Individual Auto & Home International Reinsurance (In millions) Corporate & Other Total $ 9,063 660 4,146 618 (289) $4,363 1,564 6,069 380 (311) $2,908 — 158 33 (15) $1,631 271 500 80 8 $2,648 — 431 47 62 10,023 5,048 2,139 1,456 2,109 974 (1) 1,854 1,734 1,721 2,783 1,348 779 49 51 — 2 756 187 — 143 9 652 230 (5) 184 — 764 131 — $ (38) — 168 41 (6) 36 — — 359 $20,575 2,495 11,472 1,199 (551) 20,811 . 3,035 1,731 7,168 (230) 2,445 319 414 income taxes *********************************** Net income ************************************** Net investment income and net investment gains (losses) are based upon the actual results of each segment’s speciﬁcally identiﬁable asset portfolio adjusted for allocated capital. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing. Revenues derived from any customer did not exceed 10% of consolidated revenues. Revenues from U.S. operations were $39,571 million, $34,894 million and $31,759 million for the years ended December 31, 2005, 2004 and 2003, respectively, which represented 88%, 90% and 90%, respectively, of consolidated revenues. (26) 2,217 (26) 886 — 208 — 157 — 310 — 570 — 86 19. Discontinued Operations Real Estate The Company actively manages its real estate portfolio with the objective of maximizing earnings through selective acquisitions and dispositions. Income related to real estate classiﬁed as held-for-sale or sold is presented in discontinued operations. These assets are carried at the lower of depreciated cost or fair value less expected disposition costs. The following table presents the components of income from discontinued real estate operations: Investment income ****************************************************************************** $ 140 Investment expense ***************************************************************************** (82) Net investment gains **************************************************************************** 2,125 Total revenues ******************************************************************************* Interest expense ******************************************************************************** Provision for income taxes *********************************************************************** 2,183 — 776 Income from discontinued operations, net of income taxes ****************************************** $1,407 $ 409 (240) 146 $ 491 (279) 420 315 13 105 632 4 230 $ 197 $ 398 There was no carrying value of real estate related to discontinued operations at December 31, 2005. The carrying value of real estate related to discontinued operations was $1,157 million at December 31, 2004. Years Ended December 31, 2005 2004 2003 (In millions) F-64 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The following table shows the discontinued real estate operations by segment: Years Ended December 31, 2005 2004 2003 (In millions) Net investment income Institutional *********************************************************************************** $ Individual ************************************************************************************* Corporate & Other ***************************************************************************** Total net investment income ******************************************************************* $ 11 17 30 58 Net investment gains (losses) Institutional *********************************************************************************** $ 242 Individual ************************************************************************************* 443 Corporate & Other ***************************************************************************** 1,440 Total net investment gains (losses)************************************************************** $2,125 $ 21 26 122 $169 $ 9 3 134 $146 $ 31 39 142 $212 $ 45 43 332 $420 Interest Expense Individual ************************************************************************************* $ — $ — $ 1 Corporate & Other ***************************************************************************** 3 13 Total interest expense ************************************************************************ $ — $ 13 $ 4 — In the second quarter of 2005, the Company sold its One Madison Avenue and 200 Park Avenue properties in Manhattan, New York for $918 million and $1.72 billion, respectively, resulting in gains, net of income taxes, of $431 million and $762 million, respectively. The gains are included in income from discontinued operations in the accompanying consolidated statements of income. In connection with the sale of the 200 Park Avenue property, the Company has retained rights to existing signage and is leasing space for associates in the property for 20 years with optional renewal periods through 2205. In 2004, the Company sold one of its real estate investments, Sears Tower, resulting in a realized gain of $85 million, net of income taxes. Operations On September 29, 2005, the Company completed the sale of MetLife Indonesia to a third party resulting in a gain upon disposal of $10 million, net of income taxes. As a result of this sale, the Company recognized income from discontinued operations of $5 million, net of income taxes, for the year ended December 31, 2005. The Company reclassiﬁed the assets, liabilities and operations of MetLife Indonesia into discontinued operations for all periods presented. The following tables present the amounts related to the operations and ﬁnancial position of MetLife Indonesia that has been combined with the discontinued real estate operations in the consolidated income statements: Years Ended December 31, 2005 2004 2003 (In millions) Revenues from discontinued operations ****************************************************************** Expenses from discontinued operations ****************************************************************** Income from discontinued operations before provision for income taxes *************************************** (5) Provision for income taxes ***************************************************************************** — $ 5 10 Loss from discontinued operations, net of income taxes ************************************************** Net investment gain, net of income taxes ***************************************************************** Income (loss) from discontinued operations, net of income taxes ******************************************* (5) 10 $ 5 $ 5 14 (9) — (9) — $ 4 9 (5) — (5) — $(9) $(5) December 31, 2004 (In millions) Fixed maturities ********************************************************************************************* Short-term investments *************************************************************************************** Cash and cash equivalents *********************************************************************************** Deferred policy acquisition costs ******************************************************************************* Premiums and other receivables ******************************************************************************* Total assets held-for-sale *********************************************************************************** Future policy beneﬁts **************************************************************************************** Policyholder account balances********************************************************************************* Other policyholder funds************************************************************************************** Other liabilities ********************************************************************************************** Total liabilities held-for-sale ********************************************************************************** $17 1 3 9 1 $31 $ 5 12 7 4 $28 MetLife, Inc. F-65 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. On January 31, 2005, the Company completed the sale of SSRM to a third party for $328 million in cash and stock. As a result of the sale of SSRM, the Company recognized income from discontinued operations of approximately $157 million, net of income taxes, comprised of a realized gain of $165 million, net of income taxes, and an operating expense related to a lease abandonment of $8 million, net of income taxes. Under the terms of the sale agreement, MetLife will have an opportunity to receive, prior to the end of 2006, additional payments aggregating up to approximately 25% of the base purchase price, based on, among other things, certain revenue retention and growth measures. The purchase price is also subject to reduction over ﬁve years, depending on retention of certain MetLife-related business. Also under the terms of such agreement, MetLife had the opportunity to receive additional consideration for the retention of certain customers for a speciﬁc period in 2005. In the fourth quarter of 2005, upon ﬁnalization of the computation, the Company received a payment of $12 million, net of income taxes, due to the retention of these speciﬁc customer accounts. The Company reclassiﬁed the assets, liabilities and operations of SSRM into discontinued operations for all periods presented. Additionally, the sale of SSRM resulted in the elimination of the Company’s Asset Management segment. The remaining asset management business, which is insigniﬁcant, has been reclassiﬁed into Corporate & Other. The Company’s discontinued operations for the year ended December 31, 2005 also includes expenses of approximately $6 million, net of income taxes, related to the sale of SSRM. The operations of SSRM include afﬁliated revenues of $5 million, $59 million and $54 million for the years ended December 31, 2005, 2004 and 2003, respectively, related to asset management services provided by SSRM to the Company that have not been eliminated from discontinued operations as these transactions continue after the sale of SSRM. The following tables present the amounts related to operations and ﬁnancial position of SSRM that have been combined with the discontinued real estate operations in the consolidated income statements: Years Ended December 31, 2005 2004 2003 (In millions) Revenues from discontinued operations *************************************************************** $ 19 Expenses from discontinued operations *************************************************************** 38 Income from discontinued operations before provision for income taxes ************************************ Provision for income taxes ************************************************************************** Income (loss) from discontinued operations, net of income taxes **************************************** Net investment gains, net of income taxes ************************************************************ (14) 177 Income from discontinued operations, net of income taxes ********************************************* $163 (19) (5) $328 296 $231 197 32 13 19 — 34 13 21 — $ 19 $ 21 December 31, 2004 (In millions) Equity securities ********************************************************************************************* Real estate and real estate joint ventures ************************************************************************ Short-term investments *************************************************************************************** Other invested assets **************************************************************************************** Cash and cash equivalents *********************************************************************************** Premiums and other receivables ******************************************************************************* Other assets *********************************************************************************************** Total assets held-for-sale *********************************************************************************** Short-term debt ********************************************************************************************* Current income taxes payable ********************************************************************************* Deferred income taxes payable ******************************************************************************** Other liabilities ********************************************************************************************** Total liabilities held-for-sale ********************************************************************************** $ 49 96 33 20 55 38 88 $379 $ 19 1 1 219 $240 20. Fair Value Information The estimated fair values of ﬁnancial instruments have been determined by using available market information and the valuation methodologies described below. Considerable judgment is often required in interpreting market data to develop estimates of fair value. Accordingly, the estimates presented herein may not necessarily be indicative of amounts that could be realized in a current market exchange. The use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. F-66 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Amounts related to the Company’s ﬁnancial instruments were as follows: December 31, 2005 Assets: Notional Amount Carrying Value Estimated Fair Value (In millions) Fixed maturities ************************************************************************ Trading securities ********************************************************************** Equity securities *********************************************************************** Mortgage and consumer loans *********************************************************** Policy loans *************************************************************************** Short-term investments ***************************************************************** Cash and cash equivalents ************************************************************** Mortgage loan commitments************************************************************* $2,974 Commitments to fund partnership investments ********************************************** $2,684 Liabilities: Policyholder account balances *********************************************************** Short-term debt *********************************************************************** Long-term debt************************************************************************ Junior subordinated debt securities underlying common equity units**************************** Shares subject to mandatory redemption ************************************************** Payables for collateral under securities loaned and other transactions*************************** $230,050 825 $ 3,338 $ $ 37,190 9,981 $ 3,306 $ $ 4,018 $ $ $230,050 825 $ 3,338 $ $ 37,820 9,981 $ 3,306 $ 4,018 $ (4) — $ — — $ $109,694 1,414 $ 9,888 $ 2,134 $ $ 278 $ 34,515 $107,083 $ 1,414 $ 10,296 2,098 $ $ 362 $ 34,515 December 31, 2004 Assets: Notional Amount Carrying Value Estimated Fair Value (In millions) Fixed maturities ************************************************************************ Equity securities *********************************************************************** Mortgage and consumer loans *********************************************************** Policy loans *************************************************************************** Short-term investments ***************************************************************** Cash and cash equivalents ************************************************************** Mortgage loan commitments************************************************************* $1,189 Commitments to fund partnership investments ********************************************** $1,324 Liabilities: Policyholder account balances *********************************************************** Short-term debt *********************************************************************** Long-term debt************************************************************************ Shares subject to mandatory redemption ************************************************** Payables for collateral under securities loaned and other transactions*************************** The methods and assumptions used to estimate the fair values of ﬁnancial instruments are summarized as follows: $176,377 $ 2,188 $ 32,406 8,899 $ 2,662 $ $ 4,048 $ $ $176,377 $ 2,188 $ 33,902 8,899 $ 2,662 $ 4,048 $ 4 — $ — — $ $ 70,739 1,445 $ 7,412 $ 278 $ $ 28,678 $ 69,790 1,445 $ 7,835 $ 361 $ $ 28,678 Fixed Maturities, Trading Securities and Equity Securities The fair value of ﬁxed maturities, trading securities and equity securities are based upon quotations published by applicable stock exchanges or received from other reliable sources. For securities for which the market values were not readily available, fair values were estimated using quoted market prices of comparable investments. Mortgage and Consumer Loans, Mortgage Loan Commitments and Commitments to Fund Partnership Investments Fair values for mortgage and consumer loans are estimated by discounting expected future cash ﬂows, using current interest rates for similar loans with similar credit risk. For mortgage loan commitments, the estimated fair value is the net premium or discount of the commitments. Commitments to fund partnership investments have no stated interest rate and are assumed to have a fair value of zero. Policy Loans The carrying values for policy loans approximate fair value. Cash and Cash Equivalents and Short-term Investments The carrying values for cash and cash equivalents and short-term investments approximated fair values due to the short-term maturities of these instruments. Policyholder Account Balances The fair value of policyholder account balances which have ﬁnal contractual maturities are estimated by discounting expected future cash ﬂows based upon interest rates currently being offered for similar contracts with maturities consistent with those remaining for the agreements being valued. The fair value of policyholder account balances without ﬁnal contractual maturities are assumed to equal their current net surrender. Short-term and Long-term Debt, Payables for Collateral Under Securities Loaned and Other Transactions and Shares Subject to Mandatory Redemption The fair values of short-term and long-term debt, payables under securities loaned transactions and shares subject to mandatory redemption are determined by discounting expected future cash ﬂows using risk rates currently available for debt with similar terms and remaining maturities. MetLife, Inc. F-67 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Derivative Financial Instruments The fair value of derivative instruments, including ﬁnancial futures, ﬁnancial forwards, interest rate, credit default and foreign currency swaps, foreign currency forwards, caps, ﬂoors, and options are based upon quotations obtained from dealers or other reliable sources. See Note 4 for derivative fair value disclosures. 21. Subsequent Events On February 21, 2006, the Holding Company’s board of directors declared dividends of $0.3432031 per share, for a total of $9 million, on its Series A preferred shares, and $0.4062500 per share, for a total of $24 million, on its Series B preferred shares, subject to the ﬁnal conﬁrmation that it has met the ﬁnancial tests speciﬁed in the Series A and Series B preferred shares, which the Holding Company anticipates will be made on or about March 5, 2006, the earliest date permitted in accordance with the terms of the securities. Both dividends will be payable March 15, 2006 to shareholders of record as of February 28, 2006. F-68 MetLife, Inc. BOARD OF DIRECTORS JOHN M. KEANE General, United States Army (Retired) Co-Founder and Senior Managing Director, Keane Advisors, LLC Member, Audit Committee, Governance Committee and Sales Practices Compliance Committee HUGH B. PRICE Senior Fellow, The Brookings Institution Former Senior Advisor, DLA Piper Rudnick Gray Cary US LLP Chair, Public Responsibility Committee Member, Audit Committee and Sales Practices Compliance Committee JAMES M. KILTS Vice Chairman of the Board, The Procter & Gamble Company Member, Compensation Committee, Governance Committee and Sales Practices Compensation Committee and Compliance Committee KENTON J. SICCHITANO Retired Global Managing Partner, PricewaterhouseCoopers LLP Member, Audit Committee, Sales Practices Compliance Committee CHARLES M. LEIGHTON Executive Director, US SAILING WILLIAM C. STEERE, JR. Chair, Sales Practices Compliance Committee Member, Compensation Committee and Executive Committee Retired Chairman of the Board and Chief Executive Ofﬁcer, Pﬁzer Inc. Chair, Compensation Committee Member, Audit Committee, Governance Committee and Sales Practices Compliance Committee SYLVIA M. MATHEWS Chief Operating Ofﬁcer and Executive Director, The Bill and Melinda Gates Foundation Member, Governance Committee and Public Responsibility Committee EXECUTIVE OFFICERS ROBERT H. BENMOSCHE Chairman of the Board C. ROBERT HENRIKSON President and Chief Executive Ofﬁcer STEVEN A. KANDARIAN Executive Vice President and Chief Investment Ofﬁcer LELAND C. LAUNER, JR. President, Institutional Business JAMES L. LIPSCOMB Executive Vice President and General Counsel CATHERINE A. REIN Senior Executive Vice President and Chief Administrative Ofﬁcer WILLIAM J. TOPPETA President, International LISA M. WEBER President, Individual Business WILLIAM J. WHEELER Executive Vice President and Chief Financial Ofﬁcer ROBERT H. BENMOSCHE1 Chairman of the Board, MetLife, Inc. Chair, Executive Committee C. ROBERT HENRIKSON2 President and Chief Executive Ofﬁcer, MetLife, Inc. Member, Executive Committee and Public Responsibility Committee CURTIS H. BARNETTE Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP Chair, Investment Committee of Metropolitan Life Insurance Company Member, Public Responsibility Committee BURTON A. DOLE, JR. Former Partner and Chief Executive Ofﬁcer, MedSouth Therapies, LLC Member, Audit Committee and Public Responsibility Committee CHERYL W. GRIS ´E President, Utility Group of Northeast Utilities, and Chief Executive Ofﬁcer of its principal operating subsidiaries Member, Compensation Committee, Governance Committee and Sales Practices Compliance Committee JAMES R. HOUGHTON Chairman of the Board, Corning Incorporated Chair, Audit Committee Member, Compensation Committee, Executive Committee and Governance Committee HARRY P. KAMEN Retired Chairman of the Board and Chief Executive Ofﬁcer, Metropolitan Life Insurance Company Member, Executive Committee and Governance Committee HELENE L. KAPLAN Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP Chair, Governance Committee Member, Executive Committee and Public Responsibility Committee 1 On December 1, 2005, MetLife, Inc. announced that Mr. Benmosche will retire as Chairman of the Board on April 25, 2006, following MetLife, Inc.’s Annual Shareholders Meeting. Mr. Benmosche will relinquish his corresponding role with Metropolitan Life at such time. 2 Mr. Henrikson has been elected by the Board of Directors to become Chairman of the Board on April 25, 2006. 60 MetLife, Inc. CORPORATE INFORMATION Corporate Proﬁle MetLife, Inc. is a leading provider of insurance and other ﬁnancial services to millions of individual and institutional customers throughout the United States. Through its subsidiaries and afﬁliates, MetLife, Inc. offers life insurance, annuities, automobile and homeowners insurance and retail banking services to individuals, as well as group insurance, reinsurance and retirement & savings products and services to corporations and other institutions. Outside the United States, the MetLife companies have direct insurance operations in Asia Paciﬁc, Latin America and Europe. For more visit www.metlife.com. information, please Corporate Headquarters MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 212-578-2211 Internet Address http://www.metlife.com Form 10-K and Other Information MetLife, Inc. will provide to shareholders without charge, upon written or oral request, a copy of MetLife, Inc.’s Annual Report on Form 10-K (including ﬁnancial statements and ﬁnancial statement schedules, but without exhibits) for the ﬁscal year ended December 31, 2005. MetLife, Inc. will furnish to requesting shareholders any exhibit to the Form 10-K upon the payment of reasonable expenses incurred by MetLife, Inc. in furnishing such exhibit. Requests should be directed to MetLife Investor Relations, MetLife, Inc., One MetLife Plaza, 27-01 Queens Plaza North, Long Island City, New York 11101-4007, via the Internet by going to http://ir.metlife.com and selecting ‘‘Information Requests,’’ or by calling 1-800-649-3593. The Annual Report on Form 10-K may also be accessed at http://ir.metlife.com and at the website of the U.S. Securities and Exchange Commission at http://www.sec.gov. Transfer Agent/Shareholder Records For information or assistance regarding shareholder accounts or dividend checks, please contact MetLife’s transfer agent: Mellon Investor Services, LLC P.O. Box 4410 South Hackensack, NJ 07606-2010 1-800-649-3593 TDD for Hearing Impaired: 201-680-6611 www.melloninvestor.com Trustee, MetLife Policyholder Trust Wilmington Trust Company Rodney Square North 1100 North Market Street Wilmington, DE 19890 302-651-1000 www.wilmingtontrust.com Printed on recycled paper with environmentally friendly inks in the USA. PEANUTS © United Feature Syndicate, Inc. www.snoopy.com Investor Information http://ir.metlife.com Governance Information http://www.metlife.com/corporategovernance MetLife News http://metnews.metlife.com Common Stock and Dividend Information MetLife, Inc.’s common stock is traded on the New York Stock Exchange (NYSE) under the trading symbol ‘‘MET.’’ The following table presents the high and low closing prices for the common stock of MetLife, Inc. on the NYSE for the periods indicated. MetLife, Inc. declared an annual dividend of $0.52 per common share on October 25, 2005 and $0.46 per common share on September 28, 2004. Future common stock dividend decisions will be determined by MetLife, Inc.’s Board of Directors after taking into consideration factors such as MetLife, Inc.’s current earnings, expected medium- and long- term earnings, ﬁnancial condition, regulatory capital position, and applicable governmental regulations and policies. Furthermore, the payment of dividends and other distributions to MetLife, Inc. by its insurance subsidiaries is regulated by insurance laws and regulations. See ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Holding Company — Liquidity Sources — Dividends’’ and Note 14 of Notes to Consolidated Financial Statements. 2005 First quarter Second quarter Third quarter Fourth quarter 2004 First quarter Second quarter Third quarter Fourth quarter Common Stock Price High $41.37 $45.45 $50.20 $52.15 Low $38.31 $37.85 $45.47 $46.80 Common Stock Price High $35.87 $36.66 $38.73 $41.18 Low $32.63 $33.21 $33.97 $33.98 As of February 24, 2006, there were approximately 5.6 million beneﬁcial common shareholders of MetLife, Inc. At December 31, 2005, the Company employed approximately 65,500 employees. CEO and CFO Certiﬁcations The CEO Certiﬁcation required by Section 303A.12(a) of the New York Stock Exchange Listed Company Manual was submitted to the NYSE in 2005. MetLife, Inc. has ﬁled the CEO and CFO Certiﬁcations required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 as exhibits to its Annual Report on Form 10-K for the year ended December 31, 2005. MetLife, Inc. 61 © 2006 METLIFE, INC. 0511-9421 PEANUTS © United Feature Syndicate, Inc. MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 www.metlife.com

Continue reading text version or see original annual report in PDF format above